Page last updated: 2024-09-27

Epilepsy

A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)

Synonyms(1)

Synonym
Epilepsy

Research Excerpts

Overview

ExcerptReference
"Epilepsy is a common disorder affecting approximately one in every two hundred people, from all walks of life, and presenting in addition to the seizure disorder itself, varying social, psychological and economic problems."( Gilligan, B, 1976)
"Epilepsy is a chronic disease that requires long term therapy, and most of the established antiepileptic drugs (the exception is phenobarbital) must be administered several times daily."( Bialer, M, 1992)
"Pregnant women with epilepsy are at increased risk of seizures and complications."( Yerby, MS, 1992)
"Epilepsy is a state of neuronal hyperactivity which may be caused by an altered relationship between inhibitory and excitatory influences on neurons."( Craig, CR; Fleming, WW; Gould, EM; Taylor, DA, 1991)
"The grave course of epilepsy is associated with a decrease of the LCBF on the side of the focus."( Shestakov, VV; Shutov, AA, 1990)
"Primary reading epilepsy is a rare form of reflex epilepsy, in which reading is the specific stimulus evoking attacks."( Castro, LH; Grossmann, RM; Marques-Assis, L; Yacubian, EM, 1990)
"Recently epilepsy is analysed on terms of two different conditions, seizure susceptibility and seizure induction."( Eguchi, T; Enoki, Y; Hirabayashi, H; Nakase, H; Sakaki, T; Tada, T, 1990)
"Epilepsy is the most common presentation, but it has many other variable forms of neurological manifestations."( Collignon, PJ; Crimmins, D; Danta, G; Dwyer, D, 1990)
"Epilepsy is not a benign condition."( Treiman, DM, 1989)
"Epilepsy is an ancient disorder which treatment over the centuries has been guided by preconceptions regarding its origin."( van Gelder, NM, 1987)
"Eating epilepsy is predominantly a disorder of young adults, and the triggering mechanisms are extremely complex and elaborate."( Ahuja, GK; Behari, M; Pauranik, A; Prasad, K, 1988)
"Whether epilepsy is the result of oxygen deficiency alone or is due to the combined effect of hypoxia and ischemia is not known."( Albala, BJ; Moshé, SL, 1985)
"Only when the epilepsy is uncontrolled despite high plasma concentrations which cannot be raised because of side effects, a second drug should be given."( Schmidt, D, 1983)
"Since epilepsy is a long-standing condition lasting for years to decades, short-spanned cross-sectional observations are often misleading."( Kakegawa, N; Seino, M, 1982)
""Old" cases of epilepsy are significantly more resistant to clonazepam medication."( Bacia, T; Okuszko, S; Purska-Rowińska, E, 1980)
"Reading epilepsy is rare."( Miyamoto, A; Oki, J; Takahashi, S; Tokumitsu, A, 1995)
"Temporal lobe epilepsy is associated with neuronal death, gliosis and sprouting of mossy fibres in the hippocampus of human and rats."( Ben-Ari, Y; Faissner, A; Jorquera, I; Niquet, J; Represa, A, 1995)
"Epilepsy is one of the most common neurological disorders."( Patsalos, PN; Sander, JW, 1994)
"Epilepsy is a major cause of morbidity and accounted for up to 40% of psychiatric outpatient attendances in the experience of the author in Transkei, South Africa."( Ovuga, EB, 1994)
"Once epilepsy is diagnosed, long-term treatment with AEDs is recommended, beginning with monotherapy."( Pellock, JM, 1994)
"Epilepsy is a disorder of the central nervous system in which the clinical symptoms are recurrent seizures."( Graves, NM; Leppik, IE, 1993)
"Epilepsy is the most common neurological disease of females in reproductive age."( Leppert, D; Wieser, HG, 1993)
"Epilepsy is the most common neurological disease of women of reproductive age."( Leppert, D; Wieser, HG, 1993)
"Epilepsy is by far the most prevalent serious neurologic condition."( Shorvon, SD, 1996)
"Epilepsy is common in individuals who are mentally retarded and/or otherwise multiply handicapped."( Mattson, RH, 1996)
"Epilepsy is a common condition with a prevalence of just 1% in a given population."( Korczyn, AD; Neufeld, MY, 1996)
"Epilepsy is a common condition in people with learning disabilities with many patients continuing to suffer from seizures despite antiepileptic drug (AED) treatment."( Bhaumik, S; Branford, D; Duggirala, C; Ismail, IA, 1997)
"The results suggest epilepsy is highly prevalent in this population of children and that further research is needed into its cause."( Bhakta, P; Hackett, L; Hackett, RJ, 1997)
"Epilepsy is a relatively common problem in children, adults and the elderly."( Haller, JS; Kennedy, BT, 1998)
"Epilepsy is a common and often neglected illness in developing countries requiring a conscious effort by health workers, especially at community level, to enhance access to regular treatment and to motivate patients to continue treatment."( Kok, P, 1998)
"Chronic epilepsy is associated with increased excitability which may result from abnormal glutamatergic synaptic transmission involving altered properties of N-methyl-D-aspartate (NMDA) receptors."( Ben-Ari, Y; Khrestchatisky, M; Rafiki, A; Represa, A, 1998)
"Epilepsy is the most important neurological problem in developing countries, with a total of 50 million people worldwide having the condition."( Das, T; Pal, DK; Sengupta, S, 1998)
"Digestive epilepsy is a rare disease, poorly recognized by gastroenterologists."( Mendler, MH; Pillegand, B; Ravon, R; Sautereau, D, 1998)
"Epilepsy is a disorder of recurrent seizures that are neural in origin."( March, PA, 1998)
"Idiopathic epilepsy is one of the most common and treatable neurologic diseases of small animals."( Knowles, K, 1998)
"Epilepsy is a common neurologic condition in women of reproductive age."( Zahn, C, 1998)
"Epilepsy is a common disorder, the prevalence of which is estimated at between 0."( Champagne, F; Contandriopoulos, AP; Kennedy, W; Reinharz, D; Tessier, G, 1995)
"Hot water epilepsy is a benign epilepsy."( Badinant-Hubert, N; Cheliout-Heraut, F; Fohlen, M; Ioos, C; Jalin, C; Pinard, JM; Villeneuve, N, 1999)
"Reading epilepsy is an uncommon epileptic syndrome preferentially related to the temporoparietal region of the language dominant hemisphere."( Aras, G; Ibis, E; Küçük, NO; Mutluer, N; Sener, HO; Yiğit, A, 1999)
"Epilepsy is a complex, common disorder with severe consequences for patients."( Bjork, R; Cooper, JL; Dasheiff, RM; Dick, MT; Glaze, D; Haffar, AY; Johnson, L; Kerasidis, H; Luzecky, MH; Murthy, K; Santiago, A; Stergis, G; Thompson, JM, 1999)
"Since epilepsy is assumed to be a disease syndrome which is probably manifested by abnormal expression of multifocal genes, determination of the role of each chromosomal locus in the provocation of seizure activity is important."( Jin, W; Kajiwara, K; Maruyama, C; Naramoto, F; Ohguchi, H; Sugaya, A; Sugaya, E; Tsuda, T; Wakana, S; Yokote, N, 2000)
"The course of epilepsy is more difficult to predict, but failure to respond to the first AED is worrisome."( Datta, AN; Wirrell, EC, 2000)
"Limbic epilepsy is a chronic condition associated with a broad zone of seizure onset and pathology."( Bertram, EH; Mangan, PS; Scott, CA; Williamson, JM, 2000)
"Although epilepsy is fundamentally a circuit phenomenon, the most basic manifestation of the hyperexcitability characteristic of epilepsy must be evident at the level of a single neuron."( Coulter, DA, 2001)
"Cost of epilepsy care has escalated many folds in the recent past."( Thomas, SV, 2000)
"Epilepsy is the most common serious neurological disorder and is one of the world's most prevalent noncommunicable diseases."( Lhatoo, SD; Sander, JW; Scott, RA, 2001)
"Epilepsy is a common neurologic condition."( Huff, NA; Kalis, MM, 2001)
"Catamenial epilepsy is a condition characterized by an increase in seizures during particular phases of the menstrual cycle."( Foldvary, N; Lee, J; Lim, LL; Mascha, E, 2001)
"Epilepsy is associated with excess mortality of two to three times in developed countries."( Reghunath, B; Sankara Sarma, P; Thomas, SV, 2001)
"Epilepsy care in developing countries is lagging behind than in the developed countries."( Alexander, M; Pandit, L; Sarma, PS; Shekhar, L; Thomas, SV; Trivedi, C; Vengamma, B, 2001)
"The services for epilepsy are urban-based and there is underutilization of services, general practitioners and specialists."( Alexander, M; Pandit, L; Sarma, PS; Shekhar, L; Thomas, SV; Trivedi, C; Vengamma, B, 2001)
"Epilepsy is a major public health threat in the developing world, with much higher prevalence and incidence rates than those observed in developed countries."( Cohen, H; Snyder, PJ, 2001)
"Epilepsy is one of the most prevalent neurologic disorders and affects approximately 1% of the population."( Borbély, K, 2001)
"Epilepsy is a common neurologic disorder, and antiepileptic drugs (AEDs) are the mainstays of therapy."( Biederman, TS; McAuley, JW; Moore, JL; Smith, JC, 2002)
"Epilepsy is the most common neurological feature, occurring in 96% of patients."( Bombardieri, R; Curatolo, P; Verdecchia, M, 2002)
"Many forms of epilepsy are intractable to current therapies and there is a pressing need to develop agents and strategies to not only suppress seizures, but also cure epilepsy."( Jones, OT, 2002)
"Epilepsy is a public health problem in Africa due to prevalence and social exclusion."( Desplats, D; Doumbo, O; Farnarier, G; Nimaga, K, 2002)
"Hot water epilepsy is unique in South India and single solitary ring enhancing lesion in brain imaging is a common feature in Indian subcontinent."( Bhattacharya, S; Das, SK; Kundu, TN; Ray, BK; Saha, SP, 2002)
"Epilepsy is the most prevalent neurological disorder requiring long-term treatment and compliance."( Pandhi, P; Prabhakar, S; Tandon, M, 2002)
"Epilepsy is the main revealing symptom."( Andriamamonjy, C; Andriantsimahavandy, A; Rajaonarison, P; Ralamboson, S; Ramanampamonjy, R; Ramanantoanina, CE; Razafindratrimo, F; Villeneuve, R, 2001)
"Epilepsy is a common and heterogeneous neurological disorder arising from biochemical and molecular events that are incompletely understood."( Patel, MN, 2002)
"Epilepsy is a major symptom in succinic semialdehyde dehydrogenase deficiency."( Jaeken, J, 2002)
"Epilepsy is closely related to an altered transmission of GABA, the major inhibitory transmitter in the brain."( Bettler, B; Furtinger, S; Sperk, G, 2003)
"Epilepsy is a relatively common disease, afflicting 1%-2% of the population, yet many epileptic patients are not sufficiently helped by current pharmacological therapies."( Cvitanovic, P; Mogul, DJ; Slutzky, MW, 2003)
"Epilepsy is the most common neurologic disorder in young humans."( Bittigau, P; Ikonomidou, C; Sifringer, M, 2003)
"Epilepsy is a complex brain disorder involving excessive, synchronous, abnormal electrical firing patterns of neurons."( Greene, AE; Seyfried, TN; Todorova, MT, 2003)
"Most patients with epilepsy are started on one of the classic AEDs and, if it proves ineffective, another drug is tried, usually as monotherapy."( Ben-Menachem, E, 2003)
"Men with epilepsy are known to have reduced fertility."( Bjørnenak, T; Gjerstad, L; Haugen, TB; Røste, LS; Saetre, ER; Taubøll, E, 2003)
"Epilepsy is a chronic condition that has complex effects on social, vocational, and psychological function."( Gilliam, F; Hecimovic, H; Sheline, Y, 2003)
"Epilepsy is a significant health problem."( Koob, GF; Solbrig, MV, 2004)
"Epilepsy is a chronic disorder that adversely affects social, vocational, and psychological functioning."( Brown, K; Carter, J; Gilliam, FG; Hecimovic, H; Santos, J; Vahle, V, 2004)
"Seizures and epilepsy are clearly dependent on elevated intracellular calcium concentration ([Ca2+]i) by NMDA receptor activation and can be prevented by NMDA antagonists."( Kim, S; Rhim, H, 2004)
"Epilepsy is one of the most common but genetically complex neurological disorders in humans."( Ernest, S; Frankel, WN; Friedman, L; Gallaugher, L; Kitami, T; Nadeau, JH, 2004)
"Catamenial epilepsy is a menstrual cycle-related seizure disorder characterized by an increase in seizures at the time of menstruation."( Reddy, DS, 2004)
"Epilepsy is very common in tuberous sclerosis complex and occurs in 80 to 90% of affected individuals during their lifetime."( Thiele, EA, 2004)
"Catamenial epilepsy is a menstrual cycle-related seizure disorder that affects up to 70% of women with epilepsy."( Reddy, DS, 2004)
"Epilepsy is one of the commonest neurological conditions."( Leach, JP, 2004)
"Epilepsy is one of the most common neurological disorders."( Delorenzo, RJ; Deshpande, LS; Sun, DA, 2005)
"Epilepsy is often complicated by depression requiring antidepressant treatment."( Gerschlager, W; Langosch, JM; Münchau, A; Orth, M; Rothwell, JC; Trimble, MR, 2005)
"Drug design in epilepsy is now tackling a new target--epileptogenesis."( Lyon, AP; Marone, S; Wainman, D; Weaver, DF, 2005)
"Epilepsy is the most common primary neurological disorder known."( Sriram, D; Vaigundaragavendran, J; Yogeeswari, P, 2005)
"Epilepsy is a major public-health problem in Africa."( Gaulier, JM; Laroche, ML; Merle, L; Preux, PM; Traore, H; Viana, M, 2005)
"Women with epilepsy are more likely to have maternal and fetal complications during pregnancy."( Jeha, LE; Morris, HH, 2005)
"Epilepsy is a disease of recurrent seizures that can develop after a wide range of brain insults."( Ahmed, S; Asano, E; Beaumont, TL; Chugani, HT; Draghici, S; Krauss, R; Loeb, JA; Rakhade, SN; Shah, AK; Sood, S; Yao, B, 2005)
"Migraine and epilepsy are both chronic recurrent disorders with paroxysmal attacks."( Chen, SC, 2006)
"Epilepsy is a common and devastating neurological disorder."( Beck, H; Remy, S, 2006)
"Seizures and epilepsy are a common problem in childhood."( Mackay, M, 2005)
"The prevalence of epilepsy is high in many areas of Africa."( Diop, AG; Hauser, WA; Hesdorffer, DC; Logroscino, G, 2005)
"Epilepsy is a common neurologic disorder that manifests in diverse ways."( Stafstrom, CE, 2006)
"Epilepsy is a disorder characterized by recurrent seizures, which can increase the content of reactive oxygen in the brain."( Agar, E; Ayyildiz, M; Yildirim, M, 2006)
"Epilepsy is a common medical problem and many studies have demonstrated that infants of women with epilepsy (WWE) have a two to threefold higher risk of congenital malformations compared with the background population."( Chiarelli, F; Latini, G; Pelliccia, P; Tana, M; Verrotti, A, 2006)
"Epilepsy is a common clinical problem in patients with brain tumours, strongly affecting patients' quality of life."( Albani, F; Baruzzi, A; Carapella, CM; Dinapoli, L; Jandolo, B; Maschio, M; Occhipinti, E; Pace, A; Pompili, A; Zarabla, A, 2006)
"Epilepsy is a dynamic disease in which self-organization and emergent structures occur dynamically at multiple levels of neuronal integration."( Jung, KY; Kim, S; Lee, U, 2006)
"Epilepsy is a hetergenous syndrome characterized by recurrently and repeatedly occurring seizures."( Sasa, M, 2006)
"Epilepsy is one of the most common neurological disorders."( DeLorenzo, RJ; Deshpande, LS; Sun, DA, 2006)
"People with epilepsy are more likely to die prematurely than those without epilepsy."( Bell, GS; Sander, JW, 2006)
"Epilepsy is a neurological disorder consisting of recurrent seizures, resulting from excessive, uncontrolled electrical activity in the brain."( Boon, P; De Herdt, V; De Smedt, T; Dedeurwaerdere, S; Delbeke, J; Legros, B; Raedt, R; Van Hese, P; Van Laere, K; Vonck, K; Wadman, W; Waterschoot, L; Wyckhuys, T, 2006)
"Epilepsy is a major comorbid condition in adolescents with mental retardation and is often characterized by multiple seizure types that are refractory to treatment."( Hammer, AE; McKee, JR; Sunder, TR; Vuong, A, 2006)
"Epilepsy is quite common in autism spectrum disorders, and it is increasingly recognized as an additional clinical problem that must be dealt with."( Canitano, R, 2007)
"Epilepsy is an abnormal brain state in which a large population of neurons is synchronously active, causing an enormous increase in metabolic demand."( Ma, H; Schwartz, TH; Sharif, S; Suh, M; Zhao, M, 2006)
"Epilepsy is characterized by the occurrence of spontaneous recurrent epileptiform discharges (SREDs) in neurons."( Blair, RE; Carter, DS; DeLorenzo, RJ; Deshpande, LS; Haider, SN; Sombati, S, 2006)
"Epilepsy is an important problem in neurological disorders."( Bağirici, F; Bostanci, MO, 2007)
"Temporal lobe epilepsy is a common form of drug-resistant epilepsy that sometimes responds to dietary manipulation such as the 'ketogenic diet'."( Bergendahl, K; Daley, TJ; Garriga-Canut, M; Morrison, JF; Ockuly, J; Pfender, RM; Qazi, R; Roopra, A; Schoenike, B; Stafstrom, C; Sutula, T, 2006)
"Epilepsy is one of the most common presentations of patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS)."( Lin, CM; Thajeb, P, 2007)
"Epilepsy is one of the most frequent causes of neurological disorders in young adults."( da Nóbrega, AC; de Castro, RR, 2006)
"Epilepsy is a rare cause of sinus node dysfunction which should be recognised."( Aissi, K; Bagnères, D; Demoux, AL; Francès, Y; Granel, B; Mechulan, A; Rossi, P; Sbragia, P; Somma-Mauvais, H, 2007)
"Epilepsy is one of the most important features of the syndrome, in addition to the characteristic facial appearance, cardiac anomaly, dysphagia, deafness, mental retardation and growth delay."( Imai, K; Kagitani-Shimono, K; Kamio, N; Kurosawa, K; Nabatame, S; Nagai, T; Okinaga, T; Ozono, K, 2007)
"Temporal lobe epilepsy is one of the most common types of epilepsy."( Ayala-Guerrero, F; Campos-Sepúlveda, E; González-Maciel, A; Mexicano, G; Reynoso-Robles, R; Romero, RM, 2008)
"Epilepsy is characterized by neuronal hyperexcitability and hypersynchronization."( Chen, CR; Huang, ZL; Qiu, MH; Qu, WM; Urade, Y; Xu, XH; Yao, MH, 2007)
"Epilepsy is the most common neurological disorder, approximately 1% of the population worldwide have epilepsy."( Amado, D; Arida, RM; Cavalheiro, EA; Colugnati, DB; de Lima, E; Naffah-Mazzacoratti, Mda G; Scorza, FA, 2008)
"Epilepsy is one of the most common neurologic problems worldwide."( Chiarelli, F; De Simone, M; Latini, G; Manco, R; Verrotti, A, 2007)
"Epilepsy is the most common neurological disorder; approximately 1% of the population worldwide have epilepsy."( Arida, RM; Cavalheiro, EA; Colugnati, DB; Cravo, SL; de Almeida, AC; Schoorlemmer, GH; Scorza, FA, 2008)
"Epilepsy is a major public health problem in developing countries."( Ngoungou, EB; Preux, PM; Quet, F; Tran, DS, 2007)
"Epilepsy is a neurological disorder with a worldwide prevalence estimated to be 0."( Kulig, K; Malawska, B, 2008)
"Epilepsy is a major public health problem affecting nearly 50 million people world wide."( El Elshamy, KA; Elwakkad, AS; Sibaii, H, 2008)
"Epilepsy is an important component of ME."( Grover, WD; Hardison, HH; Hobdell, EF; Khurana, DS; Legido, A; Marks, HG; Melvin, JJ; Salganicoff, L; Valencia, I, 2008)
"Epilepsy is one of the most frequent disease in children, particularly in adolescents."( Chiarelli, F; Manco, R; Scardapane, A; Verrotti, A, 2008)
"Epilepsy is a serious neurological disorder in human beings and the long-term pathological events remain largely obscure."( Chen, LW; Huang, YG; Liu, YH; Wang, L, 2008)
"Epilepsy is a symptom of cerebral dysfunction, where there is a sudden and disorganised discharge of electrical activity from a group of neurones, producing symptoms that range from sensory absences to convulsive movements and unconsciousness."( Bryan, RA; Willmott, NS, 2008)
"Epilepsy is a major health problem worldwide, and neurocysticercosis (NCC) is one of the important causes of epilepsy in the tropics."( Gupta, RK; Nath, K; Pandey, CM; Pradhan, S; Prasad, A; Prasad, KN; Tripathi, M, 2009)
"Epilepsy is a multifaceted chronic disorder which has diverse and complex effects on the well-being of the patient."( Andelman, F; Auriel, E; Blatt, I; Chistik, V; Gandelman-Marton, R; Gross, B; Landov, H; Margolin, N; Neufeld, MY; Parmet, Y; Theitler, J, 2009)
"Epilepsy is a chronic disorder often requiring years of treatment."( Montouris, G; Sheth, RD, 2008)
"Epilepsy is a disease, closely connected with sex-hormones and can lead to adverse repercussion on the reproductive health."( Bozhinov, P; Bozhinova, S, 2005)
"Early epilepsy is known to worsen the developmental prognosis of young children with a congenital focal brain lesion, but its direct role is often very difficult to delineate from the other variables."( Deonna, T; Maeder-Ingvar, M; Mayor-Dubois, C; Roulet-Perez, E, 2008)
"Epilepsy is a serious neurological disorder with neuronal loss and spontaneous recurrent seizures, but the neurochemical basis remains largely unclear."( Chen, LW; Huang, YG; Liu, YH; Wang, L; Wei, LC, 2009)
"Single seizure and epilepsy is one of the most commonly encountered neurologic disorders in elderly individuals, arising as a result of complex and often multiple acquired underlying pathologies."( Alptekin, M; Erkutlu, I; Kurtul, N; Pençe, S; Tan, U, 2009)
"Epilepsy is the most common neurological presentation and seizures are often medically intractable."( Bauer, R; Dobesberger, J; Koppelstaetter, F; Kuchukhidze, G; Ortler, M; Trinka, E; Unterberger, I; Walser, G, 2009)
"Epilepsy is a syndrome of episodic brain dysfunction characterized by recurrent unpredictable, spontaneous seizures."( Abraham, PM; Krishnakumar, A; Paul, J; Paulose, CS, 2009)
"Pharmacotherapy for epilepsy is limited by high incidence of pharmacoresistance and failure to prevent development and progression of epilepsy."( Boison, D; Kaplan, DL; Li, T; Lusardi, TA; Pritchard, EM; Szybala, C; Wilz, A, 2009)
"Epilepsy is a considerable source of stigma and misery for sufferers in Nigeria."( Abadom, TR; Aguwa, EN; Ejim, EC; Ezeala-Adikaibe, B; Illo, CK; Ndukuba, K; Onodugo, OD; Onwuekwe, IO; Onyejizu, C, 2009)
"Epilepsy is one of the oldest neurological conditions known to humankind."( Nazıroglu, M, 2009)
"Epilepsy is the most common neurological disorder in both dogs and humans."( Arida, RM; Cavalheiro, EA; Cysneiros, RM; Ribeiro, MO; Scorza, CA; Scorza, FA; Terra, VC, 2009)
"Epilepsy is a prominent sign of neurological dysfunction in children with various fetal and maternal deficiencies."( Kim, MO; Naseer, MI; Shupeng, L, 2009)
"Epilepsy is often the most important clinical manifestation of the syndrome, even if its appearance is not constantly precocious."( Canevini, MP; Dalla Bernardina, B; Darra, F; Fiorini, E; La Selva, L; Lazzarotto, F; Piazzini, A; Vignoli, A; Zucca, C, 2009)
"Epilepsy is a chronic disorder affecting approximately 1% of the population of the world."( Lee, KK; Salamon, N, 2009)
"Epilepsy is a common seizure disorder affecting approximately 70 million people worldwide."( Boison, D; Stewart, KA, 2009)
"Seizures and epilepsy are associated with significant disability and substantial treatment costs, yet little is known about primary prevention."( Bromfield, EB; Dworetzky, BA; Kang, JH; Townsend, MK, 2010)
"The incidence of epilepsy is significantly higher in children than adults."( Holmes, GL, 2009)
"Epilepsy is a common neurological disorder which predominantly affects paediatric and young adolescent population."( Khan, MA; Koul, RK; Shah, PA; Shapoo, SF, 2009)
"Idiopathic epilepsy is the most common brain disease in dogs and also occurs in cats."( Thomas, WB, 2010)
"Epilepsy is neuronal disorder characterized by learning, cognitive and memory impairments."( Mathew, J; Nandhu, MS; Paul, J; Paulose, CS, 2010)
"Epilepsy is a neurological disorder, relatively common in the paediatric population."( Cheng, LS; Prasad, AN; Rieder, MJ, 2010)
"Posttraumatic epilepsy is a frequent consequence of brain trauma, but relatively little is known about how neuronal circuits are chronically altered after closed head injury."( Hunt, RF; Scheff, SW; Smith, BN, 2010)
"Epilepsy is defined as the tendency to spontaneous, excessive neuronal discharge, manifesting as seizures."( Marson, AG; Powell, G; Saunders, M, 2010)
"Hot water epilepsy is a benign reflex epilepsy."( Gokcil, Z; Hidir, UU; Ilker, IH; Ipekdal, HI; Odabasi, Z; Ulas, UH; Zeki, G; Zeki, O, 2010)
"Epilepsy is a major public health problem worldwide which is clinically characterized by recurrent seizures."( Brincat, M; Erel, CT; Gambacciani, M; Lambrinoudaki, I; Moen, MH; Rees, M; Rozenberg, S; Schenck-Gustafsson, K; Tremollieres, F; Vujovic, S, 2010)
"Epilepsy is a disease characterized by unprovoked epileptic seizures resulting from a bioelectrical brain dysfunction."( Diaz-Bustos, R; Mora-Puga, M; Palacios, GC; Ramirez-Campos, J; Sevilla-Castillo, RA, 2009)
"Epilepsy is associated with the presence of cataract."( Hanhart, J; Kaiserman, I; Levartovsky, S; Nemet, A; Vinker, S, 2010)
"Epilepsy is one of the most frequent neurological diseases in the pediatric population."( Amine, M; Bourrous, M; Bouskraoui, M; Draiss, G; Elibrahimi, I; Safini, F, 2010)
"Pediatric epilepsy is a common, chronic, and challenging physical illness for children and their families."( Bujoreanu, IS; DeMaso, DR; Ibeziako, P, 2010)
"Epilepsy is a neurological disorder primarily characterized by recurrent, unprovoked seizures resulting from excessive or synchronous neuronal activity in the brain."( Sajatovic, M; Syed, TU, 2010)
"Epilepsy is one of the most common neurological disorders, affecting up to 2% of the population worldwide."( Chung, SS, 2010)
"People with epilepsy are socially discriminated against on the grounds of widespread negative public attitudes, misunderstandings and defensive behaviour."( Ahmadi, K; Alen, YK; Anwar, M; Goh, GK; Hasan, SS; Wayne, WG, 2010)
"The term catamenial epilepsy is used to describe the cyclical occurrence of seizure exacerbations during particular phases of menstrual cycle in women with preexisting epilepsy."( Chiarelli, F; Coppola, G; Laus, M; Mohn, A; Parisi, P; Verrotti, A, 2010)
"The development of epilepsy is often associated with marked changes in central nervous system cell structure and function."( Cao, R; Cho, HY; Choi, YS; Dziema, H; Jung, YJ; Li, A; Obrietan, K, 2010)
"Epilepsy is a common disease of childhood, in which almost 25% of cases are resistant to common antiepileptic drugs."( Ghazavi, M; Ghofrani, M; Karimzadeh, P; Mahvelati, F; Tonekaboni, SH, 2010)
"Epilepsy is a major feature of Menkes disease, an X-linked recessive infantile neurodegenerative disorder caused by mutations in ATP7A, which produces a copper-transporting ATPase."( Donsante, A; Greenfield, JC; Hicks, JD; Kaler, SG; Liew, CJ; Sato, S, 2010)
"Epilepsy is associated with various reproductive disorders and some antiepileptic drugs also influence the steroid metabolism."( Dusková, M; Hill, M; Kancheva, R; Kubátová, J; Stárka, L; Vceláková, H; Vrbíková, J; Zárubová, J, 2010)
"Epilepsy is a common neurological condition characterized by unprovoked seizure attacks."( Chatterjee, A; Dutta, S; Gangopadhyay, PK; Ghosh, S; Rajamma, U; Sinha, S, 2011)
"Epilepsy is a condition characterized by signs and symptoms of neurological disorder."( Alexandre, V; Feletti, F; Girolineto, BM; Pereira, LR; Queiroz, RH; Sakamoto, AC, 2010)
"Epilepsy is a chronic condition characterized by recurrent unprovoked seizures."( Li, P; Liu, HJ; Wei, Q, 2010)
"The AAIR of epilepsy is comparable to that observed in developed countries, but AAMR is higher."( Banerjee, TK; Chaudhuri, A; Das, SK; Ghosal, MK; Hazra, A; Raut, DK; Ray, BK; Roy, T, 2010)
"New mothers with epilepsy are advised to breastfeed their children."( Deppe, C; Noachtar, S; Weil, S, 2010)
"Acquired epilepsy is associated with long-term neuronal plasticity changes in the hippocampus resulting in the expression of spontaneous recurrent seizures."( Carter, DS; DeLorenzo, RJ; Deshpande, LS; Rafiq, A; Sombati, S, 2011)
"Epilepsy is a chronic neurological disorder affecting 1% population worldwide."( Agarwal, NB; Agarwal, NK; Jain, S; Mediratta, PK; Sharma, KK, 2011)
"Epilepsy is a chronic neurological disorder characterized by spontaneous recurrent seizures, which also occur in demyelinating diseases of the central nervous system (CNS) with a higher prevalence."( Bai, H; Chen, LW; Gao, GD; Liu, B; Wang, C; You, Y; Zhang, H, 2011)
"Epilepsy is one of the most common neurologic problems worldwide."( Ataie, Z; Babri, Sh; Ebrahimi, H; Golzar, MG; Mohaddes, G, 2011)
"Epilepsy is a neurodegenerative disease with periodic occurrences of spontaneous seizures as the main symptom."( Baek, IJ; Lee, BJ; Lee, JG; Lee, TH; Nahm, SS; Nam, SY; Oh, KW; Yon, JM; Yun, YW, 2011)
"Epilepsy is a common neurological disorder, which is attributed to uncontrollable abnormal hyper-excitability of neurons."( Bystritsky, A; Chung, YA; Fischer, K; Jolesz, FA; Jung, KI; Maeng, LS; Min, BK; Park, SI; Yoo, SS; Zhang, Y, 2011)
"Epilepsy is a common clinical syndrome with recurrent neuronal discharges in cerebral cortex and hippocampus."( Hsieh, CL; Lin, YW, 2011)
"Epilepsy is one of the most impactful diseases on social life."( Errichiello, L; Striano, P; Striano, S; Zara, F, 2011)
"Epilepsy is a brain dysfunction characterised by unpredictable occurrence of seizures."( Bhattacharya, J; Mandal, SK; Roy, T; Sadhu, M, 2010)
"Epilepsy is one of the most common neurological disorders, affecting about 1% of the population worldwide."( Schulze-Bonhage, A, 2011)
"Although epilepsy is reported to be common among patients with ASA, very few long-term follow-up studies are available."( Barboni, C; Contri, M; Corbetta, C; Furlan, F; Gamba, A; Grioni, D; Lastrico, A; Marzocchi, GM; Parini, R; Vizziello, P, 2011)
"Startle epilepsy is a rare form of epilepsy with seizures triggered by unexpected stimuli."( Bargalló, N; Boget, T; Carreño, M; Donaire, A; Falcón, C; Fernández, S; Maestro, I; Rumià, J; Seres, E; Setoain, X, 2011)
"Epilepsy is detected in about 23% of patients with fragile X syndrome (FXS)."( Ferrando, T; Genovés, J; Martorell, L; Molero, M; Naudó, M; Poo, P; Tondo, M, 2011)
"Epilepsy is a neurological disorder associated with excitatory and inhibitory imbalance within the underlying neural network."( Doretto, MC; Drumond, LE; Guidine, PA; Kushmerick, C; Massensini, AR; Moraes, MF, 2011)
"Epilepsy is a major clinical feature of this disorder."( Levin, S; Prasad, AN; Prasad, C; Rupar, CA, 2011)
"Epilepsy is a chronic disorder that significantly affects learning and behavior."( Aneja, S; Kumar, V; Seth, A; Singh, H; Unni, KE, 2012)
"Epilepsy is a serious health disorder affecting both paediatric and adult population worldwide."( Klapková, E; Komárek, V; Tesfaye, H; Tesfayeová, A, 2011)
"Epilepsy is not a singular disease, but a variety of disorders."( Szupera, Z, 2011)
"Epilepsy is a chronic neurological disorder characterized by recurrent seizures, and is highly resistant to medication with up to 40% of patients continuing to experience seizures whilst taking oral antiepileptic drugs."( Campbell, TE; Cook, MJ; Halliday, AJ; McLean, KJ; Nelson, TS; Razal, JM; Wallace, GG, 2012)
"Epilepsy is a chronic neurological disorder and well documented to induce cognitive impairment."( Goel, RK; Mishra, A, 2012)
"Epilepsy is one of the most common serious neurological conditions worldwide, with an age-adjusted incidence of approximately 50 per 100,000 persons per year in developed countries."( Becerra, JL; Corredera, E; Ojeda, J; Ruiz Giménez, J, 2011)
"Epilepsy is suppressed by reducing the temperature to reduce the duration of this epileptic episode."( Chang, CW; Chiou, JC; Hou, KC; Huang, YH; Shaw, FZ, 2011)
"Epilepsy is a common and refractory neurological disorder, but the neuronal regulatory mechanisms of epileptogenesis remain largely unclear."( Hu, XL; Liu, YY; Mei, L; Tan, GH; Xiong, ZQ; Yin, DM, 2011)
"Epilepsy is characterized by recurrent seizures, which are caused by excessive discharges from cerebral neurons."( Araki, H; Kawasaki, H; Suemaru, K; Takechi, K, 2012)
"Epilepsy is a common (50 million patients worldwide) neurological disorder characterized by seizures that are caused by episodic abnormal electrical activity in the brain."( Gasior, M; Giardina, WJ, 2009)
"Catamenial epilepsy is caused by fluctuations in progesterone-derived GABA(A) receptor-modulating anticonvulsant neurosteroids, such as allopregnanolone, that play a significant role in the pathophysiology of epilepsy."( Gangisetty, O; Gould, J; Reddy, DS, 2012)
"Epilepsy is the third most common chronic neurological disorder."( Desantis, KA; Velíšková, J, 2013)
"Epilepsy is not considered a neurodegenerative disorder, but the hippocampus is severely affected in temporal lobe epilepsy."( Szot, P, 2012)
"Epilepsy is one of the most common chronic neurologic disorders."( Brigo, F; Del Felice, A, 2012)
"Epilepsy is a serious and common chronic neurological disease with an urgent need for novel treatment options, because 30% of all epilepsy patients do not respond to currently available drugs."( Lerche, H; Nies, AT; Orhan, G; Schwab, M; Wuttke, TV, 2012)
"Epilepsy is a common neurological disorder characterized by recurrent seizures often unresponsive to pharmacological treatment."( de Curtis, M; Librizzi, L; Noè, F; Ravizza, T; Vezzani, A, 2012)
"Epilepsy is characterised by the propensity of the brain to generate spontaneous recurrent bursts of excessive neuronal activity, seizures."( Kaila, K; Kullmann, DM; Miles, R; Pavlov, I, 2013)
"Epilepsy is a neurological disorder produced by an imbalance between excitatory and inhibitory neurotransmission, in which transporters of both glutamate and GABA have been implicated."( López-Pérez, SJ; Medina-Ceja, L; Morales-Villagrán, A; Sandoval-García, F, 2012)
"Epilepsy is treated with a variety of anticonvulsants that are often used concomitantly."( Božina, N; Božina, T; Granić, P; Hajnšek, S; Kuzman, MR; Lalić, Z; Lovrić, M; Sporiš, D, 2012)
"Epilepsy is very common in tuberous sclerosis and occurs in 75-92% of affected individuals during their life-time."( Belousova, ED; Dorofeeva, MIu, 2012)
"Epilepsy is a common neurological disorder characterized by an initial injury due to stroke, traumatic brain injury, brain infection, or febrile seizures causing status epilepticus (SE)."( Chanda, S; de Araujo Furtado, M; Rossetti, F; Yourick, D, 2012)
"Epilepsy is a recurrent chronic nervous system disease."( Gao, F; He, H; Jiang, W; Li, XW; Liu, YF; Ma, L; Meng, XD; Wei, D, 2012)
"Epilepsy is one of the main symptoms in GAMT and CT1 deficiency, whereas the occurrence of febrile convulsions in infancy is a relatively common presenting symptom in all the three above-mentioned diseases."( Battini, R; Cioni, G; Leuzzi, V; Mastrangelo, M, 2013)
"Children with epilepsy are at risk for behavioral and cognitive comorbidities."( Dunn, DW; Hummer, TA; McDonald, BC, 2013)
"Epilepsy is one of the most common neurological disorders, yet its treatment remains unsatisfactory."( Bao, Y; Hu, SJ; Li, HM; Xie, W; Xing, JL; Yu, YH, 2012)
"Post-traumatic epilepsy is prevalent, often difficult to manage, and currently cannot be prevented."( D'Ambrosio, R; Darvas, F; Eastman, CL; Farin, FM; Fender, JS; Miller, JW; Ojemann, J; Rothman, SM; Smyth, MD; Temkin, NR; Verley, DR; Wilkerson, HW, 2013)
"Epilepsy is a common manifestation of mitochondrial disease associated with mutations of the mitochondrial polymerase γ (POLG)."( Jääskeläinen, S; Majamaa, K; Martikainen, MH; Päivärinta, M, 2012)
"Epilepsy is characterized by recurrent spontaneous seizures due to hyperexcitability and hypersynchrony of brain neurons."( De Lanerolle, NC; Devinsky, O; Najjar, S; Rogawski, MA; Vezzani, A, 2013)
"Patients with epilepsy are at high risk for major depression relative to the general population, and both disorders are associated with changes in adult hippocampal neurogenesis, although the mechanisms underlying disease onset remain unknown."( Kajitani, K; Kamada, T; Katogi, A; Nakabeppu, Y; Nomaru, H; Ohnishi, YH; Ohnishi, YN; Sakumi, K; Shigeto, H; Takase, K; Yutsudo, N, 2013)
"Epilepsy is a complex neurological disorder characterized by unprovoked seizures."( Bassuk, AG; Mei, X; Slusarski, DC; Wu, S, 2013)
"Epilepsy is a major clinical and social issue in Africa."( Adjien, C; Avode, G; Druet-Cabanac, M; Glitho, G; Houinato, D; Preux, PM; Yemadje, LP, 2013)
"Epilepsy is a group of conditions characterized by sporadic occurrence of seizures and unconsciousness."( Binder, DK; Fiacco, TA; Hsu, MS; Hubbard, JA, 2013)
"Epilepsy is characterized by recurrent synchronizations of neuronal activity, which are both a cardinal clinical symptom and a debilitating phenomenon."( Cossart, R; Feldt Muldoon, S; Soltesz, I, 2013)
"Epilepsy is one of the most common neurological conditions in the elderly, and the incidence of de novo geriatric epilepsy is rising."( Lossius, MI; Markhus, R; Nakken, KO; Sætre, E, 2013)
"Epilepsy is a common neurological condition characterised by recurrent seizures."( Marson, AG; Milburn-McNulty, P; Powell, G; Sills, GJ, 2013)
"Early treatment of epilepsy is warranted to avoid possible severe consequences."( Angeletti, G; Carbonetti, P; Del Casale, A; Fensore, C; Ferracuti, S; Girardi, P; Kotzalidis, GD; Lazanio, S; Muzi, A; Rapinesi, C; Savoja, V; Scatena, P; Serata, D; Tatarelli, R, 2013)
"Epilepsy is a major manifestation of tuberous sclerosis complex (TSC)."( Agricola, K; Anderson, AE; Franz, DN; Holland-Bouley, K; Kim, MO; Krueger, DA; Lopez, CM; Mays, M; Tudor, C; Wilfong, AA, 2013)
"Epilepsy is a heterogeneous and chronic neurological condition of undefined etiology in the majority of cases."( Currie, RW; Esser, MJ; Galic, MA; Moriyama, C; Mychasiuk, R; Perrot, TS; Pittman, QJ, 2013)
"Epilepsy is a chronic brain disorder involving recurring seizures often precipitated by an earlier neuronal insult."( Chang, PK; Charron, F; Dezsi, G; Gill, R; Huang, TC; Jones, NC; Machnes, ZM; McKinney, RA; O'Brien, TJ; Ozturk, E; Reist, N; Szyf, M, 2013)
"Epilepsy is one of the most common neurological disorders prevalent in childhood period."( Bharti, B; Pandey, S; Singhi, P, 2014)
"Epilepsy is a common neurological disorder."( Loiacono, G; Rossi, A; Verrotti, A; Zaccara, G, 2014)
"Epilepsy is one of the most common neurological disorders, characterized by recurrent seizures, which may increase the content of reactive oxygen and nitrogen species."( Kir, HM; Kuskay, S; Musul, M; Oztaş, B; Sahin, D, 2013)
"Epilepsy is a debilitating disease affecting 1-2% of the world's population."( Bestman, JE; Chan, SS; Chou, CJ; Inks, ES; Josey, BJ; Rahn, JJ; Rogers, CE; Stackley, KD, 2014)
"Epilepsy is a serious neural disease that affects around 50 million people all over the world."( He, J; Li, BC; Li, P; Wan, JB; Wang, YT; Xiang, C; Zhu, HL, 2014)
"Epilepsy is a chronic neurologic disorder which often induces numerous adverse long-term neurologic effects, such as behavioral and cognitive deficits, increased predisposition to additional seizures, and cell injury or death."( Bhutada, PS; Patel, FR; Vimala, PV, 2014)
"Epilepsy is a common neurological disorder with seizures, but diagnostic approaches in veterinary clinics remain limited."( Hasegawa, T; Horitani, Y; Komori, M; Sumita, M; Takenaka, S; Tamai, R; Tanaka, K, 2014)
"If the diagnosis of epilepsy is established and epilepsy surgery is not appropriate, AED treatment should be optimized."( Ben-Menachem, E, 2014)
"Epilepsy is one of the most common neurological disorders."( de Biase, S; Gigli, GL; Merlino, G; Valente, M, 2014)
"Epilepsy is defined as the tendency to spontaneous, excessive neuronal discharge manifesting as seizures."( Marson, AG; Powell, G; Saunders, M, 2014)
"Epilepsy is one of the most common neurological diseases in the world."( Breborowicz, GH; Chuchracki, M; Florek, E; Hassan-Bartz, M; Krzyścin, M; Kulza, M; Miller, R; Napierała, M; Wachowiak, A; Wozniak, A, 2013)
"Epilepsy is the most commonly encountered serious neurological problem in obstetrical practice."( Ahmed, R; Apen, K; Endean, C, 2014)
"Epilepsy is a common neurological condition characterised by recurrent seizures."( Marson, AG; Milburn-McNulty, P; Powell, G; Sills, GJ, 2014)
"Epilepsy is a family of brain disorders with a largely unknown etiology and high percentage of pharmacoresistance."( DiNuzzo, M; Giove, F; Mangia, S; Maraviglia, B, 2015)
"Acquired epilepsy is frequently associated with structural lesions after trauma, stroke, and infections."( Bar-Klein, G; Cacheaux, LP; Cheng, P; Friedman, A; Heinemann, U; Kamintsky, L; Kaufer, D; Kim, SY; Prager, O; Schoknecht, K; Weissberg, I; Wood, L, 2014)
"Epilepsy is one of the most common neurological disorders, and approximately one-third of patients with epilepsy are resistant to anti-epileptic drugs (AEDs)."( Dang, J; Ding, DX; Huang, WJ; Liu, H; Song, MY; Tian, FF; Wang, YZ, 2014)
"Hot water epilepsy is rarely described in European countries, where bathing epilepsy in younger children is more common and often confused with this type of epilepsy."( Canevini, MP; Chiesa, V; La Briola, F; Peron, A; Savini, MN; Vignoli, A; Zambrelli, E, 2014)
"Intractable epilepsy is a challenging aspects of pediatric epilepsy."( Abdollahe-Gorgi, F; Azargashb, E; Beheshti, M; Ghofrani, M; Karimzadeh, P; Sedighi, M, 2014)
"Epilepsy is frequent during the evolution of mitochondrial disorders (30%) with different presentation in childhood and adulthood in term of type of epilepsy, of efficacy of treatment and also in term of prognosis."( Desguerre, I; Hully, M; Nabbout, R; Rio, M, 2014)
"Epilepsy is a heterogeneous family of neurological disorders that manifest as seizures, i."( DiNuzzo, M; Giove, F; Mangia, S; Maraviglia, B, 2014)
"Epilepsy is a common neurological disease."( Li, D; Pan, LP; Song, YJ; Tian, X; Wu, QJ; Xie, W, 2014)
"Epilepsy is an abnormal emergent property of disturbances in neuronal networks which, even for epilepsies characterized by focal seizures, involve widely distributed systems, often in both hemispheres."( Dedeurwaerdere, S; Engel, J; Federico, P; Shultz, SR, 2014)
"Although epilepsy is a common neurological disorder, its mechanism(s) are still not completely understood."( Chen, L; Chen, Y; Jiang, G; Li, J; Li, Z; Wang, X; Wang, Z, 2014)
"Epilepsy is one of the major neurological disorders still awaiting safer drugs with improved antiepileptic effect and lesser side effects."( Goel, RK; Mishra, A, 2014)
"Epilepsy is a disorder characterised by recurrent seizures and molecular events, including the activation of early expression genes and the post-translational modifications of functional proteins."( Beas-Zarate, C; Bitar-Alatorre, EW; Castaneda-Arellano, R; Feria-Velasco, AI; Rivera-Cervantes, MC, 2014)
"Epilepsy is the most common medical neurologic disease of dogs."( Patterson, EE, 2014)
"Children with epilepsy are more likely to have behavioral problems compared to children without epilepsy."( Aldenkamp, AP; de Louw, AJ; Halma, E; IJff, DM; Klinkenberg, S; Majoie, M, 2014)
"Epilepsy is a paroxysmal condition characterized by repeated transient seizures separated by longer interictal periods."( Blauwblomme, T; Huberfeld, G; Jiruska, P, 2014)
"Epilepsy is a complex disease necessitating continuous development of new therapeutic strategies to encounter drug-resistant cases."( Alsaad, AM; Koren, G, 2014)
"Epilepsy is a chronic disease that affects metabolism either alone or through the antiepileptic drug (AED) treatment."( Abdelaziz, GH; Ahmed, SM; El-Jaafary, SI; Kamel, T; Rabah, AM; Talaat, FM, 2015)
"Although idiopathic epilepsy is regarded as having a significantly lower risk factor of developing refractory epilepsy, still a subset of patients with idiopathic epilepsy might be refractory to medical treatment."( Chiang, CT; Lin, LC; Ouyang, CS; Wu, HC; Wu, RC; Yang, RC, 2014)
"Epilepsy is characterized by the abnormal activation of neurons in the cerebral cortex, but the molecular and cellular mechanisms contributing to the development of recurrent seizures are largely unknown."( Abe, Y; Gondo, A; Morita, A; Nuriya, M; Shinotsuka, T; Yasui, M, 2014)
"Epilepsy is defined as the tendency to spontaneous, excessive neuronal discharge manifesting as seizures."( Marson, AG; Powell, G; Rigby, A; Saunders, M, 2014)
"PCDH19-related epilepsy is an emerging epileptic syndrome characterized by the occurrence of epilepsy in female patients associated with mental retardation and autistic features in most cases."( Specchio, N; Trivisano, M; Vigevano, F, 2015)
"Epilepsy is the most common neurological symptom of tuberous sclerosis complex, occurring in 80% to 90% of affected individuals over the course of their lifetimes and causing significant morbidity and mortality."( Curatolo, P, 2015)
"Epilepsy is a chronic disorder of brain whose treatment consists of controlling seizures with antiepileptic drugs that very often related with side-effects which in rare circumstances can be potentially life-threatening."( Dhanda, A; Kamboj, VK; Ranjan, S; Verma, PK, 2015)
"Epilepsy is a major neurological disorder characterized by spontaneous seizures accompanied by neurophysiological changes."( Chang, SJ; Tsai, HL, 2015)
"Epilepsy is a disease of neuronal hyper-synchrony that can involve both neocortical and hippocampal brain regions."( Andrade, R; Loeb, JA; Serafini, R, 2015)
"The diagnosis of epilepsy is usually made by a neurologist but can be difficult to be made in the early stages."( Abdel-Aziz, K; Al-Jumeily, D; Fergus, P; Hignett, D; Hussain, A, 2015)
"Epilepsy is considered to be resolved for individuals past the applicable age of an age-dependent epilepsy syndrome or those who have remained seizure-free for the past 10 years, with no seizure medicines for the past 5 years."( Fisher, RS, 2015)
"Epilepsy is a common neurological disorder."( Li, M; Wang, S; Wang, X; Xu, X; Yang, X; Zhang, Y, 2015)
"Epilepsy is a frequent neurological disorder that affects directly 0."( Orbán-Kis, K; Szabadi, T; Szilágyi, T, 2015)
"Epilepsy is one of the commonest chronic neurological disorders in developing countries."( Gregoraszczuk, EL; Grzyb, E; Kwiecińska, P, 2014)
"Drug-resistant epilepsy is believed to be multifactorial involving both genetic and non-genetic factors."( Chinvarun, Y; Keangpraphun, T; Kijsanayotin, P; Towanabut, S, 2015)
"Epilepsy is a common neurological disease characterized by recurrent unprovoked seizures."( Baum, L; Cherny, SS; Gui, H; Haerian, BS; Kwan, P; Lim, KS; Mohamed, Z; Rafia, MH; Raymond, AA; Sha'ari, HM; Sham, PC; Tan, HJ, 2016)
"Epilepsy is a chronic brain disease characterised by recurrent seizures."( Hasegawa, M; Hongo, Y; Ikegaya, Y; Ogawa, K; Sakaguchi, G; Takasu, K, 2015)
"Temporal lobe epilepsy is often presented by medically intractable recurrent seizures due to dysfunction of temporal lobe structures, mostly the temporomesial structures."( Eslamizade, MJ; Ghadiri, T; Gorji, A; Hadjighassem, M; Modarres Mousavi, SM; Saffarzadeh, F, 2015)
"Epilepsy is broadly characterized by aberrant neuronal excitability."( Barker-Haliski, M; White, HS, 2015)
"Catamenial epilepsy is a periodic increase in seizure frequency in women with epilepsy during menstruation, or at any specific point in the menstrual cycle."( Chen, K; Liang, Y; Liu, J; Sun, H; Xie, Y; Yu, N, 2015)
"Catamenial epilepsy is a common phenomenon in female epileptic patients that is, in part, influenced by the 17-β-estradiol level during the menstrual cycle, which modulates the strength of the epileptic seizures."( Huang, Y; Liu, X; Wang, G; Wang, X; Wang, Y; Zhang, Y, 2015)
"Epilepsy is common in individuals with autism spectrum disorder (ASD) and intellectual disabilities (ID)."( Katz, N; Moses, L; Weizman, A, 2015)
"Untreated epilepsy is a major global public health problem with more than 20 million people not being treated for an easily treatable disease."( Patterson, V; Rajbhandari, H; Singh, M; Vishnubhatla, S, 2015)
"Background: Epilepsy is the most common neurological disease in children."( Chotipanich, C; Khongsaengdao, S; Khusiwilai, K; Paticheep, S; Wichaporn, A, 2015)
"Epilepsy is a neurological disorder that has been associated with oxidative stress therefore epilepsy models have been develop such as kainic acid and pentylenetetrazol are usually used to understanding of the molecular mechanisms of this disease."( Díaz-Ruíz, A; Flores-Espinosa, P; Heras-Romero, Y; Juárez-Rebollar, D; Manjarrez, J; Méndez-Armenta, M; Nava-Ruíz, C; Zaga-Clavellina, V, 2015)
"Epilepsy is one of the most common and severe neurologic diseases."( Chen, G; Chen, L; Deng, W; Jiang, G; Li, J; Mi, X; Wang, N; Wang, X; Wang, Z; Zhang, Y, 2016)
"Epilepsy is an independent prognostic factor for longer survival in glioblastoma patients."( Berendsen, S; Bours, V; Broekman, ML; Kauw, F; Kroonen, J; Poulet, C; Robe, PA; Seute, T; Snijders, TJ; Spliet, WG; Varkila, M; Willems, M, 2016)
"Epilepsy is a severe neurological disorder characterized by altered electrical activity in the brain."( Borges, K; Eloqayli, H; Hadera, MG; Jaradat, S; McDonald, T; Meisingset, TW; Smeland, OB; Sonnewald, U, 2016)
"Epilepsy is the commonest clinical presentation, though it may also present with headache, symptoms of raised intracranial tension, hydrocephalus and ocular symptoms depending upon the localisation of the parasitic cysts."( Mathew, A; Sharma, M; Singh, T, 2015)
"Epilepsy is one of the most common diseases affecting the nervous system, with more than 50 million patients suffering from epilepsy worldwide."( Lu, S; Wang, X, 2015)
"Epilepsy is a common neurological condition characterised by recurrent seizures."( Marson, AG; Milburn-McNulty, P; Powell, G; Sills, GJ, 2015)
"Epilepsy is a neurological disorder with an annual incidence in the Netherlands of 30 per 100,000 people."( Admiraal-van de Pas, Y; van Rooij, FJ, 2015)
"Treatment of canine epilepsy is problematic."( Berendt, M; Fredsø, N; Møller, A; Sabers, A; Toft, N, 2016)
"Autism and epilepsy are two associated disorders that are highly prevalent, share common developmental origins, and demonstrate substantial heritability."( Jacob, J, 2016)
"Epilepsy is now recognized as the second most common neurological disease in China."( Fang, X; Fu, X; Gong, G; Hu, X; Jiang, AO; Wei, C; Yang, X, 2015)
"Symptomatic epilepsy is a common complication of glioblastoma and requires pharmacotherapy."( Chinot, O; Cloughesy, T; Gilbert, MR; Gorlia, T; Happold, C; Hegi, M; Mehta, MP; Nabors, LB; Perry, JR; Pugh, SL; Reardon, DA; Roth, P; Stupp, R; Weller, M; Wick, W, 2016)
"Epilepsy is one of the most important neurological disorders with high prevalence worldwide."( Ayati, A; Emami, S; Foroumadi, A, 2016)
"Epilepsy is a prominent feature of TSC, with seizures often occurring after the diagnosis of TSC has already been made."( Jeong, A; Wong, M, 2016)
"Epilepsy is one of the most common neurological conditions, which affect nearly 1% of the entire population."( Agarwal, KK; Jha, P; Kumar, R; Sahoo, MK, 2016)
"Women with epilepsy are exposed to social stigma, and they have anxiety and lose self-confidence in their social role as a woman."( Honda, M; Watanabe, M, 2015)
"Epilepsy is a frequent comorbidity in patients with focal cortical dysplasia (FCD)."( Akamine, S; Hara, T; Ishizaki, Y; Matsushita, Y; Nakabeppu, Y; Nishio, M; Sakai, Y; Sanefuji, M; Shigeto, H; Shimmura, M; Suzuki, A; Takada, H; Torisu, H, 2016)
"Epilepsy is a neurological disorder which occurs due to excessive firing of excitatory neurons in specific region of brain and associated with cognitive impairment and depression."( Koshal, P; Kumar, P, 2016)
"Epilepsy is a common neurological disease characterized by periodic seizures."( Aghaei, Z; Haeri, NA; Palizvan, MR; Rafiei, M; Sadegh, M, 2016)
"Epilepsy is increasingly considered as the dysfunction of a pathologic neuronal network (epileptic network) rather than a single focal source."( Abela, E; Carmichael, DW; Centeno, M; Grouiller, F; Iannotti, GR; Korff, C; Michel, C; Pittau, F; Seeck, M; Vulliemoz, S; Wiest, R, 2016)
"Epilepsy is one of the major neurological disorders frequently associated with psychiatric disorders such as depression."( Goel, RK; Singh, T, 2016)
"Epilepsy is one of the most common symptoms in Tuberous Sclerosis Complex (TSC), appearing mainly in the first year of life and often resistant to therapy."( Estalella-Mendoza, A; Flores-González, JC; Hernández-González, A; Lechuga-Sancho, AM; Quintero-Otero, S; Rubio-Quiñones, F; Saldaña-Valderas, M, 2016)
"Epilepsy is a condition where patients have seizures due to abnormal nerve impulses in the brain."( Amalakanti, S; Athina, S; Bolla, HB; Daggumati, R; Devanaboina, AK; Gajula, RK; Lavu, H; Nagarjunakonda, S; Rajanala, L; Tata, RS; Uppala, V, 2017)
"Epilepsy is a debilitating seizure disorder that affects approximately 50 million people."( Jakobsen, S; Landau, AM; Lillethorup, TP; Nielsen, EH; Simonsen, M; Tasker, RA; Thomsen, MB; Wegener, G, 2016)
"Epilepsy is a disorder that affects 1-2% of the population and a significant percentage of these patients do not respond to anticonvulsant drugs available in the market suggesting the need to investigate new pharmacological treatments."( Coitinho, AS; Glassmann, D; Gomez, R; Marafon, P; Pereira, P; Vieira, V, 2016)
"Epilepsy is too complex to be considered as a disease; it is more of a syndrome, characterized by seizures, which can be caused by a diverse array of afflictions."( Akabani, G; Aramayo, R; Clanton, RM; Wu, G, 2017)
"Catamenial epilepsy is defined as an increase in the frequency of seizures during a particular phase of the menstrual cycle."( Khishfe, BF, 2017)
"Epilepsy is significantly more frequent in AD patients than in age-matched controls, even though the true extent of the phenomenon is not clear yet."( Bonuccelli, U; Giorgi, FS; Guida, M; Vergallo, A; Zaccara, G, 2017)
"Children with epilepsy are at an increased risk of injuries and hence need supervision."( Aneja, S; Jain, P; Sajjan, S; Seth, A; Sharma, S, 2016)
"Epilepsy is a common brain disorder characterized by the occurrence of recurring, unprovoked seizures."( Cai, M; Cai, S; Chen, L; Duan, S; Gu, H; Lin, R; Ling, C; Lu, J; Pan, X; Wang, Y; Zhu, H, 2017)
"Epilepsy is one of the most common neurological disorders, affecting about 2% of the population worldwide."( Arjunan, K; Eswaramoorthy, M; Jakki, SL; Nanjan, MJ; Senthil, V; Shanmuganathan, S; Yasam, VR, 2016)
"BACKGROUND Epilepsy is the most predominant neurological disorder characterized by recurrent seizures."( Hao, F; Jia, LH; Li, XW; Liu, XW; Zhang, YR, 2016)
"Epilepsy is a highly common chronic neurological disorder, manifested in many different types, affecting ~1% of the worldwide human population."( Bindila, L; Lerner, R; Loch, S; Lutz, B; Post, J, 2017)
"Epilepsy is a serious brain disorder with diverse seizure types and epileptic syndromes."( Chen, W; Gao, J; Li, XH; Li, YS; Lin, XY, 2016)
"Epilepsy is a complex, multifactorial disease characterized by spontaneous recurrent seizures and an increased incidence of comorbid conditions such as anxiety, depression, cognitive dysfunction, and sudden unexpected death."( Danbolt, NC; Dhaher, R; Eid, T; Gruenbaum, SE; Lee, TW; Zhou, Y, 2016)
"Epilepsy is thought to be associated with oxidative stress, glutamate excitotoxicity, and mitochondrial dysfunction."( Parvez, S; Raisuddin, S; Vishnoi, S, 2016)
"Epilepsy is one of the major neurological disorders frequently associated with psychiatric disorders such as depression."( Goel, RK; Kaur, T; Singh, T, 2017)
"Epilepsy is a significant disorder for which approximately one-third of patients do not respond to drug treatments."( Baines, RA; Giachello, CN; Lin, WH, 2017)
"A cure for epilepsy is currently not available, and seizure genesis, seizure recurrence, and resistance to antiseizure drugs remain serious clinical problems."( Bauer, B; Hartz, AM; Pekcec, A; Schlichtiger, J; Soldner, EL; Zhong, Y, 2017)
"Catamenial epilepsy is a common central nervous system disease in female, which is influenced by the 17-β-estradiol (estrogen) level during the menstrual cycle."( Huang, Y; Wang, G; Wang, X; Wang, Y; Zhang, Y, 2017)
"Hot water epilepsy is sensory epilepsy, wherein seizures are triggered by an unusual stimulus: contact with hot water."( Anand, A; Karan, KR; Satishchandra, P; Sinha, S, 2017)
"Thus, epilepsy is linked with a biomarker that might be related to accelerated brain aging and can be considered a neurobiological predisposition to later-life cognitive disorders."( Anttinen, A; Hermann, B; Joutsa, J; Karrasch, M; Rinne, JO; Shinnar, S; Sillanpää, M, 2017)
"Patients with epilepsy are frequently required to take antiepileptic drugs (AEDs) for a long period of time."( Chuang, MJ; Chuang, YC; Fu, TY; Lu, YT; Shih, FY; Tsai, MH; Tsai, WC, 2017)
"Epilepsy is the second most common disease of the brain."( Cho, KH; Chu, H; Chung, CK; Jeong, W, 2017)
"Epilepsy is a chronic neurological disorder, which is not only related to the imbalance between excitatory glutamic neurons and inhibitory GABAergic neurons, but also related to abnormal central cholinergic regulation."( Chen, Z; Wang, Y, 2017)
"Epilepsy is a common neurological disease characterized by abnormal temporary discharge of neurons in the central nervous system."( Chi, G; Huang, Z; Li, G; Li, X; Zhang, K, 2018)
"Epilepsy is one of the most common neurological disorders and the administration of antiepileptic drugs (AEDs) is the most common treatment."( Li, XM; Ma, XX; Ni, KM; Sun, P; Wei, X; Xu, M; Yang, CH; Yang, CR; Zhang, Y; Zhang, YJ, 2017)
"Epilepsy is a complicated neurological disorder that occurs worldwide and features several kinds of comorbidities in addition to recurrent seizures."( Guo, Y; Hu, Q; Kang, H; Lian, L; Liu, X; Xu, F; Zhang, N; Zhou, Q; Zhu, S, 2018)
"Epilepsy is complex neural disarray categorized by recurring seizures."( Cao, YL; Guo, XQ; Hao, F; Liu, XW; Wang, ML; Yan, ZR, 2017)
"Epilepsy is a chronic neurological condition, with over 30% of cases unresponsive to treatment."( Copmans, D; de Witte, PAM; Hunyadi, B; Siekierska, A; Sourbron, J, 2017)
"Epilepsy is a common neurological disease, manifested in unprovoked recurrent seizures."( Bekenstein, U; Berson, A; Friedman, A; Greenberg, DS; Hanin, G; Milikovsky, DZ; Mishra, N; Sheintuch, L; Soreq, H; Zelig, D, 2017)
"Epilepsy is fourth most common neurological disorders associated with depression and cognitive deficits."( Bagga, N; Gawande, DY; Goel, RK; Kaur, A; Kaur, N; Singh, T, 2017)
"Epilepsy is a common neurological condition with a worldwide prevalence of around 1%."( Marson, AG; Nevitt, SJ; Sudell, M; Tudur Smith, C; Weston, J, 2017)
"Epilepsy is a chronic neurological disorder that affects approximately 50 million people worldwide."( Becker, HM; Deitmer, JW; Forero-Quintero, LS, 2017)
"Epilepsy is one of the most common neurologic disorders worldwide with no distinguishable cause in 60% of patients."( Asgari, T; Babaie, J; Choopani, S; Gharagozli, K; Golkar, M; Sayyah, M, 2017)
"Epilepsy is a highly prevalent neurological disorder."( Galván, EJ; Lara-Valderrábano, L; Rocha, L, 2017)
"Epilepsy is a spectrum of neurological disorders with many causal factors."( Chen, X; Durisic, N; Keramidas, A; Lynch, JW, 2017)
"Epilepsy is one of the most common neurological diseases in childhood and adolescence."( Hadzagic-Catibusic, F; Hasanbegovic, E; Melunovic, M; Uzicanin, S; Zubcevic, S, 2017)
"Epilepsy is prevalent and often medically intractable in Angelman syndrome (AS)."( Bey, AL; Cao, X; Chung, L; Jiang, YH; Kim, IH; Towers, AJ, 2018)
"Epilepsy is worldwide one of the most common neurologic diseases (prevalence 0."( Fauser, S; Tumani, H, 2017)
"Because epilepsy is associated with changes in functional brain connectivity, we studied the relationship between cortisol and changes in global and focal (node-centered) functional connectivity measures for individuals with stress-sensitive and non-stress-sensitive epilepsy."( Braun, KPJ; den Heijer, JM; Jansen, FE; Joels, M; Lorraine Hompe, E; Otte, WM; Sander, JW; van Campen, JS; van Diessen, E; Zijlmans, M, 2018)
"Epilepsy is one of the most prevalent neurological disorder affecting more than 50 million people worldwide."( Jamwal, S; Koshal, P; Kumar, P, 2018)
"Epilepsy is one in every of the foremost important chronic neurological disorders with high incidence worldwide."( Bari, SB; Cheke, RS; Firke, SD; Patil, RR, 2018)
"Epilepsy is a neurological disease that affects more than 70 million people worldwide and is characterized by the presence of spontaneous unprovoked recurrent seizures."( Copmans, D; De Borggraeve, W; de Witte, PAM; Dehaen, W; Exarchou, V; Foubert, K; Kim, Y; Ny, A; Orellana-Paucar, AM; Pieters, L; Siekierska, A; Steurs, G; Zhang, Y, 2018)
"Epilepsy is a common symptom in patients with glioblastoma (GB)."( Arrieta, O; Balaña, C; Bermúdez, S; Bernal, L; Cardona, AF; Carranza, H; Franco, S; Gil-Gil, M; Hakim, EJ; Hakim, F; Mayor, LC; Mejía, JA; Ortíz, C; Ortíz, LD; Otero, J; Rojas, L; Ruiz-Patiño, A; Useche, N; Vargas, C; Wills, B; Zatarain-Barrón, ZL, 2018)
"Epilepsy is a chronic brain disease affecting millions of individuals."( Chen, X; Dong, G; Liu, Y; Lu, R; Wang, L; Yun, W; Zhou, X, 2018)
"Epilepsy is among the most common neurological disorders."( Du, J; Han, Y; Jin, H; Li, Q; Niu, M; Qin, J; Zhang, J, 2018)
"Epilepsy is a common neurological condition with a worldwide prevalence of around 1%."( Marson, AG; Nevitt, SJ; Sudell, M; Tudur Smith, C; Weston, J, 2017)
"Epilepsy is one of the most common neurological diseases and it causes profound morbidity and mortality."( Chen, Q; Fazeli, W; Fricke, O; Kamsteeg, EJ; Li, X; Oundjian, NJ; Poschmann, S; Snoeijen-Schouwenaars, FM; Wang, QK; Willemsen, M, 2018)
"Epilepsy is a common disease of the central nervous system."( Lian, Y; Xie, N; Zhang, H; Zheng, Y, 2018)
"Chronic epilepsy is typified by spontaneous recurrent seizures, cognitive dysfunction, and depression, which are associated with persistent inflammation, significantly waned neurogenesis, and abnormal synaptic reorganization."( Castro, OW; Shetty, AK; Upadhya, D; Upadhya, R, 2018)
"Epilepsy is one of the common diseases seriously threatening life and health of human."( Deng, XQ; Song, MX, 2018)
"Epilepsy is a chronic and recurrent disease of the central nervous system, with a complex pathology."( Miao, W; Shi, Y; Teng, J; Zhang, L, 2018)
"Epilepsy is one of the most common neurological diseases, and current antiepileptic drugs fail to suppress seizure occurrence in around one third of epileptic patients."( Aguiar, GPS; Bertoncello, KT; Oliveira, JV; Siebel, AM, 2018)
"Epilepsy is a common pediatric neurological condition with frequent psychiatric comorbidities, including ADHD."( Choudhary, A; Gulati, S; Sagar, R; Sankhyan, N; Sripada, K, 2018)
"Purpose/Aim: Epilepsy is a complex, chronic neurological disorder characterized by increased and abnormal synchronization of neuronal electrical activity, which is manifested as seizures."( Saha, L; Singh, N; Vijayanti, S, 2018)
"The prevalence of epilepsy is estimated 5-10 per 1000 population and around 70% of patients with epilepsy can be sufficiently controlled by antiepileptic drugs (AEDs)."( Andres-Mach, M; Czuczwar, M; Czuczwar, SJ; Kruszyński, K; Łukawski, K; Łuszczki, JJ, 2018)
"Epilepsy is a serious neurological disease affecting about 1% of people worldwide (65 million)."( Kondrat-Wróbel, MW; Łuszczki, JJ, 2018)
"People with epilepsy are at increased risk of mortality, but, to date, the cause-specific risks of all unnatural causes have not been reported."( Ashcroft, DM; Carr, MJ; DelPozo-Banos, M; Gorton, HC; John, A; Webb, RT, 2018)
"The prevalence of epilepsy is increased in multiple sclerosis (MS), but information on AED treatment and seizure outcome is scarce."( Burman, J; Dagiasi, I; Kumlien, E; Vall, V; Zelano, J, 2018)
"Epilepsy is a common neurologic disorder requiring continued treatment during pregnancy."( Costa, R; Gama, H; Graça, J; Magalhães, LM; Moreira, J; Rocha, JF; Soares-da-Silva, P; Vieira, M, 2018)
"Individualised epilepsy care is the gold standard, not blanket bans on drug choice based on gender."( Lawthom, C, 2018)
"Epilepsy is a kind of disease with complicated pathogenesis."( Lu, D; Ouyang, P; Yang, S, 2018)
"Epilepsy is a common neurological disorder and is not well controlled by available antiepileptic drugs (AEDs)."( Dong, K; Gao, B; Huang, DK; Li, WZ; Wu, WN; Wu, Y; Yang, YJ; Yin, YY; Zhou, J, 2018)
"Epilepsy is one of the chronic and heterogeneous epidemic neurological disorders leading to substantial mortality."( Banik, S; Das, A; Hossain, MS; Hussain, ME; Islam, MS; Karmakar, P; Sarwar, MS, 2019)
"Epilepsy is one of the furthermost common neurodegenerative diseases affecting above 50 million individuals worldwide."( El-Azab, MF; Moustafa, YM; Tawfik, KM, 2018)
"Epilepsy is a kind of neurogenic diseases with high prevalence and characterized by seizure, brain paradoxical discharge and convulsion in spontaneous, transient, recurrent and uncontrolled manner."( Song, DQ; Tang, S; Zhang, JP; Zheng, YM, 2016)
"Epilepsy is a chronic neurological disorder which affects 65 million worldwide population and characterized by recurrent seizure in epileptic patients."( Kumari, S; Mishra, CB; Siraj, F; Tiwari, AK; Tiwari, M; Yadav, R, 2018)
"Epilepsy is associated with increased morbidity and mortality together and places a large financial burden on individuals and society."( Chen, Y; Fajol, A; Ren, B; Shi, S; Song, S, 2018)
"Epilepsy is a major public health issue in low- and middle-income countries, where the availability and accessibility of quality treatment remain important issues, the severity of which may be aggravated by poor quality antiepileptic drugs (AEDs)."( Auditeau, E; Ba, A; Dufat, H; Dugay, A; Jost, J; Jousse, C; Kariuki, SM; Leremboure, M; Mafilaza, Y; Newton, CR; Ngoungou, E; Nguyen, TL; Nguyen, TT; Preux, PM; Raharivelo, A; Ratsimbazafy, V; Sivadier, G; Traïkia, M, 2018)
"Epilepsy is a neurological disorder with a multitude of underlying causes, which may include infection with Onchocerca volvulus, the parasitic worm that causes human onchocerciasis."( Colebunders, R; Greter, H; Hendy, A; Kakorozya, A; Makunde, WH; Matuja, W; Mmbando, BP; Mnacho, M; Suykerbuyk, P, 2018)
"Epilepsy is a common neurological disease characterized by recurrent unpredictable seizures."( Kennedy, RT; Luna-Munguia, H; Stacey, WC; Zestos, AG, 2019)
"Epilepsy is one of the most common neurological disorders affecting millions of people."( Bu, G; Chen, Z; Li, Y; Pan, G; Xu, H; Zhang, Y; Zheng, H, 2018)
"Epilepsy is one of the most prevalent and drug-refractory neurological disorders."( Chen, G; Gao, X; He, M; Hu, Y; Li, Y; Ma, Y; Tian, X; Wang, Q; Wang, W; Wang, X; Xu, D; Yang, Q; Yang, Y; Zheng, F; Zhou, R, 2018)
"Epilepsy is a chronic medical disease and is associated with comorbid adverse somatic conditions due to epilepsy itself or its long-term treatment."( Hamed, SA; Oseilly, AM, 2018)
"Epilepsy is a chronic neurological disorder affecting an estimated 50 million people worldwide."( Chen, W; He, Q; Hu, Y; Jiang, L; Man, S; Wu, L, 2018)
"BACKGROUND Epilepsy is a complex neurologic disorder with abnormal electrical impulses in the brain."( Han, Z; Wang, H; Xia, J; Zhang, Q, 2018)
"Epilepsy is a neurological disease with high global prevalence."( Blanco, JR; Gómez-Eguílaz, M; Pérez-Martínez, L; Ramón-Trapero, JL, 2018)
"Epilepsy is a neurological disorder that significantly impacts the quality of life of affected persons."( Coppola, G; Greco, M; Iezzi, ML; Operto, F; Varriale, G; Verrotti, A, 2018)
"Epilepsy is a brain disorder characterized by a predisposition to suffer epileptic seizures."( González, MI; Lam, PM, 2019)
"Epilepsy is a progressive neurological disease characterized by recurrent seizures and behavioral comorbidities."( Barker-Haliski, M; Bazelot, M; Glyn, S; Jones, N; McNeish, AJ; Patra, PH; Sandhu, H; Whalley, BJ; White, HS; Williams, CM, 2019)
"Epilepsy is a common clinical syndrome characterized by sudden and recurrent attacks and temporary central nervous system dysfunction caused by excessive discharge of neurons in the brain."( Chen, C; Duan, J; Guo, J; Guo, S; Qian, D; Shang, E; Tang, Z; Yan, H; Zhao, M; Zhu, Y; Zhu, Z, 2019)
"In vivo models of epilepsy are available to explore such epileptogenic mechanisms, also assessing the efficacy of chemoprevention and therapy strategies at the pre-clinical level."( Albertini, MC; Ambrogini, P; Bartolini, D; Betti, M; Cuppini, R; Di Palma, M; Galli, F; Lattanzi, D; Marinelli, R; Minelli, A; Torquato, P, 2019)
"Epilepsy is a common life-threatening neurological disorder that is often drug-resistant and associated with cognitive impairment."( Chen, M; Jia, C; Jiao, H; Wei, L; Yang, H; Yin, W; Zhang, R, 2019)
"Epilepsy is a neurological disorder of the central nervous system characterized by hypersynchronized neuronal activity and has been associated with oxidative stress."( Díaz-Ruíz, A; Flores-Espinosa, P; Manjarrez, J; Méndez-Armenta, M; Nava-Ruíz, C; Ruíz-Díaz, A; Yescas-Gómez, P; Zaga-Clavellina, V, 2019)
"Epilepsy is a disorder of the brain characterized by an enduring predisposition to generate epileptic seizures."( Fei, Y; Han, Y; Ji, Z; Long, Y; Song, Z; Yang, H; Zheng, W; Zhuang, K, 2019)
"Epilepsy is the most prevalent neurological disorder in the pediatric age group with a prevalence of 3."( Agadi, JB; Nagabushana, D; S, PK, 2019)
"Epilepsy is one of the common neurological illnesses which affects millions of individuals globally."( Gebre, AK; Surur, A; Wondafrash, DZ; Yimer, EM, 2019)
"Epilepsy is a multi-etiological brain dysfunction syndrome."( Gao, L; Hou, S; Li, J; Liu, A; Liu, N; Ma, Z; Qiao, Z; Shen, H; Wang, F; Wei, L; Zhang, X, 2019)
"Epilepsy is a common symptom of mitochondrial disease, and in the vast majority of cases, refractory to commonly used antiepileptic drugs."( Amagata, A; Ashley, EA; Bertini, E; Bruegger, JJ; Carrozzo, R; Chapman, KA; Dionisi-Vici, C; Enns, GM; Gahl, W; Hinman, A; Hoff, KG; Holst, CR; Johnson, SC; Kahn-Kirby, AH; Kim, V; Klein, MB; Kosaka, Y; Latham, JC; Maeder, CI; Malone, SA; Martinelli, D; Mei, JJ; Saneto, RP; Shrader, WD; Sideris, S; Trimmer, JK; Wang, L; Wheeler, MT; Wolfe, L, 2019)
"People with epilepsy are at increased risk for neuropsychological dysfunction due to multiple factors, of which the most amendable are antiseizure medications (ASMs)."( Boyd, A; Falco-Walter, J; Le, S; Loring, DW; Meador, KJ; Razavi, B; Seliger, J, 2019)
"Epilepsy is one of the most devastating neurological diseases and despite significant efforts there is no cure available."( Gamkrelidze, G; Kandashvili, M; Kokaia, M; Lepsveridze, E; Lortkipanidze, T; Margvelani, G; Solomonia, R; Tsverava, L, 2019)
"Epilepsy is a chronic neurological disorder which affects not only the health of the affected child, but also has an economic, psychological and emotional impact on the family as a whole."( Kadwa, RA; Kaushik, JS; Mittal, R; Sahu, JK; Sharma, S, 2019)
"Epilepsy is accompanied by angiogenesis and blood-brain barrier (BBB) disruption."( Gao, X; Pan, X; Sun, H; Wang, Q; Yu, H; Yu, J; Zhang, M; Zhang, Y; Zhu, W, 2019)
"Epilepsy is a prevalent neurological disorder that was reported to affect about 56 million people in the world."( Guo, F; Li, X; Liu, N; Ma, L; Sun, T; Yu, J; Zhang, X; Zheng, P; Zhou, R, 2019)
"Epilepsy is a group of neurological disorders characterized by recurrent seizures that disturbs about 60 million people worldwide."( Bai, Y; Chen, X; He, X; Sun, Y; Wu, S; Xie, J; Zhang, Y; Zhao, Z; Zheng, X, 2019)
"Epilepsy is the most common brain disease in dogs."( Bathen-Nöthen, A; Berk, BA; Jokinen, TS; Knebel, A; Law, TH; Packer, RMA; Pelligand, L; Tipold, A; Volk, HA; Wessmann, A, 2019)
"Epilepsy is a group of neurological disorders which affects millions of people worldwide."( Kaszas, A; Malliaras, GG; Proctor, CM; Slezia, A; Williamson, A, 2019)
"The incidence of epilepsy is very high; hence, taking into consideration the factors associated with it during the implementation of a treatment strategy may reduce its overall load."( Dismand, H; Donald, A; Mendinatou, A; Thierry, A, 2019)
"Epilepsy is a chronic neurological disease characterized by an enduring propensity for generation of seizures."( Balosso, S; Ravizza, T; Vezzani, A, 2019)
"Epilepsy is characterized by spontaneous seizures."( An, D; Chen, L; Men, C; Qi, M; Wang, Z; Xu, W; Zhan, Y; Zhou, L, 2019)
"Epilepsy is a common worldwide neurological disorder."( Al-Hajje, A; Boumediene, F; Jost, J; Mroueh, L; Preux, PM; Ratsimbazafy, V; Salameh, P, 2019)
"Epilepsy is a common chronic disease of the central nervous system that can last for years or even decades, causing serious adverse effects on the body, mind, and psychology of patients."( Qian, S; Tu, W, 2019)
"Epilepsy is a neurological disorder characterized by an enduring predisposition to generate and aggravate epileptic seizures affecting around 1% of global population making it a serious health concern."( H S, N; K L, K; Paudel, YN, 2019)
"Epilepsy is a prominent neurological disorder that affects millions of people worldwide."( Furness, AM; Lunte, CE; Lunte, SM; Michealis, EK; Pal, R, 2019)
"Epilepsy is one of the most common chronic neurological conditions."( Bak, LK; Jensen, CD; Kjær, C; Krarup, S; Lindholm, SEH; Mertz, C; Pinborg, LH, 2020)
"Epilepsy is a common neurological condition, characterised by recurrent seizures."( Bresnahan, R; Marson, AG; Martin-McGill, KJ; Milburn-McNulty, P; Powell, G; Sills, GJ, 2019)
"Drug-resistant epilepsy is the main risk factor for future intellectual disability in patients with tuberous sclerosis complex."( Borkowska, J; Chmielewski, D; Domańska-Pakieła, D; Głowacka, J; Jozwiak, S; Kaczorowska-Frontczak, M; Kotulska, K; Sadowski, K; Sijko, K; Słowińska, M; Łojszczyk, B, 2019)
"Epilepsy is a chronic neurological disease."( Guo, C; Guo, K; Hu, Z; Li, J; Liu, R; Peng, J; Wu, S; Zhang, W, 2019)
"Epilepsy is one of the most widespread neurological diseases characterized by spontaneous recurrent seizures."( Bilanishvili, IG; Gamkrelidze, GN; Kandashvili, M; Kokaia, M; Lordkipanidze, T; Nanobashvili, ZI; Solomonia, RO, 2019)
"Epilepsy is a chronic and severe neurological disorder."( Gong, SJ; Huang, WL; Wu, ZS, 2019)
"Patients with epilepsy are often affected by not only seizures but also a variety of cognitive and psychiatric comorbidities that further impair their quality of life."( Takechi, K, 2019)
"Epilepsy is one of the most common neurological disorders worldwide, with an age-adjusted prevalence of 4 to 8 per 1000 population and an age-adjusted incidence of 44 per 100,000 person-years in developed countries."( Bragazzi, NL; Brigo, F; Igwe, SC; Lattanzi, S, 2019)
"Epilepsy is a common neurological disorder."( Karyakin, VB; Malkin, SL; Postnikova, TY; Romanova, IV; Smolensky, IV; Zaitsev, AV; Zakharova, MV; Zavyalov, V; Zubareva, OE, 2019)
"CSNK2B-related epilepsy is relatively easy to be controlled."( Cai, S; Gao, K; Hu, W; Huang, S; Jiang, Y; Li, J; Liu, Y; Wang, J; Wang, Y; Wu, Y; Xie, H; Yan, H; Yang, Z; Yu, S; Zha, J, 2019)
"Epilepsy is a debilitating neurological illness that affects all aspect of an individual life."( Alese, OO; Mabandla, MV; Mkhize, NV; Rakgantsho, C; Zulu, S, 2020)
"Epilepsy is a highly prevalent disease characterized by recurrent, spontaneous seizures."( Buchanan, GF; Joyal, KG; Petrucci, AN; Purnell, BS, 2020)
"Epilepsy is a disease characterized by seizures which impair human life considerably."( Aygun, H; Sumbul, O, 2020)
"Epilepsy is a chronic disease characterized by recurrent unprovoked seizures."( Huntsman, RJ; Shackelford, AE; Tang-Wai, R, 2020)
"Epilepsy is characterized by oxidative stress in the brain."( Huang, W; Li, S; Li, Z; Liu, Z; Song, D, 2020)
"Epilepsy is a neurological disorder characterized by the presence of seizures and neuropsychiatric comorbidities."( da Silva-Júnior, RMP; Do Val-da Silva, RA; Garcia-Cairasco, N; Lazarini-Lopes, W; Leite, JP, 2020)
"Even though Epilepsy is a significant clinical issue in ATP1A3 patients, only a minority of publications provide any information about patients' anti-epileptic treatment."( Abicht, A; Biskup, S; Boonsimma, P; Borggraefe, I; Gasser, M; Ittiwut, C; Krenn, M; Kuersten, M; Milenkovic, I; Netbaramee, W; Roser, T; Shotelersuk, V; Srichomthomg, C; Suphapeetiporn, K; Tacke, M; von Stülpnagel, C; Wagner, M; Wechapinan, T; Zimprich, F, 2020)
"Epilepsy is a syndrome specified by frequent seizures and is one of the most prevalent neurological conditions, and that one-third of people of epilepsy are resistant to available drugs."( Ahmad, MA; Akbar, M; Pottoo, FH, 2020)
"Epilepsy is a widespread neurological disease characterized by abnormal neuronal activity resulting in recurrent seizures."( Dib, L; Fontana, A; Fritschy, JM; Gschwind, T; Lafourcade, C; Paterna, JC; Rambousek, L, 2020)
"Epilepsy is the most common chronic neurologic disorder which affects an estimated 10."( Ayalew, AF; Beyene, A; Birhan, T; Mulat, G; Simachew Kassa, A, 2020)
"Prevention of epilepsy is a great unmet need."( Bar-Klein, G; Friedman, A; Hameed, MQ; Jozwiak, S; Kaminski, RM; Klein, P; Klitgaard, H; Koepp, M; Löscher, W; Prince, DA; Rotenberg, A; Twyman, R; Vezzani, A; Wong, M, 2020)
"Epilepsy is a devastating neurological condition characterized by long-term tendency to generate unprovoked seizures, affecting around 1-2 % of the population worldwide."( Angelopoulou, E; Gnatkovsky, V; Othman, I; Paudel, YN; Piperi, C; Shaikh, MF, 2020)
"Epilepsy is a neurological disorder characterized by the occurrence of spontaneous and recurrent seizures."( Kumar, P; Kumar, V; Mishra, M; Prakash, C; Sharma, D, 2021)
"Patients with epilepsy are at increased risk for mental health and substance abuse disorders."( Bishu, KG; Fox, J; Lekoubou, A; Ovbiagele, B, 2020)
"Epilepsy is a common neurological disorder characterized by recurrent epileptic seizures."( Chen, F; Dong, X; Guo, C; Hou, S; Hu, Q; Jiao, Q; Li, Y; Liu, A; Liu, N; Shen, H; Wang, F; Wei, L; Wei, S; Wu, T; Yuan, S; Zhang, K; Zhang, X, 2020)
"Epilepsy is one of the most common neurological diseases."( Bakir, D; Cigdem, B; Dogan, HO; Ersan, S, 2020)
"Early-onset epilepsy is frequent and can be pharmacoresistant."( Billiemaz, K; Ceballos, I; Denommé-Pichon, AS; Héron, B; Imbard, A; Kuentz, P; Marie, S; Piraud, M; Ramond, F; Rio, M; Touraine, R; Vincent, MF, 2020)
"Epilepsy is often associated with emotional disturbances and the endocannabinoid (eCB) system tunes synaptic transmission in brain regions regulating emotional behavior."( Colangeli, R; Hill, MN; Morena, M; Pittman, QJ; Teskey, GC, 2020)
"Epilepsy is one of the most common neurological diseases."( Dong, J; Gan, G; Hu, S; Li, X; Yang, J; Yao, Y; Zhang, A; Zhang, C; Zhengxie, J; Zhu, X, 2020)
"The causes of epilepsy are diverse and not always known but one gene mutated in a small subpopulation of patients is phosphatase and tensin homolog (PTEN)."( Danzer, SC; Gross, C; MacLeod, MC; Tiwari, D; White, AR, 2020)
"Children with epilepsy are challenging for teleconsultation as direct information from the patient is missing, regarding seizures and adverse effects, especially behavioral and psychological side effects."( Dawman, L; Panda, P; Panda, PK; Sharawat, IK, 2020)
"Epilepsy is a pivotal neurological disorder characterized by the synchronous discharging of neurons to induce momentary brain dysfunction."( Cao, Q; Wang, H; Yang, F, 2021)
"Epilepsy is a neuropsychiatric disorder, which does not have any identifiable cause."( Gautam, M; Thapa, G, 2021)
"Epilepsy is very difficult to treat and often involves the combination of two or more AEDs."( Hayashi, T; Noguchi, Y; Tachi, T; Takaoka, M; Teramachi, H, 2020)
"Epilepsy is one of the most common diseases of the central nervous system."( Guo, C; Guo, K; Hu, Z; Li, J; Liu, R; Peng, J; Wu, S; Zhang, X, 2020)
"A major source of epilepsy is Neurocysticercosis (NCC), caused by Taenia solium infection."( Carabin, H; Drevets, DA; Evangeline, B; Hanas, JS; Hocker, JRS; Oommen, A; Prabhakaran, V; Rajshekhar, V, 2020)
"New mouse models of epilepsy are needed to better understand the complex genetic architecture of seizures and to identify therapeutics."( Bell, TA; Dalton, KA; Gu, B; Hock, P; Miller, DR; Pan, Y; Pardo-Manuel de Villena, F; Philpot, BD; Shaw, GD; Shorter, JR; Williams, LH, 2020)
"The onset of epilepsy is most prevalent between 1 and 3 years of age; however, approximately 25% of patients developed epilepsy before one year of age."( Samanta, D, 2021)
"Epilepsy is a common neurological disease and its most common type is temporal lobe epilepsy (TLE)."( He, H; Huang, Y; Lin, L; Pan, X; Wang, L; Wu, Y; Zhang, Y; Zhao, Y, 2021)
"The incidence of epilepsy is higher in AD patients with shared neuropathological hallmarks in both disease states, including the formation of neurofibrillary tangles."( Exley, C; Mold, MJ; Morris, B; O'Farrell, A, 2020)
"Epilepsy is one of the most common neurological complications in pregnancy; some women continue to use antiepileptic drugs (AEDs) to control seizures."( Furugen, A, 2020)
"Epilepsy is a syndrome involving chronic recurrent transient brain dysfunction."( Li, YZ; Sun, Z; Xu, HR; Zeng, CQ; Zhang, QG, 2020)
"Epilepsy is a chronic brain disease characterized by recurrent seizures."( Feixiang, S; Guo, M; Haiyan, G; Jiahang, S; Jie, L; Shengjie, S; Sihua, Q; Xiaoying, G; Yanmei, Z; Ying, C, 2020)
"Epilepsy is a common chronic neurological condition characterized by recurrent seizures."( Miyata-Nozaka, Y; Omar, H; Raymond, AA; Tan, HJ; Wong, SW; Zain, SM, 2021)
"Epilepsy is a chronic neurological disease characterized by recurrent epileptic seizures."( Biembengute, MEF; Boleti, APA; Cardoso, PHO; de Moraes, LFRN; E Silva, PS; Frihling, BEF; Koolen, HHF; Migliolo, L; Rodrigues, TAA, 2022)
"Epilepsy is a chronic disease, while epileptogenesis is a latent period where brain will be transformed into an epileptic one."( Chen, L; Gong, M; Kinoshita, M; Lai, W; Li, W; Peng, A; Qiu, X; Yang, L; Zhang, L; Zheng, W, 2020)
"Epilepsy is characterized by a progressive predisposition to suffer seizures due to neuronal hyperexcitability, and one of its most common co-morbidities is cognitive decline."( Bonansco, C; Fuenzalida, M; Guiffa, F; Martorell, A; Wellmann, M, 2020)
"Epilepsy is a chronic nervous system disease."( Chen, Q; Chen, Y; Feng, Z; Huang, H; Peng, Y; Wang, J; Xu, Z; Zeng, J; Zhang, H; Zhang, J; Zhou, X, 2020)
"Epilepsy is a chronic brain disease affecting millions of people worldwide."( Mosaferi, B; Najdi, N; Salari, AA; Zeraati, M, 2021)
"Epilepsy is one of the most common neurological disorders that severely affect the life quality of many people worldwide."( Ergul, M; Gumus, E; Ozdemir, E; Taskıran, AS, 2020)
"Epilepsy is a neurologicaldisorder characterized by persistent predisposition to recurrent seizurescaused by abnormal neuronal activity in the brain."( Akyuz, E; Angelopoulou, E; Eroglu, E; Kullu, I; Paudel, YN; Polat, AK, 2021)
"Drug-resistant epilepsy is a problem worldwide."( Kong, FC; Lang, LQ; Ma, CL; Zhong, MK, 2021)
"Epilepsy is one of the most common neurological disorders, affecting approximately 50 million people worldwide."( Beydoun, A; DuPont, S; Lagae, L; Matta, M; Nagire, V; Zhou, D, 2020)
"Epilepsy is a devastating neurological disorder characterized by the repeated occurrence of epileptic seizures."( Akyuz, E; Angelopoulou, E; Dundar, HE; Paudel, YN; Polat, AK, 2021)
"Epilepsy is a chronic neurodegenerative disease that has seriously threatened human health."( Cheng, Z; Luo, X; Wang, R; Yu, F, 2021)
"Epilepsy is a neurological condition characterized by synchronous neuronal oscillations (seizures) in the electroencephalogram."( Crunelli, V; Deidda, G; Di Giovanni, G, 2021)
"Epilepsy is accompanied by abnormal neurotransmission, and microRNAs, as versatile players in the modulation of gene expression, are important in epilepsy pathology."( Li, Y; Wang, P; Wang, Z; Yang, A; Zhang, Q; Zhang, Y, 2021)
"Epilepsy is a frequent chronic disorder of the brain characterized by intermittent epileptic seizures caused by hypersynchronous discharge of neurons in the brain."( Ghafouri-Fard, S; Hashemi, M; Hussen, BM; Omrani, MA; Rafigh, M; Sayad, A; Taheri, M, 2021)
"Epilepsy is the disease associated with seizures and convulsions."( Anwar, F; Arshad, S; Khan, MM; Najm, S; Naureen, H; Rehman, S; Sultana, K, 2020)
"Epilepsy is a chronic neurobehavioral disorder whereby an imbalance between neurochemical excitation and inhibition at the synaptic level provokes seizures."( Flores-Soto, M; González-Burgos, I; Martín-Amaya-Barajas, FL; Orozco-Suárez, S; Romero-Guerrero, C; Tejeda-Martínez, A; Vázquez-Hernández, N, 2021)
"In Morocco, epilepsy is one of the major neurological health conditions, with an estimated prevalence of 1."( Cherkaoui Rhazouani, O; Khramaz, M; Kissani, N; Mebrouk, Y; Meryem, C; Ouazzani, R; Souirti, Z, 2021)
"Epilepsy is a neurological disease with significant effects in children."( Han, J; Li, Y; Wang, Y; Yang, Y, 2021)
"Epilepsy is common in patients with brain tumors and frequently presents as the first clinical manifestation of an underlying tumor."( Heugenhauser, J; Iglseder, S; Kerschbaumer, J; Muigg, A; Nowosielski, M; Stockhammer, G; Unterberger, I, 2021)
"Temporal lobe epilepsy is considered to be one of the most common and severe forms of focal epilepsies."( Schwarzer, C; Zangrandi, L, 2022)
"Epilepsy is one of the most common brain disorders, affecting more than 50 million people worldwide."( Bicker, J; Carona, A; Falcão, A; Fonseca, C; Fortuna, A; Silva, R, 2021)
"Epilepsy is the tendency to have unprovoked seizures."( Milligan, TA, 2021)
"Epilepsy is characterized by recurrent seizures due to abnormal hyperexcitation of neurons."( Kim, HY; Kim, JI; Suh, PG, 2021)
"Epilepsy is a result of unprovoked, uncontrollable, and repetitive outburst of abnormal and excessive electrical discharges, known as seizures, in the neurons."( Akyuz, E; Arulsamy, A; Kullu, I; Shaikh, MF, 2021)
"Epilepsy is the third most frequent neurological disorder in aged patients after stroke and dementia."( Rohracher, A; Trinka, E, 2021)
"Epilepsy is one of the most common neurological disorders, with individuals having an increased susceptibility of seizures in the first few years of life, making children at risk of developing a multitude of cognitive and behavioral comorbidities throughout development."( Binder, MS; Condon, SM; Darner, AM; Faust, AM; Hodges, SL; Kwok, EM; Lugo, JN; Nolan, SO; Quintero, SI; Senger, SS; Womble, PD, 2021)
"Epilepsy is a common chronic neurological disease caused by the over-synchronization of neurons leading to brain dysfunction."( Guo, Q; Hu, QP; Hu, RR; Huang, XY; Shi, HY; Zheng, YY, 2021)
"Epilepsy is a neurological disorder mainly characterised by recurrent seizures that affect the entire population diagnosed with the condition."( Farrelly, AM; Grintzalis, K; Vlachou, S, 2021)
"Epilepsy is a common neurological disease that affects more than 50 million people worldwide."( Liang, J; Wang, G; Wang, J; Wu, X; Xiao, J; Xin, C, 2021)
"Epilepsy is a common neurological disease that cannot be well controlled by existing antiepileptic drugs."( Cao, J; Li, X; Yang, J; Yu, L; Yu, W, 2021)
"Epilepsy is one of the most common and disabling chronic neurological disorders."( Klein, P; Löscher, W, 2021)
"Epilepsy is one of the most frequent neurological disorders characterized by an enduring predisposition to generate epileptic seizures."( Al-Rafiah, AR; Mehdar, KM, 2021)
"Epilepsy is a chronic encephalopathy and one of the most common neurological disorders."( Chen, D; Gan, CL; Hu, L; Lan, G; Lee, TH; Liu, H; Mei, Y; Shui, X; Wang, L; Xia, Y; Zhang, T; Zou, Y, 2021)
"Epilepsy is a chronic neurological disorder, characterized by the predisposition of unprovoked seizures affecting the neurobiological, psychological, cognitive, economic, and social wellbeing of the patient."( Akhtar, MJ; Khan, SA; Naim, MJ; Pal, R; Paul, J; Singh, K, 2022)
"Disclosure of epilepsy is a relevant but under-researched topic in epilepsy research."( Desai, N; Lachake, AV; Udani, V, 2021)
"Epilepsy is a chronic disease of the brain that affects approximately 50 million people globally, with over 80 % of them living in low- and middle-income countries (LMICs)."( Boumédiène, F; Bruand, PE; Mioramalala, SA; Preux, PM; Rafanomezantsoa, RM; Raharinivo, MM; Raharivelo, A; Ratsimbasoa, A; Vincent, C, 2021)
"Epilepsy is a neurodegenerative brain disorder characterized by recurrent seizure attacks."( Al Kury, LT; Alattar, A; Alshaman, R; Alvi, AM; Feng, J; Khan, AU; Li, S; Muhammad, AJ; Shah, FA; Ullah, I, 2021)
"Childhood epilepsy is one of the most common neurological problems."( Athey, T; Bahl, S; Cordeiro, D; Mercimek-Andrews, S; Silver, G; Thakral, A, 2021)
"Epilepsy is the most common neurological disorder, affecting nearly 50 million people worldwide."( Al-Harrasi, A; Behl, T; Bhatia, S; Bungau, S; Kale, MB; Najda, A; Nurzyńska-Wierdak, R; Sehgal, A; Singh, S; Umare, MD; Upaganlawar, AB; Wankhede, NL, 2021)
"Epilepsy is a common neurological condition characterised by recurrent seizures."( Marson, AG; Milburn-McNulty, P; Panebianco, M, 2021)
"Epilepsy is a complex neurological syndrome characterized by seizures resulting from neuronal hyperexcitability and sudden and synchronized bursts of electrical discharges."( Dos Santos, WF; Fontana, ACK; Green, JL, 2021)
"Epilepsy is a common neurological disorder characterized by repeated and spontaneous epileptic seizures and is not well controlled by current medication."( Chen, Z; Wang, Y; Yang, L, 2022)
"Epilepsy is highly prevalent in patients with tuberous sclerosis complex (TSC)."( Curatolo, P; de Vries, PJ; Dlugos, DJ; Franz, DN; French, JA; Herbst, F; Ikeda, H; Lawson, JA; Nabbout, R; Pelov, D; Peyrard, S; Polster, T; Yapici, Z, 2021)
"Epilepsy is one of common neurological disorders, greatly distresses the well-being of the sufferers."( Gao, D; Jin, M; Li, N; Liu, K; Mou, L; Ren, Q; Sik, A; Zhang, M; Zhang, S, 2021)
"Epilepsy is a devastating neurological disorder characterized by recurrent seizures attributed to the disruption of the dynamic excitatory and inhibitory balance in the brain."( Akyuz, E; Angelopoulou, E; Koklu, B; Paudel, YN; Uner, A, 2022)
"Epilepsy is a common chronic neurological disease."( Chen, FF; Chen, YS; Feng, W; Hu, QP; Huang, XY; Peng, F; Yan, HX; Zhang, X; Zhou, YY, 2021)
"Epilepsy is one of the most common encountered neurological disorders."( Liu, D; Wang, Y, 2022)
"Epilepsy is one of the most common chronic neurological diseases."( Guo, C; Guo, K; Hu, Z; Li, J; Peng, J; Wu, S; Zhang, X; Zhang, Z, 2022)
"Epilepsy is a common chronic neurological disorder worldwide, but its entire pathology remains unknown."( Cheng, Y; Guo, W; Jia, Z; Li, G; Lu, Y; Pei, L; Yang, X; Zhang, S, 2022)
"Epilepsy is one of the most prevalent neurological conditions and carbamazepine is a commonly used anti-seizure drug (ASD), especially in developing nations."( Aghoram, R; Balachandran, M; Indira Priya, D; Jain, S; Meher, R; Nair, PP; Nandwani, S; Sreekumaran Nair, N; Wadwekar, V; Wagh, S, 2021)
"Epilepsy is the most common childhood neurological disorder in Nigeria."( Aronu, AE; Bisi-Onyemaechi, AI; Chikani, UN; Ojinnaka, NC; Uwaezuoke, NA, 2021)
"Epilepsy is a common neurological disorder characterized by abnormal and recurrent neuronal discharges that result in epileptic seizures."( Hernandez, L; Luna, R; Rosiles, A; Rubio, C; Taddei, E, 2022)
"Epilepsy is the most common chronic neurologic disorder characterized by the recurrence of unprovoked seizures."( Karthick, PA; Mathew, J; Ramakrishnan Manuskandan, S; Sivakumaran, N, 2021)
"Epilepsy is a disease that affects millions of people around the globe and has a multifactorial cause."( de Oliveira, MCVA; Duarte, FS; Pereira, MC; Pitta, IR; Pitta, MGR; Silva, AA; Viana, DCF, 2022)
"Epilepsy is one of the most common neurological disorders, whose development is typically detected via early seizures."( Duncan, D; Garner, R; Lai, M; Yıldız, İ, 2022)
"Epilepsy is a chronic neurological disorder that is treated with multiple medications that can have significant side effects."( Acikgoz, M; Aciman Demirel, E; Atasoy, HT; Celebi, U; Comert, E; Piri Cinar, B, 2022)
"Epilepsy is a chronic neurological disease that affects more than 50 million people worldwide."( Ateş, B; Çolakoğlu, N; Parlakpınar, H; Vardı, N; Yıldız, A, 2022)
"Epilepsy is a long-term recurrent chronic brain disease that can cause significant emotional burden to the patient and their family, as well as huge economic costs to society."( He, J; Wu, X; Zhou, D, 2022)
"Epilepsy is a severe neurological disease characterized by spontaneous recurrent seizures (SRS)."( Burjanadze, M; Dashniani, M; Gamkrelidze, G; Kandashvili, M; Kokaia, M; Lagani, V; Lepsveridze, E; Lordkipanidze, T; Solomonia, R; Tsverava, L, 2022)
"Epilepsy is one of the most common neurological disorders worldwide, with an age-adjusted prevalence of 4 to 8 per 1000 population and an age-adjusted incidence of 44 per 100,000 person-years in developed countries."( Bragazzi, NL; Brigo, F; Igwe, SC; Lattanzi, S, 2022)
"Epilepsy is one of the most common serious brain disorders, affecting about 1% of the population all over the world."( Abd El-Gawad, HS; Abd Elkader, HAE; Alhasani, RH; El-Sayed, SA; Essawy, AE; Tousson, E, 2022)
"Since autism and epilepsy are common neurodevelopmental disorders with high coincidence, we tested whether early-life chronic subconvulsive activity compared to convulsive activity alters handling, spatial memory, lateralization, coping strategy and the seizure threshold in a sex-dependent manner."( Friedman, LK; Kahen, BA; Velíšek, L; Velíšková, J, 2022)
"Epilepsy is an abnormal brain state that may be induced by synchronous neuronal activation and also abnormalities in energy metabolism or the oxygen supply vascular system."( Gao, DS; Hu, JM; Xi, W; Yin, L; Zhong, C, 2022)
"Epilepsy is one of the most common neurologic unit diseases that have different prevalence in different parts of the world."( Avan, R; Ershadi, F; Mousavi Mirzaei, SM; Roshanravan, B; Sahebnasagh, A; Tabrizi, N, 2022)
"Epilepsy is a neurological disease that pathologically affects brain functions."( Acar, S; Akbas, F; Gorucu Yilmaz, Ş; Meral, I; Okur, SK; Pala Acikgoz, N; Pala, M; Taslidere, E, 2022)
"Epilepsy is one of the most common neurological disorders, and it places a significant economic strain on the healthcare system around the world."( Abdallah, AAM; Ahmed, AE; Alotaibi, G; Bakri, AH; Halim, PR; Hassan, MH; Rashwan, NI, 2023)
"Epilepsy is a common neurological condition with a worldwide prevalence of around 1%."( Cividini, S; Marson, AG; Nevitt, SJ; Sudell, M; Tudur Smith, C, 2022)
"Epilepsy is a relatively complicated neurological disorder that results in seizures."( Aggarwal, NB; Akhter, J; Arora, I; Asad, M; Hoda, U; Rastogi, S; Samim, M; Siddiqui, MA, 2022)
"Epilepsy is a common neurological disorder affecting more than 70 million people worldwide."( Gao, Y; Jiang, X; Liang, X; Liu, W; Lu, H; Wang, N; Xing, B; Xu, X; Zhao, Q; Zhou, L, 2023)
"Epilepsy is a chronic neurological disorder that is characterized by episodes of seizure."( Guan, S; Liu, J; Qian, F; Wang, Y; Wu, H; Yang, J, 2022)
"Epilepsy is a common neurological condition induced by losing equilibrium of different pathway as well as neurotransmitters that affects over 50 million people globally."( Manavi, MA, 2022)
"Epilepsy is one of the most common neurological disorders affecting most social, economic and biological aspects of human life."( Abdelbasset, WK; Huldani, H; Jalil, AT; Jasim, SA; Margiana, R; Mohammad, HJ; Ridha, HS; Rudiansyah, M; Yasin, G, 2022)
"Epilepsy is increasing, being more common in older adults, with more than 20% of late-onset cases with unknown aetiology (LOEU)."( Aluisantonio, L; Chiaravalloti, A; Di Santo, S; Fernandes, M; Franchini, F; Izzi, F; Liguori, C; Manfredi, N; Mercuri, NB; Placidi, F; Schillaci, O, 2022)
"Epilepsy is a neurological disease that requires long-term antiepileptic drugs (AEDs)."( Abd El Hady, NMS; Abdallah, HM; Abdelmageed, SM; Aboelghar, HM; Garib, MI; Mahmoud, AA, 2022)
"Epilepsy is characterised by abnormal neuronal discharges, including aberrant expression of extracellular matrix (ECM) components and synaptic plasticity stabilisation."( Chen, L; Huang, H; Huang, Q; Niu, J; Ren, J; Su, X; Sun, T; Wan, D; Wang, P; Yang, L; Zhang, C, 2022)
"The challenges in epilepsy care in resource-limited regions were highlighted 10 years ago, and still remain an ongoing issue."( Fong, SL; Hung, SK; Khoo, CS; Lim, KS; Looi, I; Suppiah, PD; Tan, HJ; Tee, SK, 2022)
"Epilepsy is characterized by the occurrence of seizures, and the high prevalence of epilepsy-associated comorbidities affects the quality of patients' life."( Bertoncello, KT; Bonan, CD; Zanandrea, R, 2022)
"Epilepsy is a common neurological disorder which affects 50 million people worldwide."( Aguiar, GPS; Lima-Rezende, CA; Müller, LG; Oliveira, JV; Pedroso, J; Piato, A; Schneider, SE; Siebel, AM, 2022)
"Insular epilepsy is a great mimicker and can be mistaken for seizures originating from other areas of the brain or as nonepileptic spells."( Dieppa, M; Li, D; Perven, G; Podkorytova, I, 2022)
"Epilepsy is a neurological disease characterized by abnormal or synchronous brain activity causing seizures, which may produce convulsions, minor physical signs, or a combination of symptoms."( Belperio, G; Corso, C; Duarte, CB; Mele, M, 2022)
"Epilepsy is often considered to be a progressive neurological disease, and the nature of this progression remains unclear."( Cheng, P; Jia, P; Liao, S; Meng, K; Xiao, C; Xu, R; Zhao, X; Zheng, X, 2022)
"Epilepsy is characterized by seizures of diverse types that affect about 1-2% of the population worldwide."( Jiang, J; Li, W; Yu, Y, 2022)
"Epilepsy is a paroxysmal brain disorder that results from an imbalance between neuronal excitation and inhibition."( Deng, YC; Feng, Y; Gan, YJ; Li, GY; Liu, C; Qiao, XZ; Wei, ZH; Zhang, CC, 2022)
"Epilepsy is a chronic neurological disease with recurrent seizures."( Vasileva, Z, 2021)
"Epilepsy is a devastating brain disorder for which effective treatments are very limited."( Castillo, PE; Frechou, MA; Gonçalves, JT; Nasrallah, K; Persaud, S; Yoon, YJ, 2022)
"The prevalence of epilepsy is slightly higher in women than in men and sensitivity to seizure stimuli differs between sexes."( Cepeda, MS; Kern, DM; Novak, G; Teneralli, RE, 2022)
"PCDH19-related epilepsy is a rare X-linked type of epilepsy caused by genomic variants of the Protocadherin 19 (PCDH19) gene."( Dell'Isola, GB; Di Cara, G; Fattorusso, A; Imperatore, V; Mencaroni, E; Prontera, P; Striano, P; Tascini, G; Verrotti, A, 2022)
"Epilepsy is a chronic neurological disorder affecting 70 million people globally."( Banday, N; Batiha, GE; Bhat, MM; Mir, PA; Mir, RH; Mohi-Ud-Din, R; Pottoo, FH; Sawhney, G; Shah, AJ, 2022)
"Epilepsy is the second most prevalent neurodegenerative disease in the world."( López-López, F; Moreno, W; Rodríguez-Quintero, P; Rojas-Hernández, D; Rubio, C; Rubio-Osornio, M, 2022)
"People with epilepsy are at a higher risk of developing vascular disease."( Chen, Z; Kwan, P; Nicolo, JP; Nightscales, R; O'Brien, TJ, 2022)
"Epilepsy is one of the most common neurological disorders worldwide."( Amos, A; Escheu, G; Harrison, W; Hauke, P; Kaducu, J; Keller, L; Matuja, W; Ngowi, BJ; Ovuga, E; Pfausler, B; Richter, V; Schmidt, V; Schmutzhard, E; Stelzle, D; Welte, TM; Winkler, AS, 2022)
"Epilepsy is common in sub-Saharan Africa, often caused by neurocysticercosis or ischaemic strokes."( Amos, A; Escheu, G; Harrison, W; Hauke, P; Kaducu, J; Keller, L; Matuja, W; Ngowi, BJ; Ovuga, E; Pfausler, B; Richter, V; Schmidt, V; Schmutzhard, E; Stelzle, D; Welte, TM; Winkler, AS, 2022)
"Epilepsy is a widespread and mainly severe neurological condition portrayed by recurring spontaneous seizures caused by the brain's abnormal electrical activity."( Erbas, O; Erdogan, MA; Kirazlar, M, 2022)
"Epilepsy is a prevalent and frequently devastating neurological disorder defined by recurring spontaneous seizures caused by aberrant electrical activity in the brain."( Erbas, O; Erdogan, A; Erdogan, MA, 2023)
"Temporal lobe epilepsy is the most drug-resistant type with the highest incidence among the other focal epilepsies."( Behzadi, G; Davoudi, S; Hosseinmardi, N; Janahmadi, M; Khatibi, VA; Mirnajafi-Zadeh, J; Mohammadi, M; Nazari, M; Rahdar, M; Raoufy, MR; Rezaei, M, 2023)
"Epilepsy is one of the most common neurological disorders in childhood."( Bentley, R; Hu, G; Jiang, X; Lowe, S; Mei, H; Sun, C; Wu, Y; Xie, R; Zhao, W, 2022)
"Epilepsy is a neurological disorder caused by abnormally elevated neuronal firing and excitability."( Guo, Y; Hao, L; Jing, W; Peng, X; Wang, X; Yang, M; Yang, Y; Zhang, H, 2022)
"Epilepsy is a chronic neurological disorder and there is increasing evidence about the role of inflammation in epileptogenesis."( Barbosa, BB; Coitinho, AS; de Lima Rosa, G; Domingues, AM; Guzzo, EFM; Nunes, SEB; Padilha, RB; Siqueira, IR, 2022)
"Epilepsy is a common neurological condition, affecting over 70 million individuals worldwide."( Elkommos, S; Mula, M, 2022)
"Women with epilepsy are recommended high doses of folic acid before and during pregnancy owing to risk of congenital anomalies associated with antiseizure medications."( Alvestad, S; Bjørk, MH; Christensen, J; Dreier, JW; Gilhus, NE; Gissler, M; Igland, J; Leinonen, MK; Sun, Y; Tomson, T; Vegrim, HM; Zoega, H, 2022)
"Epilepsy is a neurological disease affected by an imbalance of inhibitory and excitatory signaling in the brain."( de Moura, JP; Dos Santos, AMF; Lopes, SM; Monteiro, AFM; Rodrigues, TCML; Scotti, L; Scotti, MT, 2023)
"Children with epilepsy are at increased risk of vitamin D deficiency."( Likasitthananon, N; Nabangchang, C; Numbenjapon, N; Phatarakijnirund, V; Suwanpakdee, P; Vichutavate, S, 2022)
"Epilepsy is a nervous system disease, and seizures are closely related to oxidative stress."( Ge, K; Jin, M; Liu, D; Liu, H; Ma, M; Wang, S; Yang, Y; Yin, C; Zhang, C; Zhang, J; Zhang, Y, 2022)
"Epilepsy is a common neurological disorder characterized by recurrent unprovoked seizures."( Appendino, JP; Au, PYB; Chahine, M; Ebdalla, A; Plumereau, Q; Poulin, H; Scantlebury, MH, 2022)
"Epilepsy is one of the most common brain disorder and, despite the possible use of several therapeutic options, many patients continue to have seizures for their entire lifespan and they need new therapeutic approaches."( Calvani, M; Giovannini, MG; Lana, D; Landucci, E; Magni, G; Mazzantini, C; Pellegrini-Giampietro, DE, 2022)
"Epilepsy is a neurological brain disease, and its recurrent seizures are related to the reductive substance-powered antioxidant defense system (ADS)."( Li, J; Qing, Z; Song, L; Wang, Q; Yang, R; Yang, S; Zhang, XB; Zhou, Y, 2022)
"Epilepsy is one of the most common and disabling chronic neurological diseases affecting people of all ages."( Engel, T; Wong, ZW, 2023)
"Epilepsy is one of the most common and refractory neurological disorders globally."( Liu, Y; Meng, J; Tao, X; Wang, F; Wang, W; Wang, Z; Xue, T; Yan, Z, 2023)
"Epilepsy is a brain disorder characterized by recurrent epileptic seizures and neurobiological, physiological, mood, and cognitive consequences."( Atanasova, M; Georgieva, K; Ioanidu, L; Nenchovska, Z; Shishmanova-Doseva, M; Tchekalarova, J; Uzunova, Y, 2022)
"Epilepsy is the results from the imbalance between inhibition and excitation in neural circuits, which is mainly treated by some chemical drugs with side effects."( Cao, C; Ji, Y; Lan, W; Li, G; Liu, X; Tao, J; Wang, C; Xue, H; Yao, Y; Zhang, S, 2022)
"Epilepsy is a chronic disease that affects a wide range of people."( Li, M; Li, S; Wang, S; Wu, J; Zhao, W, 2023)
"Epilepsy is a chronic disease that affects a wide range of people."( Li, M; Li, S; Wang, S; Wu, J; Zhao, W, 2023)
"Epilepsy is a chronic disease that affects a wide range of people."( Li, M; Li, S; Wang, S; Wu, J; Zhao, W, 2023)
"Epilepsy is one of the most common chronic diseases in children, and cannot be controlled with conventional antiepileptic drugs in 30% of cases."( Blažeković, I; Kolić, I; Prpić, I; Radić Nišević, J, 2021)
"Epilepsy is one of the most common chronic diseases in children, and cannot be controlled with conventional antiepileptic drugs in 30% of cases."( Blažeković, I; Kolić, I; Prpić, I; Radić Nišević, J, 2021)
"Epilepsy is one of the most common chronic diseases in children, and cannot be controlled with conventional antiepileptic drugs in 30% of cases."( Blažeković, I; Kolić, I; Prpić, I; Radić Nišević, J, 2021)
"Epilepsy is a neurological condition that causes unprovoked, recurrent seizures."( Jiang, S; Jin, WN; Li, Y; Shi, FD; Shi, K; Zhang, Z, 2023)
"Epilepsy is a neurological condition that causes unprovoked, recurrent seizures."( Jiang, S; Jin, WN; Li, Y; Shi, FD; Shi, K; Zhang, Z, 2023)
"Epilepsy is a disease which affects between 1 and 2% of the population, and a large proportion of these people do not react to currently available anticonvulsant medications, indicating the need for further research into novel pharmacological therapies."( Erbas, O; Erdogan, A; Erdogan, MA; Gurgul, S, 2023)
"Epilepsy is a disease which affects between 1 and 2% of the population, and a large proportion of these people do not react to currently available anticonvulsant medications, indicating the need for further research into novel pharmacological therapies."( Erbas, O; Erdogan, A; Erdogan, MA; Gurgul, S, 2023)
"Nocturnal epilepsy is a neurological disease that has a significant effect on sleep."( Ayala-Guerrero, F; Castro-Domínguez, D; Gutiérrez-Chávez, CA; Mateos-Salgado, EL; Mexicano-Medina, G, 2023)
"Nocturnal epilepsy is a neurological disease that has a significant effect on sleep."( Ayala-Guerrero, F; Castro-Domínguez, D; Gutiérrez-Chávez, CA; Mateos-Salgado, EL; Mexicano-Medina, G, 2023)
"Epilepsy is a group of chronic neurological disorders characterized by recurrent and abrupt seizures."( Chen, H; Ji, T; Jiang, Y; Liu, X; Wang, W; Yu, G; Zhan, X; Zhou, XH, 2022)
"Epilepsy is a common neurological disorder and glutamate excitotoxicity plays a key role in epileptic pathogenesis."( Mai, D; Qu, Q; Qu, S; Ren, S; Wang, J; Zhang, W; Zhang, Y, 2022)
"Epilepsy is a chronic neurological disorder that presents as recurrent, unprovoked seizures."( Chou, IC; Wang, HS; Yang, MT, 2023)
"Epilepsy is a common neurological disorder associated with alterations of excitation-inhibition balance within brain neuronal networks."( Bryson, A; Petrou, S; Reid, C, 2023)
"Epilepsy is characterized by the manifestation of spontaneous and recurrent seizures."( Bertoncello, KT; Bonan, CD, 2023)
"Epilepsy is one of the most common neurological disorders in the world."( Bonaccorso, A; Di Martino, P; Gigliobianco, MR; Lombardo, R; Mancuso, A; Musumeci, T; Pellitteri, R, 2023)
"Epilepsy is a common and severe neurological disorder in which impaired glucose metabolism leads to changes in neuronal excitability that slow or promote the development of epilepsy."( Chen, Y; Gu, H; Shan, Y; Sun, Y; Wang, Y, 2023)
"Epilepsy is a chronic neurological disorder characterized by recurrent unprovoked seizures."( Darwish, HA; Seleem, MM; Shaheen, AA; Zayed, AA, 2023)
"Epilepsy is a common, chronic neurological disorder characterized by recurrent spontaneous seizures."( Ai, M; Chen, H; Chen, L; Liu, Y; Mei, R; Pang, R; Xia, D; Zhang, L; Zhong, L, 2023)
"The treatment of epilepsy is associated with the inhibition of γ-aminobutyric acid-aminotransferase (GABA-AT), which suppresses the concentration of a key neurotransmitter GABA."( Akshinthala, P; Kapavarapu, R; M, AR; Salaria, P, 2023)
"Epilepsy is a chronic disease characterized by an ongoing predisposition to seizures."( Coitinho, AS; de Lima Rosa, G; Domingues, AM; Guzzo, EFM; Padilha, RB, 2023)
"Epilepsy is a chronic disease of the central nervous system characterized by recurrent epileptic seizures."( Czuczwar, SJ; Kamieniak, M; Kośmider, K; Miziak, B, 2023)
"Epilepsy is a complex neurological disease characterized by spontaneous recurrent seizures that affect around 1% of the global population."( Jiang, X; Liu, J; Wang, Y, 2023)
"Epilepsy is the most common symptom in patients with brain tumors."( Aronica, E; Ciusani, E; Coppola, A; Costa, C; Maschio, M; Perversi, F; Russo, E; Salmaggi, A, 2023)
"Epilepsy is a chronic neurological condition in which inflammation and oxidative stress play a key role in the pathogenesis."( Dolatshahi, M; Hashemi, P; Karimpour, S; Nazarinia, D, 2023)
"Epilepsy is one of the most prevalent neurological illnesses defined by periodic seizures with or without loss of consciousness caused by aberrant neural activity."( Alhalmi, A; Bharadwaj, A; Kumar, G; Pathak, D; Sharma, A; Singh, T; Virmani, T, 2023)
"Epilepsy is highly prevalent in SSADHD, and its onset and severity correlate with an age-related decline in GABA and GABA-related metabolite levels as well as TMS markers of reduced cortical inhibition."( Arning, E; Aygun, D; Bertoldi, M; DiBacco, ML; García-Cazorla, À; Gibson, KM; Jeltsch, K; Lee, HHC; MacMullin, P; Opladen, T; Pearl, PL; Rotenberg, A; Roullet, JB; Sachee, D; Tokatly Latzer, I; Tsuboyama, M, 2023)
"Epilepsy is an important cause of morbidity and mortality especially in low- and middle-income countries."( Chhetri, B; Dhakal, GP; Dorji, T; Jamtsho, S; Nirola, DK; Pema, D; Tenzin, K; Wangmo, S, 2023)
"Epilepsy is one common brain disorder, which is not well controlled by current pharmacotherapy."( Chen, Z; Ji, XM; Jiang, XH; Liu, JY; Qiu, XY; Sun, MJ; Tan, B; Wang, F; Wang, Y; Xu, CL, 2023)
"Epilepsy is considered to result from an imbalance between excitation and inhibition of the central nervous system."( Gu, J; Guo, HK; Hu, DM; Huang, R; Ke, PY; Kwan, P; Liu, J; Ma, YL; Tang, FL; Zang, QW; Zhang, H; Zhang, XG; Zhang, ZJ, 2023)
"Epilepsy is a common neurological disease requiring long-term therapy also during pregnancy."( Beyersmann, J; Dathe, K; Fietz, AK; Hoeltzenbein, M; Onken, M; Schaefer, C; Slimi, S; Stegherr, R, 2023)
"Epilepsy is a common chronic neurological disorder in the pediatric population and its evolution can be fatal."( Bourrous, M; Gyamfi, SO; Lahmini, W, 2023)
"Epilepsy is a chronic brain disease and often occurs suddenly for no reason."( Li, HM; Li, XZ; Liu, Q; Yang, WD; Zhang, SN; Zhou, Y, 2023)
"Epilepsy is not well controlled by current anti-seizure drugs (ASDs)."( Chen, Z; Cho, WS; Dai, SJ; Li, ZS; Nishibori, M; Park, SB; Qiu, XY; Shao, YY; Shi, JY; Sun, JY; Wang, Y; Xu, CL; Yan, MQ; Yi, S; Zheng, Y, 2023)
"Epilepsy is one of the most common neurologic disorders globally."( Fazlollahi, A; Gharagozli, K; Golabi, B; Kolahi, AA; Nejadghaderi, SA; Safiri, S; Sullman, MJM; Zahmatyar, M; ZareDini, M, 2023)
"Epilepsy is widely investigated as a common neurological disease requiring pharmacologically effective agents."( Azak Pazarlar, B; Bilister Egilmez, C; Erbas, O; Erdogan, MA, 2023)
"Focal epilepsy is thought to be a network disease, in which epileptiform activity can spread noncontiguously through the brain via highly interconnected nodes, or hubs, within existing networks."( Estin, J; Li, D; Li, J; Lin, W; Liou, JY; Luo, P; Ma, H; Niemeyer, JE; Schwartz, TH; Yang, F; Zhan, F; Zhao, M, 2023)
"Epilepsy is a neurological disorder affecting both children and adults, and many aspects of this disease are still poorly understood."( D'Amora, M; De Angelis, F; Faraguna, U; Galgani, A; Giorgi, FS; Marchese, M; Tantussi, F, 2023)
"Epilepsy is a common chronic brain disease."( Chen, L; Cui, W; Huang, H; Luo, T; Xu, Z; Zhu, M, 2023)
"Epilepsy is one of the most common and serious brain syndromes and has adverse consequences on a patient's neurobiological, cognitive, psychological, and social wellbeing, thereby threatening their quality of life."( Liu, J; Xia, Z; Xie, C; Zhang, X; Zhao, W, 2023)
"Epilepsy is one of the most serious worldwide neurological disorders that lead to the cognitive-psychosocial insults in recurrent seizures."( Abdelaziz, EZ; Ali, DA; Kolieb, E; Mohamed, AM, 2023)
"Epilepsy is the most common chronic disorder in the nervous system, mainly characterized by recurrent, periodic, unpredictable seizures."( Huang, H; Luo, Y; Tai, Z; Xu, Z; Yang, J; Zhang, H; Zhang, L, 2023)
"Epilepsy is one of the most common neurologic diseases, and around 30% of all epilepsies, particularly the temporal lobe epilepsy (TLE), are highly refractory to current pharmacological treatments."( Bascuñana, P; Delgado, M; García-García, L; Gomez, F; Hernández-Martín, N; Pozo, MÁ; Rosa, RF; Silván, Á, 2023)
"Epilepsy is a nervous system disease that affects millions of individuals worldwide, and up to 25% of patients have seizures that are resistant to antiepileptic drugs."( Dogru, YZ; Erat, M; Nacar, T, 2023)
"Epilepsy is one of the most prevalent neurological human diseases, affecting 1% of the population in all age groups."( Challal, S; Crawford, AD; Esguerra, CV; Langlois, M; Skalicka-Woźniak, K; Skiba, A; Wolfender, JL, 2023)
"Epilepsy is one of the most common chronic neurological disorders, affecting more than 50 million people globally."( Abakumova, T; Hoyle, CHV; Ziganshina, LE, 2023)
"Epilepsy is marked by unpredictable and recurrent episodes of seizures."( Shende, P; Trivedi, R, 2023)
"Epilepsy is a prevalent disease that requires personalized care to control seizures, reduce side effects, and ameliorate the burden of comorbidities."( Funaro, MC; Khan, W; Moeller, JJ; Narrett, JA, 2023)
"Patients with epilepsy are significantly burdened by the disease due to long-term health risks, the severe side effect profiles of anti-epileptic drugs, and the strong possibility of pharmacoresistant refractory seizures."( Burkett, JP; Kile, KB; Lloyd, EAR; Neifer, AE; Neifer, KL; Swain, CC; Wischmeier, JN, 2023)
"Epilepsy is a complex neurological condition characterized by recurrent seizures."( Attisano, L; Carlen, PL; El Soufi El Sabbagh, D; Nader, G; Santos, AC; Urban, K, 2023)
"Epilepsy is a chronic brain disorder characterized by unprovoked and recurrent seizures, of which 60% are of unknown etiology."( Ameli, C; Cordero-Maldonado, ML; Crawford, AD; Donato, C; Martins, TG; Mombaerts, L; Peri, F; Skupin, A; Soliman, R, 2023)
"Epilepsy is a common neurological disease caused by synchronous firing of hyperexcitable neurons."( Chen, T; Gu, N; Ju, Y; Li, M; Lin, X; Liu, Y; Tang, J; Wang, X; Yang, F, 2023)
"Epilepsy is a group of neurological diseases characterized by susceptibility to recurrent seizures."( Harris, KM; Hope, OA, 2023)
"Epilepsy is a major symptom in patients with glioma."( Arakawa, Y; Furukawa, K; Hattori, EY; Kikuchi, T; Mineharu, Y; Miyamoto, S; Tanji, M; Terada, Y; Yamao, Y, 2023)
"Epilepsy is the most common neurological disorder which is accompanied with behavioral and psychiatric alternations."( Hashemi, P; Moslehi, A; Nazarinia, D, 2023)
"Epilepsy is caused by an excessive recurrent excitatory neuronal firing, characterized by motor, psychomotor, and sensory impairments."( Dhureja, M; Gupta, R; Kumar, P; Soni, D; Upadhayay, S, 2023)
"Epilepsy is one of the most common chronic neurological disorders, affecting around 50 million people worldwide, but its underlying cellular and molecular events are not fully understood."( Dzwonek, J; Grajkowska, W; Marchel, A; Matyja, E; Rysz, A; Skupien-Jaroszek, A; Szczepankiewicz, AA; Wilczynski, GM, 2023)
"Epilepsy is a neurological disease with high global prevalence."( Khoo, CS; Lim, KY; Rajah, R; Tajurudin, FW; Tan, HJ, 2023)
"Epilepsy is a serious neurological disorder characterised by a tendency to have recurrent, spontaneous, seizures."( Anderson, C; Bagshaw, AP; Cook, MJ; D'Souza, W; Lightman, SL; Marinelli, I; Seneviratne, U; Terry, JR; Walker, JJ; Woldman, W, 2023)
"Epilepsy is characterized by repeated seizure activity."( Kesavan, R; Kumar, RR; Narayan, SK; Ramakrishnan, K; Shewade, D; Venkatraman, S, 2023)
"Epilepsy is a prevalent neurological disease, affecting approximately 1-2% of the global population."( Benvenutti, R; Chitolina, R; Herrmann, AP; Linazzi, A; Marcon, M; Piato, A; Reis, CG; Stahlhofer-Buss, T, 2023)
"Pediatric epilepsy is a debilitating disease cluster that is much less researched than adult epilepsy."( Daniel, J, 2023)
"Epilepsy is a prevalent neurological disorder with a complex pathogenesis and unpredictable nature, presenting limited treatment options in >30 % of affected individuals."( Barbosa, RM; Fernandes, E; Gerhardt, GA; Ledo, A, 2024)
"Epilepsy is a chronic neurological disease with recurrent seizures."( Akyüz, E; Ateş, Ş; Doğanyiğit, Z; Okan, A; Shaikh, MF; Taheri, S; Yılmaz, S; Yılmaz, Z, 2023)
"Epilepsy is a neurological disorder characterized by recurrent seizures, partially correlated with genetic origin, affecting over 70 million individuals worldwide."( He, MF; Lin, YM; Liu, CQ; Mao, YL; Qiao, JD; Zhang, XX, 2023)
"Epilepsy is a chronic neurological condition that disrupts the normal functioning of the brain and it is characterized by seizures."( Amidu, SB; Boamah, VE; Ekuadzi, E; Mante, PK, 2023)
"Epilepsy is a very common neurological disease with high morbidity and mortality."( Cánovas-Iniesta, M; Navarro-Lozano, M; Palazón-Cabanes, B; Pérez-Navarro, VM, 2023)

Context

ExcerptReference
"High rates of epilepsy have been observed after cranial surgery in patients with meningioma, aneurysm, and head injury with or without intracranial clots, and routine prophylaxis with phenytoin would seem to be indicated in such patients."( Challen, RG; Frewin, DB; Hanieh, A; Hann, CS; North, JB; Penhall, RK, 1980)
"They conclude that epilepsy has a presentation rate of 9,6% in patients with previous febrile seizures, having the highest risk when they show previous familial seizures, neonatal pathology and altered EEG after the first febrile convulsion."( Díez, JM; Palencia Luances, R; Sánchez-Villares, S; Tresierra, F, 1981)
"Epilepsy has important effects on puberty, contraceptive efficacy, pregnancy and fetal development, and menopause."( El-Sayed, YY, 1998)
"Epilepsy has a tremendous impact on quality of life."( , 1998)
"Epilepsy has been documented in about 10% of patients with systemic lupus erythematosus (SLE)."( Afeltra, A; Amoroso, A; Del Porto, F; Francia, A; Galluzzo, S; Gandolfo, GM; Mitterhofer, AP; Vadacca, M, 2002)
"This type of epilepsy has generally been defined as an increase in seizure frequency beginning immediately before or during menses."( Falcone, T; Foldvary-Schaefer, N, 2003)
"Men with epilepsy have reduced fertility, and antiepileptic drugs may affect semen quality."( Isojärvi, JI; Juntunen, KS; Löfgren, E; Päivänsalo, M; Pakarinen, AJ; Rautakorpi, I; Tuomivaara, L, 2004)
"Kainate-induced epilepsy has been shown to be associated with increased levels of neuropeptide Y (NPY) in the rat hippocampus."( Cavadas, C; Cristóvão, A; Ferreira, R; Grouzmann, E; Lourenço, J; Malva, JO; Oliveira, CR; Pinheiro, PS; Silva, AP; Xapelli, S, 2005)
"Many men with epilepsy have low testosterone, and aromatase inhibition may be helpful in restoring levels to normal."( Harden, C; MacLusky, NJ, 2005)
"Epilepsy has been studied in vitro, mostly on rat hippocampus, through brain slices techniques."( Breda, RV; Costa da Costa, J; de Abreu, DS; de Borba Cunha, F; de Oliveira, RM; Konno, K; Nihei, K; Palma, MS; Salamoni, SD; Tavares, AA; Venturin, GT, 2005)
"Women with epilepsy have a higher risk of having dysmorphic child."( Batukan, C; Ceylaner, G; Ceylaner, S; Guven, MA; Uzel, M, 2006)
"Epilepsy has been associated with poor obstetric outcomes that could be the result of the epilepsy itself or a direct effect of anti-epileptic medication on placentation."( Anin, S; Bates, MD; Chadwick, D; Neilson, JP; Quenby, SM; Vince, GS, 2008)
"People with epilepsy have twice the fracture rate of nonepilepsy populations."( Elliott, JO; Jacobson, MP; Seals, BF, 2008)
"Patients with epilepsy have excess morbidity and mortality due to ischemic cardiovascular disease."( Apeland, T; Frøyland, ES; Kristensen, O; Mansoor, MA; Strandjord, RE, 2008)
"People with epilepsy have a higher risk of accidents and injuries when compared to others in the community."( John, J; Sapna, CS; Sheeba, SL; Thomas, SV, 2008)
"Children with epilepsy have high rates of sleep problems."( Abd-Elhamid, IA; Asaad, T; Elkhayat, HA; Elwakkad, AS; Hassanein, SM; Tomoum, HY, 2010)
"Patients with epilepsy have increased risk of myocardial infarction (MI)."( Abildstrøm, SZ; Andersson, C; Erdal, J; Gislason, GH; Hansen, PR; Olesen, JB; Schmiegelow, M; Torp-Pedersen, C; Weeke, P, 2011)
"Epilepsy has a high mortality rate due to sudden death, which is poorly understood."( Li, C; Lin, W; Lv, Y; Ma, D; Meng, H, 2012)
"Children with epilepsy have a significant risk for attention-deficit/hyperactivity disorder (ADHD), which is often accompanied by deficits in working memory performance."( Bechtel, N; Capone, A; Klarhöfer, M; Kobel, M; Opwis, K; Penner, IK; Scheffler, K; Schmitt-Mechelke, T; Specht, K; Weber, P, 2012)
"Epilepsy has frequently been portrayed in literary works, films and television series, often relating it with madness, delinquency, violent behaviours or possession by the divine or the diabolical, all of which has helped perpetuate our ancestral beliefs."( Carrillo, JM; Collado-Vázquez, S, 2012)
"Patients with epilepsy have higher stroke-related morbidity and mortality, leading to the suspicion that the increased stroke events may be associated with antiepileptic drug (AED) exposure."( Hsieh, CY; Lai, EC; Lin, SJ; Yang, YH, 2013)
"Patients with epilepsy have high unemployment rate in Malaysia despite a robust economy and minimal social security."( Lim, KS; Tan, CT; Wo, SW; Wong, MH, 2013)
"People with epilepsy have a high incidence of mood disorders that may affect their quality of life."( Kajita, Y; Nagai, T; Wakabayashi, T; Yoshida, K, 2013)
"Pregnant women with epilepsy have a significantly increased risk of mortality and morbidity compared to non-pregnant women."( Al Wattar, BH; Bagary, M; Doug, M; Greenhill, L; Houston, V; Khan, KS; McCorry, D; Pirie, AM; Pirie, DA; Siddiqua, A; Thangaratinam, S, 2014)
"Drug-resistant epilepsy has remained a problem since the inception of antiepileptic drug development, despite the large variety of antiepileptic drugs available today."( Walker, MC; Williams, RS, 2013)
"Epilepsy has previously been regarded as exclusively a disturbance in the functioning of neurons and especially of their contact points, the synapses."( Heuser, K; Szokol, K; Taubøll, E, 2014)
"Neuroimaging in epilepsy has progressed from correlations with demographic, semiologic, neuropsychological and other observational data primarily in patients undergoing presurgical investigations to imaging network connectivity changes in epilepsy syndromes, and testing specific mechanisms underlying drug-resistant epilepsy."( Koepp, MJ, 2014)
"Individuals with epilepsy have increased risk factors for vascular disease, particularly lipid abnormalities and elevated total plasma homocyst(e)ine (tHcy)."( Keenan, N; Sadlier, LG; Wiltshire, E, 2014)
"Epilepsy has been never reported so far in literature as a possible feature of Stickler syndrome, although neurological presentations, including epilepsy and brain abnormalities, have been occasionally described in other COL2A1-related phenotypes (e."( Foiadelli, T; Laino, D; Lobefalo, L; Marseglia, GL; Salpietro, V; Savasta, S; Spartà, MV; Verrotti, A, 2015)
"Epilepsy has 2-3% incidence worldwide."( Nazıroğlu, M, 2015)
"Although epilepsy has been prevalent for thousands of years, it is still not possible to completely control the disease."( Lu, S; Wang, X, 2015)
"Although epilepsy has traditionally been thought of as a disease caused by changes in neuronal properties exclusively, these new findings challenge us to consider the contribution of glial cells as drivers of epileptogenesis in acquired epilepsies."( Robel, S; Sontheimer, H, 2016)
"Epilepsy has an impact on the reproductive system."( Bayraktutan, OF; Ceylan, M; Karabulut, I; Sonkaya, AR; Yalcin, A, 2016)
"Epilepsy has been recognized as a brain network disorder."( An, D; Xiao, F; Zhou, D, 2017)
"Epilepsy has been associated with cardiovascular comorbidity."( Díez, L; Elosua, R; Gomez, A; Moreira, A; Roquer, J; Vivanco-Hidalgo, RM, 2017)
"rubra and C."( Bayram, AK; Elmalı, F; Gümüş, H; Per, H; Per, S; Saraymen, R; Taşdemir, A; Tubaş, F; Uzun, A; Yıldırım, M, 2017)
"Children with epilepsy have reduced health-related quality of life (HRQOL) due to disease and medications."( Azad, C; Bansal, D; Dasari, A; Gudala, K, 2017)
"Children with epilepsy have diminished HRQOL than healthy children in all subdomains of PedsQL."( Azad, C; Bansal, D; Dasari, A; Gudala, K, 2017)
"Epilepsy has many causes and comorbidities affecting as many as 4% of people in their lifetime."( Beyer, BS; Ferland, RJ; Gracias, J; Hains, L; Herron, BJ; Kadiyala, SB; Kang, EY; O'Brien, B; Papandrea, D; Smith, J, 2017)
"As a consequence, epilepsy has a negative pervasive impact in children with epilepsy (CWE), and their parents."( Lai, PSM; Low, WY; Ong, LC; Wo, SW, 2018)
"Epilepsy has a growing frequency, particularly in the elderly."( Calabresi, P; Cesarini, EN; Costa, C; Di Santo, S; Farotti, L; Franchini, F; Izzi, F; Lanari, A; Liguori, C; Manfredi, N; Mercuri, NB; Parnetti, L; Placidi, F; Romoli, M; Salvadori, N; Spanetta, M, 2019)
"Pharmaco-resistant Epilepsy has been a major challenge for medical interventions in controlling seizures."( Amalakanti, S; Bhat, UA; Chakravarty, S; Khandelwal, N; Kumar, A; Mylavarapu, MB; Sundarachary, NV, 2021)
"The management of epilepsy has advanced considerably since the early nineties."( Cherkaoui Rhazouani, O; Khramaz, M; Kissani, N; Mebrouk, Y; Meryem, C; Ouazzani, R; Souirti, Z, 2021)
"Epilepsy has now become one of the most prevalent CNS disorders."( Forouzanfar, F; Jamialahmadi, T; Majeed, M; Sahebkar, A, 2021)
"Epilepsy has emerged as a global health concern affecting about 70 million people worldwide."( Akyuz, E; Angelopoulou, E; Koklu, B; Paudel, YN; Uner, A, 2022)
"Patients with epilepsy have a higher mortality rate than the general population."( Chiou, MJ; Chou, IJ; Chung, TT; Hung, PC; Lin, JJ; Lin, KL; Liu, YH; See, LC; Wang, HS, 2021)
"Epilepsy has neuropsychiatric comorbidities such as depression, bipolar disorder, and anxiety."( Kilinc, E; Kılınc, YB; Torun, IE, 2022)
"Also, epilepsy has been related to an increased prevalence of obesity and called type 2 diabetes mellitus."( Manavi, MA, 2022)
"Most patients with epilepsy have uncontrolled seizures and drug side effects despite the medications."( Abdelbasset, WK; Huldani, H; Jalil, AT; Jasim, SA; Margiana, R; Mohammad, HJ; Ridha, HS; Rudiansyah, M; Yasin, G, 2022)
"Dementia and epilepsy have a complicated relationship, thus targeting mitophagy for cure of epileptic dementia makes sense."( Agrawal, M; Dhurandhar, Y; Panda, SP, 2022)
"Sleep and epilepsy have reciprocal effects - on one hand electrical brain activity during sleep is a strong modulator of epileptic activity and on the other epileptic activity during sleep may disrupt sleep architecture."( Chaneva, O, 2021)
"Epilepsy has been associated with an increased risk of cardiovascular events."( Bilo, L; Bosso, G; De Luca, M; Oliviero, U; Pirone, D; Striano, P; Trinchillo, A; Valvano, A, 2022)
"Epilepsy has been associated with an increased risk of cardiovascular events."( Bilo, L; Bosso, G; De Luca, M; Oliviero, U; Pirone, D; Striano, P; Trinchillo, A; Valvano, A, 2022)
"Epilepsy has been associated with an increased risk of cardiovascular events."( Bilo, L; Bosso, G; De Luca, M; Oliviero, U; Pirone, D; Striano, P; Trinchillo, A; Valvano, A, 2022)

Actions

ExcerptReference
"Epilepsy affects individuals of all ages."( Leppik, IE, 1992)
"Epilepsy affects more than 0."( Jentsch, TJ; Kubisch, C; Schroeder, BC; Stein, V, 1998)
"Epilepsy affects 1."( Jagoda, A; Yoon, Y, 2000)
"Epilepsy affects over one percent of the population, including nearly one million women of childbearing potential."( Foldvary, N, 2001)
"Epilepsy affects homeostasis and autonomic nervous system functions."( Aker, R; Gören, MZ; Onat, FY; Yananli, HR, 2003)
"Catamenial epilepsy affects approximately one-third of women with epilepsy."( Falcone, T; Foldvary-Schaefer, N, 2003)
"Catamenial epilepsy affects up to 70% of women with epilepsy."( Reddy, DS, 2004)
"Drug resistance in epilepsy affects about a third of patients and is an important clinical problem, associated with increased morbidity and mortality."( Sisodiya, SM, 2005)
"Epilepsy affects differently both genders, due to hormonal influence in women."( Barriga, J; Cobaleda, S; Codina, M; Lahuerta, J; Morales, MD; Viteri, C, 2010)
"Epilepsy affects half of patients."( Jakobs, C; Michael Gibson, K; Pearl, PL; Shukla, L; Theodore, WH, 2011)
"Epilepsy affects 0."( Cammarota, M; DaCosta, JC; Greggio, S; Machado, DC; Marinowic, DR; Venturin, GT; Zanirati, G, 2011)
"Epilepsy affects approximately 3 million people in the USA and up to 2% of the worldwide population."( Holder, JL; Wilfong, AA, 2011)
"Epilepsy affects fetal brain development during gestation in pregnant rats, therefore anti-epileptic therapy should be continued during pregnancy."( Doğan, Z; Kamışlı, Ö; Soysal, H, 2016)
"Epilepsy affects 60 million people worldwide."( Benninger, F; Griffioen, K; Gross, A; Illouz, T; Madar, R; Offen, D; Okun, E; Steiner, I, 2017)
"11/17, p=0."( Bui, E; Clark, SJ; Dema, U; Dorji, C; Grundy, SJ; Halani, S; Lhamo, S; Mateen, FJ; Nirola, DK; Pem, T; Tshering, L, 2017)
"Epilepsy affects 90% of the patients and appears in the first 2 years of life in the majority of them."( Canevini, MP; Curatolo, P; Jóźwiak, S; Kotulska-Jozwiak, K; La Briola, F; Peron, A; Strzelecka, J; Słowińska, M; Vignoli, A, 2018)
"Epilepsy affects the physical, cognitive, emotional, social wellbeing, and thereby the overall quality of life (QOL)."( Agadi, JB; Nagabushana, D; S, PK, 2019)
"Epilepsy affects all ages, races, genders, and socioeconomic groups."( Danzer, SC; Gross, C; MacLeod, MC; Tiwari, D; White, AR, 2020)
"Epilepsy affects 70 million people worldwide and is a significant cause of morbidity and early mortality."( Klein, P; Pong, AW; Xu, KJ, 2023)
"Epilepsy affects millions of people worldwide, yet we still lack a successful treatment for all epileptic patients."( Buszka, A; Dzwonek, J; Kalita, K; Kruk, PK; Nader, K; Olech-Kochańczyk, G; Skupien-Jaroszek, A; Wilczynski, GM; Wójtowicz, T; Worch, R; Włodarczyk, J, 2023)
"Epilepsy affects approximately 1% of the global population, with 30% of patients experiencing uncontrolled seizures despite treatment."( Kovac, S; Saadi, A; Sandouka, S; Shekh-Ahmad, T; Taiwo, RO, 2023)
"Epilepsy affects over 65 million people worldwide and significantly burdens patients, caregivers, and society."( Deeb, L; Guignet, M; Saadi, A; Sandouka, S; Sheeni, Y; Shekh-Ahmad, T; Singh, PK; Taiwo, RO; White, SH; Zhang, T, 2023)

Treatment

ExcerptReference
"Carbamazepine (CBZ) used in the treatment of epilepsy, is metabolized in man to an active metabolite: carbamazepine 10-11 epoxide (CBZ-E)."( Bonneton, J; Genton, P; Mesdjian, E, 1992)
"Since they are usually under treatment for epilepsy, it is difficult to determine whether the absence of pain is due to these patients' epileptic condition or to its treatment, since most antiepileptic drugs also have analgesic effects."( Dano, P; Guieu, R; Mesdjian, E; Pouget, J; Roger, J; Serratrice, G, 1992)
"Two female patients, one treated for epilepsy by phenobarbital (PB) and carbamazepine (CBZ), the other suffering from neurosis and free of any drug therapy, were given group B vitamins (riboflavin and nicotinic acid respectively) and showed during the long-term administration of these vitamins 2-3 Hz generalized electro-encephalographic (EEG) abnormalities."( Albani, F; Gastaut, H; Gobbi, G; Santanelli, P, 1988)
"The introduction of bromide for the treatment of epilepsy was an important episode in the history of neurology, and the individual responsible for it is therefore deserving of special recognition."( Friedlander, WJ, 1986)
"The prevalence of treated epilepsy in Wellington is 4."( Johnson, RH; Lambie, DG; Stanaway, L, 1981)
"The medication regimens used to treat epilepsy are further complicated by the fact that most seizure medications are metabolized in the liver and have the potential for serious pharmacokinetic drug-drug interactions with many other medications."( Cloyd, J; Garnett, WR; Holmes, GL; Meyer, MC; Schiffer, JR, 1995)
"Trends in treatment of epilepsy in an institution for handicapped patients with epilepsy were investigated in a retrospective longitudinal study."( May, T; Wohlhüter, M; Wolf, P, 1994)
"Gabapentin's potential role in the treatment of epilepsy also was assessed."( Andrews, CO; Fischer, JH, 1994)
"CLB appears to be a useful treatment for epilepsy as intermittent or short-term add-on therapy; but it should also be tried as long-term therapy in some situations, especially as add-on therapy for patients with refractory epilepsy, as add-on or monotherapy for patients with anxiety, or in some women in association with oral contraceptives."( Remy, C, 1994)
"As with all benzodiazepines used for treating epilepsy, sedation and withdrawal effects, together with the development of tolerance, limit its usefulness."( Schmidt, D, 1994)
"The latter 2 cases had been treated as epilepsy."( Ikeno, T; Nagai, H, 1993)
"All the children had treatment-resistant epilepsy and most had two or more seizure types."( Alving, J; Besag, FM; Dulac, O; Hosking, G; Spencer, SC; Wallace, SJ, 1995)
"For many years, the medical treatment of epilepsy was based on the use of the same few drugs, which were chosen according to the seizure type in a fairly standardized manner."( Bourgeois, BF, 1996)
"Carbamazepine, a drug used for the treatment of epilepsy and neuralgias, may exert hazardous effects on the cardiac conduction system."( Jiménez, JE; Johnson, CD; Rivera, H, 1997)
"Invasive or complex treatments for epilepsy with partial and generalized tonic-clonic seizures should not be used until at least two AEDs have failed to control seizures."( Camfield, CS; Camfield, PR; Dooley, JM; Gordon, K, 1997)
"Physicians treating epilepsy must be aware that CBZ can exacerbate seizures, and cause developmental regression in children."( Nagarajan, L; Prasad, AN; Stefanelli, M, 1998)
"The course of untreated epilepsy is not well established."( Arida, RM; Cavalheiro, EA; Peres, CA; Scorza, FA, 1999)
"In 1993, 27% of patients were being treated for epilepsy and in 1995/6, 30."( Carvill, S; Cassidy, G; Clarke, D, 1999)
"To most effectively treat children with epilepsy syndromes, further research must be completed to validate the positive effects described in case reports, open-label clinical trials, and early controlled clinical trials."( Pellock, JM, 1999)
"Surgical treatment of epilepsy should be considered an important alternative to medical therapy."( Bal, CS; Bhatia, M; Dash, HH; Gaekwad, S; Gupta, S; Jain, S; Maheshwari, MC; Padma, MV; Sarkar, C; Singh, VP, 1999)
"Surgical treatment of epilepsy is a safe, effective mode of therapy."( Bal, CS; Bhatia, M; Dash, HH; Gaekwad, S; Gupta, S; Jain, S; Maheshwari, MC; Padma, MV; Sarkar, C; Singh, VP, 1999)
"A test for an interaction between treatment and epilepsy type (partial versus generalized) was also undertaken."( Chadwick, DW; Clough, HE; Hutton, JL; Marson, AG; Williamson, PR, 2000)
"The test for an interaction between treatment and epilepsy type was non significant for time to treatment withdrawal and 12 month remission, but significant for time to first seizure."( Chadwick, DW; Clough, HE; Hutton, JL; Marson, AG; Williamson, PR, 2000)
"A 57-year-old woman was under treatment for epilepsy with lamotrigine 2 mg/kg/d since 1996."( Cazzola, M; Muzzupappa, S; Panni, B; Sarzi-Puttini, P; Turiel, M, 2000)
"When discussing the treatment of epilepsy, targeted populations need to be defined."( Leppik, IE, 2001)
"Locock introduced bromide in the treatment of epilepsy in 1857."( Lund, M, 1997)
"Ideally any pregnancy in a woman being treated for epilepsy should be planned, and both an obstetrician and a neurologist should be consulted."( Barcik, U; Bourgeois, M; El Ghouzzi, V; Lajeunie, E; Renier, D; Thorne, JA, 2001)
"are used for the treatment of epilepsy by traditional healers in subcontinent."( Choudhary, MI; DeLorenzo, RJ; Rahman, AU; Raza, M; Shaheen, F; Sombati, S, 2002)
"Pharmacological treatment of epilepsy is needed whenever epilepsy occurs."( Artigas-Pallarés, J; Brun-Gasca, C, 2001)
"Both the vigabatrin treated epilepsy group and conventionally treated epilepsy group exhibited significantly reduced POBF (p=<0."( Embleton, SJ; Gupta, AK; Hosking, SL; Roff Hilton, EJ, 2003)
"The safety and efficacy of treatment with antiepilepsy drugs combined with methylphenidate were determined by assessing seizure frequency, changes in ADHD symptoms, the Conners' Rating Scales, EEG differences, and side effects."( Erdemoglu, AK; Gucuyener, K; Kockar, AI; Senol, S; Serdaroglu, A; Soysal, S, 2003)
"Valproate is used widely for the treatment of epilepsy but has been associated with hyperandrogenism, hyperinsulinemia, and dyslipidemia."( Ayala, R; Dam, M; Gomez, G; Isojärvi, J; Messenheimer, J; Morrell, MJ; O'Neill, F; Taylor, AE; Tennis, P, 2003)
"The utility of vigabatrin in the treatment of epilepsy is partially offset by its retinal toxicity."( Frisén, L, 2004)
"The VPA-treated girls with epilepsy had normal serum T4 and FT4 concentrations, but slightly increased TSH levels (3."( Isojärvi, JI; Knip, M; Mikkonen, K; Myllylä, VV; Pakarinen, AJ; Rättyä, J; Vainionpää, LK, 2004)
"The average annual cost of outpatient treatment of epilepsy was found to be 47 US dollars per patient."( Kapoor, SK; Krishnan, A; Sahariah, SU, 2004)
"We describe the incidence of newly treated epilepsy in primary care and patterns of antiepileptic drug prescription, numbers of patients who remain on initial therapy and health service utilisation."( Buchan, S; Kerr, MP; Morgan, CL, 2004)
"Manipulation of neurosteroids to treat epilepsy has been an area of active research."( Harden, C; MacLusky, NJ, 2005)
"The use of VPA in the treatment of epilepsy is not associated with visual field defects similar to vigabatrin, but may induce abnormalities in colour vision."( Kälviäinen, R; Mäntyjärvi, M; Rissanen, E; Sorri, I, 2005)
"Physicians with basic training could treat epilepsy patients with phenobarbital, with beneficial effects for most patients with convulsive seizures."( Bell, GS; Dai, XY; de Boer, HM; Hong, Z; Ma, GY; Prilipko, L; Sander, JW; Wang, TP; Wang, WZ; Wu, JZ; Yang, B; Yuan, CL, 2006)
"On pharmacological treatment of epilepsy in people with intellectual disabilities, there were two articles on topiramate and one on levetiracetam."( Huber, B; Seidel, M, 2006)
"The current treatment of epilepsy focuses exclusively on the prophylaxis or suppression of seizures and thus provides merely a symptomatic treatment, without clear influence on the course of the disease."( Brandt, C; Heile, A; Löscher, W; Potschka, H; Stoehr, T, 2006)
"Agents introduced for the treatment of epilepsy have also been usedsimultaneously for psychiatric indications."( Bidzan, L, 2006)
"The aim of drug treatment for epilepsy is to prevent seizures without causing adverse effects."( Dahl, ML; Kimland, E; Tomson, T, 2007)
"In the melatonin-treated epilepsy plus Px group, the number of TUNEL positive cells decreased significantly compared to both epilepsy and epilepsy plus Px groups; however, there was no statistically significant difference from the control groups as a result of melatonin activity."( Ateş, U; Baka, M; Turgut, M; Uyanikgil, Y; Yavaşoğlu, A; Yurtseven, M, 2007)
"The development of novel treatments for epilepsy in TSC would benefit greatly from a suitable animal model, but most animal models of TSC to date have few reported neurological abnormalities, such as epilepsy."( Erbayat-Altay, E; Gutmann, DH; Wong, M; Xu, L; Zeng, LH, 2007)
"Currently, the trend is to treat patients with epilepsy with ER formulations because of the better compliance, convenience and flat plasma concentration versus time curve."( Bialer, M, 2007)
"The clinic treatment of epilepsy with epileptic foci overlapped with eloquent cortex is not satisfactory."( Gao, GD; Guo, H; Jing, XR; Wang, HW; Yao, QH; Zhang, H, 2008)
"Thirty untreated epilepsy patients were randomly divided into two groups receiving TPM or VPA, respectively."( Sun, W; Wang, W; Wang, Y; Wu, X, 2008)
"Vigabatrin was a major drug in the treatment of epilepsy until the discovery that it was associated with an irreversible constriction of the visual field."( Craft, CM; Duboc, A; Dubus, E; Gong, J; Jammoul, F; Picaud, S; Sahel, JA; Simonutti, M; Wang, QP; Ye, W, 2008)
"Women with untreated epilepsy are more likely to have irregular menstrual cycles than are nonepileptic controls, indicating that the disease itself plays a role in the etiology of these reproductive abnormalities."( Hayes, FJ; Joffe, H, 2008)
"Phenytoin (PHT) is widely used to treat epilepsy in elderly patients, but information on its pharmacokinetics in this population is limited."( Ahn, JE; Birnbaum, AK; Brundage, RC; Cloyd, JC; Conway, JM; Leppik, IE; Marino, SE; Musib, LC; Ramsay, RE; Rarick, JO; White, JR, 2008)
"For these reasons, pharmacological treatment of epilepsy that might also confer antidepressant effects may be particularly beneficial in older patients."( Fakhoury, TA; Hammer, AE; Miller, JM; Vuong, A, 2008)
"Our studies find that topiramate treatment in epilepsy children increases energy metabolism, resulting in weight loss."( Feng, JH; Gao, F; Li, HF; Xia, ZZ; Yang, CW; Zou, Y, 2009)
"For the treatment of epilepsy there is no generally accepted treatment algorithm, as individual epilepsy centers follow different diagnostic and therapeutic guidelines."( Jobst, BC, 2009)
"Most current treatments for epilepsy are symptomatic therapies that suppress seizures but do not affect the underlying course or prognosis of epilepsy."( Wong, M, 2010)
"Topiramate is licensed for the treatment of epilepsy and for migraine prophylaxis, but is also used off-licence for a wide range of indications."( Marson, AG; Mirza, N; Pirmohamed, M, 2009)
"P is being evaluated as a treatment for epilepsy, traumatic brain injury, and other complex neurological conditions."( Briyal, S; Gangisetty, O; Reddy, DS, 2010)
"Two cohorts of patients with valproate-treated epilepsy and sex- and age-matched individuals (controls) from the general Danish population were identified by individual-level-linkage of nationwide registries and followed for 10 years."( Abildstrøm, SZ; Andersson, C; Erdal, J; Gislason, GH; Hansen, PR; Olesen, JB; Schmiegelow, M; Torp-Pedersen, C; Weeke, P, 2011)
"Medical treatment of epilepsy is quite different for women than for men."( Chiba, S, 2011)
"Approximately one third of newly treated epilepsy patients do not respond to antiepileptic drugs (AEDs)."( Haerian, BS; Lim, KS; Mohamed, EH; Mohamed, Z; Raymond, AA; Tan, CT; Tan, HJ; Wong, CP; Wong, SW, 2011)
"Although bromide (Br) is used to treat intractable epilepsy, serum Br concentrations are not routinely analyzed."( Fukuda, M; Ishii, E; Kikuchi, C; Motoki, T; Ohmori, H; Okamoto, K; Suemaru, K; Suzuki, Y; Wakamoto, H, 2011)
"(Passifloraceae) has been used for the treatment of epilepsy in several traditional systems of medicine."( Goel, RK; Singh, B; Singh, D, 2012)
"Our findings may have implications for treatment of epilepsy in female patients."( Aurlien, D; Gjerstad, L; Larsen, JP; Taubøll, E, 2012)
"Bacopa monnieri and Bacoside-A treatment reverses epilepsy associated changes to near control suggesting that decreased GABA receptors in the cerebral cortex have an important role in epileptic occurrence; Bacopa monnieri and Bacoside-A have therapeutic application in epilepsy management."( Abraham, PM; Antony, S; Balakrishnan, S; Mathew, J; Paulose, CS, 2012)
"Phenobarbital is an effective treatment for epilepsy but concerns remain over its potential neurocognitive toxicity."( Bell, GS; de Boer, HM; Ding, D; Hong, Z; Kwan, P; Li, S; Lin, W; Sander, JW; Sun, J; Thompson, PJ; Wang, W; Wu, J; Wu, Q; Yu, P; Zhang, Q; Zhao, Q; Zhou, D, 2012)
"He had been on a lamotrigine treatment due to epilepsy, and after cessation of lamotrigine, his cardiac enzyme levels returned to normal."( Bayhan, T; Karagöz, T; Sahin, M; Yıldırım, I, 2012)
"Subsequently, others using the drug to treat epilepsy failed to obtain the degree of benefit that the reports of Locock's comments would have led them to expect."( Eadie, MJ, 2012)
"For this reason, novel approaches to treat epilepsy are highly needed."( Kokaia, M; Sørensen, AT, 2013)
"Despite the use in treatment of epilepsy since 1924, the clinical efficacy was not demonstrated in a controlled, randomized trial until 2008, showing its capability of reducing seizure frequency with more than 50%."( Korsholm, K; Law, I, 2013)
"One indirect pathway for the treatment of epilepsy includes the inhibition of carbonic anhydrase (CA), thereby increasing CO(2) levels in the brain."( Aggarwal, M; Kondeti, B; McKenna, R, 2013)
"Therefore, we tried to use GA to treat PTZ-induced epilepsy rats."( Bai, H; Liu, Z; Meng, F; Xu, R; You, Y; Zhang, H; Zhao, Y, 2013)
"Valproate is used for the treatment of epilepsy and other neuropsychological disorders and may be the only treatment option for women of childbearing potential."( Christensen, J; Grønborg, TK; Parner, ET; Pedersen, LH; Schendel, D; Sørensen, MJ; Vestergaard, M, 2013)
"Early treatment of epilepsy is warranted to avoid possible severe consequences."( Angeletti, G; Carbonetti, P; Del Casale, A; Fensore, C; Ferracuti, S; Girardi, P; Kotzalidis, GD; Lazanio, S; Muzi, A; Rapinesi, C; Savoja, V; Scatena, P; Serata, D; Tatarelli, R, 2013)
"Long-term untreated epilepsy may expose to accident proneness and further psychiatric deterioration."( Angeletti, G; Carbonetti, P; Del Casale, A; Fensore, C; Ferracuti, S; Girardi, P; Kotzalidis, GD; Lazanio, S; Muzi, A; Rapinesi, C; Savoja, V; Scatena, P; Serata, D; Tatarelli, R, 2013)
"The ultimate treatment goal in epilepsy therapy is always freedom from seizures with as few treatment adverse effects as possible."( Ben-Menachem, E, 2014)
"Medical treatment of epilepsy is quite different for women than for men."( Chiba, S; Yoshizawa, M, 2014)
"To explore a possible link between the treatment of AD and epilepsy, the molecular interactions of recently Food and Drug Administration approved antiepileptic drug Aptiom (Eslicarbazepine acetate) with BACE and VSC were studied."( Biswas, D; Hameed, N; Kamal, MA; Khan, M; Rizvi, SM; Shaikh, S; Shakil, S, 2014)
"Mitchell had distinct opinions on the treatment of epilepsy, and helped to advance its therapeutics during his career."( Boes, CJ; Burkholder, DB, 2014)
"Neurologists treating epilepsy continued to be more likely to prescribe folate (86."( Cavitt, J; Moseley, BD; Privitera, M; Sharma, A, 2015)
"Its role in the treatment of epilepsy in individuals with tuberous sclerosis complex (TSC) has yet to be determined."( Belt, OD; Geffrey, AL; Paolini, JL; Thiele, EA, 2015)
"The development of new drugs for the treatment of epilepsy is a major challenge for modern neurology and its first steps demand basic research."( Cambiaghi, M; Cursi, M; Magri, L, 2015)
"We asked all pediatric neurologists treating pediatric epilepsy in Finland if they had seen patients with pyridoxine-responsive infantile epilepsy."( Gaily, E; Mankinen, K; Riikonen, R, 2015)
"Lamotrigine (LTG) is used to treat epilepsy."( Hirai, K; Imai, K; Inoue, K; Inoue, Y; Itoh, K; Suzuki, E; Takahashi, T; Takahashi, Y; Tsuji, D; Umemura, A; Yamamoto, Y, 2016)
"Use of LCM to treat children with epilepsy has been supported by multiple studies with limited information on iv use in children."( Arkilo, D; Gustafson, M; Ritter, FJ, 2016)
"An unmet need in the treatment of epilepsy has been targeted therapies that prevent the onset or progression of seizures in the susceptible individual."( Jeong, A; Wong, M, 2016)
"Successful treatment of the epilepsy may alleviate anxiety symptoms."( Brandt, C; Mula, M, 2016)
"Cannabis has been associated with the treatment of epilepsy throughout history, and if ancient Assyrian sources referring to "hand of ghost" are considered credible, this relationship may span four millennia."( Russo, EB, 2017)
"The use of cannabis products in the treatment of epilepsy has long been of interest to researchers and clinicians alike; however, until recently very little published data were available to support its use."( Friedman, D; Gaston, TE, 2017)
"In spite of recent advances in the treatment of epilepsy, up to 35% of people living with the condition do not respond to accessible anti-epileptic drugs (AEDs) and continue to experience regular, devastating and potentially life-threatening seizures."( Asadi-Shekaari M, M; Esmaeili-Mahani, S; Kalantaripour, TP; Najafipour, H; Sheibani, V, 2017)
"Use of perampanel for the treatment of epilepsy was associated with significant reduction in all-cause and epilepsy-related health care resource utilization, including hospitalizations, especially for status epilepticus, and outpatient visits."( Barghout, V; Choi, J; Duh, MS; Faught, E; Germain, G; Haider, B; Laliberté, F; Lejeune, D; Wagh, A; Wang, Z, 2017)
"Presently, treatment of epilepsy is palliative in nature, providing only symptomatic relief to patients."( Jamwal, S; Koshal, P; Kumar, P, 2018)
"The ESL group was all patients with treatment-resistant epilepsy who developed intolerable PBSEs to LEV, subsequently trialed on ESL."( Ahmed, A; Henley, W; Jalihal, V; McLean, BN; Parrett, M; Sander, JW; Shankar, R; Tittensor, P, 2018)
"Twenty-one CSWS patients treated for epilepsy from January 2006 to December 2016 in Pediatric Department of Peking University First Hospital were enrolled into the study."( Bian, KG; Gong, P; Liu, XY; Qian, P; Xue, J; Yang, HP; Yang, ZX, 2018)
"Although some drugs used in the treatment of epilepsy are known to affect body weight, the hormonal factors responsible have not been sufficiently described."( Alver, A; Cansu, A; Çiçek, NP; Kamaşak, T; Okten, A; Serin, M, 2018)
"Carbamazepine (CBZ) is used for the treatment of epilepsy and other neurological and psychiatric disorders."( Fricke-Galindo, I; Jung-Cook, H; LLerena, A; López-López, M, 2018)
"Valproic acid (VPA) provides a common treatment for both epilepsy and bipolar disorder; however, common cellular mechanisms relating to both disorders have yet to be proposed."( Kelly, E; Sharma, D; Wilkinson, CJ; Williams, RSB, 2018)
"Future research strategies for new drug treatments in epilepsy will probably take comorbidities into account."( Mula, M, 2018)
"Patients with onset of AED-treated epilepsy after stroke in 2005-2010 were included."( Åsberg, S; Kumlien, E; Larsson, D; Zelano, J, 2019)
"Neurotrophic factors are candidates for treating epilepsy, but their development has been hampered by difficulties in achieving stable and targeted delivery of efficacious concentrations within the desired brain region."( Barbieri, M; Bell, WJ; Emerich, DF; Falcicchia, C; Fradet, T; Kokaia, M; Lovisari, F; Paolone, G; Simonato, M; Wahlberg, LU, 2019)
"Antiepileptic drugs are the mainstream treatment for epilepsy; however, the drug resistance occurring in 20-30% of patients and side effects of available medications have resulted in a search for natural remedies that can support disease therapy."( Andres-Mach, M; Bryda, J; Szewczyk, A; Zagaja, M, 2019)
"Na+ channel blockers in the treatment of SCN8A epilepsy may correlate with the effect of such agents on pathological Na+ current observed in heterologous systems."( Abou Tayoun, A; Goldberg, EM; Zaman, T, 2019)
"In India, it is used for the treatment of epilepsy as traditional medicine."( Dinda, AK; Kaleekal, T; Katyal, J; Pattnaik, SS; Sarangi, SC, 2020)
"We reviewed records of patients treated for epilepsy due to posterior reversible encephalopathy syndrome after liver transplant seen at our pediatric neurology clinic between January 2010 and March 2019."( Akdur, A; Balcı Sezer, O; Haberal, M; Özçay, F; Sezer, T; Torgay, A, 2020)
"The drugs currently available for treating epilepsy are only partially effective in managing this condition."( Dukhinova, M; Kopeikina, E; Kuznetsova, IS; Lau, TYB; Levchuk, K; Ponomarev, ED; Veremeyko, T; Yung, AWY, 2020)
"To study the efficacy of reamberin in treatment of epilepsy in children and to evaluate its effect on the antioxidant status."( Dorovskikh, VA; Nosal', LA; Shtarberg, MA; Simonova, NV, 2019)
"It is successfully used in treatment of epilepsy for 30 years."( Belova, YA; Kotov, AS; Romanova, MV; Rudakova, IG, 2019)
"In addition to medical treatment, epilepsy surgery may be offered to drug-resistant patients but carries a high risk of relapse of herpetic encephalitis."( Chipaux, M; Delalande, O; Dorfmuller, G; Ferrand-Sorbets, S; Fohlen, M; Maurey, H; Petrescu, A; Taussig, D, 2020)
"This study provided children with treatment-resistant epilepsy (TRE) access to plant-derived highly purified cannabidiol (CBD; Epidiolex® in the US; Epidyolex® in the EU; 100 mg/mL oral solution)."( Diamond, MP; Flamini, JR; Linder, DF; Long, SA; Moretz, K; Park, YD; Pope, J, 2020)
"Thirty-nine patients with treatment-resistant epilepsy completed the study protocol, i."( Geiger, MJ; Hirsch, M; Klotz, KA; Metternich, B; Schulze-Bonhage, A; Wagner, K, 2021)
"To study the efficacy of reamberin in treatment of epilepsy in children and to evaluate its effect on the cognitive functions."( Dorovskikh, VA; Nosal', LA; Simonova, NV, 2020)
"Rhynchophylline target genes to treat epilepsy were identified using PharmMapper, SwissTargetPrediction and DrugBank databases integration."( Chen, X; Geng, H; Wang, C, 2021)
"Twenty-two days after tacrolimus treatment, epilepsy occurred."( Mo, Y; Ren, R; Wang, F; Yang, Y; Zhang, L, 2021)
"Valproic acid, a first-line drug to treat epilepsy, is associated with serious side effects, which precludes its wider use."( Gao, M; Qu, K; Wang, X; Zhang, W, 2021)
"Cannabis has been used to treat epilepsy for millennia, with such use validated by regulatory approval of cannabidiol (CBD) for Dravet syndrome."( Absalom, NL; Anderson, LL; Arnold, JC; Bahceci, D; Benson, MJ; Bowen, MT; Chebib, M; Doohan, PT; Hawkins, NA; Heblinski, M; Kearney, JA; McGregor, IS; Zhang, F, 2021)
"OV329, a novel drug candidate for the treatment of epilepsy and addiction, has been shown in vitro to be substantially more potent as a GABA-AT inactivator than vigabatrin, an antiseizure drug approved as an add-on therapy for adult patients with refractory complex partial seizures and monotherapy for pediatric patients with infantile spasms."( Deking, LS; During, MJ; Feja, M; Gernert, M; Kaczmarek, E; Meller, S; Silverman, RB, 2021)
"Valproic acid (VPA) is used for the treatment of epilepsy and bipolar disorder (BD)."( Hsieh, TC; Lin, CC; Wu, LS, 2022)
"We included beneficiaries with newly treated epilepsy (International Classification of Diseases codes for epilepsy/convulsions 2014-2017, no ASM in the previous 2 years)."( Burke, JF; Choi, H; Terman, SW; Youngerman, BE, 2022)
"Valproate (VPA) is an effective treatment for epilepsy and also used in bipolar disorder."( Eriksson, SH; Sisodiya, SM; Tittensor, P, 2022)
"We evaluated everolimus in 14 treatment resistant epilepsy patients undergoing surgical resection (4."( Askenazi, M; Devinsky, O; Devore, S; Friedman, D; Jones, D; Kanshin, E; Leitner, DF; Siu, Y; Ueberheide, B; Wisniewski, T, 2022)
"LEV seems as a rational drug for treatment of epilepsy patients, particularly for those with osteoporosis, since the comparative results of one year and longer than 5-years usage data did not show any statistically significant difference."( Aydın, Z; Gözükızıl, ST; Yalçın, AD, 2022)
"Currently, the treatment for epilepsy includes the administration of drugs or surgery, but about 30% of the patients treated with antiepileptic drugs develop time-dependent pharmacoresistence."( Belperio, G; Corso, C; Duarte, CB; Mele, M, 2022)
"The outcome was the development of treatment resistant epilepsy (TRE), defined as having at least three distinct antiseizure medications in 1 year."( Cepeda, MS; Kern, DM; Novak, G; Teneralli, RE, 2022)
"CBD is a recognized novel treatment for epilepsy."( Castro, LHM; Oshiro, CA, 2022)
"Both the prevalence of treatment for epilepsy and of treatment for psychosis was 0."( Bakken, IJ; Bråthen, G; Brodtkorb, E; Landmark, CJ; Morken, G; Revdal, E, 2022)
"In the histopathological examination of treatment-resistant epilepsy, focal cortical dysplasia (FCD) is the most common diagnosis in the pediatric group."( Bilgic, B; Dolgun, M; Gurkan, ZM; Gürses, C; Kapar, O; Sencer, A, 2022)
"Pharmacologic treatment of epilepsy in pregnant women is balancing between risks for the mother and fetus."( Edens, M; Schelhaas, M; Ter Horst, P; Touw, D; Wammes-Van Der Heijden, E; Wegner, I, 2023)
"Most comparative studies focusing on treatment of epilepsy in older adults have found that levetiracetam has the best chance of long-term seizure freedom."( Akamatsu, N; Beghi, E; Costa, C; Cretin, B; Dhakar, MB; DiFrancesco, JC; Faught, E; Giussani, G; Krämer, G; Kwan, P; Leppik, I; O'Dwyer, R; Piccenna, L, 2023)
"Topiramate (TPM) is effective for treating epilepsy, but executive dysfunction is a common side effect that could significantly affect everyday life."( Elger, CE; Hansen, N; Helmstaedter, C; von Wrede, R; Widman, G; Witt, JA, 2022)
"Pharmacotherapy is the main treatment for epilepsy, but at least 30% of patients with epilepsy have pharmacoresistant epilepsy."( Chou, IC; Wang, HS; Yang, MT, 2023)
"Effective treatment of epilepsy is a major challenge in the field of neurology."( Alyan NajafAbadi, S; Maghbooli, M; MalekMahmoudi, G; Molseghi, MH, 2023)
"Difficult-to-treat epilepsy related to conditions including tuberous sclerosis complex (TSC), Lennox Gastaut syndrome (LGS) and Dravet syndrome (DS) have been the target of recent developments."( Klein, P; Pong, AW; Xu, KJ, 2023)
"Medicinal treatment against epilepsy is faced with intractable problems, especially epileptogenesis that cannot be blocked by clinical antiepileptic drugs (AEDs) during the latency of epilepsy."( Chen, Q; Fan, H; Guo, Y; Jiang, C; Li, K; Liu, P; Sun, T; Zhou, Z, 2023)
"Patients with WHS who were treated for epilepsy at the Saitama Children's Medical Center under 5 years of age were included."( Daida, A; Hamano, SI; Hirata, Y; Horiguchi, A; Kikuchi, K; Koichihara, R; Matsuura, R; Nonoyama, H; Oba, D; Ohashi, H, 2023)
"However, the efficacy of perampanel treatment in epilepsy patients younger than 4 years has been less documented."( Handy, MJ; Hashimoto, K; Ito, Y; Jensen, FE; Roberts, NS; Talos, DM, 2023)
"Levetiracetam (LEV), clinically used to treat epilepsy, may have pro-cognitive effects by restoring balance to neuronal signalling."( Botha, TL; Brouwer, G; Finger-Baier, K; van der Westhuizen, C; Wolmarans, W, 2023)
"ZNS may be available to treat idiopathic epilepsy in cats."( Maeda, S; Motegi, T; Yonezawa, T; Yoshida, S, 2023)
"Moreover, DMF treatment reversed epilepsy-induced behavioral deficits in the treated rats."( Deeb, L; Guignet, M; Saadi, A; Sandouka, S; Sheeni, Y; Shekh-Ahmad, T; Singh, PK; Taiwo, RO; White, SH; Zhang, T, 2023)

Research

Studies (22,795)

TimeframeStudies, This Condition (%)All Conditions %
pre-19907102 (31.16)23.3326
1990's3534 (15.50)12.5806
2000's4971 (21.81)18.1394
2010's4959 (21.75)28.8240
2020's2229 (9.78)9.53
DrugIndicatedRelationship StrengthStudiesTrials
acetylcarnitine0medium52
dinitrochlorobenzene0low20
alpha-hydroxyglutarate0low110
protocatechuic acid0low10
3-hydroxyanthranilic acid0low20
3-hydroxykynurenine0low10
acetoacetic acid0low30
phosphoserine0low40
cysteine sulfinic acid0low20
n-carbamoyl-beta-alanine0low10
4-hydroxyphenylacetic acid0low20
aminolevulinic acid0low30
5-hydroxytryptophan0medium212
ethylene glycol0low10
acetic acid0low40
acetone0low140
adenine0low60
agmatine0low30
ammonium hydroxide0medium975
anthranilic acid0medium11
quinacrine0low190
beta-alanine0medium81
benzene0low10
betaine0low20
bromide0medium1105
2,3-butylene glycol0low10
butyric acid0low50
carbamates0medium662
carbamic acid0low10
ureidosuccinic acid0low10
carbon monoxide0low60
formic acid0low40
aminooxyacetic acid0low80
carnitine0medium8911
methane0low40
choline0medium383
citric acid, anhydrous0low60
chlorine0low1370
hydrochloric acid0low30
coumarin0low20
salicylic acid0medium2509
gallic acid0low10
octanoic acid0low10
hydrogen sulfide0low20
3-hydroxybutyric acid0medium383
bupropion0low60
2-aminoadipic acid0low220
methylmalonic acid0low40
gamma-guanidinobutyric acid0low10
n(g),n(g')-dimethyl-l-arginine0low50
malic acid0low10
1-aminocyclopropane-1-carboxylic acid0low10
phosphonoacetic acid0low10
3,4-dihydroxyphenylacetic acid0low60
creatine0medium594
cytosine0low20
lactic acid0medium583
dihydroxyacetone0low10
dimethylglycine0low70
dimethyl sulfoxide0low90
ethanolamine0low20
formaldehyde0low20
gamma-butyrobetaine0low10
glutaric acid0low20
glycine0low980
glyceric acid0low30
glycerol0low180
glycolic acid0low10
glyoxylic acid0low10
glycocyamine0low30
carbonic acid0low10
hydrogen carbonate0medium341
dalteparin0low20
histamine0medium291
hydrogen0low130
hydroxylamine0low10
imidazole0low210
indoleacetic acid0low10
iodine0low110
dihydroxyphenylalanine0medium172
kynurenine0medium272
pipecolic acid0low180
thioctic acid0low40
malonic acid0low10
pyruvaldehyde0low10
methanol0low120
inositol0medium222
nickel0low40
niacinamide0low110
niacin0low190
nitrates0low50
nitroxyl0low30
nitrites0low110
nitrous oxide0medium223
1-octanol0low20
orotic acid0medium51
4-aminobenzoic acid0low40
palmitic acid0low20
parathion0low10
phenylacetic acid0low20
phenethylamine0low20
5-phenylhydantoin, (+-)-isomer0low10
phosphorylethanolamine0low20
porphobilinogen0medium41
pqq cofactor0low10
propylene glycol0low20
1-propanol0low10
propionic acid0low30
pteridines0low50
putrescine0low20
pyridoxal0low50
pyridoxal phosphate0medium621
pyridoxamine0low10
pyridoxamine phosphate0low10
pyridoxine 5-phosphate0low30
pyruvic acid0low110
quinolinic acid0low160
sarcosine0low70
selenic acid0low20
sulfites0low30
spermidine0low20
spermine0low80
succinic acid0low20
sulfur dioxide0low20
taurine0medium923
thiamine0medium221
thymine0low20
toluene0low20
trimethylamine0low60
tryptamine0low20
tungstic(vi) acid0low10
uracil0low50
uric acid0low250
urea0medium944
vanillin0low30
xanthine0low20
2-amino-5-phosphonovalerate0low1340
7-hydroxy-2-n,n-dipropylaminotetralin0low10
8-hydroxy-2-(di-n-propylamino)tetralin0low110
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid0medium321
sk&f 829580low10
2,3-piperidinedicarboxylic acid0low10
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid0low250
4-iodo-2,5-dimethoxyphenylisopropylamine0low20
1-hydroxy-3-amino-2-pyrrolidone0low10
ibotenic acid0low130
gallopamil0low10
b 844-390low10
sk&f-383930low60
vanilmandelic acid0low30
huperzine a0low30
menthol0low50
4-carboxy-3-hydroxyphenylglycine0low30
1,2-dimethylhydrazine0low10
1,3-dipropyl-8-cyclopentylxanthine0low120
pk 111950low80
1-(3-chlorophenyl)biguanide0low10
1-(3-chlorophenyl)piperazine0low20
1-anilino-8-naphthalenesulfonate0low60
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine0low10
n-(3-(aminomethyl)benzyl)acetamidine0low10
2-hydroxysaclofen0low30
mercaptoethanol0low20
2-aminoethoxydiphenyl borate0low20
3,4-methylenedioxyamphetamine0low30
n-methyl-3,4-methylenedioxyamphetamine0low20
phaclofen0low30
3-aminobenzamide0low10
tramiprosate0medium11
3-methoxytyramine0low10
3-methoxytyrosine0low20
enprofylline0low10
3-nitropropionic acid0low10
ro 5-48640low70
4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol0low10
4-aminopyridine0low1680
homovanillic acid0medium403
5,7-dichlorokynurenic acid0low10
5-hydroxydecanoate0low10
hydroxyindoleacetic acid0medium575
7-chlorokynurenic acid0low50
etofylline0low10
7-nitroindazole0low90
8-(4-sulfophenyl)theophylline0low10
8-cyclopentyl-1,3-dimethylxanthine0low40
8-phenyltheophylline0low40
tacrine0low30
acetaminophen0medium152
beta-aminoethyl isothiourea0low10
1-aminoindan-1,5-dicarboxylic acid0low20
albendazole0medium295
albuterol0low50
altretamine0low10
am 2510low70
amantadine0low90
diatrizoic acid0low40
aminoglutethimide0low80
4-amino-3-hydroxybutyric acid0low210
theophylline0low440
amiodarone0low30
amitriptyline0medium363
amlodipine0low20
amobarbital0medium2229
amodiaquine0low10
amoxapine0low20
anastrozole0medium11
antipyrine0low200
2-amino-4-phosphonobutyric acid0low60
apraclonidine0low10
arecoline0low10
aspirin0low190
atenolol0medium41
alpha-amino-3-hydroxy-5-tert-butyl-4-isoxazolepropionate0low20
azathioprine0low100
azelastine0low10
azosemide0low20
baclofen0medium701
barbital0low50
bay-k-86440low40
bemegride0medium703
bencyclane0low20
benserazide0low20
benzamide0low10
benzamidine0low10
benzothiazide0low10
bepridil0low10
berberine0low10
bethanechol0low10
biperiden0medium31
bisoprolol0low10
bromperidol0low10
seratrodast0low10
bumetanide0medium331
bupivacaine0low30
buspirone0low30
busulfan0low40
butalbital0low10
caffeine0medium612
verapamil0medium442
pantogab0medium11
metrizoate0medium31
camphor, (+-)-isomer0low80
carbamazepine epoxide0medium8715
carbetapentane0low20
carisoprodol0low20
carmustine0medium71
celecoxib0low20
cetirizine0low20
cgp 371570low10
cgs 159430low20
chelerythrine0low10
chloral hydrate0medium211
chlorambucil0low30
chlordiazepoxide0medium725
chloroquine0low170
chlorothiazide0low20
chloroxylenol0low10
chlorpheniramine0low30
chlorpromazine0medium1175
chlorpropamide0low10
chlorpyrifos0low10
chlorthalidone0low20
cimetidine0low70
eucalyptol0low10
ciprofloxacin0low80
cisapride0low10
citalopram0low90
clioquinol0low30
clobenpropit0low10
clomipramine0low70
clonidine0low190
clotrimazole0low10
cloxazolam0medium21
cyclobenzaprine0low10
cyclocreatine0low10
cycloleucine0low130
cyclopentolate0low20
cyclothiazide0low50
cyproheptadine0low40
dantrolene0medium81
dapi0low40
dapsone0low20
debrisoquin0medium11
decanoic acid0low50
deferoxamine0low50
desipramine0medium122
nordazepam0low90
amphetamine0low430
diazoxide0low120
diclofenac0low90
ddt0low50
dichlorphenamide0low50
diethylcarbamazine0medium61
pentetic acid0low50
dimercaprol0low20
dimethadione0medium21
diphenhydramine0low130
dipyridamole0low30
disulfiram0medium121
2-amino-7-phosphonoheptanoic acid0low130
racemetirosine0low10
p-chloroamphetamine0low10
donepezil0medium31
doxapram0low10
doxepin0low20
droperidol0medium61
dipropizine0low10
dsp 40low20
dyphylline0low10
e 40310low10
ebselen0low10
edrophonium0low30
9-(2-hydroxy-3-nonyl)adenine0low30
emodin0low10
endosulfan0low20
enflurane0low90
erythrosine0low160
ethacrynic acid0low50
ether0low30
ethinamate0low10
ethoxzolamide0low10
eicosapentaenoic acid ethyl ester0low10
ethyl loflazepate0medium22
famotidine0low10
felodipine0low10
fenofibrate0low10
fenoldopam0low10
fentanyl0medium252
fexofenadine0low10
flecainide0low10
fluconazole0low10
flufenamic acid0low40
fluphenazine0low110
flumazenil0medium718
flunitrazepam0low140
fluorouracil0low40
flurazepam0low40
furosemide0medium192
gaboxadol0medium61
4-amino-5-hexynoic acid0low10
vanoxerine0low10
gentamicin0low10
glimepiride0low10
glutethimide0low60
glyburide0low150
guaifenesin0low30
guanethidine0low10
guanidine0low10
gyki 524660low160
n-(2-aminoethyl)-5-isoquinolinesulfonamide0low10
haloperidol0medium441
halothane0low190
harmaline0low10
hexamethonium0low10
hexobarbital0low180
alpha-methylhistamine0low20
ethidium0low20
hydralazine0low20
hydrochlorothiazide0low10
hydroflumethiazide0low10
hydroxychloroquine0low70
hydroxyurea0low10
hydroxyzine0low50
ibuprofen0low70
phenelzine0low40
lidocaine0medium623
mephentermine0low10
ici 1185510low10
ifenprodil0medium111
ifosfamide0low30
imipramine0medium333
indapamide0low10
indomethacin0low90
iofetamine0medium222
iohexol0medium41
iomeprol0low10
iopromide0low10
iothalamic acid0low80
iproniazid0low80
avapro0low10
1-methyl-3-isobutylxanthine0low40
isocarboxazid0low20
isoflurane0medium162
isoguvacine0low30
isoniazid0medium601
2-propanol0low110
isoproterenol0low60
isradipine0low20
staurosporine aglycone0low40
ketanserin0low40
ketoconazole0low20
ketotifen0low30
khellin0low10
kynurenic acid0low330
pyrrolidine-2,4-dicarboxylic acid0low30
labetalol0low10
letrozole0low10
qx-3140low10
linopirdine0low30
lomerizine0low10
lomustine0low40
loratadine0low30
losartan0medium111
loxapine0low10
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one0low10
maprotiline0medium81
edaravone0low30
mebendazole0low20
mecamylamine0low20
mechlorethamine0low20
meclofenamic acid0low10
meclofenoxate0low10
medazepam0low10
mefenamic acid0low50
memantine0low80
vitamin k 30low10
meperidine0low70
mephenesin0low50
mepivacaine0low20
meprobamate0low340
mesalamine0low10
mescaline0low60
metformin0low90
methadone0medium71
methazolamide0low10
methenamine0low10
methoxsalen0low10
methyl salicylate0low10
methylphenidate0medium6111
metoclopramide0low50
metolazone0low10
metoprolol0low20
metronidazole0low30
metyrapone0low80
mexiletine0medium91
mianserin0medium91
miconazole0low10
midodrine0low20
minoxidil0low10
mirtazapine0low30
mitoxantrone0medium21
moclobemide0low20
modafinil0low40
molsidomine0low10
1-(3-trifluoromethylphenyl)piperazine0low10
ethylmaleimide0low20
fg 71420low20
apnea0medium881
nafronyl0low10
nan 1900low10
naphazoline0low20
nefazodone0low20
nefopam0low10
neostigmine0low70
nevirapine0low10
nialamide0low50
nicardipine0low60
nifedipine0medium271
niflumic acid0low10
nimesulide0low20
nimodipine0medium194
nipecotic acid0low40
nisoldipine0low20
nisoxetine0low10
nitrendipine0low20
nitroglycerin0low20
nomifensine0medium43
norfloxacin0low20
norfluoxetine0low30
nortriptyline0medium61
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide0low20
omeprazole0medium31
ondansetron0low20
orphenadrine0low10
oxamniquine0low10
oxazepam0low140
oxidopamine0low100
oxiracetam0low20
oxotremorine m0low20
oxotremorine0low40
oxybutynin0low10
oxymetazoline0low10
oxyphenbutazone0medium281
aminosalicylic acid0low20
fenclonine0low60
papaverine0low120
pd 980590low10
pemoline0low10
pentobarbital0medium331
perazine0low20
periciazine0low20
perphenazine0medium91
phenolphthalein0low10
phenoxybenzamine0low20
4-phenylbutyric acid0low20
phenylbutazone0low100
o-phthalaldehyde0low20
pifithrin0low20
pinacidil0low10
pindolol0low10
pioglitazone0low30
piperazine0low20
piperidine-4-sulfonic acid0low10
piracetam0medium55279
pirenzepine0low20
potassium chloride0low300
potassium iodide0low10
4-aminobenzoic acid0low30
ag 18790low10
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid0low10
praziquantel0medium261
prazosin0low60
prilocaine0low10
primaquine0low10
probenecid0low140
procainamide0low20
procaine0low190
procarbazine0low20
prochlorperazine0low60
procyclidine0medium31
promazine0low160
promethazine0medium71
propafenone0low10
propantheline0low10
proxymetacaine0low10
propidium0low20
propofol0medium8510
propranolol0medium231
protriptyline0low10
pyrilamine0low40
pyrimethamine0low50
7-chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol0low10
riluzole0low70
risperidone0medium181
ritanserin0low10
ro 15-45130low10
4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone0low10
rofecoxib0low10
rolipram0low20
safrole0low10
sb 2021900low10
secobarbital0low40
carbamylhydrazine0low30
sennoside a&b0low10
sevoflurane0medium4410
sulfadiazine0low10
linsidomine0low10
sk&f 975410low20
sodium iodide0low10
sotalol0low30
spiperone0low10
stearic acid0low10
vorinostat0low30
succinylcholine0low70
sulfadimethoxine0low10
sulfamethizole0low10
sulfamethoxazole0low30
sulfamethoxypyridazine0low10
sulfanilamide0low10
sulfaphenazole0low40
sulfasalazine0low60
sulfathiazole0low10
sulfinpyrazone0low10
sulfisoxazole0low10
sulfobromophthalein0low10
sulforaphane0low50
sulpiride0low40
sumatriptan0low70
suramin0low30
tazarotene0low10
tegafur0low10
temazepam0low10
temozolomide0medium91
terbutaline0low30
terfenadine0low10
tetraethylammonium0low150
krypton0low10
theobromine0medium51
thiethylperazine0low10
thioridazine0medium325
thiotepa0low20
thiothixene0low30
ticlopidine0low30
tiopronin0low20
tipepidine0low10
tizanidine0low20
nikethamide0low10
tolbutamide0low110
n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine0low10
(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid0low10
tranexamic acid0low20
trazodone0low10
triamterene0low10
triazolam0low10
triclofos0low10
triclosan0low40
trifluoperazine0medium102
trifluperidol0low20
triflupromazine0low50
trihexyphenidyl0low10
trimeprazine0low20
trimethoprim0low30
trimipramine0low10
tripelennamine0low20
tyramine0medium92
urethane0low40
viloxazine0medium81
w 70low10
xanthurenic acid0low20
xylazine0low30
zaleplon0low10
zinc chloride0low10
zolpidem0medium91
hydroxyphenamate0low10
corticosterone0low340
prednisolone0medium484
estriol0low40
lysergic acid diethylamide0low200
reserpine0low300
cephaloridine0low10
phentolamine0low60
sorbitol0low10
thymidine0low20
benzimidazole0low10
hydroxyproline0medium101
thyroxine0medium604
dibenzylchlorethamine0low10
dextroamphetamine0low170
carbachol0low280
spironolactone0low40
aldosterone0low60
penicillamine0low40
trichlorfon0low10
lynestrenol0low40
prednisone0medium391
estrone0low40
androsterone0low50
etiocholanolone0low10
dehydroepiandrosterone0medium121
adrenochrome0low10
penicillin g0low700
metaraminol0low20
pilocarpine0low5240
pentylenetetrazole0medium8657
amifampridine0low20
triiodothyronine0low350
(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride0low10
isoflurophate0low40
biguanides0medium31
carbon tetrachloride0low10
cantharidin0low10
alanine0low310
serine0low240
desoxycorticosterone acetate0low20
4-nitroquinoline-1-oxide0low10
chloramphenicol0low90
aspartic acid0medium1292
glutamine0medium762
lysine0low440
cyanides0low10
physostigmine0low140
sulfamic acid0low10
sucrose0medium81
ethinyl estradiol0medium91
testosterone propionate0low20
tubocurarine0low50
apomorphine0low110
aminopyrine0medium111
methyltestosterone0low10
adenosine diphosphate0low70
2,3,4,6-tetrachlorophenol0medium111
uridine0low80
kanamycin a0low20
bromodeoxyuridine0low210
galactose0low50
carbostyril0medium141
phenylephrine0low70
levodopa0medium443
edetic acid0low20
tyrosine0low220
cysteamine0low50
mepazine0low10
acepromazine0low30
methoxamine0low20
adenosine monophosphate0low70
methylene blue0low40
leucine0low210
methacholine chloride0low30
aniline0low10
2-aminoisobutyric acid0low10
androstenedione0medium104
uridine triphosphate0low10
lactose0low30
methionine0medium362
phenylalanine0low210
n-phenylurea0low20
desoxycorticosterone0medium121
colchicine0low100
etimizol0low10
gallamine triethiodide0low30
cytidine0low10
oxacillin0low50
cycloheximide0low120
egtazic acid0low130
barbituric acid0low180
chloroform0low50
fluocinolone acetonide0low20
dimethylformamide0low10
norethindrone0medium72
norethynodrel0low10
cycloserine0low60
17-alpha-hydroxyprogesterone0low10
caffeine citrate0medium11
tubercidin0low30
ampicillin0low70
mannitol0medium101
cytarabine0low30
dithionitrobenzoic acid0low10
mephenoxalone0low10
ornithine0low70
asparagine0low90
histidine0low140
n-pentanol0low10
medroxyprogesterone acetate0medium61
veratridine0low20
valine0low450
threonine0low100
mestranol0medium21
methaqualone0low90
methandrostenolone0low30
tryptophan0medium824
isoleucine0low100
arginine0low710
methyl chloride0low10
propane0low10
acetonitrile0medium11
tetramethylammonium0low30
tribromoethanol0low10
tert-butylhydroperoxide0low10
perfluoroethane0low10
phencyclidine0low160
caramiphen0low20
butobarbital0low10
methylpentynol0low10
tromethamine0low10
tetraethyl lead0low10
3-mercaptopropionic acid0low120
triparanol0low10
linalool0low10
methylethyl ketone0low10
acrylic acid0low10
isobutyric acid0low10
dichloroacetic acid0low10
pantothenic acid0medium52
phenaglycodol0low20
taurocholic acid0medium11
pyridoxic acid0medium32
skatole0low10
methylprednisolone0medium311
rotenone0low20
9,10-phenanthrenequinone0low10
diquat0low10
propoxycaine0low10
penicillanic acid0low10
xylitol0low10
thymol0low10
2-phenylbutyric acid0low10
quinoxalines0low770
isatin0low40
diphenyl0low30
xanthenes0low50
phenothiazine0low100
propylparaben0low10
benzothiazole0low30
4-butyrolactone0low80
soman0medium111
pyrrolidonecarboxylic acid0low20
carveol0low10
carvone0low10
4-chloronitrobenzene0low10
4-(dimethylamino)benzaldehyde0low10
quinuclidines0low10
pyridostigmine bromide0low60
boric acid0low20
dibenzylamine0low10
phenylisothiocyanate0low10
benzonatate0low10
caprolactam0low10
acrolein0low20
allylamine0low10
2-methylpentane0low10
deanol0low40
cyclohexanol0low50
3-hydroxypyridine0low10
n-pentanoic acid0low10
pyrroles0low180
thiophenes0low80
n-hexane0low10
piperidine0low10
heptanol0low20
octylamine0medium11
carbitol0low10
ergotamine0low60
methylergonovine0low10
phenformin0low10
obidoxime chloride0low10
dimethyl ether0low10
acetol0low10
tecnazene0low10
etryptamine0low10
hexachlorobenzene0low10
framycetin0low10
isoquinoline0low10
vanillic acid0low10
cyclonite0low10
iodoantipyrine0low10
pamoic acid0low10
meglumine0medium31
iodohippuric acid0medium11
1-naphthylamine0low30
2-naphthol0low20
shikimic acid0low10
dodecyl sulfate0low10
ethyl acetate0low10
n-heptane0low10
pregnenolone0low70
20-alpha-dihydroprogesterone0low10
yohimbine0low90
3-o-methylglucose0low20
2-chloroadenosine0low70
diphenhydramine hydrochloride0low60
nafcillin0low10
ditiocarb0low50
potassium cyanide0low10
methohexital0medium434
catechin0low40
thiamine pyrophosphate0low30
homoarginine0low10
quinazolines0medium101
acridines0medium103
indazoles0low100
adamantane0low30
cyclopentane0low40
isoxazoles0medium19025
oxazoles0medium462
thiazoles0medium271
1,2,4-triazole0low40
pyrimidine0low20
pyrazines0low70
ethynodiol diacetate0low10
ephedrine0medium31
diiodotyrosine0low10
muscarine0low40
hydrazine0low70
chlormadinone acetate0medium22
benactyzine0low40
2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-0low20
paraoxon0medium21
hemicholinium 30low10
evans blue0low50
thioproperazine0low40
aminophylline0low90
azacitidine0low20
flurothyl0low350
tetrapropylammonium0low10
carbutamide0low10
5-fluorotryptophan0low10
galantamine0medium41
aminoimidazole carboxamide0low20
methysergide0medium131
thymidine monophosphate0low10
cuprizone0low10
citrulline0low90
betamethasone0low70
4-hydroxyphenobarbital0low20
nandrolone0low10
xanthinol niacinate0low20
hydantoins0medium4025
3-aminopyridine0low40
homocystine0low10
hydantoic acid0low10
n-pentyl nitrite0low10
dextropropoxyphene0medium61
limestone0low10
chenodeoxycholic acid0low30
rhein0low10
indirubin0low10
lucanthone0low10
imperatorin0low10
osthol0low10
reticulin0low30
bicuculline0low2740
kainic acid0medium6761
thymoquinone0low50
phenylpropanolamine0low50
4-hydroxybutyric acid0low30
isovaleric acid0low10
alpha-aminopyridine0low150
1,3-propanediol0low10
thiazolidines0low50
oleanolic acid0low70
dihydroergotamine0low10
estriol succinate0low10
hematoxylin0low10
psilocybin0low40
medroxyprogesterone0low60
dihydrotestosterone0low40
luminol0low10
dimenhydrinate0low30
8-chlorotheophylline0low10
copper gluconate0low10
azomycin0medium21
thiamine monophosphate0low10
chlormethiazole0low190
methoxyhydroxyphenylglycol0low170
3,5-dibromotyrosine0low10
methamphetamine0low100
isovaleramide0low10
malondialdehyde0medium554
myristic acid0low10
trinitrobenzenesulfonic acid0medium11
eosine yellowish-(ys)0low10
paeonol0low10
lithium carbonate0low70
tripalmitin0low10
phenoperidine0low20
glycerylphosphorylcholine0low10
congo red0low10
succinimide0low120
3-tyramine0low10
alpha-naphthoflavone0low10
c.i. 425100low20
clopenthixol0medium31
erythromycin0medium71
dehydroepiandrosterone sulfate0low80
2-piperidone0medium51
decan-4-olide0low10
benzobarbital0medium121
ethylnitrosourea0low30
ameltolide0low10
levonorgestrel0low50
potassium citrate0medium31
1,4-androstadiene-3,17-dione0low10
deoxycytidine0low40
deoxyuridine0low10
testolactone0medium21
dinobuton0low10
cytidine diphosphate choline0low10
4-ethyl-1-phospha-2,6,7 trioxabicyclo(2.2.2)octane-1-oxide0low10
acetylhydrazine0low10
allylglycine0low50
ethambutol0low30
pyrithioxin0low40
tetramethylpyrazine0low30
cycloate0low10
phenazocine0low10
durapatite0low10
thorium dioxide0low40
vancomycin0low50
glycyrrhizic acid0low10
d-alpha tocopherol0medium423
tocopherols0low10
propanidid0low50
fluanisone0low10
vincamine0low10
metylperon0low10
laudanosine0low10
paraquat0low20
s,n,n'-tripropylthiocarbamate0low90
2-tert-butylhydroquinone0low10
5-hydroxyindole0low10
dronabinol0low350
methionine sulfoximine0low180
amiloride0low60
pimozide0low30
benperidol0low30
fluorescein0low10
methylprednisolone hemisuccinate0low20
thioflavin t0low10
fucose0low20
ddms0low20
n,n-dimethylacrylamide0low10
hydroxyphenytoin0medium111
2,2-bis(bromomethyl)-1,3-propanediol0low10
fluorescein-5-isothiocyanate0low10
benzolamide0low10
sabinene0medium21
mannose0low20
dithiothreitol0low10
azo rubin s0low10
cyclazocine0low20
deanol acetamidobenzoate0low10
tranylcypromine0medium51
streptomycin0low110
chloric acid0low10
carbonates0medium62
2-octanol0low10
valnoctamide0low20
carbenicillin0low10
metanephrine0low10
trimetazidine0low40
floxacillin0low20
isometheptene0low10
n-methylaspartate0medium1291
trimethaphan0low10
phenylethylmalonamide0low90
methylglucamine metrizoate0low10
molindone0low10
iridium0low20
manganese0medium221
mercury0low70
palladium0low10
platinum0low40
silver0low50
tantalum0low10
technetium0low230
thorium0low10
titanium0low60
tungsten0low80
argon0low10
cadmium0low60
chromium0low10
gadolinium0medium131
gold0low100
helium0low30
xenon0low50
cupric chloride0low10
magnesium sulfate0low50
mercuric chloride0low10
acetylglucosamine0medium21
galactosamine0low10
cesium chloride0low20
hypochlorous acid0low20
camptothecin0medium31
ferric chloride0low300
nickel chloride0low10
bromine0medium31
barium sulfate0low30
monoethylglycinexylidide0low20
zinc sulfate0low20
potassium nitrate0low10
sodium sulfate0low10
calcium phosphate, dibasic, anhydrous0low10
calcium phosphate, monobasic, anhydrous0low10
tricalcium phosphate0low30
ferrous chloride0low100
metoprine0low20
deuterium0low30
fluorine0low80
chlorine0medium91
ethinyl estradiol-norgestrel combination0low10
galactose0low40
vasotocin0low10
ozone0low10
radon0low10
sodium selenite0low10
4-chloro-7-nitrobenzofurazan0low20
barium chloride0low10
chlormerodrin0low10
trolamine salicylate0low260
ammonium chloride0low150
titanium dioxide0low10
misonidazole0medium11
tiletamine0low10
tiletamine hydrochloride0low10
etorphine0low10
selegiline0low20
pizotyline0low10
cephalexin0low10
cromolyn sodium0low10
tetradecanoylphorbol acetate0low10
sodium bisulfide0low10
fluorides0low50
etamiphylline0low10
danazol0low10
metergoline0low10
lisuride0low20
cresyl violet0low70
1-deoxynojirimycin0low20
mercaptomerin0low10
iodine0low10
daunorubicin0low10
lofexidine0low10
carbimazole0low20
bromocriptine0low50
phenyl acetate0medium19919
cetylpyridinium chloride anhydrous0low160
paraldehyde0low280
pyrrolidine0low10
carbamide peroxide0low10
triamcinolone0low20
fludrocortisone0low20
pregnanolone0medium393
4-methoxyamphetamine0low190
8-bromo cyclic adenosine monophosphate0low10
transferrin0low90
androstane-3,17-diol0low20
alkenes0low10
calcium oxalate0low10
glutamic acid0medium4836
glucaric acid0medium132
alovudine0low10
cefazolin0low30
bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide0low10
pivampicillin0low10
torpedo0low20
azides0low50
adenosine diphosphate ribose0low40
amoxicillin0low20
timolol0low10
tramadol0low70
eterobarb0medium51
nicergoline0low10
safrazine0low10
tetrahydrocannabivarin 90low20
s-adenosylmethionine0medium112
zidovudine0low20
zolazepam0low10
5,7-dihydroxytryptamine0low30
etoposide0low60
substance p0low120
promegestone0low10
dobutamine0low10
butaclamol0low10
phorbol 12,13-dibutyrate0low10
10-carboxymethyl-9-acridanone0low20
methyldopa0medium21
sq-117250low10
diltiazem0low30
vecuronium bromide0medium41
ng-nitroarginine methyl ester0low130
quisqualic acid0low160
1-carboxyglutamic acid0low10
desogestrel0low40
nitazoxanide0low20
sufentanil0medium11
torsemide0low30
desflurane0medium11
enkephalin, methionine0low130
dihydroalprenolol0low40
propiconazole0low70
piperacillin0low10
paroxetine0low40
captopril0low10
progabide acid0low20
progabide0medium316
atracurium0low20
gabapentin-lactam0low10
colforsin0low80
buserelin0low10
doxofylline0low10
pimonidazole0low10
avobenzone0low10
pefloxacin0low20
daurisoline0low10
nafimidone0low20
alfentanil0medium72
fomesafen0medium1722
fenoxycarb0low10
miglustat0low20
pramiracetam0low10
lovastatin0low70
flupirtine0low50
milacemide0low20
denzimol0low10
idazoxan0low70
remoxipride0low10
quinpirole0low20
pravastatin0medium11
atomoxetine hydrochloride0low40
raloxifene hydrochloride0low10
mifepristone0low100
fluorodopa f 180medium21
salmeterol xinafoate0low10
ranolazine0low30
ipsapirone0low10
fura-20low40
finasteride0low90
naxagolide0low10
esmolol0low10
sabeluzole0medium11
adapalene0low10
remacemide0medium187
clopidogrel0low20
mibefradil0low10
besipirdine0low10
topotecan0medium11
tenidap0low10
gemcitabine0low10
enadoline0low10
aripiprazole0low60
sipatrigine0low50
xanomeline0low10
remifentanil0medium163
atorvastatin0low110
duloxetine hydrochloride0low10
irinotecan0medium11
valsartan0low10
zolmitriptan0medium11
capecitabine0low30
adenosine0medium1152
safranal0low10
3-n-butylphthalide0low40
nitrogen chloride0low50
dimethylhydrazines0low10
carfentanil0low20
acridine orange0low10
vanillyl alcohol0low10
potassium phosphate0medium11
tenocyclidine0low40
venlafaxine hydrochloride0medium51
trazodone hydrochloride0low20
mandrax0low10
tetramethylenedisulfotetramine0low10
glucose, (beta-d)-isomer0medium91
magnesium salicylate0low10
3,4-dihydro-2(1h)-quinolinone0low10
chloroquine diphosphate0low10
ursolic acid0low10
3-aminoisobutyric acid0medium21
thiazolyl blue0low10
baicalin0low20
plerixafor0low10
thionine0low10
epigallocatechin gallate0low30
n-acetylaspartic acid0medium462
fluorexon0low10
gallocatechol0low10
6-sulfatoxymelatonin0medium21
10,10'-dimethyl-9,9'-biacridinium0low10
hexamidine0low30
fluorophosphate0low20
o-(6)-methylguanine0low10
glutathione disulfide0low40
4-nitrobenzylthioinosine0low20
iopamidol0low30
cephalosporin c0low90
lathosterol0low10
cm 409070medium21
abecarnil0low20
bepafant0low10
lubeluzole0low20
telmisartan0low10
methacycline0low10
xenon radioisotopes0medium101
sc-11800 ee0low10
chloranilic acid0low10
1,7-phenanthroline0low20
triazoles0medium826
guanidinopropionic acid0low20
tangeretin0low10
delphinidin0low20
2-aminobenzaldehyde0low10
guanidinoethane sulfonate0low10
isobutyramide0low10
medetomidine0medium61
fluorodeoxyglucose f180medium2749
sertraline0medium81
selfotel0low10
talinolol0low10
pirlindole0low10
delta sleep-inducing peptide0low70
mesulergine0low20
tianeptine0low30
drospirenone0low10
ryodipine0low20
acetylurea0low60
triheptanoin0low50
beta-hydroxyisovaleric acid0low20
resorufin0low10
glutarimide0low40
nefiracetam0low30
n-methylscopolamine0low30
cromakalim0low40
barbexaclone0medium81
taltrimide0medium11
atipamezole0low40
uk 687980low10
ljc 106270low10
dicolinium iodide0low10
aceclofenac0low10
fluoresone0low10
panipenem0low10
prednisolone phosphate0low10
methotrimeprazine0low60
magnolol0low10
honokiol0low10
beta-aminoglutaric acid0low10
corilagin0low10
oxazolidin-2-one0medium81
sodium selenide0low10
4-(trifluoromethyl)benzamide0low10
4,5,6,7-tetrachloro-2-trifluoromethylbenzimidazole0low10
2-aminoethylmethacrylate0low10
tutin0low30
4-methoxymethylpyridoxine0low20
eletriptan0medium31
rosiglitazone0low40
3-chloropropionamide0low30
lithium bromide0low10
bexarotene0low10
s200980low30
1-ethyl-2-benzimidazolinone0low30
4-phenylbutylamine0low10
biocytin0low130
chloroquine diorotate0low10
10,11-dihydro-10,11-dihydroxy-5h-dibenzazepine-5-carboxamide0medium197
biotin sulfone0low10
d-aspartic acid0low10
clarithromycin0low40
bromates0low20
tebuconazole0low10
bisnorbiotin0low10
cholest-5-ene-3,4-diol0low10
coenzyme a0low10
valproic acid glucuronide0low10
7,8-dihydromethysticin0low10
nicotine0medium201
nsc-1727550medium161
n-desmethylclobazam0medium203
fibrinogen0medium161
17-alpha-hydroxypregnenolone0low10
beta-thujone0low20
aucubin0low10
3,4-dihydroxyphenylglycol0low90
homocysteine0medium887
alpha,beta-methyleneadenosine 5'-triphosphate0low20
5-(3-hydroxyphenyl)-5-phenylhydantoin0low10
8-((4-chlorophenyl)thio)cyclic-3',5'-amp0low10
sk&f 952820low10
n-desmethylmethsuximide0low20
levobupivacaine0low10
n-(4,4-diphenyl-3-butenyl)nipecotic acid0low50
melamine phosphate0low10
lopinavir0low10
propionyl-coenzyme a0low10
5-alpha-dihydroprogesterone0low10
5-methyltryptophan0low10
glucuronic acid0low20
palmitone0low10
5-iodotubercidin0low30
daq0low10
diosgenin0low10
isosteviol0low10
3,7-dimethyl-1-propargylxanthine0low10
enkephalinamide-met, ala(2)-0low30
tetrahydrodeoxycorticosterone0low60
n-methyladenosine0low20
1,2-distearoylphosphatidylethanolamine0low10
cobalt0low1060
fulvestrant0low10
1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid0low40
1-amino-1,3-dicarboxycyclopentane0low130
chlorates0low10
tert-butylbicyclophosphorothionate0low20
enkephalin, d-penicillamine (2,5)-0low20
fotemustine0low10
vitamin b 60medium411
1,4-dihydropyridine0low10
imipenem, anhydrous0low40
alphaxalone0low10
sr1417160low100
bicuculline methiodide0low320
cp-55,9400low10
2-propyl-4-pentenoic acid0low40
2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one0low10
fluo-30low20
methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate0low40
artesunic acid0low10
dihydrorhodamine 1230low10
cyanates0low20
indo-10low10
deoxypyridinoline0low40
pregnenolone sulfate0low40
methyllycaconitine0low10
fluorocitrate0low20
cgp 353480low140
beta-carboline-3-carboxylic acid methyl ester0low50
pyronaridine0low10
1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol0low20
saikosaponin d0low60
perindopril0low10
enkephalin, ser(2), leu(5), thr(6)-0low10
afdx 1160low10
procyanidin0low10
anhydrotetrodotoxin0low10
dihydrokainate0low30
sr 955310low110
bretazenil0low10
ecopipam0low30
1,9-dideoxyforskolin0low10
cl 2188720low10
fingolimod hydrochloride0low70
triptolide0low10
3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide0low10
3,5-dihydroxyphenylglycine0low60
2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one0low20
2-deoxyglucose-6-phosphate0low10
dynorphin (1-8)0low20
senktide0low10
kt 58230low10
1-hexadecyl-2-acetyl-glycero-3-phosphocholine0low20
zacopride0low10
exp31740medium11
deoxyglucose0medium802
st 5870low10
valerates0medium7619
thromboxanes0low10
n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride0low10
tanshinone0low10
tert-butylbicyclo-2-benzoate0low20
s-sulphocysteine0low10
gastrodin0low30
2-(2,3-dicarboxycyclopropyl)glycine0low30
megestrol acetate0low10
ifosfamide0low40
3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate0low10
zk 934260low10
panipenem-betamipron0low10
sc 581250low10
phenobarbital-n-glucoside0medium11
imidazenil0low10
ginsenoside rh20low30
arg-3-hyp-7-phe-bradykinin0low10
3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole0low10
caprylates0low70
tris(2-carboxyethyl)phosphine0low10
n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine0low20
gamma-glutamylaminomethylsulfonic acid0low20
pramipexole0low10
jstx-30low20
gr 736320low10
2-hydroxydesipramine0medium11
zk 934230low10
6-aminomethyl-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide0low10
pd 817230low10
pd 1173020low10
saclofen0low20
luzindole0low20
inositol 2,4,5-trisphosphate0low10
tryptophan methyl ester0low20
kallidin, des-arg(10)-0low10
5-chloromethylfluorescein diacetate0low10
astragaloside a0low10
peroxynitrous acid0low20
imatinib mesylate0low30
mk 06630low10
propyl beta-carboline-3-carboxylate0low20
n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine0low10
1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine0low10
zk 912960low20
nnc 7110low60
acth (4-10)0low10
angiotensin ii, des-phe(8)-0low10
ro 8-05760low10
angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-0low30
n-acetylglucosaminylasparagine0low10
n,n-dimethylarginine0low50
cyclic adp-ribose0low10
4-iodoamphetamine0low30
sodium-binding benzofuran isophthalate0low10
1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone0low60
zd 72880low90
acth (4-9)0medium11
4-amino-n-(2,6-dimethylphenyl)phthalimide0low10
desloratadine0low20
isononanoyl oxybenzene sulfonate0low10
glycerophosphoinositol 4,5-bisphosphate0low50
valproylcarnitine0low30
1-amino-3-(phosphonomethylene)cyclobutane-1-carboxylic acid0low10
amthamine0low10
gyki 536550low20
methotrexate0low170
pyrrolidine-2,3-dicarboxylic acid0low10
reboxetine0low20
ro 19-46030low10
sdz 220-5810low10
2-iminobiotin0low10
1-naphthylacetylspermine0low10
cgp 367420low30
5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine0low20
ci 9530low10
nafimidone alcohol0low10
2-methoxyisobutylisonitrile0low10
o-demethyltramadol0low10
8-(dicyclopropylmethyl)-1,3-dipropylxanthine0low10
cornuside0medium11
4-benzyl-3-crotonyl-2-oxazolidinone0low10
safinamide0low50
ly 2746140low10
l 6942470low10
cgp 524320low10
5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate0low30
af-cx 921xx0low30
omega-n-methylarginine0low10
(3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid0low10
sk&f 839590low10
l 7416260low10
n-aminomethylpiperazine 3,3-diethyl-2,4-pyridinedione0low30
eg 10880low10
carbapenems0low110
3-nitrobenzothiazolo(3,2-a)quinolinium0low10
triiodothyronine0low30
aspartame0medium52
sk&f 100330-a0low10
ethylketocyclazocine0low10
xylose0low20
5-phenyl-5-(4-hydroxyphenyl)hydantoin glucuronide0low10
2-acetamido-n-benzyl-2-methylacetamide0low10
beta-lactams0low70
3-methylcytosine0low10
proline0low210
escitalopram0medium11
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a0low10
ym 8720low10
tariquidar0low60
ertapenem0low20
allophanic acid0low20
cariporide0low10
copper bis(histidinate)0low10
5-(3,4-dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin0low10
cyanopindolol0low10
dn 14170low50
hydroxyl radical0low70
atazanavir sulfate0low10
rhodioloside0low10
tipifarnib0medium11
ios 112120low20
baldrinal0low10
ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination0low10
saccharopine0low20
allysine0low160
vanillactic acid0low10
saicar0low10
methindione0low20
adepren0medium11
2-deoxy-2-fluorogalactose0low10
substance p, sar(9)-met(o2)(11)-0low10
4-methyl-3-methylsulfonyl-5-phenyl-4h-1,2,4-triazole0low10
1-methyl-1,2-diphenylethylamine monohydrochloride0low30
lamotrigine 2-n-glucuronide0medium31
calcium pyrophosphate0low10
thymidine 5'-4-nitrophenyl phosphate0low10
delta-1-piperidine-6-carboxylic acid0low50
clorazepate dipotassium0low120
anacardic acid0low10
aminopterin0low10
beta-methylcrotonylglycine0low10
8-hydroxy-delta(9)-tetrahydrocannabinol0low10
n,n-di-n-propylserotonin0low10
17 alpha-hydroxyprogesterone caproate0low10
varenicline0low10
biotin0low290
angiotensin ii0low80
dipiperidinoethane-di-n-oxide0low20
gabaculine0low10
sk&f 756700low10
atropine0low500
sb 2035800low40
homocysteic acid0low50
dizocilpine0low10
2,2,3,3-tetramethylcyclopropane carboxamide0low40
psyllium0low10
esketamine0medium11
pilocarpic acid0low10
u 54494a0low20
7-aminoclonazepam0low10
isospaglumic acid0medium72
bd 10470low10
deflazacort0medium11
troleandomycin0low20
eglumetad0low10
butyrylcarnitine0medium11
tolvaptan0low10
deoxycholic acid0low20
estradiol 3-benzoate0low10
cortisone0low160
norethindrone enanthate0low10
eudesmin0low10
3-nitrotyrosine0low40
lanosterol0low20
anisomycin0low30
benzofurans0low80
potassium bromide0medium424
sodium bromide0low40
hydroxydione0low10
estramustine0low10
metribolone0low10
noscapine0low20
u-1040low10
wortmannin0low20
2-oxindole0low10
menthofuran0low10
trimethoprim, sulfamethoxazole drug combination0low20
calcein am0low30
ritonavir0low50
Bardoxolone0low10
dihydropyridines0low40
permanganate0low10
lithium chloride0low320
s-adenosylhomocysteine0low10
glycogen0low240
n-acetylneuraminic acid0low30
fibrin0low10
bradykinin0low40
glucosamine0low20
elastin0low10
carnosine0medium141
formiminoglutamic acid0low30
naringenin0low10
deoxyglucose0low10
oxytocin0low90
inositol 1,4,5-trisphosphate0low80
cysteinylglycine0medium21
ouabain0low150
puromycin0low10
taxifolin0low10
nitroarginine0low60
trimethyllysine0low10
inositol 3-phosphate0low80
dehydroascorbic acid0low10
cortodoxone0low10
arbutin0low10
strychnine0low640
quinidine0low200
meropenem0low140
griseofulvin0low20
digitoxin0low30
pentazocine0low30
pancuronium0low10
rocuronium0medium41
linezolid0low20
indican0low10
ryanodine0low20
scilliroside0low10
furostanol i0low10
picrotoxinin0low10
genipin0low10
pulegone0low10
lignans0low20
bq 1230low20
n-formylmethionine leucyl-phenylalanine0low10
diprenorphine0low10
3,5-dihydroxyphenylglycine0low10
ergonovine0low20
metrizamide0medium132
betadex0low70
acetyl coenzyme a0low10
tretinoin0low20
arachidonic acid0low60
farnesol0low10
phosphoramidon0low10
resveratrol0low80
retinol0low110
latrunculin a0low20
oleic acid0low10
tacrolimus0low190
ferulic acid0low30
pectins0low10
cocaine0low220
alpha-methyl-4-carboxyphenylglycine0low70
thapsigargin0low60
mycophenolic acid0low10
clindamycin0low20
keratan sulfate0low10
lycopene0low10
zithromax0low20
adenosine-5'-(n-ethylcarboxamide)0low20
prostaglandin d20low10
diethylstilbestrol0low10
h 890low30
decitabine0low20
iridoids0low10
kt 57200low10
melphalan0low20
enkephalin, leucine0low230
favipiravir0low10
riboflavin0medium61
m404010low10
potassium permanganate0low10
sodium bicarbonate0low20
potassium acetate0low10
sodium benzoate0low30
tetronic acid0low20
dipyrone0medium21
oxazolidine0low110
cholestane-3,5,6-triol0low20
bromochloroacetic acid0low30
3-carbamoyl-2,2,5,5-tetramethyl-3-pyrroline-1-yloxyl0low10
carbenoxolone sodium0low230
alpha-asarone0low60
cinnamaldehyde0low20
dimethyl fumarate0low30
glycosides0low10
isomethyleugenol0low240
isosafrole0low10
piperine0medium101
squalene0low10
stilbenes0low80
isoliquiritigenin0low10
ilepcimide0medium41
flavin-adenine dinucleotide0low10
pseudococaine0low10
11-hydroxy-delta(9)-tetrahydrocannabinol0low10
arginine vasopressin0medium101
pyrophosphate0low10
gw96620low10
s 10330low10
mezlocillin0low10
trilostane0low10
methylatropine0low10
iothalamate meglumine0low30
ly3828840low10
xe 991, anthracenone0low30
nsc 43470medium21
n(6)-cyclopentyladenosine0low10
sesquiterpenes0low70
chlorprothixene0low70
etomidate0medium202
mercaptopurine0low20
sb 3667910low10
3,3',4,5'-tetrahydroxystilbene0low10
bemesetron0low10
alpha-methyltryptophan, (l)-isomer0low90
1-methyltryptophan0low10
thioinosine0low20
phenylthiourea0low30
cinromide0medium31
caffeic acid0low20
rg1080low20
1-(3-chlorophenyl)sulfonylpyrrolidine0low10
flunarizine0medium4413
tetrahydropalmatine0low20
curcumin0low220
ica-1214310low30
hc 0300310low30
thiouracil0low10
thiohydantoins0medium11
methimazole0low10
urb 5970low10
cinnarizine0medium52
capsaicin0low70
enclomiphene0low90
terbinafine0low20
tosylarginine methyl ester0low10
chlorogenic acid0low10
thioguanine anhydrous0low10
thiobarbituric acid0low10
thiosemicarbazide0low30
thiourea0low20
sodium propionate0low20
D-fructopyranose0medium48684
unithiol0low10
tempo0low10
succimer0low10
N1-[4-(aminosulfonyl)phenyl]-2,2-dimethylpropanamide0low10
capsazepine0low30
fumonisin b10low10
tamoxifen0low90
nadp0medium61
1,1-diphenyl-2-picrylhydrazyl0low20
hc-0670470low10
horminone0low20
t 00709070low10
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole0low20
monastrol0low10
lincomycin0low20
rhyncophylline0low20
thiopental0medium462
estrone sulfate0low20
ranitidine0low20
maraviroc0low20
u 01260low10
telaprevir0low10
pica0low30
4-diphenylacetoxy-n-methylpiperidine methiodide0low10
6-oxopiperidine-2-carboxylate0low10
6-methyl-2-(phenylethynyl)pyridine0low90
lithium0medium997
thiamylal0low10
cobaltous chloride0low80
nitrogen dioxide0low20
dermatan sulfate0low10
orlistat0low10
loreclezole0low60
quinine0medium82
1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester0low40
androstane-3,17-diol glucuronide0low10
ici 1541290low30
deltorphin0low10
rtki cpd0low10
8-bromoguanosino-3',5'-cyclic monophosphorothioate0low10
4-(1h-imidazol-4-ylmethyl)piperidine0low10
thioperamide0low20
ee 5810low20
cystine0low40
u-504880low40
sch 233900low10
beta-cyclodextrin tetradecasulfate0low10
irampanel0low10
freedom0medium281
homoquinolinic acid0low10
oxalylglycine0low10
substance p (4-11), beta-ala(4)-sar(9)-met(02)(11)-0low10
awd 131-1380medium208
ginsenosides0low20
N-(2,4,6-trimethylphenyl)-3-bicyclo[2.2.1]heptanecarboxamide0low10
napelline0low10
2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline0low320
4-aminopyrrolidine-2,4-dicarboxylic acid0low40
sodium dodecyl sulfate0low20
crocin0low10
galactomannan0low10
ncs 3820low10
2-chloro-5-hydroxyphenylglycine0low10
rs 1022210low10
6-cyano-7-nitroquinoxaline-2,3-dione0low690
l 1528040low10
n-(6-chloropyridin-3-yl)-4-fluorobenzamide0low20
3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3h)-quinazolinone0low20
fg 90410low140
17-ketosteroids0medium131
naphthoquinones0low10
4-(5-(4-bromophenyl)-3-(6-methyl-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)-4,5-dihydro-1h-pyrazol-1-yl)-4-oxobutanoic acid0low10
am 6300low10
sc 5600low10
alpha-carotene0medium11
digitoxigenin0low10
cfm 20low20
osteoprotegerin0low20
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide0low30
rhodamine 1230low40
9-(2-morpholinoethyl)-2-(4-fluorophenyl)imidazo(1,2-alpha)benzimidazole0low10
myelin basic protein0low140
tcn 2010low10
cgp 79300low10
sphingosine0low20
quercetin0low70
ubiquinone q20low10
bilirubin0medium241
dinoprostone0low130
dinoprost0medium71
biochanin a0low10
leukotriene a40low10
vitexin0low20
apigenin0low30
luteolin0low10
calcitriol0medium162
vitamin k semiquinone radical0medium341
beta carotene0medium41
11-cis-retinal0low20
leukotriene b40low10
thromboxane a20low20
alprostadil0low10
vitamin d 20medium275
rutin0low20
6-ketoprostaglandin f1 alpha0low10
lipoxin a40low10
gamma-linolenic acid0low30
alpha-linolenic acid0low40
harmine0low10
genistein0low20
clavulanic acid0low10
pyrantel pamoate0low10
oxymetholone0low10
montelukast0low10
ethchlorvynol0low10
paricalcitol0low10
astaxanthine0low10
lutein0low10
harman0low10
esculetin0low10
7-hydroxycoumarin0low10
humulene0low870
garcinol0low10
baicalein0low30
chrysin0low30
morin0low10
myricetin0low10
echinacoside0low10
caffeic acid phenethyl ester0low10
rosmarinic acid0low10
acteoside0low10
rottlerin0low10
flupenthixol0low10
coenzyme q100low10
anandamide0low110
l 6835900low30
tak 1470low10
domoic acid0low130
8-epi-prostaglandin f2alpha0medium31
glyceryl 2-arachidonate0low30
isotretinoin0low20
olopatadine hydrochloride0low10
dothiepin hydrochloride0low10
4-hydroxy-2-nonenal0low40
oleylamide0low10
sphingosine 1-phosphate0low20
codeine0low20
phenylephrine hydrochloride0low170
acitretin0low10
cyproterone0low10
granisetron0low10
oxycodone0medium21
vitamin k 10low10
sirolimus0medium843
morphine0low290
arachidonyl-2-chloroethylamide0low40
atosiban0low10
beta-funaltrexamine0low20
bibo 34570low10
bibp 32260low20
deamino arginine vasopressin0low20
olvanil0low10
sb 2770110low10
herbimycin0low10
kallidin0low10
goserelin0low10
iloprost0low10
lysophosphatidylcholines0low10
cytochalasin b0low10
neurokinin a0low10
neurokinin b0low10
ciguatoxins0low10
r 7150low10
sulprostone0low10
iridal0low10
andrographolide0low10
icariin0low20
1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta(c)quinolin-8-yl)ethanone0low10
thebaine0low10
fluvoxamine0low50
casein kinase ii0low20
ag-4900low10
mitoguazone0low10
ergothioneine0low10
lead0low60
15-hydroxy-5,8,11,13-eicosatetraenoic acid0low10
6,7-dihydroxyflavone0low20
antimony0low10
cesium0medium121
barium0low120
rubidium0medium41
trimethyltin0low30
aluminum0low360
levorphanol0low10
bismuth0low40
dihydromorphine0low10
thallium0low30
arsenic0low50
naltrexone0low90
morphine-6-glucuronide0low10
dextromethorphan0low120
dextrorphan0low20
gallium0medium11
sulfur0low60
methylazoxymethanol acetate0low210
enalapril0low10
1-methyl-beta-carboline-3-carboxylic acid0low10
sinomenine0low10
2,3-oxidosqualene0low10
ecdysterone0low10
cysteine0medium533
silicon0medium61
phosphorus0medium533
boron0low20
heroin0medium51
enkephalin, ala(2)-mephe(4)-gly(5)-0low10
metkephamid0low10
cinanserin0low10
pepstatin0low20
cefepime0low40
norbinaltorphimine0low20
dermorphin0low40
enkephalin, ala(2)-mephe(4)-gly(5)-0low50
sinigrin0low10
naltrindole0low20
3,3'-dioctadecylindocarbocyanine0low10
carbocyanines0low30
25-hydroxyvitamin d 20medium72
3,4-dichlorophenyl propenylisobutylamide0low20
1,2-dielaidoylphosphatidylethanolamine0low10
cgp 378490low50
bisabolol0low10
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid0low10
proguanil0low40
coomassie brilliant blue0low20
iodoresiniferatoxin0low10
saralasin0low10
tetrodotoxin0low670
selenium0medium271
radium0low70
clovoxamine0low10
cgp 395510low30
dihydroergotoxine0low10
dizocilpine maleate0low890
pregnanediol0low10
cholestanol0low10
neramexane0low10
methylazoxymethanol0low150
24,25-dihydroxyvitamin d 30low60
cilastatin0low20
ralitoline0low30
trans-2-en-valproate0low30
pumiliotoxin b0low10
3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid0low40
cgp 396530low20
2-(4-amylcinnamoyl)amino-4-chlorobenzoic acid0low10
smr 20low10
1,1'-dipropyl-3,3,3',3'-tetramethylindocarbocyanine0low10
pregna-4,17-diene-3,16-dione0low10
2-amino-5-phosphono-3-pentenoic acid0low10
cannabigerolic acid0low10
cdw17 antigen0low10
clopenthixol decanoate0medium11
trisialoganglioside gt10low20
ganglioside, gd20low10
laniquidar0low10
oc 144-0930low10
salvianolic acid B0low10
i(3)so3-galactosylceramide0low10
oxepins0low10
tanespimycin0low20
verlukast0low10
paclobutrazol0low10
beta-escin0low160
4-(2-(phenylsulfonylamino)ethylthio)-2,6-difluorophenoxyacetamide0low10
sb 2222000low10
nitrofurantoin0low10
ro 25-69810low20
iem 14600low20
tubacin0low10
bicuculline methobromide0low10
6 beta-hydroxycortisol0low40
gadolinium dtpa0medium101
morphinans0low20
ergoline0low80
adenosine-3',5'-cyclic phosphorothioate0low10
sq-233770low10
org 27660low20
enkephalin, leucine-2-alanine0low10
etonogestrel0low30
montirelin0low20
dexniguldipine0low10
ciclesonide0low10
n-valproyl glycinamide0low20
jwh-1330low10
rebaudioside a0low10
3-hydroxyphenylacetate0low10
isoborneol0low30
staurosporine0low30
chloralose0low80
aminomethyltransferase0low10
n-(4-methylthiazol-2-yl)-2-(6-phenylpyridazin-3-ylthio)acetamide0low10
hypericum0low10
phosphocreatine0medium142
sidnocarb0low10
chlorhexidine0medium21
ropizine0low10
cgp 56999a0low20
biie 02460low10
jasplakinolide0low10
anatibant0low10
davunetide0low20
sincalide0low50
vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-0low10
18f-fluoroethyl-l-tyrosine0low10
dysiherbaine0low10
n(6)-cyclohexyladenosine0low40
ro 64-61980low10
ursodoxicoltaurine0low20
paliperidone palmitate0low20
gc 1 compound0low10
mocetinostat0low40
sc 2360low10
ticagrelor0low10
rivaroxaban0low10
lipid a0low20
dapagliflozin0low10
mk 3860low10
ginsenoside rb10low10
g(m2) ganglioside0low20
ica 272430low10
ic 871140low10
thiocolchicoside0low20
bpc 1570low10
pitolisant0low10
u 18666a0low10
cgp 55845a0low110
nuvaring0low10
g(m1) ganglioside0low60
vortioxetine0low10
capsazocaine0low10
aluminum oxide0low200
arachidonoylserotonin0low10
bicuculline methochloride0low20
antillatoxin0low10
4-[(2-butyl-6,7-dichloro-2-cyclopentyl-1-oxo-3H-inden-5-yl)oxy]butanoic acid0low10
pimavanserin0low10
4-hydroxy-n-desmethyltamoxifen0low10
linagliptin0low10
losigame0low50
2,2,3,3-tetramethylcyclopropanecarbonylurea0low10
dimethylarginine0low10
ns 16430low10
apixaban0low10
indantadol0low10
vitamin u0low10
ar c1558580low10
homocarnosine0medium131
ro 16-01540medium185
alpha-synuclein0low40
oxadiazoles0low90
ribose0low20
acebutolol0low20
8-oxo-2'-deoxyadenosine0low10
calpain inhibitor iii0low10
(+)-erythravine0low10
brimonidine tartrate0low10
rh 4140low40
resolvin d20low10
rh 7950low30
fr 1802040low10
sitagliptin phosphate0low20
col-1440low10
veratridine0low90
ro 49563710low10
n,n'-dibenzhydrylethane-1,2-diamine dihydrochloride0low10
2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine0low10
losartan potassium0medium181
alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc0low10
2-(n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose0low20
technetium tc 99m exametazime0medium955
dihydroouabain0low10
dextrothyroxine0medium372
scopolamine hydrobromide0low250
pituitrin0low200
lhrh, ala(6)-gly(10)-ethylamide-0low10
enerbol0low20
dihydrotachysterol0low30
clove0low120
acid phosphatase0low90
argipressin, des-glynh2(9)-0low10
mefloquine0low50
25,26-dihydroxycholecalciferol0low20
silver carbonate0low10
eth 10010low10
curcumol0low10
physalaemin0low10
icatibant0low10
jaw0low80
carbon-11 methionine0low10
ly 2330530low10
thiamine pyrophosphate0low10
nad0low190
protectin d10low30
cytochrome c-t0low60
picogreen0low10
calcitonin0low10
cosyntropin0medium72
cholecystokinin0low170
ceruletide0low10
dynorphins0low200
somatostatin0low10
atrial natriuretic factor0low10
adrenocorticotropin zinc0low10
m 350low10
nociceptin0low60
galantide0low10
galanin (1-16)0low10
acetylcholine receptor alpha-subunit (125-148)0low10
gastrins0low20
glucagon0low70
mast cell degranulating peptide0low20
beta-endorphin0low150
sauvagine0low10
thymosin beta(4)0low10
neuropeptide y0medium1022
conotoxin gv0low10
iberiotoxin0low10
angiotensinogen0low10
tannins0low20
oligonucleotides0medium41
anticodon0low20
liraglutide0low40
ziconotide0low10
glucagon-like peptide 10low30
msh, 4-nle-7-phe-alpha-0low10
c-peptide0medium61
calcium orange0low10
cellulose0low10
sodium borate0low10
endothelin-10low100
phosphatidylcholines0medium52
3-benzyl-5-((2-nitrophenoxy)methyl)dihydrofuran-2(3h)-one0low10
chlorophyll a0low10
nsc 237660low10
adenosine kinase0low370
sphingosine kinase0low10
ubiquinone0low80
calpain0low130
lucifer yellow0low40
succinyladenosine0low10
hydroxyoctadecadienoic acid0low10
zetekitoxin ab0low10
chitosan0low30
2-(2'-carboxy-3'-phenylcyclopropyl)glycine0low10
nnc 55-03960low10
septide0low10
technetium tc 99m sestamibi0low10
s-nitro-n-acetylpenicillamine0low10
arginine butyrate0low10
mesna0low20
sodium oxybate0low100
bucladesine0low20
potassium bromate0low10
sodium glutamate0low40
ro13-99040low110
sodium pertechnetate tc 99m0low10
sodium ethylxanthate0low110
piperacillin, tazobactam drug combination0low10
s-adenosylmethionine0low90
picrotoxin0low1250
st28250low10
intrinsic factor0low10
jzl 1840low10
quetiapine fumarate0low50
cardiovascular agents0medium211
trelstar0low30
dynorphins0low10
neurotensin0low40
deslorelin0low10
histrelin0low10
apelin-13 peptide0low10
cerebellin0low10
mannans0low10
bms-7900520low10
guanidinosuccinic acid0low20
phosphinothricin0low10
(5-(2,4-bis((3s)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol0low10
triiodothyronine, reverse0low30
gw 10000low50
glycolipids0low20
clp2570low10
piperidines0medium999
thymosin0low10
7,8-dihydroxyflavanone0low10
interleukin-80medium51
antibiotic cv-10low10
ulixacaltamide0low10
hemopressin0low20
tat-nr2b9c0low10
colistin0low10
hydroxocobalamin0low10
sofosbuvir0low10
kavain0low10
endrin0low10
alpha-tocotrienol quinone0low10
pr-9570low10
fructose-1,6-diphosphate0low20
inflachromene0low10
vasoactive intestinal peptide0low80
natriuretic peptide, brain0low70
heme0medium41
vu04244650low10
ortho evra0low10
chondroitin0low10
heparitin sulfate0low20
tuftsin0low20
glutarylcarnitine0low10
tetracycline0low40
chlortetracycline0low30
oxytetracycline, anhydrous0low20
minocycline0low90
salicylates0low140
dicumarol0low40
acenocoumarol0low10
mobic0low10
phenprocoumon0low20
l 7013240low20
byl7190low10
mebolazine0low10
2'-hydroxy-5,9-dimethyl-2-allyl-6,7-benzomorphan0low10
omega-agatoxin iva0low20
snx 2300low10
epidermal growth factor0low10
charybdotoxin0low10
transforming growth factor beta0medium172
semaglutide0low10
cgs 12066b0low10
saxitoxin0low30
okadaic acid0low50
gs-4589670low40
minozac0low30
coriaria lactone0low330
kiss1 protein, human0low10
rome0low70
3-hydroxyisovalerylcarnitine0low10
agar0low10
rta 4080low10
glutaminase0low50
cyclin d10low20
contraceptives, postcoital0low20
ganoderic acid0low10
lysophosphatidylinositol0low10
caseins0low10
MLI-20low10
g(m3) ganglioside0low40
nitrophenols0low10
neuropeptide y, leu(31)-pro(34)-0low20
peptide yy0low10
kaliotoxin0low10
angiotensin i0low20
amikacin0medium11
hyaluronoglucosaminidase0low30
bacoside a0low50
angiotensin iii0low10
deltakephalin0low10
6-benzoylheteratisine0low30
ginkgolide b0low10
tridihexethyl0low10
ganoderic acid a0low10
3-acetylaconitine0low10
aldrin0low10
vitamin b 120medium10011
aconitine0low110
insulin glargine0low10
norgestrel0low60
s 89320low10
oxyntomodulin0low10
lysergic acid0low30
cyclosporine0medium221
flavin mononucleotide0low10
peptide yy0low40
myelin oligodendrocyte glycoprotein (35-55)0low10
catalpol0low10
phenylbutazone, propyphenazone drug combination0low10
apyrase0low20
thromboplastin0low20
muramidase0low10
amyloid beta-peptides0low10
chondroitin sulfates0low20
exudates0medium595
neuropeptide y (13-36)0low10
acyclovir0low60
levoleucovorin0medium151
cyclic gmp0low170
deoxyguanosine0low60
guanosine diphosphate0low10
guanosine monophosphate0low10
guanosine triphosphate0low40
guanine0medium51
guanosine0low30
hypoxanthine0low20
inosine0low40
inosine diphosphate0low10
sapropterin0low30
3-methyladenine0low10
guanosine 5'-o-(3-thiotriphosphate)0low30
neopterin0low30
rifampin0low90
clozapine0low330
dacarbazine0medium81
ganciclovir0low20
valacyclovir0low10
olanzapine0low120
allopurinol0medium142
sildenafil citrate0medium31
spd 5020low10
vardenafil dihydrochloride0low10
8-hydroxyguanine0medium21
trypan blue0low10
8-hydroxy-2'-deoxyguanosine0low60
clozapine n-oxide0low10
coelenterazine0low10
5-methyltetrahydrofolate0low90
ns 3090low10
pteropterin0low10
hb 70low20
molybdenum cofactor0low30
batrachotoxinin a 20-alpha-benzoate0low10
avermectin0low10
eye0medium401
carbidopa0medium51
ego0low70
concanavalin a0low30
technetium tc 99m bicisate0medium342
nirmatrelvir0low10
gq1b ganglioside0low10
metallothionein0low70
dinitrobenzenes0low10
2',7'-bis-(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester0low10
phosphorus radioisotopes0low50
galanin-like peptide0low10
n-succinyl-chitosan0low10
preproenkephalin0low10
leptin0medium455
reamberin0medium21
pyrimidinones0low30
filipin0low10
phenanthrenes0low30

Protein Targets (4,606)

ProteinPotency MeasurementsInhibition MeasurementsActivation MeasurementsDrugs
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE28300283
Gamma-aminobutyric acid type B receptor subunit 20549
Gamma-aminobutyric acid receptor subunit alpha-10502980
Gamma-aminobutyric acid receptor subunit beta-1033539
Gamma-aminobutyric acid receptor subunit gamma-20482271
Gamma-aminobutyric acid receptor subunit rho-103515
Gamma-aminobutyric acid receptor subunit beta-30461360
Gamma-aminobutyric acid receptor subunit rho-20129
Gamma-aminobutyric acid receptor subunit alpha-50441964
Gamma-aminobutyric acid receptor subunit alpha-30451359
Gamma-aminobutyric acid receptor subunit alpha-20451561
Gamma-aminobutyric acid receptor subunit beta-20391959
Gamma-aminobutyric acid receptor subunit alpha-4035642
Gamma-aminobutyric acid receptor subunit alpha-6041648
Gamma-aminobutyric acid type B receptor subunit 10549
endonuclease IV750075
thioredoxin reductase30000300
aldehyde dehydrogenase 1 family, member A132400324
euchromatic histone-lysine N-methyltransferase 248600486
Bloom syndrome protein isoform 116800168
lamin isoform A-delta1039000390
Muscarinic acetylcholine receptor M2010912130
Muscarinic acetylcholine receptor M401078121
Muscarinic acetylcholine receptor M50967107
Muscarinic acetylcholine receptor M1011913143
Muscarinic acetylcholine receptor M301069120
Muscarinic acetylcholine receptor012215
PPM1D protein790079
Bone morphogenetic protein receptor type-1B0066
Membrane-associated progesterone receptor component 10033
Serine/threonine-protein kinase PLK402810
ATP-dependent RNA helicase DDX3X0055
Pyridoxal kinase0059
Citron Rho-interacting kinase0189
Serine/threonine-protein kinase Chk10099
Aurora kinase A02810
Cyclin-G-associated kinase0189
Ephrin type-B receptor 60066
Peroxisomal acyl-coenzyme A oxidase 30055
Receptor-interacting serine/threonine-protein kinase 202810
Mitotic checkpoint serine/threonine-protein kinase BUB10044
Dynamin-like 120 kDa protein, mitochondrial0055
Eukaryotic translation initiation factor 5B0055
Rho-associated protein kinase 20178
Serine/threonine-protein kinase ULK10066
Serine/threonine-protein kinase/endoribonuclease IRE10066
Ribosomal protein S6 kinase alpha-50189
U5 small nuclear ribonucleoprotein 200 kDa helicase0055
Ribosomal protein S6 kinase alpha-40088
Serine/threonine-protein kinase 160088
Serine/threonine-protein kinase 100088
Serine/threonine-protein kinase D307916
Structural maintenance of chromosomes protein 20055
Mitogen-activated protein kinase kinase kinase 60066
Mitogen-activated protein kinase kinase kinase kinase 40088
Serine/threonine-protein kinase LATS10088
Serine/threonine-protein kinase PAK 40088
Tyrosine-protein kinase ABL10121023
Epidermal growth factor receptor038846
Interferon beta28400284
High affinity nerve growth factor receptor01910
Guanine nucleotide-binding protein G(i) subunit alpha-20033
ADP/ATP translocase 20055
Protein kinase C beta type010717
Insulin receptor02811
Tyrosine-protein kinase Lck0161027
Tyrosine-protein kinase Fyn027936
Cyclin-dependent kinase 1011516
Glycogen phosphorylase, liver form0257
Tyrosine-protein kinase Fes/Fps0088
Adenine phosphoribosyltransferase0044
Tyrosine-protein kinase Yes04812
Tyrosine-protein kinase Lyn03811
Proto-oncogene tyrosine-protein kinase receptor Ret0189
Insulin-like growth factor 1 receptor02810
Signal recognition particle receptor subunit alpha0055
Cytochrome c1, heme protein, mitochondrial0055
Hepatocyte growth factor receptor03811
Tyrosine-protein kinase HCK02810
Platelet-derived growth factor receptor beta01810
Serine/threonine-protein kinase A-Raf0055
Glycogen phosphorylase, brain form0257
Breakpoint cluster region protein04611
Serine/threonine-protein kinase pim-1010921
Fibroblast growth factor receptor 10089
DNA topoisomerase 2-alpha08627
Cyclin-dependent kinase 405611
ADP/ATP translocase 30055
Inosine-5'-monophosphate dehydrogenase 20358
Proto-oncogene tyrosine-protein kinase Src014823
cAMP-dependent protein kinase type II-alpha regulatory subunit0055
Serine/threonine-protein kinase B-raf04812
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform0088
Ribosyldihydronicotinamide dehydrogenase [quinone]010717
Tyrosine-protein kinase Fer0088
Protein kinase C alpha type013823
cAMP-dependent protein kinase catalytic subunit alpha06814
General transcription and DNA repair factor IIH helicase subunit XPD0055
Casein kinase II subunit alpha'015823
Ras-related protein Rab-6A0055
Ephrin type-A receptor 10088
Multifunctional protein ADE20055
cAMP-dependent protein kinase catalytic subunit gamma0448
cAMP-dependent protein kinase catalytic subunit beta04812
Ferrochelatase, mitochondrial0055
Ribosomal protein S6 kinase beta-10167
Tyrosine-protein kinase JAK102810
Cyclin-dependent kinase 20111122
Beta-adrenergic receptor kinase 10189
Probable ATP-dependent RNA helicase DDX60055
Mitogen-activated protein kinase 3 05814
MAP/microtubule affinity-regulating kinase 30088
Deoxycytidine kinase00510
Phosphatidylinositol 3-kinase regulatory subunit alpha0809
Mitogen-activated protein kinase 1013922
Ephrin type-A receptor 20189
Ephrin type-B receptor 202911
Non-receptor tyrosine-protein kinase TYK20088
UMP-CMP kinase 0055
Phosphatidylethanolamine-binding protein 10055
Wee1-like protein kinase0088
Heme oxygenase 20055
S-adenosylmethionine synthase isoform type-20156
DnaJ homolog subfamily A member 10055
RAC-alpha serine/threonine-protein kinase06814
RAC-beta serine/threonine-protein kinase0189
Dual specificity protein kinase TTK0178
DNA replication licensing factor MCM40055
Myosin-100044
Dual specificity mitogen-activated protein kinase kinase 202810
Receptor-type tyrosine-protein kinase FLT3011819
Bone morphogenetic protein receptor type-1A0088
Activin receptor type-1B0088
TGF-beta receptor type-103912
TGF-beta receptor type-20178
Electron transfer flavoprotein subunit beta0044
Tyrosine-protein kinase CSK02810
Glycine--tRNA ligase0055
Protein kinase C iota type07714
Exosome RNA helicase MTR40055
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform09515
Serine/threonine-protein kinase mTOR010515
Tyrosine-protein kinase Tec0088
Tyrosine-protein kinase ABL202810
Tyrosine-protein kinase FRK0088
G protein-coupled receptor kinase 60246
Tyrosine-protein kinase SYK071421
26S proteasome regulatory subunit 6B0055
Mitogen-activated protein kinase 8001010
Mitogen-activated protein kinase 9011011
Dual specificity mitogen-activated protein kinase kinase 40167
Dual specificity mitogen-activated protein kinase kinase 30088
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha0044
Casein kinase I isoform alpha04610
Casein kinase I isoform delta07815
MAP kinase-activated protein kinase 20189
Elongation factor Tu, mitochondrial0055
Cysteine--tRNA ligase, cytoplasmic0055
Casein kinase I isoform epsilon05813
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial0055
Dual specificity protein kinase CLK10189
Dual specificity protein kinase CLK20189
Glycogen synthase kinase-3 alpha08816
Glycogen synthase kinase-3 beta015924
Cyclin-dependent kinase 702810
Cyclin-dependent kinase 902810
Ras-related protein Rab-27A0044
Interleukin-1 receptor-associated kinase 10066
Ribosomal protein S6 kinase alpha-30088
Serine/threonine-protein kinase Nek20189
Serine/threonine-protein kinase Nek30066
Dual specificity mitogen-activated protein kinase kinase 60189
LIM domain kinase 10088
LIM domain kinase 20088
Mitogen-activated protein kinase 100111021
Tyrosine--tRNA ligase, cytoplasmic0055
5'-AMP-activated protein kinase subunit gamma-10089
Ephrin type-B receptor 30088
Ephrin type-A receptor 50088
Ephrin type-B receptor 40088
Ephrin type-A receptor 40088
Adenylate kinase 2, mitochondrial0056
Adenosine kinase03510
Ras-related protein Rab-100055
Actin-related protein 30055
Actin-related protein 20055
GTP-binding nuclear protein Ran0055
Casein kinase I isoform gamma-20178
Cyclin-dependent kinase 30178
Cyclin-dependent kinase 605510
Cyclin-dependent-like kinase 5 07815
Cyclin-dependent kinase 160189
Cyclin-dependent kinase 170178
ATP-dependent 6-phosphofructokinase, platelet type0055
Dual specificity mitogen-activated protein kinase kinase 105813
DNA topoisomerase 2-beta02616
Protein kinase C theta type081018
Activin receptor type-10088
Macrophage-stimulating protein receptor0066
Focal adhesion kinase 10189
Protein kinase C zeta type07411
Protein kinase C delta type0101020
Tyrosine-protein kinase BTK0189
Activated CDC42 kinase 10088
Epithelial discoidin domain-containing receptor 102810
Potassium voltage-gated channel subfamily H member 201601164
Mitogen-activated protein kinase kinase kinase kinase 20066
Serine/threonine-protein kinase 40088
5'-AMP-activated protein kinase catalytic subunit alpha-1001011
Dual specificity mitogen-activated protein kinase kinase 50066
Mitogen-activated protein kinase 70088
Serine/threonine-protein kinase PAK 20088
Serine/threonine-protein kinase 30088
Mitogen-activated protein kinase kinase kinase 10066
Integrin-linked protein kinase0044
Rho-associated protein kinase 10066
Non-receptor tyrosine-protein kinase TNK10088
Serine/threonine-protein kinase ATR0426
Calcium/calmodulin-dependent protein kinase type II subunit gamma0189
Calcium/calmodulin-dependent protein kinase type II subunit delta0189
Dual specificity tyrosine-phosphorylation-regulated kinase 1A05611
Activin receptor type-2B0077
Bone morphogenetic protein receptor type-20088
Protein-tyrosine kinase 60088
cGMP-dependent protein kinase 1 0189
Cyclin-dependent kinase 130167
Inhibitor of nuclear factor kappa-B kinase subunit epsilon0088
Protein-tyrosine kinase 2-beta0088
Maternal embryonic leucine zipper kinase0088
Structural maintenance of chromosomes protein 1A0055
Chromodomain-helicase-DNA-binding protein 40055
Peroxisomal acyl-coenzyme A oxidase 10044
Ephrin type-A receptor 70077
Delta(24)-sterol reductase0055
Ribosomal protein S6 kinase alpha-10189
Dual specificity testis-specific protein kinase 10088
Myosin light chain kinase, smooth muscle06814
Mitogen-activated protein kinase 1105813
Serine/threonine-protein kinase STK110088
Serine/threonine-protein kinase N10189
Serine/threonine-protein kinase N20088
Mitogen-activated protein kinase 140261036
Calcium/calmodulin-dependent protein kinase type IV0077
Mitogen-activated protein kinase kinase kinase 110189
Discoidin domain-containing receptor 202810
AP2-associated protein kinase 10088
Myosin light chain kinase 30167
Putative heat shock protein HSP 90-beta 20055
Rab-like protein 30022
Serine/threonine-protein kinase MRCK alpha0088
Serine/threonine-protein kinase MRCK gamma0088
Acyl-CoA dehydrogenase family member 100055
Serine/threonine-protein kinase N30044
Serine/threonine-protein kinase ULK30066
Rapamycin-insensitive companion of mTOR0101
Uncharacterized protein FLJ452520055
Acyl-CoA dehydrogenase family member 110055
Serine/threonine-protein kinase/endoribonuclease IRE20055
Serine/threonine-protein kinase MARK20088
ATP-dependent RNA helicase DHX300044
Serine/threonine-protein kinase TAO10066
STE20-related kinase adapter protein alpha0055
Myosin-140055
AarF domain-containing protein kinase 10055
ATP-dependent RNA helicase DDX420022
Mitogen-activated protein kinase kinase kinase kinase 30088
MAP kinase-activated protein kinase 503710
Regulatory-associated protein of mTOR0303
Misshapen-like kinase 10055
Atypical kinase COQ8A, mitochondrial0088
Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma0055
Mitogen-activated protein kinase 150088
Serine/threonine-protein kinase Nek90088
Serine/threonine-protein kinase Nek70066
ATP-dependent RNA helicase DDX10055
Mitogen-activated protein kinase kinase kinase kinase 10077
Aurora kinase B07916
MAP/microtubule affinity-regulating kinase 40077
Serine/threonine-protein kinase Nek10088
PAS domain-containing serine/threonine-protein kinase0044
Calcium/calmodulin-dependent protein kinase kinase 20189
EKC/KEOPS complex subunit TP53RK0055
Dual specificity testis-specific protein kinase 20044
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase0088
Mitogen-activated protein kinase kinase kinase 50189
Mitogen-activated protein kinase kinase kinase 30066
Target of rapamycin complex 2 subunit MAPKAP10101
Eukaryotic translation initiation factor 2-alpha kinase 10066
Target of rapamycin complex subunit LST80303
Nucleolar GTP-binding protein 10055
Serine/threonine-protein kinase D20088
NUAK family SNF1-like kinase 20077
RNA cytidine acetyltransferase0055
Serine/threonine-protein kinase SIK20088
STE20-like serine/threonine-protein kinase 0088
Serine/threonine-protein kinase TAO30066
dCTP pyrophosphatase 10257
Dual specificity protein kinase CLK40189
Casein kinase I isoform gamma-10189
Serine/threonine-protein kinase PAK 60055
Phenylalanine--tRNA ligase beta subunit0055
Isoleucine--tRNA ligase, mitochondrial0044
BMP-2-inducible protein kinase0088
Obg-like ATPase 10055
Midasin0055
Interleukin-1 receptor-associated kinase 40066
Mitogen-activated protein kinase kinase kinase 200088
Cyclin-dependent kinase 120156
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 130033
Serine/threonine-protein kinase pim-20055
Serine/threonine-protein kinase 260088
Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial0055
Serine/threonine-protein kinase NLK0178
5'-AMP-activated protein kinase subunit gamma-20067
Serine/threonine-protein kinase TBK10066
Septin-90055
Ribosomal protein S6 kinase alpha-60088
TRAF2 and NCK-interacting protein kinase0189
Serine/threonine-protein kinase TAO20066
Serine/threonine-protein kinase ICK0055
RAC-gamma serine/threonine-protein kinase0189
Serine/threonine-protein kinase 38-like0055
Serine/threonine-protein kinase SIK30066
Mitogen-activated protein kinase kinase kinase 20066
Thyroid hormone receptor-associated protein 30055
Dual specificity tyrosine-phosphorylation-regulated kinase 1B0268
Mitogen-activated protein kinase kinase kinase kinase 50088
Receptor-interacting serine/threonine-protein kinase 30055
Serine/threonine-protein kinase MRCK beta0088
Interleukin-1 receptor-associated kinase 30088
Serine/threonine-protein kinase 240066
Casein kinase I isoform gamma-30088
Mitogen-activated protein kinase kinase kinase 40088
TDP1 protein54200542
Thrombopoietin750075
thyroid stimulating hormone receptor24100241
arylsulfatase A20100201
cytochrome P450 2D6 isoform 115300153
cytochrome P450 2C19 precursor14500145
D(1A) dopamine receptor13300133
cytochrome P450 3A4 isoform 127800278
muscarinic acetylcholine receptor M116300163
lethal factor (plasmid)15000150
Gamma-aminobutyric acid receptor subunit pi2787015363
Polyunsaturated fatty acid lipoxygenase ALOX15B11030113
Gamma-aminobutyric acid receptor subunit beta-12787015363
Gamma-aminobutyric acid receptor subunit delta2787015363
Gamma-aminobutyric acid receptor subunit gamma-22787017365
Gamma-aminobutyric acid receptor subunit alpha-52787015363
Gamma-aminobutyric acid receptor subunit alpha-32787015363
Gamma-aminobutyric acid receptor subunit gamma-12787115364
Gamma-aminobutyric acid receptor subunit alpha-22787016364
Sodium-dependent dopamine transporter054862
Gamma-aminobutyric acid receptor subunit alpha-42787015363
Gamma-aminobutyric acid receptor subunit gamma-32787015363
Gamma-aminobutyric acid receptor subunit alpha-62787015363
Glutamate receptor ionotropic, NMDA 1 1701398
Lysosomal Pro-X carboxypeptidase0505
Histamine H2 receptor198104228
Gamma-aminobutyric acid receptor subunit alpha-12787317368
Gamma-aminobutyric acid receptor subunit beta-32787015363
Gamma-aminobutyric acid receptor subunit beta-22787017365
Glutamate receptor ionotropic, NMDA 2A 1691094
Glutamate receptor ionotropic, NMDA 2B1691195
Glutamate receptor ionotropic, NMDA 2C1671093
Sodium-dependent dopamine transporter 01228130
Glutamate receptor ionotropic, NMDA 2D1651090
Glutamate receptor ionotropic, NMDA 3B1651090
GABA theta subunit2787015363
Gamma-aminobutyric acid receptor subunit epsilon2787015363
Glutamate receptor ionotropic, NMDA 3A1651090
ATP-dependent phosphofructokinase22800228
5-hydroxytryptamine receptor 3E015319
GLS protein23300233
cytochrome P450 2C9 precursor12400124
5-hydroxytryptamine receptor 3B015420
Integrin beta-3766183
Integrin alpha-V 0101
D(1A) dopamine receptor01059122
5-hydroxytryptamine receptor 3A0718
Delta-type opioid receptor053872
5-hydroxytryptamine receptor 3A023530
Inositol monophosphatase 1990099
Trace amine-associated receptor 50044
5-hydroxytryptamine receptor 3D015319
5-hydroxytryptamine receptor 3C015319
Chain A, TYROSYL-DNA PHOSPHODIESTERASE17000170
acetylcholinesterase15600156
cytochrome P450 2D624700247
v-jun sarcoma virus 17 oncogene homolog (avian)19200192
cellular tumor antigen p53 isoform a11100111
thyroid hormone receptor beta isoform a12400124
thyroid hormone receptor beta isoform 235600356
huntingtin isoform 2570057
peripheral myelin protein 2221300213
ATP-binding cassette sub-family C member 302700270
Multidrug resistance-associated protein 402750282
Bile salt export pump04260428
Beta-1 adrenergic receptor0451560
5-hydroxytryptamine receptor 1A0533187
5-hydroxytryptamine receptor 2C0731389
D(2) dopamine receptor013715163
5-hydroxytryptamine receptor 2A09017109
Alpha-1B adrenergic receptor012614141
D051156
5-hydroxytryptamine receptor 1A015020175
Alpha-1D adrenergic receptor0781495
5-hydroxytryptamine receptor 2A016111178
5-hydroxytryptamine receptor 2C01637171
5-hydroxytryptamine receptor 1B011310124
5-hydroxytryptamine receptor 1D0311143
5-hydroxytryptamine receptor 1F0301041
5-hydroxytryptamine receptor 5A0101
5-hydroxytryptamine receptor 2B0671380
Sodium-dependent serotonin transporter014015156
5-hydroxytryptamine receptor 7 033942
5-hydroxytryptamine receptor 7041246
Alpha-1B adrenergic receptor0311149
5-hydroxytryptamine receptor 2B01645171
Alpha-1A adrenergic receptor013715153
5-hydroxytryptamine receptor 601101115
Beta-2 adrenergic receptor0404
D(2) dopamine receptor08715108
Canalicular multispecific organic anion transporter 102570258
5-hydroxytryptamine receptor 1A0011
histone acetyltransferase KAT2A isoform 116700167
5-hydroxytryptamine receptor 1D017125
estrogen receptor alpha, partial0011
GPER protein0011
Estrogen receptor1451161
Orexin receptor type 20112
Estrogen receptor beta124935
G-protein coupled estrogen receptor 10213
atrial natriuretic peptide receptor 1 precursor460046
serine/threonine-protein kinase mTOR isoform 1910091
Metabotropic glutamate receptor 808111
Metabotropic glutamate receptor 608718
Glutamate receptor 11030858
Glutamate receptor 2190259234
Glutamate receptor 31025853
Glutamate receptor 41025853
Glutamate receptor ionotropic, kainate 1120328
Metabotropic glutamate receptor 108412
Metabotropic glutamate receptor 20246
Metabotropic glutamate receptor 30246
Metabotropic glutamate receptor 40279
Metabotropic glutamate receptor 505510
Metabotropic glutamate receptor 60134
Metabotropic glutamate receptor 70134
Metabotropic glutamate receptor 5014825
Glutamate receptor ionotropic, kainate 2119327
Glutamate receptor ionotropic, kainate 3125131
Metabotropic glutamate receptor 80033
Glutamate receptor ionotropic, kainate 4116021
Metabotropic glutamate receptor 1016726
Metabotropic glutamate receptor 2014724
Metabotropic glutamate receptor 706413
Metabotropic glutamate receptor 306312
Metabotropic glutamate receptor 4012722
Glutamate receptor ionotropic, kainate 5116122
Chain A, Glutamate [NMDA] receptor subunit zeta 10202
Chain A, Glutamate [NMDA] receptor subunit zeta 10202
Chain A, Glutamate [NMDA] receptor subunit zeta 10202
phosphopantetheinyl transferase19100191
chromobox protein homolog 131000310
Chain A, 2-oxoglutarate Oxygenase17400174
Microtubule-associated protein tau23800239
DNA polymerase beta580058
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1800080
DNA polymerase eta isoform 1470047
M-phase phosphoprotein 810700107
Chain B, pheromone binding protein0011
Chain A, pheromone binding protein0011
Chain A, JmjC domain-containing histone demethylation protein 3A10300103
Chain A, RNA-directed RNA polymerase NS50303
acid sphingomyelinase230023
USP1 protein, partial25200252
vitamin D3 receptor isoform VDRA17300173
importin subunit beta-1 isoform 1600060
flap endonuclease 111600116
serine/threonine-protein kinase PLK1350136
snurportin-1600060
GTP-binding nuclear protein Ran isoform 1330033
DNA polymerase iota isoform a (long)17400174
urokinase-type plasminogen activator precursor840084
plasminogen precursor840084
urokinase plasminogen activator surface receptor precursor840084
geminin44800448
DNA polymerase kappa isoform 114000140
fibroblast growth factor 22 isoform 1 precursor0002
Mitogen-activated protein kinase 130538
Beta-lactamase015015
Transthyretin091428
Fatty acid-binding protein, intestinal08210
Fatty acid-binding protein, adipocyte06410
Cyclin-A20505
Cannabinoid receptor 1023932
Choline O-acetyltransferase0404
Mitogen-activated protein kinase 1205510
Guanine nucleotide-binding protein G510051
Fatty acid-binding protein 50426
Fatty acid-binding protein 50033
glucocerebrosidase800080
Alpha-mannosidase0202
alpha-galactosidase420042
Trehalase 0202
lysosomal alpha-glucosidase preproprotein520052
Trehalase0101
Maltase-glucoamylase, intestinal0505
Trehalase 0202
Lysosomal acid glucosylceramidase0415
Alpha-galactosidase A0101
Alpha-glucosidase MAL620101
Lactase-phlorizin hydrolase0202
Lysosomal alpha-glucosidase0606
Beta-glucosidase A0101
Sucrase-isomaltase, intestinal0404
Sucrase-isomaltase, intestinal0707
Beta-glucosidase0101
Protein-lysine 6-oxidase0606
Alpha-mannosidase 20202
Glycogen debranching enzyme0202
Glycogen debranching enzyme0101
Alpha-glucosidase MAL320202
Oligo-1,6-glucosidase IMA10202
Alpha-glucosidase MAL120606
Oxysterols receptor LXR-beta0325
Spike glycoprotein195723225
Alpha-amylase 0101
Trehalose synthase/amylase TreS0101
Lactase-phlorizin hydrolase 0202
Oxysterols receptor LXR-alpha0325
Neutral alpha-glucosidase AB0303
Ceramide glucosyltransferase0202
Lysosomal acid glucosylceramidase0101
Probable maltase-glucoamylase 20202
Beta-glucosidase 0101
Lysosomal alpha-glucosidase0505
Cytosolic beta-glucosidase0101
Non-lysosomal glucosylceramidase0202
Putative alpha-glucosidase0202
Small conductance calcium-activated potassium channel protein 3010111
Chain A, Cruzipain870087
regulator of G-protein signaling 420400204
Platelet-activating factor receptor2508
dopamine D1 receptor440044
ATAD5 protein, partial20000200
Chain A, High-affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A0101
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D0101
Chain A, Phosphodiesterase 9A0101
Chain A, Class I phosphodiesterase PDEB10101
Chain A, High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A0101
Chain A, cGMP-dependent 3',5'-cyclic phosphodiesterase0101
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera0101
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera0101
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A0101
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A0101
glp-1 receptor, partial12700127
estrogen-related nuclear receptor alpha42100421
Phosphodiesterase 0505
mitogen-activated protein kinase 115600156
cGMP-dependent 3',5'-cyclic phosphodiesterase011011
Monocarboxylate transporter 40103
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A0505
cGMP-specific 3',5'-cyclic phosphodiesterase016017
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A0202
Renin013114
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A 0707
cAMP-specific 3',5'-cyclic phosphodiesterase 4D 0506
cAMP-specific 3',5'-cyclic phosphodiesterase 4C0506
cAMP-specific 3',5'-cyclic phosphodiesterase 4B0507
Adenosine receptor A1354877
Adenosine receptor A3020020
Adenosine receptor A2a0461573
Adenosine receptor A2b019736
Adenosine receptor A2b027447
Adenosine receptor A10411469
Adenosine receptor A2a047778
Sodium-dependent serotonin transporter050658
Adenosine receptor A2a0718
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'0202
cAMP-specific 3',5'-cyclic phosphodiesterase 4A0506
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A09010
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B0707
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B09010
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B0505
cAMP-specific 3',5'-cyclic phosphodiesterase 4B015117
cAMP-specific 3',5'-cyclic phosphodiesterase 4D018120
cGMP-inhibited 3',5'-cyclic phosphodiesterase B013014
Voltage-dependent L-type calcium channel subunit alpha-1C054156
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A0606
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C012013
cGMP-inhibited 3',5'-cyclic phosphodiesterase A014015
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C0505
Phosphodiesterase 0101
Phosphodiesterase 0505
cAMP-specific 3',5'-cyclic phosphodiesterase 7B0303
Dihydropteridine reductase0101
Amine oxidase [flavin-containing] A058062
Amine oxidase [flavin-containing] B051356
Amine oxidase [flavin-containing] B012015
apical membrane antigen 1, AMA1490049
bromodomain adjacent to zinc finger domain 2B940094
Dihydrofolate reductase017020
Indoleamine 2,3-dioxygenase 1010214
Indoleamine 2,3-dioxygenase 10707
Tryptophan 2,3-dioxygenase0101
Indoleamine 2,3-dioxygenase 20202
Carbonic anhydrase 12053380
Carbonic anhydrase 101123152
Carbonic anhydrase 2012111170
Carbonic anhydrase 3038253
Carbonic anhydrase 4071294
Carbonic anhydrase 6047371
Carbonic anhydrase 5A, mitochondrial054482
Carbonic anhydrase 7050374
Carbonic anhydrase 9068397
Carbonic anhydrase 15034041
Carbonic anhydrase 13031051
Carbonic anhydrase 14040264
Carbonic anhydrase 5B, mitochondrial043269
Chain A, HADH2 protein16400164
Chain B, HADH2 protein16400164
RAR-related orphan receptor gamma33800338
GLI family zinc finger 335900359
AR protein46500465
estrogen receptor 2 (ER beta)20400204
nuclear receptor subfamily 1, group I, member 330200302
progesterone receptor23800238
glucocorticoid receptor [Homo sapiens]36300363
retinoic acid nuclear receptor alpha variant 134600346
pregnane X nuclear receptor32800328
estrogen nuclear receptor alpha52600526
aryl hydrocarbon receptor17100171
thyroid stimulating hormone receptor14500145
activating transcription factor 614700147
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a14000140
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 113100131
nuclear factor erythroid 2-related factor 2 isoform 133000330
Voltage-dependent calcium channel gamma-2 subunit18300183
Kelch-like ECH-associated protein 10145
Histone acetyltransferase KAT80305
peroxisome proliferator activated receptor gamma23900239
Cannabinoid receptor 10351053
Cannabinoid receptor 2 0251144
Cannabinoid receptor 20729
Chain A, Putative fructose-1,6-bisphosphate aldolase900090
retinoid X nuclear receptor alpha29300293
Histone H2A.x14500145
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)10700107
67.9K protein12400124
peripheral myelin protein 22 isoform 110400104
nuclear factor erythroid 2-related factor 2 isoform 211100112
nuclear receptor ROR-gamma isoform 117200172
Adenosine receptor A3079890
Adenosine receptor A1013013
Vasopressin V2 receptor0003
Mu-type opioid receptor07928119
Adenosine receptor A109415
Adenylate cyclase type 509010
Adenylate cyclase type 10216
Sigma non-opioid intracellular receptor 1027431
Chain A, Pentaerythritol Tetranitrate Reductase0011
Chain A, Pentaerythritol Tetranitrate Reductase0011
Chain A, PENTAERYTHRITOL TETRANITRATE REDUCTASE0011
Rap guanine nucleotide exchange factor 3500050
Cholinesterase040141
Aromatase045054
Chain A, Ferritin light chain12800128
hypoxia-inducible factor 1 alpha subunit12400124
SMAD family member 212700127
SMAD family member 312700127
farnesoid X nuclear receptor21400214
G21700217
peroxisome proliferator-activated receptor delta21400214
vitamin D (1,25- dihydroxyvitamin D3) receptor22300223
Stimulator of interferon genes protein0011
heat shock protein beta-113300133
Trypsin0507
HLA class I histocompatibility antigen, B alpha chain 21700217
Cellular tumor antigen p5330410305
TAR DNA-binding protein 4310010101
Stimulator of interferon genes protein0011
Inositol hexakisphosphate kinase 121700217
cytochrome P450 2C9, partial21700217
P2X purinoceptor 40718
Chain A, Retinaldehyde-binding protein 10011
Chain A, Retinaldehyde-binding protein 10011
Fumarate hydratase11400114
Smad311500115
cytochrome P450 family 3 subfamily A polypeptide 432500325
polyprotein11400114
IDH114100141
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a23400234
Caspase-7410041
parathyroid hormone/parathyroid hormone-related peptide receptor precursor730073
caspase-3410041
survival motor neuron protein isoform d17700177
replicative DNA helicase0006
recombinase A0066
neuropeptide S receptor isoform A800080
Alpha-synuclein4223166
Sex hormone-binding globulin012627
pregnane X receptor520052
nuclear receptor subfamily 1, group I, member 2500050
Glucocorticoid receptor147769
Glycine receptor subunit alpha-1043043
Corticosteroid-binding globulin016016
Replicase polyprotein 1ab0553186
Androgen receptor079181
Glycine receptor subunit beta042042
Glycine receptor subunit alpha-2043043
Glycine receptor subunit alpha-3042042
Phenylethanolamine N-methyltransferase09011
Sodium-dependent noradrenaline transporter 015418173
Transporter038443
Potassium channel subfamily K member 20151732
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-10101
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-10101
Chain A, Methyltransferase Wbdd0101
15-lipoxygenase, partial11100111
NFKB1 protein, partial990099
EWS/FLI fusion protein22500226
Parkin520052
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform06310
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha0101
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta0123
Bromodomain-containing protein 40325
5-hydroxytryptamine receptor 401262128
Cytochrome P450 1A2060368
Integrin alpha-IIb765182
Neuronal acetylcholine receptor subunit alpha-42022548
Neuronal acetylcholine receptor subunit beta-22021547
Proteinase-activated receptor 10214
Bromodomain-containing protein 20303
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform0101
Type-1 angiotensin II receptor0527
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform 0101
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform05310
Serine/threonine-protein kinase mTOR0101
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform 09313
D(1A) dopamine receptor574061
Serine/threonine-protein kinase PLK109615
Casein kinase II subunit beta015015
Casein kinase II subunit alpha017421
DNA-dependent protein kinase catalytic subunit011011
Mu-type opioid receptor0461164
Serine-protein kinase ATM0404
Bromodomain-containing protein 30101
Serine/threonine-protein kinase pim-30246
Phosphoinositide 3-kinase regulatory subunit 50202
Serine/threonine-protein kinase PLK306410
Serine/threonine-protein kinase PLK20426
Amyloid-beta precursor protein536447
nonstructural protein 1800080
polyunsaturated fatty acid lipoxygenase ALOX12340034
Transient receptor potential cation channel subfamily M member 20617
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1014115
Transient receptor potential cation channel subfamily V member 10121229
Transient receptor potential cation channel subfamily V member 30214
Transient receptor potential cation channel subfamily V member 20113
Proton-coupled amino acid transporter 1023024
Chain A, Beta-lactamase14000140
Alpha-1A adrenergic receptor0391361
Peroxisome proliferator-activated receptor gamma0132035
Beta-secretase 1020223
Peroxisome proliferator-activated receptor delta06514
Adenosine receptor A10404
Adenosine receptor A2a0303
Adenosine receptor A2b0126
Adenosine receptor A30426
Broad substrate specificity ATP-binding cassette transporter ABCG2044453
NPYLR7B001111
vasopressin V1b receptor5005
glycogen synthase kinase-3 beta isoform 1001111
eukaryotic translation initiation factor 2-alpha kinase 3 isoform 1 precursor0022
relaxin receptor 1 isoform 19009
high affinity choline transporter 1 isoform a0606
relaxin receptor 2 isoform 16006
Heat shock protein HSP 90-alpha010920
Endoplasmin0449
Adenosine deaminase 0203
Ataxin-220200202
Chain B, STREPTAVIDIN0011
Chain D, STREPTAVIDIN0011
Luciferase16000160
DNA repair and recombination protein RadA0033
Cytochrome P450 2A6019525
Sulfotransferase 1A1 0002
Cytochrome P450 2A50405
Sulfotransferase 1E10002
Sulfotransferase 1A10418
Sulfotransferase 2A10203
Phenol oxidase 0101
Chymase0202
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial0303
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial0303
Alcohol dehydrogenase E chain07010
Alcohol dehydrogenase S chain07010
Peptidyl-prolyl cis-trans isomerase FKBP50224
interleukin 8560056
potassium voltage-gated channel subfamily H member 2 isoform d19600196
Nuclear receptor subfamily 1 group I member 2022325
Tyrosinase011011
Nuclear receptor ROR-gamma734279
Nuclear factor erythroid 2-related factor 201714
Chain A, ATP-DEPENDENT DNA HELICASE Q1740074
Glutamate receptor ionotropic, kainate 109211
Glutamate receptor 1016522
Glutamate receptor 2016522
Glutamate receptor 3013316
Glutamate receptor 4014217
Glutamate receptor ionotropic, kainate 209211
Glutamate receptor ionotropic, kainate 30606
Peroxisome proliferator-activated receptor alpha961328
ATPase family AAA domain-containing protein 511200112
Sodium- and chloride-dependent GABA transporter 1014014
Sodium- and chloride-dependent GABA transporter 2015015
Sodium- and chloride-dependent GABA transporter 3013013
Sodium- and chloride-dependent betaine transporter013013
Skn7p0003
muscleblind-like protein 1 isoform 1660066
HSP40, subfamily A [Plasmodium falciparum 3D7]0007
Synaptic vesicular amine transporter0404
Synaptic vesicular amine transporter0617
Poly [ADP-ribose] polymerase 20202
Poly [ADP-ribose] polymerase 10606
Poly [ADP-ribose] polymerase 1 0101
Botulinum neurotoxin type A 0303
D-amino-acid oxidase0303
D-aspartate oxidase0404
Chain A, Phenazine biosynthesis protein phzF0011
Caspase 6, apoptosis-related cysteine peptidase0005
isocitrate dehydrogenase 1, partial140014
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase0606
glucose-6-phosphate 1-dehydrogenase isoform b0606
Caspase-7190021
Caspase-90203
large T antigen018119
Protein skinhead-10101
Monocarboxylate transporter 20404
Solute carrier family 22 member 20014014
Solute carrier family 22 member 6014014
Kynureninase0001
Cytochrome P450 3A401279150
D(4) dopamine receptor054567
D(3) dopamine receptor113610158
Stromelysin-107310
Beta-lactamase 0407
Trace amine-associated receptor 10099
Acetylcholine receptor subunit alpha0426
Acetylcholine receptor subunit beta0426
Acetylcholine receptor subunit gamma0426
Acetylcholine receptor subunit delta0426
Neuronal acetylcholine receptor subunit alpha-3012518
Muscarinic acetylcholine receptor M1046761
Muscarinic acetylcholine receptor M3045960
Muscarinic acetylcholine receptor M4043554
Muscarinic acetylcholine receptor M5043554
Muscarinic acetylcholine receptor M2048662
Neuronal acetylcholine receptor subunit alpha-206411
Neuronal acetylcholine receptor subunit beta-305511
Neuronal acetylcholine receptor subunit beta-4012518
Neuronal acetylcholine receptor subunit beta-2010315
Neuronal acetylcholine receptor subunit alpha-505410
Neuronal acetylcholine receptor subunit beta-407312
Neuronal acetylcholine receptor subunit alpha-307310
Neuronal acetylcholine receptor subunit alpha-7010616
Neuronal acetylcholine receptor subunit alpha-607513
Neuronal acetylcholine receptor subunit alpha-905410
Neuronal acetylcholine receptor subunit alpha-409314
Neuronal acetylcholine receptor subunit alpha-7019525
Neuronal acetylcholine receptor subunit alpha-1005410
Chain A, DNA-3-methyladenine glycosylase I0011
Chain A, DNA-3-METHYLADENINE GLYCOSYLASE I0011
Chain A, Dna-3-methyladenine Glycosylase I0011
Chain A, VP390011
Chain A, VP390011
Chain A, VP390011
Chain A, VP390011
thyrotropin-releasing hormone receptor280028
hemoglobin subunit beta140014
Delta-aminolevulinic acid dehydratase0202
Isocitrate lyase 10101
Isocitrate lyase0303
Isocitrate lyase0101
pyruvate kinase PKM isoform a120012
Glycoprotein hormones alpha chain8008
Tubulin--tyrosine ligase0202
Calcium dependent protein kinase0101
Nrf2170017
BRCA1110011
thioredoxin glutathione reductase620062
hypothetical protein, conserved280028
luciferase8008
P53100010
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)540054
Replicase polyprotein 1ab0162440
NPC intracellular cholesterol transporter 1 precursor570057
atrial natriuretic peptide receptor 2 precursor480048
ras-related protein Rab-9A780078
FAD-linked sulfhydryl oxidase ALR0004
dual specificity tyrosine-phosphorylation-regulated kinase 1A0004
lethal(3)malignant brain tumor-like protein 1 isoform I220022
glycogen synthase kinase-3 alpha0004
DNA dC->dU-editing enzyme APOBEC-3G isoform 1205025
serine/threonine-protein kinase 33 isoform a0033
endoribonuclease toxin MazF0033
Arginase-10101
Polyunsaturated fatty acid 5-lipoxygenase028031
Dipeptidyl peptidase 40606
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 10505
Lactoylglutathione lyase013013
Arginase-10303
Rap guanine nucleotide exchange factor 4380038
phosphoglycerate kinase160016
Chain A, Penicillin Amidohydrolase0202
Chain B, Penicillin Amidohydrolase0202
Chain A, Penicillin Amidohydrolase0202
Chain B, Penicillin Amidohydrolase0202
Chain A, Penicillin Amidohydrolase0202
Chain B, Penicillin Amidohydrolase0202
Chain A, Penicillin Amidohydrolase0202
Chain B, Penicillin Amidohydrolase0202
Chain A, Penicillin Amidohydrolase0202
Chain B, Penicillin Amidohydrolase0202
Chain A, Penicillin Amidohydrolase0202
Chain B, Penicillin Amidohydrolase0202
Chain A, Penicillin Amidohydrolase0202
Chain B, Penicillin Amidohydrolase0202
Chain A, Protocatechuate 3,4-dioxygenase0011
Chain M, Protocatechuate 3,4-dioxygenase0011
Olfactory receptor class A-like protein 10033
RGS127007
alkaline phosphatase, intestinal0134
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein0314
intestinal alkaline phosphatase precursor0314
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 16006
alkaline phosphatase, germ cell type preproprotein0134
POsterior Segregation0099
Prolyl 4-hydroxylase subunit alpha-10606
Zinc finger protein mex-50088
5-hydroxytryptamine receptor 6011819
5-hydroxytryptamine receptor 5A011819
5-hydroxytryptamine receptor 5B011819
5-hydroxytryptamine receptor 3A0251136
5-hydroxytryptamine receptor 4 013924
5-hydroxytryptamine receptor 3B0251136
Receptor-type tyrosine-protein phosphatase alpha0303
Ectonucleotide pyrophosphatase/phosphodiesterase family member 10202
Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 0303
Histamine H2 receptor065571
Histamine H4 receptor020932
Histamine H3 receptor07116
Histamine H3 receptor022631
transcriptional regulator ERG isoform 3440044
Tumor necrosis factor0314
cAMP-specific 3',5'-cyclic phosphodiesterase 4A015218
cGMP-dependent 3',5'-cyclic phosphodiesterase0303
cAMP-specific 3',5'-cyclic phosphodiesterase 4C010010
cGMP-specific 3',5'-cyclic phosphodiesterase0303
Glutamate receptor ionotropic, NMDA 2D020222
Glutamate receptor ionotropic, NMDA 2B027331
Glutamate receptor ionotropic, NMDA 2C020222
Chain A, TGF-beta receptor type-10101
tyrosine-protein kinase Yes110011
Serine/threonine-protein kinase 250044
Serine/threonine-protein kinase RIO30044
Serine/threonine-protein kinase DCLK10044
Muscle, skeletal receptor tyrosine-protein kinase0044
3-phosphoinositide-dependent protein kinase 10145
Death-associated protein kinase 30044
NUAK family SNF1-like kinase 10145
Tyrosine-protein kinase JAK20459
Serine/threonine-protein kinase PAK 30044
Serine/threonine-protein kinase 17B0145
Cyclin-dependent kinase 140145
RAF proto-oncogene serine/threonine-protein kinase0448
Receptor tyrosine-protein kinase erbB-2014418
Macrophage colony-stimulating factor 1 receptor0145
Proto-oncogene tyrosine-protein kinase ROS0145
Tyrosine-protein kinase Fgr0066
Mast/stem cell growth factor receptor Kit0358
Myosin light chain kinase, smooth muscle0235
Insulin receptor-related protein0044
Platelet-derived growth factor receptor alpha0257
Vascular endothelial growth factor receptor 1 0246
Interferon-induced, double-stranded RNA-activated protein kinase0044
Cyclin-dependent kinase 11B0145
Fibroblast growth factor receptor 20045
Fibroblast growth factor receptor 40045
Fibroblast growth factor receptor 30045
Protein kinase C eta type08614
Activin receptor type-2A0044
Ephrin type-A receptor 30055
Ephrin type-A receptor 80044
Leukocyte tyrosine kinase receptor0044
Tyrosine-protein kinase receptor UFO0145
Mitogen-activated protein kinase 40044
Tyrosine-protein kinase receptor Tie-10044
Vascular endothelial growth factor receptor 30246
Vascular endothelial growth factor receptor 208412
Serine/threonine-protein kinase receptor R30055
Tyrosine-protein kinase TXK0044
Tyrosine-protein kinase ZAP-700145
Cyclin-dependent kinase 80145
Dual specificity protein kinase CLK30066
Tyrosine-protein kinase Blk0145
Cytoplasmic tyrosine-protein kinase BMX0145
cAMP-dependent protein kinase catalytic subunit PRKX0044
Tyrosine-protein kinase JAK30549
Death-associated protein kinase 109413
5'-AMP-activated protein kinase catalytic subunit alpha-20067
Ephrin type-B receptor 10044
Serine/threonine-protein kinase SIK10044
Tubulin alpha-1A chain0033
Phosphatidylinositol 5-phosphate 4-kinase type-2 beta0044
SRSF protein kinase 20044
Mitogen-activated protein kinase kinase kinase 90145
Protein kinase C epsilon type010616
Angiopoietin-1 receptor0167
Mitogen-activated protein kinase kinase kinase 100145
Tyrosine-protein kinase receptor TYRO30044
Cyclin-dependent kinase 180156
Tyrosine-protein kinase ITK/TSK0044
Myotonin-protein kinase0145
Tyrosine-protein kinase Mer0055
Serine/threonine-protein kinase PAK 10246
cGMP-dependent protein kinase 20044
Receptor-interacting serine/threonine-protein kinase 10044
Calcium/calmodulin-dependent protein kinase type II subunit beta0347
Calcium/calmodulin-dependent protein kinase type 10044
Serine/threonine-protein kinase D107512
Ribosomal protein S6 kinase alpha-20044
NT-3 growth factor receptor0044
BDNF/NT-3 growth factors receptor0044
Mitogen-activated protein kinase 60055
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform0044
Serine/threonine-protein kinase TNNI3K0044
Serine/threonine-protein kinase Nek50044
Serine/threonine-protein kinase tousled-like 20044
Serine/threonine-protein kinase 32C0044
Myosin light chain kinase family member 40044
Calcium/calmodulin-dependent protein kinase type 1D0044
Serine/threonine-protein kinase BRSK20044
Serine/threonine-protein kinase DCLK20044
Calcium/calmodulin-dependent protein kinase kinase 10044
Casein kinase I isoform alpha-like0044
Myosin-IIIa0044
Ankyrin repeat and protein kinase domain-containing protein 10044
Serine/threonine-protein kinase BRSK10044
Myosin-IIIb0044
Atypical kinase COQ8B, mitochondrial0044
Calcium/calmodulin-dependent protein kinase type 1G0055
SRSF protein kinase 10044
Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha0044
Serine/threonine-protein kinase RIO10044
MAP kinase-interacting serine/threonine-protein kinase 10145
Cyclin-dependent kinase 190145
Testis-specific serine/threonine-protein kinase 10044
Serine/threonine-protein kinase 330044
Serine/threonine-protein kinase DCLK30044
Myosin light chain kinase 2, skeletal/cardiac muscle0044
Tyrosine-protein kinase Srms0044
MAP kinase-interacting serine/threonine-protein kinase 20246
Serine/threonine-protein kinase Nek60145
Serine/threonine-protein kinase LATS20044
Serine/threonine-protein kinase 360145
Serine/threonine-protein kinase 32B0044
Serine/threonine-protein kinase MARK10044
Serine/threonine-protein kinase PAK 50044
eIF-2-alpha kinase GCN20044
Serine/threonine-protein kinase 17A0044
Ephrin type-A receptor 60044
Death-associated protein kinase 20044
Serine/threonine-protein kinase tousled-like 10044
ALK tyrosine kinase receptor0246
Cyclin-dependent kinase 11A0044
Aurora kinase C0044
Calcium/calmodulin-dependent protein kinase type II subunit alpha0347
Chain A, REPLICASE POLYPROTEIN 1AB0101
histone deacetylase 9 isoform 3400040
Cytochrome P450 2A1307512
Aminopeptidase N0404
Aminopeptidase N0404
Dipeptidyl peptidase 4017223
Genome polyprotein 0112
Polyphenol oxidase 2033141
Thiopurine S-methyltransferase0202
Succinate-semialdehyde dehydrogenase, mitochondrial0303
4-aminobutyrate aminotransferase, mitochondrial0607
Cytochrome P450 1B1029233
Dihydropteroate synthase 0011
Chain A, Toluene-4-monooxygenase system protein A0101
Potassium voltage-gated channel subfamily A member 30314
Acetylcholinesterase011012
Pteridine reductase 10606
Potassium voltage-gated channel subfamily A member 10617
Carbonic anhydrase 20516
Carbonic anhydrase 13018325
short transient receptor potential channel 6 isoform 10044
voltage-dependent T-type calcium channel subunit alpha-1H isoform a0011
Muscarinic acetylcholine receptor DM10606
Transient receptor potential cation channel subfamily A member 104610
Calcium/calmodulin-dependent protein kinase type II subunit alpha0202
Tetraspanin0101
Chain A, PROTOCATECHUATE 3,4-DIOXYGENASE0101
Chain M, PROTOCATECHUATE 3,4-DIOXYGENASE0101
Chain A, PROTOCATECHUATE 3,4-DIOXYGENASE0101
Chain M, PROTOCATECHUATE 3,4-DIOXYGENASE0101
Chain A, PROTOCATECHUATE 3,4-DIOXYGENASE0101
Chain M, PROTOCATECHUATE 3,4-DIOXYGENASE0101
Chain A, PROTOCATECHUATE 3,4-DIOXYGENASE0101
Chain M, PROTOCATECHUATE 3,4-DIOXYGENASE0101
Chain A, PROTOCATECHUATE 3,4-DIOXYGENASE0101
Chain M, PROTOCATECHUATE 3,4-DIOXYGENASE0101
Chain A, Protocatechuate 3,4-dioxygenase0101
Chain M, Protocatechuate 3,4-dioxygenase0101
Carbonic anhydrase 0808
Beta-carbonic anhydrase 1017017
Carbonic anhydrase 011018
Carbonic anhydrase016024
5-hydroxytryptamine receptor 2C 0607
5-hydroxytryptamine receptor 2A0405
5-hydroxytryptamine receptor 5A014015
Chain A, Pyridoxal kinase0202
Chain A, Pyridoxal Kinase0202
Equilibrative nucleoside transporter 1011011
Solute carrier family 28 member 30505
Adenosine kinase0103
Chain A, TRYPSIN0202
Chain A, TRYPSIN0202
Chain A, TRYPSIN0202
Chain A, TRYPSIN0202
Chain A, TRYPSIN0202
Chain A, TRYPSIN0202
Membrane primary amine oxidase0003
Cationic trypsin0909
Membrane primary amine oxidase0205
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Histone deacetylase 3025129
Histone deacetylase 4024128
Histone deacetylase 1029335
Histone deacetylase 7024229
Histone deacetylase 2028233
Polyamine deacetylase HDAC10021125
Histone deacetylase 11 022126
Histone deacetylase 8026231
NAD-dependent protein deacylase sirtuin-5, mitochondrial0708
Histone deacetylase 6028334
Histone deacetylase 9024128
Histone deacetylase 5025129
G-protein coupled bile acid receptor 1041216
Gamma-aminobutyric acid receptor subunit rho-30016
Sodium- and chloride-dependent GABA transporter 1010010
Sodium- and chloride-dependent GABA transporter 20808
Sodium- and chloride-dependent GABA transporter 30808
Solute carrier family 15 member 1021022
5-hydroxytryptamine receptor 1B017523
5-hydroxytryptamine receptor 7036037
5-hydroxytryptamine receptor 1D0303
Glutathione S-transferase P0404
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
Chain A, Leukotriene A-4 hydrolase0202
90-kda heat shock protein beta HSP90 beta, partial0707
ubiquitin carboxyl-terminal hydrolase 2 isoform a490049
heat shock protein HSP 90-alpha isoform 207018
Leukotriene A-4 hydrolase09111
Tyrosinase0909
Disintegrin and metalloproteinase domain-containing protein 17364040
DNA repair protein RAD51 homolog 10011
Chain A, Mitogen-activated protein kinase 30101
Adenosine kinase0101
Adenosine kinase0101
Adenosine kinase0101
Histone-lysine N-methyltransferase, H3 lysine-79 specific0415
Macrophage metalloelastase0404
Chain A, N-methyl-D-aspartate Receptor Subunit 10202
Chain A, N-methyl-D-aspartate Receptor Subunit 10202
Chain A, N-methyl-D-aspartate Receptor Subunit 10202
Chain A, Phosphoglycerate Kinase0011
P2X purinoceptor 10167
P2Y purinoceptor 10156
P2X purinoceptor 10134
P2X purinoceptor 30156
Glycine--tRNA ligase0202
P2Y purinoceptor 120459
histone-lysine N-methyltransferase 2A isoform 2 precursor490049
Solute carrier organic anion transporter family member 2A10309
pyruvate kinase230023
beta-2 adrenergic receptor90211
pyruvate kinase PKM isoform b190019
Luciferin 4-monooxygenase0617
Ornithine decarboxylase191021
Cytochrome P450 2D60993108
Amine oxidase [flavin-containing] A0203
2,3-bisphosphoglycerate-independent phosphoglycerate mutase130013
caspase-1 isoform alpha precursor190019
Aldo-keto reductase family 1 member B10909
Gamma-aminobutyric acid receptor subunit pi031031
Gamma-aminobutyric acid receptor subunit delta031031
Translocator protein011215
Gamma-aminobutyric acid receptor subunit epsilon031031
Gamma-aminobutyric acid receptor subunit gamma-1031031
Gamma-aminobutyric acid receptor subunit gamma-3031132
Gamma-aminobutyric acid receptor subunit theta031031
D(1B) dopamine receptor019023
Vesicular glutamate transporter 30404
D(3) dopamine receptor042349
Histamine H3 receptor0719
Sigma non-opioid intracellular receptor 1024630
ERAP1 protein0002
Acetylcholinesterase038342
Glyceraldehyde-3-phosphate dehydrogenase0707
Seed linoleate 13S-lipoxygenase-1015023
Aldo-keto reductase family 1 member B1034035
Acetylcholinesterase071478
Glyceraldehyde-3-phosphate dehydrogenase, glycosomal0303
Genome polyprotein0101
Substance-P receptor016019
Quinone oxidoreductase0008
Xanthine dehydrogenase/oxidase025026
Cholinesterase031032
Sorbitol dehydrogenase0404
Induced myeloid leukemia cell differentiation protein Mcl-10707
Zn finger protein 0202
Dihydroorotate dehydrogenase 0808
NPC1-like intracellular cholesterol transporter 10022
Amine oxidase [flavin-containing] A 021224
Nitric oxide synthase, endothelial0608
Nitric oxide synthase, endothelial0809
Nitric oxide synthase, brain014117
Nitric oxide synthase, brain 09011
Nitric oxide synthase, inducible013014
Nitric oxide synthase, inducible010115
Nitric oxide synthase, endothelial 0101
Chain A, Endochitinase0202
Chain A, Endochitinase0202
Chain A, Endochitinase0202
Endochitinase0202
Endochitinase A10202
Acidic mammalian chitinase0202
mu-type opioid receptor isoform MOR-10088
5-hydroxytryptamine receptor 2A0088
Cytochrome P450 2C9 01196130
Translocator protein017826
Alpha-2B adrenergic receptor0531367
D(2) dopamine receptor015015
Alpha-2C adrenergic receptor0511365
Alpha-2A adrenergic receptor0521366
Alpha-1D adrenergic receptor011210129
D0707
5-hydroxytryptamine receptor 2A0404
Sigma non-opioid intracellular receptor 111093113
Lysosomal alpha-glucosidase0303
Chain A, Avidin0022
Chain A, Avidin0022
Chain B, Avidin0022
Olfactory receptor 51E20167
Adenosine receptor A10404
Adenosine deaminase0203
Sphingosine-1-phosphate receptor 40101
PTK2B protein tyrosine kinase 2 beta0101
Valosin-containing protein0303
Phospholipase C, gamma 10101
Apoptotic peptidase activating factor 10202
Phospholipase C, beta 3 (phosphatidylinositol-specific)0101
photoreceptor-specific nuclear receptor0202
galactokinase6006
phospholipase A2 precursor0202
perilipin-5010010
nuclear receptor corepressor 2 isoform 20101
fructose-bisphosphate aldolase A4004
perilipin-1010010
caspase-9 isoform alpha precursor0202
sphingosine 1-phosphate receptor 10101
glyceraldehyde-3-phosphate dehydrogenase isoform 13003
caspase-3 isoform a preproprotein0202
protein-arginine deiminase type-40101
cysteine protease ATG4B isoform a0202
peroxisome proliferator-activated receptor gamma isoform 20101
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a010010
tyrosyl-DNA phosphodiesterase 20101
Vpr200020
4-(cytidine 5'-phospho)-2-C-methyl-D-erithritol kinase2002
streptokinase A precursor002121
Cocaine esterase0404
Telomerase reverse transcriptase0505
Coagulation factor XII0404
Papain0101
Receptor-type tyrosine-protein phosphatase C0202
Tyrosine-protein phosphatase non-receptor type 1025230
Liver carboxylesterase 109015
Protein S100-A40011
Genome polyprotein 0404
putative polyprotein0101
Major prion protein0099
Trypanothione reductase022024
Solute carrier family 22 member 6027029
UDP-glucuronosyltransferase 1A903113
Bile salt export pump056058
Cytochrome P450 2B10406
Cytochrome P450 1A10103
Myoglobin0101
Cytochrome P450 1A1024328
Prostaglandin G/H synthase 1035238
Polyunsaturated fatty acid lipoxygenase ALOX15027027
UDP-glucuronosyltransferase 1-6012116
Arachidonate 5-lipoxygenase-activating protein0404
UDP-glucuronosyltransferase 1A1 022130
Prostaglandin G/H synthase 1054055
Prostaglandin G/H synthase 2056566
Cytochrome P450 2J2060061
toxin B0001
Chain A, CARBONIC ANHYDRASE II0011
Chain A, CARBONIC ANHYDRASE II0011
Chain A, CARBONIC ANHYDRASE II0011
Chain A, Carbonic Anhydrase Ii0011
Chain A, Carbonic Anhydrase Ii0011
Chain A, Class Iii Chitinase Chia10101
Chain A, Carbonic anhydrase 130101
Chain A, Carbonic anhydrase II0303
Chain A, Carbonic anhydrase 20303
Chain A, Carbonic anhydrase 20303
Chain A, Carbonic anhydrase 20303
Chain A, Carbonic anhydrase 20303
Chain A, Carbonic anhydrase 20303
Chain A, Carbonic anhydrase 20303
Chain A, Carbonic anhydrase 20303
Chain A, Carbonic anhydrase 20303
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase0101
Chain B, Carbonic anhydrase0101
Chain A, Carbonic anhydrase 20101
Carbonic anhydrase 00010
Carbonic anhydrase 018018
GALC protein360036
Carbonic anhydrase 013013
Carbonic anhydrase 016016
Carbonic anhydrase016016
Carbonic anhydrase0909
Prolyl endopeptidase0606
Carbonic anhydrase-related protein 110103
Glycogen phosphorylase, muscle form010010
Cathepsin B0202
Steryl-sulfatase0608
Cytochrome P450 2C8024127
Cytochrome P450 2B6018222
Carbonic anhydrase 5A, mitochondrial0808
Serum paraoxonase/arylesterase 10808
Cytochrome P450 2C19061267
Delta-type opioid receptor048964
Mu-type opioid receptor0601277
Carbonic anhydrase027033
Kappa-type opioid receptor032750
Carbonic anhydrase0202
Corticosteroid 11-beta-dehydrogenase isozyme 10314
Carbonic anhydrase013020
Fatty-acid amide hydrolase 1219022
Carbonic anhydrase 2015015
Squalene synthase0404
Carbonic anhydrase0404
Carbonic anhydrase, alpha family 015015
Carbonic anhydrase 30808
Carbonic anhydrase011019
Carbonic anhydrase 013013
Sigma intracellular receptor 2015015
Delta carbonic anhydrase013013
Renin0101
Carbonic anhydrase 010017
Multidrug resistance-associated protein 10202
Carbonic anhydrase 4017022
Carbonic anhydrase 70101
Carbonic anhydrase 0707
Carbonic anhydrase 0101
Carbonic anhydrase 2, isoform A 0101
Free fatty acid receptor 30033
Free fatty acid receptor 20224
Fibrinogen C domain-containing protein 10101
N-alpha-acetyltransferase 500022
Putative glycosyltransferase WbgO0001
Killer cell lectin-like receptor subfamily B member 1A0101
Early activation antigen CD690101
eyes absent homolog 2 isoform a150015
Reverse transcriptase/RNaseH 012425
Transient receptor potential cation channel subfamily A member 1031419
Choline O-acetyltransferase 0607
integrase, partial0505
lens epithelium-derived growth factor p750505
Arginase 0606
Protein kinase C alpha type0606
Protein kinase C delta type0606
Protein kinase C epsilon type0606
Protein kinase C zeta type0606
Protein kinase C gamma type0606
Protein kinase C beta type0606
Prostaglandin G/H synthase 2025026
Protein kinase C eta type0606
Integrase 022022
Protein kinase C theta type0606
Chain E, Purine nucleoside phosphorylase0101
Thymidine kinase 0304
Solute carrier family 22 member 1 075094
Purine nucleoside phosphorylase0507
Thymidine kinase, cytosolic07014
POU domain, class 2, transcription factor 20103
Purine nucleoside phosphorylase0044
Solute carrier family 22 member 6017025
Thymidine kinase 0101
Solute carrier family 22 member 8019028
Thymidine kinase0203
60 kDa chaperonin018018
Retinoic acid receptor alpha05715
60 kDa heat shock protein, mitochondrial021021
Retinoic acid receptor beta05715
Retinoic acid receptor gamma 05715
Aspartate aminotransferase, cytoplasmic0202
Glycine receptor subunit alpha-10279
10 kDa heat shock protein, mitochondrial021021
Thiosulfate sulfurtransferase021021
60 kDa chaperonin 022022
10 kDa chaperonin 022022
Chain A, MTA/SAH nucleosidase0101
Chain A, Ribosome-inactivating protein alpha-trichosanthin0011
Chain A, Ricin A chain0011
Chain A, Ribosome-inactivating protein 30011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
Chain A, Phenylethanolamine N-methyltransferase0011
tumor susceptibility gene 101 protein120012
Heat shock protein HSP 90-beta06312
Protein mono-ADP-ribosyltransferase PARP150303
Leucine-rich repeat serine/threonine-protein kinase 20336
Chain A, Membrane lipoprotein tmpC0033
Chain A, Membrane lipoprotein tmpC0033
Chain A, Membrane lipoprotein tmpC0033
Chain A, Structure of PAE2307 in complex with adenosine0011
Chain B, Structure of PAE2307 in complex with adenosine0011
Chain A, ADENOSINE RECEPTOR A2A0202
Chain A, ADENOSINE RECEPTOR A2A0202
Chain A, tRNA (guanine-N(1)-)-methyltransferase0011
Chain A, Uncharacterized protein MJ08830011
signal transducer and activator of transcription 6, interleukin-4 induced3003
Sodium/nucleoside cotransporter 10404
Calcium dependent protein kinase0101
Mitogen-activated protein kinase kinase kinase 70055
Sodium/nucleoside cotransporter 20404
Phosphoglycerate kinase 1 0202
Avidin0011
Adenosine deaminase0001
Phosphoglycerate kinase 20202
Heat shock 70 kDa protein 1A 0213
Heat shock cognate 71 kDa protein0033
Inosine-5'-monophosphate dehydrogenase 1 0303
Streptavidin0022
Adenosylhomocysteinase0205
Adenylate kinase 2, mitochondrial0203
Adenylate kinase isoenzyme 1 0203
Phosphatidylinositol 4-kinase alpha0607
Equilibrative nucleoside transporter 20404
Phosphatidylinositol 4-kinase type 2-beta0506
Phosphatidylinositol 4-kinase type 2-alpha0607
Phosphatidylinositol 4-kinase beta0629
5-methylthioadenosine/S-adenosylhomocysteine deaminase0002
Adenosine transporter 10001
Chain A, Heat Shock Protein 900011
Chain A, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE0011
Chain B, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE0011
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN0101
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN0101
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN0101
Chain A, Myosin Ie Heavy Chain0011
Chain A, Preprotein translocase secA0011
Chain A, Ribonuclease pancreatic0101
Chain A, Ribonuclease pancreatic0101
Chain A, Ribonuclease pancreatic0101
Chain A, Ribonuclease pancreatic0101
Chain A, Ribonuclease pancreatic0101
Chain A, Phosphoribosylformylglycinamidine synthase0101
Chain A, nucleoside diphosphate kinase A0011
Chain B, nucleoside diphosphate kinase A0011
Chain D, DNA polymerase III subunit gamma0011
Chain D, DNA polymerase III subunit gamma0011
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 30011
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 30011
Chain A, Kinesin-like protein KIF110101
HPr kinase/phosphorylase0011
ATP-dependent molecular chaperone HSP820102
2-dehydropantoate 2-reductase0246
Endoplasmic reticulum chaperone BiP0213
Pyruvate kinase PKM 0001
Pyruvate kinase PKLR 0001
Heat shock cognate 71 kDa protein0011
5'-nucleotidase0404
Delta-type opioid receptor0592396
Kappa-type opioid receptor0652099
Endoplasmin0235
P2Y purinoceptor 20167
P2Y purinoceptor 10055
P2X purinoceptor 40257
P2X purinoceptor 50044
P2X purinoceptor 60145
Heat shock protein 75 kDa, mitochondrial0202
P2Y purinoceptor 60145
P2Y purinoceptor 110145
Sensor protein kinase WalK0101
P2X purinoceptor 20123
Chain A, Glycogen Phosphorylase B0011
Chain B, Glycogen Phosphorylase B0011
Chain A, ADP-dependent glucokinase0101
Chain A, Ribonuclease pancreatic0101
Chain A, Ribonuclease pancreatic0101
Chain A, phosphodiesterase-nucleotide pyrophosphatase0101
Chain A, GLYCOGEN PHOSPHORYLASE B0011
Chain B, GLYCOGEN PHOSPHORYLASE B0011
Chain A, GLYCOGEN PHOSPHORYLASE B0011
2'-deoxynucleoside 5'-phosphate N-hydrolase 10101
2'-deoxynucleoside 5'-phosphate N-hydrolase 10101
5'-AMP-activated protein kinase subunit beta-20012
L-lactate dehydrogenase A chain0426
Adenylate kinase isoenzyme 10001
Fructose-1,6-bisphosphatase 10101
Alkaline phosphatase, tissue-nonspecific isozyme0607
Fructose-1,6-bisphosphatase 10303
Inosine-5'-monophosphate dehydrogenase0101
Amine oxidase [flavin-containing] B027028
5'-nucleotidase0102
GTP:AMP phosphotransferase AK3, mitochondrial0001
Adenosine deaminase-like protein0001
Protease 013520
5'-AMP-activated protein kinase subunit gamma-30012
5'-AMP-activated protein kinase subunit beta-10034
Chain A, Endoplasmin0011
thyrotropin-releasing hormone receptor1001
Transmembrane domain-containing protein TMIGD30101
Thyroid hormone receptor beta0606
Aflatoxin B1 aldehyde reductase member 30101
Endoplasmin0011
2-oxoglutarate receptor 10101
Muscarinic acetylcholine receptor M20219
Chain A, Lck Kinase0101
Chain A, BCL-2-RELATED PROTEIN A10079
Chain A, Tyrosine-protein kinase Lyn0101
Chain A, Tyrosine-protein kinase Lyn0101
LAP40022
RPL19A0022
amino acid transporter AGP10011
Proto-oncogene tyrosine-protein kinase Src0123
Proto-oncogene tyrosine-protein kinase LCK 0101
WRN140014
chaperonin-containing TCP-1 beta subunit homolog8008
Tyrosyl-DNA phosphodiesterase 10505
Solute carrier family 22 member 2034044
Polyamine oxidase 10101
Solute carrier family 22 member 3020022
Solute carrier family 22 member 30507
Nischarin0505
Solute carrier family 22 member 1030039
Deoxyhypusine synthase0101
Solute carrier family 22 member 2026032
Alanine racemase, biosynthetic0001
Adenosine deaminase0001
caspase 7, apoptosis-related cysteine protease620062
caspase-3620062
Vif0405
Methionine aminopeptidase0202
Beta-2 adrenergic receptor0391858
Beta-3 adrenergic receptor0341448
Beta-2 adrenergic receptor 01510
Beta-2 adrenergic receptor071019
Mineralocorticoid receptor 112621
Mineralocorticoid receptor0213
Solute carrier organic anion transporter family member 1A1011021
ATP-dependent translocase ABCB109713139
Hypoxanthine-guanine phosphoribosyltransferase0106
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase 0202
Nuclear receptor ROR-gamma0202
Xanthine dehydrogenase/oxidase018123
Shiga toxin subunit A0202
Thymidylate kinase0506
Glutamate receptor ionotropic, NMDA 3B016117
Glutamate receptor 10215
Glutamate receptor 20204
Excitatory amino acid transporter 10607
Excitatory amino acid transporter 20506
Excitatory amino acid transporter 30506
Glutamate receptor ionotropic, NMDA 1026127
Glutamate receptor ionotropic, NMDA 2A025227
Glutamate receptor ionotropic, kainate 40202
Glutamate receptor ionotropic, kainate 50404
Glutamate receptor ionotropic, NMDA 3A016117
Glutamate receptor 40204
Glutamate receptor 30204
Neutrophil cytosol factor 10303
Tyrosine-protein kinase 0011
3-hydroxy-3-methylglutaryl-coenzyme A reductase0909
3-hydroxy-3-methylglutaryl-coenzyme A reductase0202
Methylcytosine dioxygenase TET20314
DNA dC->dU-editing enzyme APOBEC-3F isoform a9009
Free fatty acid receptor 10044
Prostaglandin G/H synthase 1 016018
Coagulation factor VII010010
Tissue factor013013
Free fatty acid receptor 40011
Carboxylic ester hydrolase 0101
Cytochrome P450 3A60101
UDP-glucuronosyltransferase 2B7012125
Substance-K receptor044045
UDP-glucuronosyltransferase 1A4011125
Thromboxane-A synthase 020020
Aryl hydrocarbon receptor0101
Multidrug resistance-associated protein 1 016125
UDP-glucuronosyltransferase 2B10 010111
Chain A, 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase0011
Chain A, 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase0011
Chain A, Calmodulin-sensitive adenylate cyclase0101
Chain A, 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase0011
S-adenosylmethionine synthase isoform type-10203
S-adenosylmethionine synthase isoform type-20102
P2X purinoceptor 20235
P2X purinoceptor 70224
Gamma-aminobutyric acid receptor subunit alpha-109014
Gamma-aminobutyric acid receptor subunit beta-109014
Gamma-aminobutyric acid receptor subunit alpha-209014
Gamma-aminobutyric acid receptor subunit alpha-309014
Gamma-aminobutyric acid receptor subunit alpha-409014
Gamma-aminobutyric acid receptor subunit gamma-209014
Cholecystokinin receptor type A19010
Cholecystokinin receptor type A0606
Prostaglandin E2 receptor EP3 subtype0303
Prostaglandin E2 receptor EP4 subtype0314
Prostaglandin E2 receptor EP1 subtype0303
Prostacyclin receptor0639
Nuclear receptor subfamily 4 group A member 20077
Nuclear receptor subfamily 4 group A member 20011
Nuclear receptor subfamily 4 group A member 20011
Prostaglandin E2 receptor EP2 subtype0314
Solute carrier organic anion transporter family member 2A10307
Solute carrier organic anion transporter family member 2B10204
Solute carrier organic anion transporter family member 3A10001
fMet-Leu-Phe receptor0303
CREB-binding protein4307
Cannabinoid receptor 20358
putative alpha-glucosidase3003
Matrix protein 20112
Matrix protein 20123
Multidrug and toxin extrusion protein 1044044
POU domain, class 2, transcription factor 10107
Chain U, UROKINASE-TYPE PLASMINOGEN ACTIVATOR0202
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR0202
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR0202
Membrane primary amine oxidase 0303
Prothrombin010518
Coagulation factor X0909
Plasminogen0416
Urokinase-type plasminogen activator0909
Tissue-type plasminogen activator0606
Coagulation factor XI0101
Plasma kallikrein02010
Vitamin K-dependent protein C0101
Urokinase-type plasminogen activator0505
Trypsin-10707
Trypsin-20505
Sodium/hydrogen exchanger 10202
Sodium/hydrogen exchanger 10404
Sodium/hydrogen exchanger 30202
Trypsin-30505
Amiloride-sensitive sodium channel subunit alpha0101
Sodium/hydrogen exchanger 20303
Acid-sensing ion channel 10202
Sodium channel protein type 5 subunit alpha039039
Sodium/hydrogen exchanger 50303
Acid-sensing ion channel 30101
Sodium/hydrogen exchanger0101
Sterol O-acyltransferase 10404
Cholesterol side-chain cleavage enzyme, mitochondrial 0101
Triosephosphate isomerase0404
Steroid 17-alpha-hydroxylase/17,20 lyase0808
Cholesterol side-chain cleavage enzyme, mitochondrial0101
Aromatase0224
Cytochrome P450 11B2, mitochondrial0101
aryl hydrocarbon receptor nuclear translocator0002
transforming acidic coiled-coil-containing protein 30002
Glutaminyl-peptide cyclotransferase0707
Guanine deaminase0405
Solute carrier family 15 member 10909
Solute carrier family 15 member 2013014
Cystathionine gamma-lyase0505
Cystathionine beta-synthase0202
Dihydrofolate reductase0507
Dihydrofolate reductase0507
Dihydrofolate reductase010415
Folylpolyglutamate synthase, mitochondrial0206
Solute carrier organic anion transporter family member 1A305011
Folylpolyglutamate synthase, mitochondrial0106
Nicotinate phosphoribosyltransferase010010
ORF730055
microphthalmia-associated transcription factor isoform 90404
Voltage-dependent L-type calcium channel subunit alpha-1C019019
Solute carrier organic anion transporter family member 1A4010021
Voltage-dependent L-type calcium channel subunit alpha-1F042143
Lysine-specific demethylase PHF20101
Thyroid hormone receptor alpha0101
ATP-dependent translocase ABCB1030030
Aldo-keto reductase family 1 member B101280128
Alpha-2A adrenergic receptor015213170
Thyroid hormone receptor alpha06612
Thyroid hormone receptor beta06612
Lethal factor0404
Alpha-2B adrenergic receptor01387150
ATP-dependent translocase ABCB1029333
Carnitine O-palmitoyltransferase 2, mitochondrial0404
Endothelin-1 receptor010112
Lysine-specific demethylase 5A0404
B2 bradykinin receptor07110
Melanocortin receptor 4010111
C-8 sterol isomerase0909
Melanocortin receptor 5014115
Sodium channel protein type 1 subunit alpha017017
Sodium channel protein type 4 subunit alpha020023
Squalene synthase0101
C-C chemokine receptor type 20808
Melanocortin receptor 3010111
Carnitine O-palmitoyltransferase 1, liver isoform0404
C-C chemokine receptor type 40606
Sodium channel protein type 7 subunit alpha013013
Voltage-dependent L-type calcium channel subunit alpha-1D 042143
Voltage-dependent L-type calcium channel subunit alpha-1S042143
Squalene monooxygenase0303
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase010111
Sodium channel protein type 9 subunit alpha023023
Lysine-specific demethylase 7A0202
Carnitine O-palmitoyltransferase 1, muscle isoform0303
Sodium channel protein type 2 subunit alpha019019
NAD-dependent protein deacetylase sirtuin-3, mitochondrial0145
Sodium channel protein type 3 subunit alpha018018
Sodium channel protein type 11 subunit alpha013013
Histone lysine demethylase PHF80202
Sodium channel protein type 8 subunit alpha014014
Sodium channel protein type 10 subunit alpha015015
Albumin001515
Angiotensin-converting enzyme061062
Alpha-2C adrenergic receptor011912136
Histamine H1 receptor020121
Histamine H1 receptor09912115
UDP-glucuronosyltransferase 1A30019
Voltage-dependent N-type calcium channel subunit alpha-1B018018
Nuclear receptor subfamily 3 group C member 3 053053
NEDD8-activating enzyme E1 regulatory subunit isoform a0202
NEDD8-conjugating enzyme Ubc120202
Voltage-dependent L-type calcium channel subunit alpha-1C019020
Potassium channel subfamily K member 2 0505
Chain A, Histamine N-methyltransferase0303
Chain A, Histamine N-methyltransferase0303
Chain A, Histamine N-methyltransferase0303
Chain A, Histamine N-methyltransferase0303
Spike glycoprotein072330
Transmembrane protease serine 2072330
Procathepsin L0142337
Replicase polyprotein 1a0122436
Replicase polyprotein 1ab0102333
Replicase polyprotein 1ab0302555
Angiotensin-converting enzyme 2 0102434
transient receptor potential cation channel subfamily V member 19009
Beta-lactamase 0104
Beta-lactamase 0106
Beta-lactamase 0005
Beta-lactamase 0107
Beta-lactamase 0004
Beta-lactamase SHV-10104
Beta-lactamase SHV-10209
Beta-lactamase0108
B2 metallo-beta-lactamase 0008
Solute carrier family 15 member 20909
Beta-lactamase 0104
Beta-lactamase 0105
Beta-lactamase 0104
Beta-lactamase 0005
Substance-P receptor0606
Chain A, Mutant Al2 6e7p9g0011
Beta-lactamase 0205
Beta-lactamase 0107
Beta-lactamase 0006
Metallo-beta-lactamase type 20129
Metallo-beta-lactamase VIM-11 0005
Metallo-beta-lactamase VIM-20005
Beta-lactamase 0007
Metallo-beta-lactamase0005
Beta-lactamase 0107
Beta-lactamase OXA-70004
Beta-lactamase 0103
Beta-lactamase 0103
Beta-lactamase 0103
Metallo-beta-lactamase VIM-130107
Efflux transporter 0003
Beta-lactamase 0004
Beta-lactamase Toho-10003
Beta-lactamase 0003
Class D beta-lactamase0106
Metallo-beta-lactamase0004
Beta-lactamase 0105
Beta-lactamase 0016
Metallo-b-lactamase 00010
Carbapenem-hydrolyzing beta-lactamase KPC0208
Beta-lactamase class B VIM-2 01214
Beta-lactamase VIM-1 0107
Histone acetyltransferase p3000506
Probable linoleate 9S-lipoxygenase 50101
Histone acetyltransferase KAT2B0303
Histone acetyltransferase KAT50303
SUMO-activating enzyme subunit 10101
Fatty-acid amide hydrolase 1014015
Fatty-acid amide hydrolase 10304
Potassium channel subfamily K member 30606
Fatty acid-binding protein, liver0707
Cannabinoid receptor 108311
Corticotropin-releasing factor receptor 20303
Lanosterol 14-alpha demethylase020223
Transient receptor potential cation channel subfamily V member 2011415
Nuclear factor NF-kappa-B p105 subunit0405
Signal transducer and activator of transcription 30314
Hexokinase-20202
Bile acid receptor09312
nuclear factor NF-kappa-B p105 subunit isoform 1170219
Beta-glucuronidase0303
Gastrin/cholecystokinin type B receptor17110
Testosterone 17-beta-dehydrogenase 30808
Chain A, retinol dehydratase0101
Glucose-6-phosphate 1-dehydrogenase013013
Atrial natriuretic peptide receptor 30202
Type-1A angiotensin II receptor 09514
Type-1 angiotensin II receptor0011
Type-1B angiotensin II receptor011112
Type-1 angiotensin II receptor015728
Type-2 angiotensin II receptor010111
Type-2 angiotensin II receptor010212
Interleukin-1 receptor antagonist protein0101
Endoplasmic reticulum aminopeptidase 20101
Endoplasmic reticulum aminopeptidase 10101
Leucyl-cystinyl aminopeptidase0101
M17 leucyl aminopeptidase0101
Steroid C26-monooxygenase0055
Cytochrome P450 1300033
Cytochrome P450 1300033
PAX80009
Hsf1 protein001115
hepatitis C virus polyprotein1001
heat shock protein 900044
caspase recruitment domain family, member 150202
receptor-interacting serine/threonine-protein kinase 2 isoform 10202
bcl-2-like protein 11 isoform 10077
Bcl-2-like protein 110001
Glucose transporter0303
Hexose transporter 1 0303
Solute carrier family 2, facilitated glucose transporter member 10516
Beta lactamase (plasmid)0303
Apelin receptor0112
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0202
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0202
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0202
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0202
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0202
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0202
Chain A, Transthyretin0044
Chain A, Transthyretin0044
Chain A, Transthyretin0044
Chain A, Transthyretin0044
Chain B, Transthyretin0044
Chain A, Transthyretin0044
Chain B, Transthyretin0044
Chain A, Casein kinase II subunit alpha0202
Chain A, Casein kinase II subunit alpha0202
Chain A, Casein Kinase Ii Subunit Alpha0202
Neuraminidase 014014
Aldo-keto reductase family 1 member B10015015
G2/mitotic-specific cyclin-B20606
Poly [ADP-ribose] polymerase tankyrase-10202
Lysozyme C-10202
Myeloperoxidase013013
Beta-glucuronidase0303
Neutrophil elastase015016
Androgen receptor1211041
Sialidase0505
Cystic fibrosis transmembrane conductance regulator0257
17-beta-hydroxysteroid dehydrogenase type 10708
Pyruvate kinase PKM0628
G2/mitotic-specific cyclin-B1010010
Urease subunit alpha012012
G2/mitotic-specific cyclin-B0505
Mucin-10101
Glycogen synthase kinase-3 beta0505
Proteasome subunit beta type-5014016
17-beta-hydroxysteroid dehydrogenase type 20808
Peroxisome proliferator-activated receptor gamma0167
Homeobox protein Nkx-2.5 0202
Estrogen receptor0011
Urease subunit beta012012
Lactoperoxidase0407
MO15-related protein kinase Pfmrk 0707
Cyclin homolog0404
Transcription factor GATA-4 0202
Cyclin-dependent kinase 5 activator 10707
Substance-K receptor010010
Casein kinase II subunit alpha 3012012
Inositol polyphosphate multikinase0505
G2/mitotic-specific cyclin-B30606
Enoyl-acyl-carrier protein reductase 012012
NACHT, LRR and PYD domains-containing protein 3 0404
Myocilin0011
Cyclin-dependent kinase 10505
Prenyltransferase homolog0004
Poly [ADP-ribose] polymerase tankyrase-20303
Carboxylic ester hydrolase 0507
NADPH oxidase 40303
Dipeptidyl peptidase 30606
Estrogen receptor beta0011
Inositol hexakisphosphate kinase 20505
Short transient receptor potential channel 50404
Sialidase-2010010
Chain A, Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor)0101
Coagulation factor X0101
Tryptophan 5-hydroxylase 10707
D(1B) dopamine receptor026026
D(4) dopamine receptor028129
E3 ubiquitin-protein ligase Mdm20303
D012012
Monocarboxylate transporter 10101
Chain A, ADIPOCYTE LIPID-BINDING PROTEIN0011
Chain A, SERUM ALBUMIN0022
Chain A, SERUM ALBUMIN0022
Calmodulin 0269
Solute carrier organic anion transporter family member 1B3034043
Cytosolic phospholipase A2 gamma0202
Solute carrier organic anion transporter family member 1B1038048
Polyphenol oxidase 10101
Taste receptor type 2 member 160023
Muscarinic acetylcholine receptor M104612
Muscarinic acetylcholine receptor M30149
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN0033
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN0033
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN0033
Cationic amino acid transporter 30202
Vasopressin V2 receptor09313
Oxytocin receptor0549
Vasopressin V1a receptor0135
Vasopressin V1a receptor014418
Vasopressin V1b receptor0437
Vasopressin V2 receptor0011
Vasopressin V1b receptor0215
Translocator protein0305
Oxytocin receptor0426
Vasopressin V2 receptor 0326
5-hydroxytryptamine receptor 3A0224
Histamine H1 receptor012418
3-hydroxy-3-methylglutaryl-coenzyme A reductase 0808
Multidrug and toxin extrusion protein 2021021
Chain A, Hyaluronidase, phage associated0101
Pancreatic alpha-amylase0202
Albumin0304
Urease0607
Prolyl 4-hydroxylase subunit alpha-10001
Hyaluronate lyase0101
Prolyl hydroxylase EGLN20124
Egl nine homolog 10348
Prolyl hydroxylase EGLN30023
Hypoxia-inducible factor 1-alpha inhibitor0304
Solute carrier family 23 member 10101
Neutral amino acid transporter A0505
Neutral amino acid transporter B(0)0505
Carbonic anhydrase-like protein, putative00010
Amino acid transporter0505
Excitatory amino acid transporter 40202
Glutamate transporter homolog0022
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase0202
Chain A, Phospholipase A2 isoform 30011
GTP-binding protein (rab7)0044
ras protein, partial0044
Rac1 protein0044
cell division cycle 42 (GTP binding protein, 25kDa), partial0044
Prostaglandin-H2 D-isomerase0202
Prostaglandin G/H synthase 2 0708
Fatty acid-binding protein, liver011112
Glutathione hydrolase 1 proenzyme0101
Urotensin-2 receptor0202
4-aminobutyrate aminotransferase, mitochondrial0303
Ras-related protein Rab-2A0044
Rho-associated protein kinase 20303
Beta-1 adrenergic receptor 02812
Solute carrier organic anion transporter family member 2B1 010016
Insulin receptor 0505
Dipeptidyl peptidase 40101
Atrial natriuretic peptide receptor 10112
Atrial natriuretic peptide receptor 1 0011
cystic fibrosis transmembrane conductance regulator0404
Muscarinic acetylcholine receptor M40416
Thromboxane A2 receptor 0329
Sodium/bile acid cotransporter09111
Leukotriene B4 receptor 21226
DNA (cytosine-5)-methyltransferase 10808
Histone-lysine N-methyltransferase EHMT20909
Protein-arginine deiminase type-4014014
Gamma-aminobutyric acid type B receptor subunit 20909
Gamma-aminobutyric acid type B receptor subunit 10707
Lysine-specific demethylase 4E0909
Lysine-specific histone demethylase 1A017018
Progesterone receptor018930
Polyunsaturated fatty acid 5-lipoxygenase010013
Cytochrome P450 11B1, mitochondrial0404
Polyunsaturated fatty acid lipoxygenase ALOX150506
Cyclic AMP-responsive element-binding protein 10001
Polyunsaturated fatty acid lipoxygenase ALOX120304
Prostaglandin G/H synthase 2 011012
Linoleate 9S-lipoxygenase-40303
1-deoxy-D-xylulose 5-phosphate reductoisomerase0404
Prolyl endopeptidase0707
Receptor-type tyrosine-protein phosphatase S0202
Prostaglandin G/H synthase 1 011012
Polyunsaturated fatty acid lipoxygenase ALOX15B0101
G-protein coupled receptor 350131225
Canalicular multispecific organic anion transporter 106010
Nuclear factor erythroid 2-related factor 20002
NAD(P)H dehydrogenase [quinone] 10005
Ghrelin O-acyltransferase0404
Kelch-like ECH-associated protein 10002
Voltage-dependent L-type calcium channel subunit alpha-1D011012
Voltage-dependent L-type calcium channel subunit alpha-1S010011
Transient receptor potential cation channel subfamily A member 10099
Zinc finger protein mex-50011
Genome polyprotein0101
Nicotinamide N-methyltransferase0303
Poly(ADP-ribose) glycohydrolase0101
Chain A, TRYPSIN0101
Chain H, Thrombin heavy chain0101
Chain H, Thrombin heavy chain0101
Chain A, PROTEIN (TRYPSIN)0101
Chain A, PROTEIN (TRYPSIN)0101
Chain A, PROTEIN (TRYPSIN)0101
Chain A, PROTEIN (TRYPSIN)0101
Chain B, PROTEIN (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)0101
Chain B, PROTEIN (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)0101
Chain B, PROTEIN (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)0101
Chain A, PROTEIN (TRYPSIN)0202
Chain A, TRYPSIN IVA0101
Chain A, trypsin II, anionic0101
Chain A, Trypsin II, anionic0101
Chain A, Trypsin II, anionic0101
Chain T, Trypsin II, anionic0101
Chain A, trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain A, PROTEIN (TRYPSIN)0202
Prothrombin 0404
Coagulation factor X0101
Acrosin0101
Aldehyde oxidase012016
Suppressor of tumorigenicity 14 protein0303
Chain A, Integrase0101
Chain A, Integrase0101
Chain A, T4 LYSOZYME0011
Chain A, GCN4P10011
Chain B, GCN4P10011
Chain C, GCN4P10011
Chain A, T4 LYSOZYME0011
Chain A, T4 LYSOZYME0011
Chain A, Replicase polyprotein 1ab0101
Chain A, 3C-like proteinase0101
Endolysin0022
Chain A, GTPase KRas, isoform 2B0011
Chain A, GTPase KRas, isoform 2B0011
GTPase KRas0011
Glutaminyl-peptide cyclotransferase0505
Mu-type opioid receptor019530
Amiloride-sensitive amine oxidase [copper-containing]0001
Lysyl oxidase homolog 20303
Platelet-activating factor receptor0303
Envelope glycoprotein0055
Neuraminidase0303
Neuraminidase0202
Aldo-keto reductase family 1 member C3013013
Aldo-keto reductase family 1 member C2 010010
Tissue alpha-L-fucosidase0101
core protein, partial0101
Sodium- and chloride-dependent betaine transporter0505
Sodium- and chloride-dependent GABA transporter 30404
Sodium- and chloride-dependent GABA transporter 20303
Bifunctional aspartokinase/homoserine dehydrogenase 10202
Kappa-type opioid receptor018729
Chain A, D-MALTODEXTRIN BINDING PROTEIN0011
Chain A, Limit Dextrinase0011
Chain A, Solute-binding protein0011
Chain A, Solute-binding protein0011
Chain B, SusD0011
Chain A, SusD0011
Chain A, SusD0011
Chain A, Alpha-hemolysin0011
Chain B, Alpha-hemolysin0011
Chain C, Alpha-hemolysin0011
Chain D, Alpha-hemolysin0011
Chain E, Alpha-hemolysin0011
Chain F, Alpha-hemolysin0011
Chain G, Alpha-hemolysin0011
Chain A, Betaine ABC transporter permease and substrate binding protein0011
Chain A, Osmoprotection protein (ProX)0011
Chain A, Glycine betaine/carnitine/choline-binding protein0022
Chain A, Glycine betaine/carnitine/choline-binding protein0022
Chain A, Glycine betaine/carnitine/choline-binding protein0022
Chain A, Glycine betaine/carnitine/choline-binding protein0022
galanin receptor type 30303
Cytochrome P450 26A10202
Retinoic acid receptor RXR-alpha06917
Retinoic acid receptor RXR-alpha0246
Retinoic acid receptor RXR-beta0336
Retinoic acid receptor RXR-beta0246
Retinoic acid receptor RXR-gamma0246
Retinoic acid receptor RXR-gamma0336
Retinoic acid receptor RXR-alpha0011
Cytochrome P450 26B10101
Neuropeptide Y receptor type 10416
Neuropeptide Y receptor type 20303
Neuropeptide Y receptor type 40101
Neuropeptide Y receptor type 50101
NPY-Y2 receptor 0101
Neuropeptide FF receptor 10112
Neuropeptide FF receptor 20112
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 10101
STAT3, partial0314
signal transducer and activator of transcription 1-alpha/beta isoform alpha0314
transcription factor p65 isoform 10022
Estrogen receptor beta0228
Pancreatic triacylglycerol lipase013015
Carbonyl reductase [NADPH] 108010
Estrogen receptor0228
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein)0808
Chain A, Avidin0011
Chain A, Protein (streptavidin)0011
Chain B, Protein (streptavidin)0011
Chain A, Streptavidin0011
Chain D, Streptavidin0011
Chain A, Streptavidin0011
Chain D, Streptavidin0011
Chain A, Streptavidin0011
Chain D, Streptavidin0011
Chain A, Streptavidin Complex With Biotin0011
Chain D, Circularly Permuted Core-streptavidin E51/a460011
Chain A, Core-streptavidin0011
Chain D, Core-streptavidin0011
Chain A, Core-streptavidin0011
Chain D, Core-streptavidin0011
Chain A, Core-streptavidin0011
Chain D, Core-streptavidin0011
Chain A, Core-streptavidin0011
Chain D, Core-streptavidin0011
Chain A, Avidin0011
Chain A, Streptavidin0011
Chain B, Streptavidin0011
Chain A, Streptavidin0011
Chain B, Streptavidin0011
nonstructural protein 10202
green fluorescent protein, partial0101
insulin-degrading enzyme isoform 10011
Receptor-type tyrosine-protein phosphatase beta0002
Beta-1 adrenergic receptor0415
Nonstructural protein 5A 0112
Beta-lactamase0205
Multidrug resistance-associated protein 60001
Solute carrier organic anion transporter family member 1A50009
Endothelin receptor type B0909
Endothelin-1 receptor5409
Endothelin-1 receptor0202
Solute carrier organic anion transporter family member 1B20107
Angiotensin-converting enzyme 012114
B2 bradykinin receptor0101
B1 bradykinin receptor0303
Genome polyprotein 08210
Nuclear hormone receptor family member daf-120011
oxysterols receptor LXR-beta isoform 10011
Thymidine phosphorylase0014
Thymidylate kinase0304
Thymidine kinase0002
N-acetyltransferase Eis0505
cAMP-dependent protein kinase type I-alpha regulatory subunit0011
cAMP-dependent protein kinase type II-beta regulatory subunit0011
cAMP-dependent protein kinase catalytic subunit beta isoform 10011
cAMP-dependent protein kinase catalytic subunit beta isoform 30011
Solute carrier family 12 member 20202
Potassium channel subfamily K member 30202
Potassium channel subfamily K member 90202
Acetylcholine receptor subunit alpha0538
Acetylcholine receptor subunit gamma0538
Integrin alpha-50101
Acetylcholine receptor subunit beta0538
Acetylcholine receptor subunit delta0538
Beta-2 adrenergic receptor011114
Beta-1 adrenergic receptor015321
Beta-3 adrenergic receptor0819
Alpha-2A adrenergic receptor0505
Matrix metalloproteinase-9011011
Chain A, Nitrile Hydratase alpha subunit0101
Chain B, Nitrile Hydratase beta subunit0101
Methyl-accepting chemotaxis protein NahY0033
Phosphatidylinositol 3-kinase catalytic subunit type 30101
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform0101
RNA polymerase beta subunit (EC 2.7.7.6), partial0202
Lipoxygenase 0101
Neuraminidase0202
Interstitial collagenase011112
72 kDa type IV collagenase012012
Tyrosine-protein phosphatase non-receptor type 70202
Dual specificity protein phosphatase 30303
Anthrax toxin receptor 20606
Hyaluronidase-10303
BiP isoform A0101
Aldo-keto reductase family 1 member A10202
Aldo-keto reductase family 1 member C40505
Aldo-keto reductase family 1 member C10909
Chain A, Glycogen Phosphorylase0101
Chain A, Glycogen phosphorylase, liver form0022
Chain A, glycogen phosphorylase, liver form0022
Chain A, Glycogen phosphorylase, liver form0022
Chain A, Glycogen phosphorylase, liver form0022
Chain A, Chitinase0101
Glycogen phosphorylase, liver form0101
Glycogen phosphorylase, muscle form0101
Chitotriosidase-10202
Palmitoleoyl-protein carboxylesterase NOTUM0235
Endochitinase B10202
Chain A, Vitamin D Nuclear Receptor0011
Vitamin D3 receptor0011
Vitamin D-binding protein0011
Vitamin D3 receptor05615
Vitamin D3 receptor0113
Vitamin D3 receptor0022
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial0213
Vitamin D3 receptor0112
Transporter0909
Vitamin D3 receptor A0022
Calpain-90101
Calpain-1 catalytic subunit0101
Cathepsin D0405
Calpain-1 catalytic subunit0202
Cathepsin B0505
Pro-cathepsin H0202
Calpain-2 catalytic subunit0303
Calpain-1 catalytic subunit0202
Falcipain 2B 0101
Cysteine proteinase falcipain 2a 0202
DNA topoisomerase 0101
Type-2 restriction enzyme ScaI0101
Deoxyribonuclease-2-alpha0101
Tyrosyl-DNA phosphodiesterase 20101
Deoxyribonuclease-10101
Type-2 restriction enzyme PstI0101
Type-2 restriction enzyme EcoRI0101
DNA ligase0202
Heterogeneous nuclear ribonucleoprotein A10022
DNA topoisomerase 108319
Type-2 restriction enzyme BamHI0101
Somatostatin receptor type 10303
Somatostatin receptor type 20314
Somatostatin receptor type 40303
Somatostatin receptor type 30314
Somatostatin receptor type 50314
Type-2 restriction enzyme HindIII0101
Ribonuclease pancreatic0202
DNA topoisomerase 10203
DNA topoisomerase 10101
DNA topoisomerase type IB small subunit 0011
Cytochrome P450 2C11 0303
Steroid 17-alpha-hydroxylase/17,20 lyase 0303
Cytochrome P450 3A50618
Cytochrome P450 3A70303
Caspase-118111
N-acylethanolamine-hydrolyzing acid amidase0303
Heat sensitive channel TRPV30123
Sigma intracellular receptor 20808
Transient receptor potential cation channel subfamily M member 80325
Transient receptor potential cation channel subfamily V member 40549
G-protein coupled receptor 550146
Diacylglycerol lipase-alpha0404
G-protein coupled receptor 60011
Transient receptor potential cation channel subfamily M member 80529
Transient receptor potential cation channel subfamily V member 40314
Protein phosphatase 1B0101
Serine/threonine-protein phosphatase PP1-gamma catalytic subunit0101
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B 0101
Chain A, Beta-lactoglobulin0011
Chain A, Beta-lactoglobulin0011
UDP-3-O-acyl-N-acetylglucosamine deacetylase0011
Transient receptor potential cation channel subfamily V member 1011314
NADH-ubiquinone oxidoreductase chain 10202
Transient receptor potential cation channel subfamily M member 80101
Chain A, angiotensin converting enzyme0101
Chain A, angiotensin converting enzyme0101
Neprilysin0202
Neprilysin0303
EEF1AKMT4-ECE2 readthrough transcript protein0202
Leukotriene A-4 hydrolase0101
Endothelin-converting enzyme 10202
Succinyl-diaminopimelate desuccinylase0505
Angiotensin-converting enzyme0617
Beta-lactamase TEM06012
Beta-lactamase 0303
Sodium channel protein type 1 subunit alpha111012
Sodium channel protein type 2 subunit alpha115117
Sodium channel protein type 3 subunit alpha111012
Frizzled-80011
Dihydroxyacetone phosphate acyltransferase0003
Lactoperoxidase0202
Cytochrome P450 2E10516
Chain A, serum paraoxonase0101
Kappa-type opioid receptor018828
Sodium/hydrogen exchanger 10101
Sodium/hydrogen exchanger 30101
Sodium/hydrogen exchanger 30101
Sodium/hydrogen exchanger 20101
Glutathione reductase, mitochondrial014017
Glutathione reductase0202
Solute carrier family 22 member 50002
Solute carrier family 22 member 50203
Solute carrier family 22 member 160001
Solute carrier family 22 member 210001
Solute carrier family 22 member 50002
Toll-like receptor 40202
Potassium channel subfamily K member 100101
Chain A, Protein kinase CK2, alpha Subunit0101
Chain A, PROTEIN KINASE CK2, alpha SUBUNIT0101
Chain A, Protein Kinase Ck2, Alpha Subunit0101
Serine/threonine-protein kinase Sgk10101
Casein kinase II subunit alpha 0101
Casein kinase II subunit beta0101
Cyclin-A10303
Single-stranded DNA cytosine deaminase8008
Melatonin receptor type 1A0538
Melatonin receptor type 1B0538
Solute carrier family 22 member 1108015
Solute carrier family 22 member 8012016
Beta-lactamase 0104
Beta-lactamase 0003
Metallo-beta-lactamase VIM-19 0006
Beta-lactamase 0105
Beta-lactamase0003
Beta-lactamase04010
Beta-lactamase0003
Beta-lactamase0003
Beta-lactamase 0105
Metallo-beta-lactamase VIM-20005
Beta-lactamase 0005
BlaVIM-1 0005
Beta-lactamase 0003
Beta-lactamase 0106
Chain A, Carbonic anhydrase II0101
interferon gamma precursor0007
prostaglandin E2 receptor EP2 subtype1005
Prostaglandin E synthase0505
Cytochrome c oxidase subunit 10101
Cytochrome c oxidase subunit 20101
Catechol O-methyltransferase0101
Cytochrome c oxidase subunit 20505
Quinolone resistance protein NorA0405
Prostaglandin G/H synthase 10505
Cruzipain0707
Bifunctional epoxide hydrolase 2013013
Prostaglandin G/H synthase 2010011
Prostaglandin G/H synthase 10101
Cyclooxygenase-2 0202
Beta-lactamase OXA-100002
Beta-lactamase 0002
Beta-lactamase 0004
Solute carrier family 22 member 705010
Beta-lactamase IMP-1 0004
Beta-lactamase 0004
Solute carrier family 22 member 70408
Caspase-20022
Mitochondrial sodium/calcium exchanger protein0101
serine-protein kinase ATM isoform a170017
DNA polymerase III, partial180018
hexokinase-4 isoform 1170017
glucokinase regulatory protein170017
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 0202
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 0101
Aromatic-L-amino-acid decarboxylase0101
Bcl-2-like protein 10404
Ileal sodium/bile acid cotransporter0405
Bile acid receptor0123
30S ribosomal protein S60719
30S ribosomal protein S70719
50S ribosomal protein L150719
50S ribosomal protein L100719
50S ribosomal protein L110719
50S ribosomal protein L7/L120719
50S ribosomal protein L190719
50S ribosomal protein L10719
50S ribosomal protein L200719
50S ribosomal protein L270719
50S ribosomal protein L280719
50S ribosomal protein L290719
50S ribosomal protein L310719
50S ribosomal protein L31 type B0719
50S ribosomal protein L320719
50S ribosomal protein L330719
50S ribosomal protein L340719
50S ribosomal protein L350719
50S ribosomal protein L360719
30S ribosomal protein S100719
30S ribosomal protein S110719
30S ribosomal protein S120719
30S ribosomal protein S130719
30S ribosomal protein S160719
30S ribosomal protein S180719
30S ribosomal protein S190719
30S ribosomal protein S200719
30S ribosomal protein S20719
30S ribosomal protein S30719
30S ribosomal protein S40719
30S ribosomal protein S50719
30S ribosomal protein S80719
30S ribosomal protein S90719
50S ribosomal protein L130719
50S ribosomal protein L140719
50S ribosomal protein L160719
50S ribosomal protein L230719
30S ribosomal protein S150719
50S ribosomal protein L170719
50S ribosomal protein L210719
50S ribosomal protein L300719
50S ribosomal protein L60719
30S ribosomal protein S140719
30S ribosomal protein S170719
30S ribosomal protein S10719
50S ribosomal protein L180719
50S ribosomal protein L20719
50S ribosomal protein L30719
50S ribosomal protein L240719
50S ribosomal protein L40719
50S ribosomal protein L220719
50S ribosomal protein L50719
30S ribosomal protein S210719
50S ribosomal protein L250719
50S ribosomal protein L36 20719
Methionine--tRNA ligase, mitochondrial0011
PINK1110011
calcineurin A1, putative0022
hepatocyte nuclear factor 4-alpha isoform 20303
ubiquitin-conjugating enzyme E2 N0707
protein AF-9 isoform a0006
melanocortin receptor 40101
CAAX prenyl protease0002
bcl-2-related protein A10505
hexokinase HKDC10112
DNA repair protein RAD52 homolog isoform a0006
Synaptojanin-20101
Synaptojanin-10101
Peroxisomal N(1)-acetyl-spermine/spermidine oxidase0101
Spermine oxidase0101
1,3-beta-D-glucan synthase catalytic subunit 0101
Tyrosine-protein phosphatase non-receptor type 20404
Dihydrofolate reductase 0505
Riboflavin-binding protein0235
Histidine-rich protein PFHRP-II0607
Spike glycoprotein0314
DNA ligase 10101
Calcium-dependent protein kinase 10011
DNA ligase A0101
Phosphoethanolamine N-methyltransferase0202
Cysteine proteinase falcipain 2a 0101
MBT domain-containing protein 10303
Lethal(3)malignant brain tumor-like protein 40303
Lethal(3)malignant brain tumor-like protein 30303
Chloroquine resistance transporter0404
Lethal(3)malignant brain tumor-like protein 10303
Proteasome subunit beta type-110001
NADPH oxidase 10505
Snq2p00014
Adenylate cyclase type 1 0404
Proteasome subunit alpha type-70001
Albumin0152142
Major prion protein0112
Cys-loop ligand-gated ion channel0101
Calmodulin-10729
Sphingomyelin phosphodiesterase0202
Proteasome subunit beta type-10204
Adenylate cyclase type 30404
Proteasome subunit alpha type-10001
Proteasome subunit alpha type-20001
Proteasome subunit alpha type-30001
Proteasome subunit alpha type-40001
Adenylate cyclase type 20415
Adenylate cyclase type 40404
Proteasome subunit beta type-80001
Proteasome subunit beta type-90001
Proteasome subunit alpha type-50001
Proteasome subunit beta type-40001
Proteasome subunit beta type-60001
Pleiotropic ABC efflux transporter of multiple drugs014028
Adenylate cyclase type 80404
Proteasome subunit beta type-100001
Proteasome subunit beta type-30001
Proteasome subunit beta type-20204
Gastrin/cholecystokinin type B receptor0505
Proteasome subunit alpha type-60045
Aldehyde oxidase 10303
Adenylate cyclase type 60404
Adenylyl cyclase 7 0404
Proteasome subunit alpha-type 80001
Proteasome subunit beta type-70001
Acetylcholinesterase 0101
Carboxylic ester hydrolase 0101
P2Y purinoceptor 120909
cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 70005
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Putative Glycine Betaine-binding Abc Transporter Protein0011
Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN0011
Chain A, Choline-binding protein0011
Solute carrier family 22 member 108010
Solute carrier family 22 member 20506
Sodium- and chloride-dependent creatine transporter 10101
High affinity choline transporter 10101
Chain A, Glycogen phosphorylase, muscle form0101
Chain A, Glycogen phosphorylase, muscle form0101
nuclear receptor subfamily 0 group B member 10404
steroidogenic factor 10404
3-oxoacyl-acyl-carrier protein reductase 0707
Dipeptidase 10101
Potassium-transporting ATPase alpha chain 10202
Potassium-transporting ATPase subunit beta0202
Solute carrier family 22 member 40404
Platelet glycoprotein VI0247
shiga toxin 1 variant A subunit1001
shiga toxin 1 B subunit1001
Cell division protein FtsZ0115
Estrogen receptor 10303
estrogen receptor beta isoform 10606
DNA gyrase subunit B0101
DNA gyrase subunit A0101
DNA gyrase subunit B0405
DNA gyrase subunit A07011
DNA gyrase subunit B07011
DNA topoisomerase 4 subunit A0101
DNA topoisomerase 4 subunit B0102
DNA topoisomerase 4 subunit A0304
DNA gyrase subunit A0405
Multidrug resistance protein MdtK0022
DNA gyrase subunit B0608
DNA gyrase subunit A0709
Enoyl-[acyl-carrier-protein] reductase [NADH]0408
DNA topoisomerase 4 subunit A0101
DNA topoisomerase 4 subunit B0101
5-hydroxytryptamine receptor 40326
Heparanase0033
Sodium-dependent noradrenaline transporter0505
Sodium-dependent serotonin transporter0505
Sodium-dependent dopamine transporter0606
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase0011
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase0011
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase0011
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase0011
Beta-lactamase0101
3-dehydroquinate dehydratase0011
ATP-citrate synthase 0102
Ribonuclease T0002
Cell death-related nuclease 40002
3-dehydroquinate dehydratase0011
Prolyl 4-hydroxylase0606
Alpha-ketoglutarate-dependent dioxygenase FTO0606
N(G),N(G)-dimethylarginine dimethylaminohydrolase 10608
General amino-acid permease GAP10001
Beta-lactamase 0101
Beta-lactamase 0203
Beta-lactamase OXA-10101
Beta-lactamase0101
Beta-lactamase 0101
Beta-lactamase 0101
mu opioid receptor, partial0011
MEP20011
delta-type opioid receptor0112
kappa-type opioid receptor isoform 10101
Catechol O-methyltransferase0315
Beta-galactosidase0011
heat shock protein 90, putative00011
Histamine H3 receptor0527
Histamine H4 receptor0347
Trypanothione reductase0101
Translocator protein0202
Alpha-1B adrenergic receptor 0044
Alpha-1A adrenergic receptor07411
Alpha-2B adrenergic receptor0507
Alpha-2C adrenergic receptor0507
Alpha-2A adrenergic receptor0507
Nischarin0808
Intermediate conductance calcium-activated potassium channel protein 40101
Chymotrypsinogen A011012
Estrogen receptor021114
Heme oxygenase 1 0707
Epoxide hydrolase 10004
Potassium-transporting ATPase subunit beta0202
Potassium-transporting ATPase alpha chain 10202
Heme oxygenase 20606
C-X-C chemokine receptor type 10303
Substance-P receptor017118
Malate dehydrogenase, cytoplasmic0707
Transitional endoplasmic reticulum ATPase0202
Cytochrome P450 1440033
Steroid C26-monooxygenase0033
Mycocyclosin synthase0033
Lanosterol 14-alpha demethylase0044
Nuclear receptor subfamily 1 group I member 3 0404
Sterol 14-alpha demethylase0022
Estrogen receptor beta011113
Indoleamine 2,3-dioxygenase 20404
14-alpha sterol demethylase 0023
Cysteinyl leukotriene receptor 10617
Endothelin receptor type B57012
D(2) dopamine receptor0303
D(3) dopamine receptor0303
D(2) dopamine receptor0505
5-hydroxytryptamine receptor 2B0404
5-hydroxytryptamine receptor 1A0606
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION0011
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION0011
Chain H, Fab M82G2, Heavy chain0011
Chain L, Fab M82G2, Light chain0011
Chain H, Fab M82g2, Heavy Chain0011
Chain L, Fab M82g2, Light Chain0011
Fatty acid-binding protein, heart0101
Muscarinic acetylcholine receptor M20134
Leukotriene B4 receptor 11305
Cytochrome P450 2D10606
Cytochrome P450 2D260707
Cytochrome P450 2D30707
Cytochrome P450 2D40707
Mas-related G-protein coupled receptor member X2001111
5-hydroxytryptamine receptor 1F0415
Tubulin alpha-1A chain0314
Tubulin beta chain0314
Tubulin beta-4A chain0359
Tubulin beta chain0359
Tubulin alpha-3C chain0359
Tubulin alpha-1B chain0359
Tubulin alpha-4A chain0359
Tubulin beta-4B chain0359
Vesicular acetylcholine transporter0101
Tubulin beta-3 chain0359
Tubulin beta-2A chain0359
Tubulin polymerization-promoting protein0011
Tubulin beta-8 chain0359
Tubulin beta-2B chain0505
Tubulin alpha-3E chain0359
Tubulin alpha-1A chain0359
Similar to alpha-tubulin isoform 1 0404
Similar to alpha-tubulin isoform 1 0404
Tubulin alpha-1C chain0359
Tubulin beta-6 chain0359
Tubulin beta-2B chain0359
Tubulin beta-1 chain0359
Adenylate cyclase type 80112
Relaxin receptor 10011
Nuclear receptor subfamily 1 group I member 20066
B2 bradykinin receptor0505
Dihydrofolate reductase0404
Beta-galactosidase0203
Ectonucleotide pyrophosphatase/phosphodiesterase family member 20505
PH domain leucine-rich repeat-containing protein phosphatase 20101
Chymotrypsin-C0303
DNA repair protein RAD52 homolog0303
Squalene monooxygenase 0405
RNA-directed RNA polymerase 0114
Exportin-10202
NAD-dependent histone deacetylase SIR20204
Acetylcholinesterase012113
N-arachidonyl glycine receptor0213
Sodium- and chloride-dependent creatine transporter 10101
ATP-binding cassette sub-family C member 90224
ATP-binding cassette sub-family C member 80325
ATP-sensitive inward rectifier potassium channel 110426
ATP-sensitive inward rectifier potassium channel 80011
Alkaline phosphatase, germ cell type0101
G protein-coupled receptor GPR350022
G-protein coupled receptor 350011
Chain A, Breast cancer type 1 susceptibility protein5005
toll-like receptor 90101
TPA: protein transporter TIM100404
hypothetical protein SA14220101
D-amino-acid oxidase0202
Phospholipase A20314
Neuronal proto-oncogene tyrosine-protein kinase Src 0101
Microtubule-associated protein tau0517
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 0101
Sarcoplasmic/endoplasmic reticulum calcium ATPase 20202
Thioredoxin reductase 1, cytoplasmic0304
Thioredoxin reductase 30202
Sortase A0202
Sarcoplasmic/endoplasmic reticulum calcium ATPase 30202
Cysteine protease 0101
Thioredoxin reductase 2, mitochondrial0202
CDGSH iron-sulfur domain-containing protein 1012012
Lymphocyte antigen 960011
Multidrug resistance-associated protein 50203
transactivating tegument protein VP16 [Human herpesvirus 1]0606
COUP transcription factor 2 isoform a0101
Eukaryotic initiation factor 4A-I0101
Peptidyl-prolyl cis-trans isomerase FKBP1A07310
Peptidyl-prolyl cis-trans isomerase FKBP30101
Peptidyl-prolyl cis-trans isomerase FKBP40202
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 10415
Hypoxia-inducible factor 1-alpha0527
Endothelial PAS domain-containing protein 10314
Peptidyl-prolyl cis-trans isomerase FKBP140101
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 40101
D-alanine--D-alanine ligase0101
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase 0101
chaperonin GroEL3003
Glycogen phosphorylase, muscle form0202
Histone-lysine N-methyltransferase SETD70505
Histone-lysine N-methyltransferase EHMT10505
LMP1 [Human herpesvirus 4]0005
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]0404
nuclear receptor coactivator 3 isoform a0404
Thymidine kinase 2, mitochondrial0101
Thymidine kinase0203
Thymidylate synthase0406
Thymidine kinase0101
Probable deoxycytidylate deaminase0002
Cytidine deaminase0206
Enoyl-[acyl-carrier-protein] reductase [NADH] 0404
Deoxynucleoside kinase0101
Cdk-related protein kinase 60101
Protein kinase domain-containing protein0101
Calcium-dependent protein kinase 10123
Mitogen-activated protein kinase 0101
Proline--tRNA ligase0101
Calcium-dependent protein kinase 40202
Lysine--tRNA ligase 0101
Uridine-cytidine kinase 1 0002
neutrophil cytosol factor 10505
Solute carrier family 2, facilitated glucose transporter member 30101
Solute carrier family 2, facilitated glucose transporter member 40101
Deoxycytidine kinase0001
Alpha-tocopherol transfer protein0011
Sodium/glucose cotransporter 10112
Sodium/glucose cotransporter 20112
Sodium/glucose cotransporter 20011
Sodium/myo-inositol cotransporter 20202
Solute carrier family 5 member 40101
Glandular kallikrein0101
6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase 0101
Dihydrofolate reductase0809
runt-related transcription factor 1 isoform AML1b7007
core-binding factor subunit beta isoform 27007
NADH-ubiquinone oxidoreductase chain 40001
Potassium voltage-gated channel subfamily E member 10101
G-protein coupled receptor 840336
exodeoxyribonuclease V subunit RecD0505
exodeoxyribonuclease V subunit RecB0505
exodeoxyribonuclease V subunit RecC0505
Lysine-specific demethylase 4A0202
Deoxyhypusine hydroxylase0101
Beta-glucuronidase0101
Glucose-6-phosphate 1-dehydrogenase 0101
Solute carrier organic anion transporter family member 1A20109
ATP-binding cassette sub-family C member 110002
Solute carrier organic anion transporter family member 1A10003
Chain A, STEROID DELTA-ISOMERASE0011
Steroid Delta-isomerase0011
Thymidine kinase 2 0101
AAA family ATPase 0002
AAA family ATPase 0001
Sterol O-acyltransferase 10202
Chain A, Dutpase0011
Chain A, Dutpase0011
Chain B, Dutpase0011
Chain A, Dutpase0011
Chain B, Dutpase0011
Nociceptin receptor07412
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha0202
Protein farnesyltransferase subunit beta0202
Sodium-dependent neutral amino acid transporter B(0)AT20202
Gonadotropin-releasing hormone receptor0213
Alpha-1A adrenergic receptor0224
Trace amine-associated receptor 10022
Trace amine-associated receptor 10055
Trace amine-associated receptor 10066
Taste receptor type 2 member 460033
Gamma-aminobutyric acid 0437
Alpha-1-acid glycoprotein 10002
Gamma-aminobutyric acid receptor subunit alpha-60437
Gamma-aminobutyric acid receptor subunit gamma-20437
Gamma-aminobutyric acid receptor subunit delta0437
Gamma-aminobutyric acid receptor subunit alpha-20437
Gamma-aminobutyric acid receptor subunit alpha-30437
Gamma-aminobutyric acid receptor subunit gamma-30437
Gamma-aminobutyric acid receptor subunit beta-10437
Gamma-aminobutyric acid receptor subunit alpha-10639
Gamma-aminobutyric acid receptor subunit beta-30437
Gamma-aminobutyric acid receptor subunit alpha-50437
Gamma-aminobutyric acid receptor subunit pi0437
Sphingosine-1-phosphate lyase 10202
Gamma-aminobutyric acid receptor subunit alpha-40437
Gamma-aminobutyric acid receptor subunit theta0437
Gamma-aminobutyric acid receptor subunit gamma-10437
Nicotinamide phosphoribosyltransferase0011
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial0202
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial0202
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Interleukin-80202
UDP-glucuronosyltransferase 1A70215
UDP-glucuronosyltransferase 1A100215
NAD0101
NAD0105
ATP phosphoribosyltransferase0101
Proprotein convertase subtilisin/kexin type 70202
Estrogen-related receptor gamma0112
UDP-glucose 4-epimerase0303
Chain A, DigA160011
Chain A, DigA160011
TSHR protein3003
Sodium/potassium-transporting ATPase subunit alpha-1 0708
Sodium/potassium-transporting ATPase subunit beta-10708
Sodium/potassium-transporting ATPase subunit alpha-30506
Sodium/potassium-transporting ATPase subunit beta-20506
Sodium/potassium-transporting ATPase subunit alpha-20708
Sodium/potassium-transporting ATPase subunit alpha-10303
Potassium-transporting ATPase alpha chain 20102
Sodium/potassium-transporting ATPase subunit beta-30506
Sodium/potassium-transporting ATPase subunit gamma0506
Sodium/potassium-transporting ATPase subunit alpha-40506
Solute carrier organic anion transporter family member 4C10205
tumor necrosis factor7007
Sodium/potassium-transporting ATPase subunit alpha-20202
Sodium/potassium-transporting ATPase subunit alpha-3 0202
Sodium/potassium-transporting ATPase subunit beta-1 0202
Sodium/potassium-transporting ATPase subunit alpha-40202
Solute carrier organic anion transporter family member 4C10002
Solute carrier organic anion transporter family member 1A40001
fatty acid synthase0303
Chain A, GLUTAMATE RECEPTOR SUBUNIT 20303
Chain A, Glutamate Receptor Subunit 20303
Chain B, Glutamate Receptor Subunit 20303
Chain A, Glutamate receptor 20101
Chain A, Glutamate receptor 20101
Chain A, Glutamate receptor0101
Chain A, Sex Hormone-Binding Globulin0011
Progesterone receptor0101
Glucocorticoid receptor0326
Sex hormone-binding globulin0202
Androgen receptor0134
Neuropeptide FF receptor 20002
C-terminal-binding protein 14004
Cereblon isoform 40909
Insulin-like growth factor-binding protein 50011
Protein cereblon019121
Glutathione S-transferase omega-10404
Prostaglandin E2 receptor EP1 subtype0336
Prostaglandin E2 receptor EP4 subtype0315
Prostaglandin F2-alpha receptor0202
Prostaglandin F2-alpha receptor0224
Prostaglandin E2 receptor EP3 subtype0427
Prostaglandin E2 receptor EP2 subtype0325
Prostaglandin F2-alpha receptor0011
Prostaglandin D2 receptor0112
Solute carrier organic anion transporter family member 2A10202
Prostaglandin E2 receptor EP4 subtype0112
Prostaglandin E2 receptor EP2 subtype0112
Solute carrier family 22 member 70002
Histamine N-methyltransferase0104
Calcium release-activated calcium channel protein 10303
Protein orai-20101
Protein orai-30101
Chain A, limonene-1,2-epoxide hydrolase0101
Chain A, Epoxide hydrolase0101
LANA0002
kelch-like ECH-associated protein 10002
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta0101
3',5'-cyclic-AMP phosphodiesterase 0505
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha0101
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma0101
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta0101
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma0101
Exopolyphosphatase PRUNE10101
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A0202
Phosphodiesterase 0303
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A0405
LacZ protein (plasmid)0011
type-1 angiotensin II receptor0101
polypyrimidine tract-binding protein 1 isoform a1001
apelin receptor0202
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase0303
Carbamate kinase0101
Retinal dehydrogenase 10202
Aldehyde dehydrogenase, mitochondrial0112
C-X-C chemokine receptor type 20202
C-C chemokine receptor type 50528
Gasdermin-D0202
Lysyl oxidase homolog 30101
NACHT, LRR and PYD domains-containing protein 3 0303
Lysyl oxidase homolog 40101
Monoglyceride lipase0404
Gasdermin-D0202
hypothetical protein CAALFM_CR05890CA0004
H3 histone acetyltransferase0004
Acetylcholinesterase0819
Amine oxidase [flavin-containing] A 0809
Acetylcholinesterase 010010
Cholinesterase0404
Acetylcholine receptor subunit epsilon0325
Acyl-CoA:cholesterol acyltransferase 0404
Carboxylic ester hydrolase 0909
Lysophosphatidylserine lipase ABHD120202
Monoacylglycerol lipase ABHD60202
Arrestin, beta 10101
MPI protein0303
TPA: protein transporter TIM230101
hexokinase0303
hexokinase-1 isoform HKI0011
phosphomannomutase 20101
phosphoethanolamine/phosphocholine phosphatase isoform 10101
eukaryotic translation initiation factor 4 gamma 1 isoform 40404
eukaryotic translation initiation factor 4E isoform 10404
Sulfhydryl oxidase 10101
Gamma-butyrobetaine dioxygenase0112
Macrophage migration inhibitory factor014014
Insulin-degrading enzyme0202
Toxin B0101
Methionine aminopeptidase 20101
Structural capsid protein 0101
Ultraspiracle0202
20-hydroxy-ecdysone receptor 0202
Ecdysone receptor0101
Protein ultraspiracle0101
Ecdysone receptor0101
Ultraspiracle 0101
20-hydroxy-ecdysone receptor 0101
Ultraspiracle protein 0101
20-hydroxy-ecdysone receptor 0101
UDP-glucuronosyltransferase 2B170012
Eyes absent homolog 20101
Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta))0101
Oxoeicosanoid receptor 10101
Chain A, PROTEIN KINASE CK2, ALPHA SUBUNIT0101
Chain A, Casein kinase II, alpha chain0101
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0011
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0011
3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ0101
Protein tyrosine phosphatase type IVA 30101
Accessory gene regulator protein A0101
Genome polyprotein0101
Casein kinase II subunit alpha0101
Tissue alpha-L-fucosidase0303
Gastrin/cholecystokinin type B receptor0358
Nociceptin receptor0202
Cytosol aminopeptidase0303
Opioid receptor, delta 1b 0202
Opioid receptor homologue0202
Proenkephalin-B0011
Mu-type opioid receptor0202
Catechol O-methyltransferase0202
UDP-glucuronosyltransferase 2B150012
Chain A, Troponin C, slow skeletal and cardiac muscles0011
Chain A, Peptidyl-prolyl cis-trans isomerase NIMA-interacting 10011
Chain A, POLYMERASE PA0101
Chain A, Polymerase Pa0101
Chain A, Polymerase Pa0101
Chain A, Polymerase Pa0101
Chain A, Polymerase Pa0101
Polycomb protein EED0112
NAD kinase0213
Polymerase acidic protein0112
Plasminogen activator inhibitor 10303
Matrilysin0606
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI0404
Alpha-amylase 1A 0404
Apoptosis regulator Bcl-20303
Glucose-6-phosphate 1-dehydrogenase0101
Fatty acid synthase0303
CPG DNA methylase0202
Phosphoglycerate mutase 10101
Signal transducer and activator of transcription 1-alpha/beta0011
Fatty acid synthase0808
Matrix metalloproteinase-140101
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT60404
6-phosphogluconate dehydrogenase, decarboxylating0606
BH3-interacting domain death agonist0101
Alpha-(1,3)-fucosyltransferase 70404
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 10404
Bcl-2-related protein A10101
Dual specificity tyrosine-phosphorylation-regulated kinase 1A0202
3-oxoacyl-[acyl-carrier-protein] reductase 0101
Bcl-2-like protein 20101
Bcl2-associated agonist of cell death 0101
Bcl-2-like protein 100101
Adenylate cyclase 0101
Solute carrier family 22 member 40102
Motilin receptor0011
low molecular weight phosphotyrosine protein phosphatase isoform c0202
Motilin receptor0112
Chitinase B0101
Low molecular weight phosphotyrosine protein phosphatase0505
Flavin reductase (NADPH)0033
ERAP2 protein0001
M17 leucyl aminopeptidase0101
M18 aspartyl aminopeptidase0303
M1-family alanyl aminopeptidase0101
leucyl-cystinyl aminopeptidase [Mus musculus]0001
Tyrosine-protein phosphatase non-receptor type 110405
Sodium/bile acid cotransporter0104
Solute carrier organic anion transporter family member0002
Solute carrier organic anion transporter family member 1C10404
Chain A, GLUTATHIONE TRANSFERASE A1-10101
Chain A, Glutathione S-transferase P1-10101
Chain A, Glutathione S-transferase P1-10101
Chain B, Glutathione S-transferase P1-10101
Hematopoietic prostaglandin D synthase0202
Glutathione S-transferase A10101
14 kDa phosphohistidine phosphatase0303
Pantothenate synthetase0202
3-oxo-5-alpha-steroid 4-dehydrogenase 1 0404
Voltage-dependent T-type calcium channel subunit alpha-1I0516
Chain A, Carbonic anhydrase 20101
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)0101
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)0101
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)0101
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)0101
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)0101
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)0101
ClpP100010
Acetylcholine receptor subunit delta0101
Acetylcholine receptor subunit alpha0101
Acetylcholine receptor subunit gamma0101
Acetylcholine receptor subunit beta0101
Cytochrome P450 11B1, mitochondrial0505
Cytochrome P450 11B2, mitochondrial0505
Regulatory protein E20011
DNA topoisomerase 20002
Caspase-30303
DNA topoisomerase 2-alpha 0001
Ubiquitin carboxyl-terminal hydrolase isozyme L30202
Ubiquitin carboxyl-terminal hydrolase isozyme L10202
Tyrosine-protein phosphatase 10202
Cell division cycle 7-related protein kinase0033
Potassium voltage-gated channel subfamily E member 10909
Choline-phosphate cytidylyltransferase A0022
Potassium voltage-gated channel subfamily KQT member 10909
Eukaryotic peptide chain release factor GTP-binding subunit ERF3B0011
Potassium voltage-gated channel subfamily D member 30202
Long-chain-fatty-acid--CoA ligase 50011
Potassium voltage-gated channel subfamily KQT member 300510
Potassium voltage-gated channel subfamily KQT member 201511
UDP-glucuronosyltransferase 2B110011
Potassium voltage-gated channel subfamily KQT member 20011
Potassium voltage-gated channel subfamily KQT member 3 0011
UDP-glucuronosyltransferase 2B40011
UDP-glucuronosyltransferase 2A10011
UDP-glucuronosyltransferase 2A20011
UDP-glucuronosyltransferase 1A50011
Potassium voltage-gated channel subfamily KQT member 40034
UDP-glucuronosyltransferase 2A30011
UDP-glucuronosyltransferase 2B280011
UDP-glucuronosyltransferase 1A80015
Potassium voltage-gated channel subfamily KQT member 50035
Potassium voltage-gated channel subfamily KQT member 2 0011
Amine oxidase [flavin-containing] B0304
Cathepsin B0101
procathepsin L isoform 1 preproprotein0202
fructose-bisphosphate aldolase0101
Fatty acid-binding protein, liver0123
Peroxisome proliferator-activated receptor alpha0235
Peroxisome proliferator-activated receptor alpha0011
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 10101
3-oxo-5-alpha-steroid 4-dehydrogenase 10202
3-oxo-5-alpha-steroid 4-dehydrogenase 20303
3-oxo-5-alpha-steroid 4-dehydrogenase 20303
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase0101
Sphingosine 1-phosphate receptor 10123
RCG53912, isoform CRA_a 0001
Sphingosine kinase 1 0001
Sphingosine kinase 20304
Sphingosine kinase 10203
Potassium voltage-gated channel subfamily A member 50404
Potassium voltage-gated channel subfamily D member 20303
unnamed protein product0101
Lanosterol 14-alpha demethylase0113
Lanosterol 14-alpha demethylase0011
Sterol 14-alpha demethylase0213
likely tRNA 2'-phosphotransferase0101
Chain A, PROTEIN (TRANSTHYRETIN)0011
Chain B, PROTEIN (TRANSTHYRETIN)0011
Transcription factor SOX-180303
Transcriptional enhancer factor TEF-30325
Potassium channel subfamily K member 180112
Acid-sensing ion channel 50011
Voltage-dependent T-type calcium channel subunit alpha-1G0426
Voltage-dependent T-type calcium channel subunit alpha-1H0516
Voltage-dependent L-type calcium channel subunit beta-10202
Voltage-dependent calcium channel subunit alpha-2/delta-10202
Voltage-dependent N-type calcium channel subunit alpha-1B0303
Prostaglandin D2 receptor 20314
Chain A, Uracil Phosphoribosyltransferase0101
Solute carrier family 22 member 80407
Potassium voltage-gated channel subfamily C member 10202
Gastrin/cholecystokinin type B receptor 0101
Ubiquitin carboxyl-terminal hydrolase 10404
WD repeat-containing protein 480404
Serine hydroxymethyltransferase, mitochondrial0303
Cytochrome P450 1A2 0303
Chain A, Dihydrofolate reductase0011
Thymidylate synthase0606
Multidrug resistance associated protein0205
Menin0011
Lecithin retinol acyltransferase0101
Protein Rev 0011
Aminoglycoside 3'-phosphotransferase 0001
Fucose-binding lectin PA-IIL0202
CD209 antigen0303
Steroid hormone receptor ERR10303
Corticosteroid 11-beta-dehydrogenase isozyme 10314
Holo-[acyl-carrier-protein] synthase0101
Voltage-dependent calcium channel subunit alpha-2/delta-10202
Sterol O-acyltransferase 10022
Lipopolysaccharide heptosyltransferase 10101
PA-I galactophilic lectin0011
Jacalin0011
Galanin receptor type 20235
Galanin receptor type 30033
Galanin receptor type 10235
Chain A, ACETYLCHOLINESTERASE0101
Chain A, Acetylcholinesterase0101
L-selectin0101
P-selectin0101
E-selectin0101
Autoinducer 2-binding periplasmic protein LuxP0101
Polypeptide N-acetylgalactosaminyltransferase 20112
Toll-like receptor 2 0101
Sodium- and chloride-dependent GABA transporter 106110
Sodium- and chloride-dependent taurine transporter0202
Sodium- and chloride-dependent betaine transporter0303
4-aminobutyrate aminotransferase, mitochondrial0102
Chain A, DEOXYNUCLEOSIDE KINASE0101
Chain A, Estrogen receptor 1 (alpha)0101
Chain A, Transthyretin0011
Chain A, Transthyretin0011
Steroid hormone receptor ERR20101
Ornithine decarboxylase0202
Solute carrier family 2, facilitated glucose transporter member 40202
G1/S-specific cyclin-D10505
Cystic fibrosis transmembrane conductance regulator0011
DNA (cytosine-5)-methyltransferase 3-like0303
DNA (cytosine-5)-methyltransferase 3A0404
beta-amyloid peptide, A beta {N-terminal} [human, cerebrospinal fluid, conditioned medium of mixed-brain cell cultures, Peptide Partial, 33 aa]1001
alpha synuclein, partial1001
Glucagon-like peptide 1 receptor0011
Glucagon-like peptide 1 receptor0336
Glucagon receptor0011
Glucagon receptor0011
Asialoglycoprotein receptor 10112
Chain A, Slr1257 protein0011
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing]0101
Excitatory amino acid transporter 3 0001
Glutamate racemase0001
Metabotropic glutamate receptor 80213
Glutamate carboxypeptidase 20203
Glutamate racemase0001
Protein-glutamine gamma-glutamyltransferase 20505
Chain A, Glutamine Binding Protein0011
Asc-type amino acid transporter 10202
Chain A, Protein (aspartate Aminotransferase)0022
Chain A, Aspartate Aminotransferase0022
Glutathione reductase0103
ATP synthase subunit beta, mitochondrial0101
ATP synthase subunit delta, mitochondrial0101
ATP synthase subunit gamma, mitochondrial0101
ATP synthase subunit epsilon, mitochondrial0101
Cholesteryl ester transfer protein0101
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E0011
Sodium- and chloride-dependent glycine transporter 10202
Large neutral amino acids transporter small subunit 1010011
Serine racemase0303
Sodium- and chloride-dependent glycine transporter 20101
Pancreatic alpha-amylase0305
High mobility group protein B10033
High mobility group protein B10001
Corticosteroid 11-beta-dehydrogenase isozyme 20112
4-hydroxy-tetrahydrodipicolinate synthase0101
Ricin0202
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase0022
Purine nucleoside phosphorylase 0024
Chain A, Probable hydrogenase nickel incorporation protein hypB0011
Chain B, Probable hydrogenase nickel incorporation protein hypB0011
Chain A, ELONGATION FACTOR TU (EF-TU)0011
Chain A, Elongation Factor G0011
Chain A, ADP-RIBOSYLATION FACTOR-LIKE PROTEIN 30011
Chain A, Eukaryotic peptide chain release factor GTP-binding subunit0011
Chain A, ras-related C3 botulinum toxin substrate 1 isoform Rac1b0011
Chain A, ras-related C3 botulinum toxin substrate 1 isoform Rac1b0011
Chain A, interferon-inducible GTPase0011
Chain A, interferon-inducible GTPase0011
Chain A, Elongation factor 20011
Chain A, Guanine nucleotide-binding protein G(i), alpha-1 subunit0011
Ras-related protein Rab-7a0022
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT50101
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 90404
Chain A, Hypoxanthine Phosphoribosyltransferase0101
Chain A, HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE0101
Chain A, HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE0011
Chain B, HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE0011
Chain A, HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE0011
Chain A, Xanthine phosphoribosyltransferase0011
Histidine triad nucleotide-binding protein 10011
Chain A, Uracil Phosphoribosyltransferase0011
Chain B, Uracil Phosphoribosyltransferase0011
Chain C, Uracil Phosphoribosyltransferase0011
Chain E, C-amp-dependent Protein Kinase0101
Chain I, Protein Kinase Inhibitor Peptide0101
Chain E, C-amp-dependent Protein Kinase0101
Chain E, C-amp-dependent Protein Kinase0101
Chain I, Protein Kinase Inhibitor Peptide0101
cAMP-dependent protein kinase type II-alpha regulatory subunit0101
cAMP-dependent protein kinase catalytic subunit alpha0404
Protein kinase C gamma type09211
cAMP-dependent protein kinase catalytic subunit beta 0101
cAMP-dependent protein kinase catalytic subunit alpha 0112
cAMP-dependent protein kinase type II-beta regulatory subunit0101
Vitamin D-binding protein0101
HLA class I histocompatibility antigen, A alpha chain 0044
Integrin beta-10202
Integrin alpha-40202
5-hydroxytryptamine receptor 2A0213
AP-2 complex subunit sigma0101
Calcitonin gene-related peptide type 1 receptor0101
Zinc finger protein 6640101
Vesicular acetylcholine transporter0303
STE240002
DNA repair and recombination protein RAD54-like isoform 10001
Tryptophan 2,3-dioxygenase0203
Chain A, Dual specificity tyrosine-phosphorylation-regulated kinase 1A0101
Glycogen synthase kinase-3 beta 0303
CDC-like kinase 1, isoform CRA_c0001
[Tau protein] kinase 0303
dual specificity protein kinase CLK41001
Dual specificity protein kinase CLK20101
Dual specificity protein kinase CLK30101
Dual specificity protein kinase CLK40101
Dual specificity tyrosine-phosphorylation-regulated kinase 30101
Cyclin-T10101
Dual specificity protein kinase CLK10101
Sodium-dependent dopamine transporter0101
Neuromedin-B receptor0101
Cyclin-H0101
Mitogen-activated protein kinase 10202
Serine/threonine-protein kinase haspin0101
Dual specificity tyrosine-phosphorylation-regulated kinase 20123
Dual specificity tyrosine-phosphorylation-regulated kinase 40101
Tyrosine-protein kinase JAK1 0101
Tyrosine-protein kinase JAK30101
Transient receptor potential cation channel subfamily V member 4 0112
Chain E, Fibrin beta chain0202
Mcl-10707
Cyclin-dependent kinase 5, regulatory subunit 1 (p35)0001
CDK50001
major prion protein preproprotein Prp precursor0101
Tat0303
Vesicular acetylcholine transporter0101
calpain II, partial0101
SUMO-10101
envelope glycoprotein0101
heat shock 70kDa protein 1A0101
neuropeptide Y receptor type 10011
neuropeptide Y receptor type 20011
small ubiquitin-related modifier 2 isoform b precursor0101
enteropeptidase precursor1001
heat shock cognate 71 kDa protein isoform 10101
heat shock cognate 71 kDa protein isoform 20101
N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D0101
N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D0101
M1-family alanyl aminopeptidase0202
BZLF20101
Protein arginine N-methyltransferase 50213
Protein arginine N-methyltransferase 10606
Chain A, CARBONIC ANHYDRASE II0011
Chain A, Protein (female-specific Histamine Binding Protein 2)0011
Histamine N-methyltransferase 0202
Equilibrative nucleoside transporter 40001
Histamine H4 receptor0224
Histamine H4 receptor 0101
Chain A, HISTIDINE-BINDING PROTEIN0011
Histidine-binding periplasmic protein0011
Intestinal-type alkaline phosphatase0505
Phospholipase A-2-activating protein0505
Cystine/glutamate transporter0404
N-glycosylase/DNA lyase0404
tyrosine-protein phosphatase non-receptor type 7 isoform 20303
Cyclic GMP-AMP synthase0202
Toll-like receptor 90101
Toll-like receptor 70101
Uracil nucleotide/cysteinyl leukotriene receptor0404
Ribonucleoside-diphosphate reductase large subunit0102
Chain A, Purine-nucleoside Phosphorylase0101
Chain C, Xanthine dehydrogenase/oxidase0011
Acid-sensing ion channel 30101
Caspase-40202
Caspase-50202
Dehydrogenase/reductase SDR family member 90101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
potassium voltage-gated channel subfamily KQT member 20033
Sodium channel protein type 9 subunit alpha0101
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase0101
Prostacyclin receptor0112
Beta-lactamase 0001
Metallo-beta-lactamase type 20001
Beta-lactamase 0102
Chain A, Cell Division Protein Kinase 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, Cell Division Protein Kinase 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, Cell Division Protein Kinase 20101
Malate dehydrogenase0505
Chymotrypsinogen B0505
Kit ligand0101
G1/S-specific cyclin-E10202
Cyclin-dependent kinase 100101
Cyclin-dependent kinase 200101
Cyclin-dependent kinase 150123
Peptide deformylase 1A, chloroplastic/mitochondrial0101
Peptide deformylase 0101
Chain A, membrane-associated prostaglandin E synthase-20101
Phospholipase A2, major isoenzyme0202
C-X-C chemokine receptor type 30505
Prostaglandin D2 receptor 0202
Dehydrogenase/reductase SDR family member 90101
Chain A, ADENOSINE DEAMINASE0101
Chain A, ADENOSINE DEAMINASE0101
Chain B, Pulmonary surfactant-associated protein D0101
Chain A, Pulmonary surfactant-associated protein D0101
Chain A, BETA-SPECTRIN0011
Chain A, Phospholipase C Delta-10011
Chain A, Inositol 1,4,5-trisphosphate receptor type 10011
Inositol-trisphosphate 3-kinase A0101
Inositol 1,4,5-trisphosphate receptor type 1 0022
Inositol 1,4,5-trisphosphate receptor type 20101
Inositol 1,4,5-trisphosphate receptor type 30112
Inositol polyphosphate-5-phosphatase A0101
Inositol 1,4,5-trisphosphate receptor type 10112
Peptidylglycine alpha-amidating monooxygenase0001
Chain A, Acetylcholinesterase0101
Liver carboxylesterase 10101
Secreted chorismate mutase0404
Chain A, meta-Cleavage product hydrolase0101
Free fatty acid receptor 30033
Lysosomal protective protein0101
Fatty acid synthase 0101
Liver carboxylesterase0101
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, isoform CRA_a0011
Protein disulfide-isomerase0101
Collagenase 30707
Nuclear factor NF-kappa-B p100 subunit 0303
Transcription factor p650505
3-oxoacyl-[acyl-carrier-protein] synthase 3 0202
Formamidopyrimidine-DNA glycosylase0101
Endonuclease III-like protein 10101
Putative FAD-containing monooxygenase MymA0101
Dihydrofolate reductase0303
Endonuclease 8-like 10101
Beta-2 adrenergic receptor0011
Beta-3 adrenergic receptor0011
Taste receptor type 2 member 380036
Taste receptor type 2 member 390011
Taste receptor type 2 member 400011
Taste receptor type 2 member 410011
Taste receptor type 2 member 430011
Taste receptor type 2 member 310033
Taste receptor type 2 member 450011
Taste receptor type 2 member 300011
Taste receptor type 2 member 190011
Taste receptor type 2 member 200011
Taste receptor type 2 member 500011
Taste receptor type 2 member 600022
Taste receptor type 2 member 420011
Taste receptor type 2 member 140023
Taste receptor type 2 member 130022
Taste receptor type 2 member 100023
Taste receptor type 2 member 90022
Taste receptor type 2 member 80011
Taste receptor type 2 member 70011
Taste receptor type 2 member 50011
Taste receptor type 2 member 40022
Taste receptor type 2 member 30011
Taste receptor type 2 member 10011
Ornithine decarboxylase0002
Retinoic acid receptor alpha0224
Retinoic acid receptor gamma0224
Retinoic acid receptor beta0224
Cellular retinoic acid-binding protein 20022
Cellular retinoic acid-binding protein 10203
Cellular retinoic acid-binding protein 10022
All-trans-retinol dehydrogenase [NAD(+)] ADH1B0001
Alcohol dehydrogenase 1C0001
Alcohol dehydrogenase 1A0001
All-trans-retinol dehydrogenase [NAD(+)] ADH40001
Alcohol dehydrogenase class-30001
Alcohol dehydrogenase 60001
All-trans-retinol dehydrogenase [NAD0001
Voltage-dependent L-type calcium channel subunit alpha-1C0101
Monoglyceride lipase0101
Monoglyceride lipase0101
Chain A, Glutamate receptor 20022
Chain A, Glutamate receptor 20022
Chain C, Glutamate receptor 20022
3-oxoacyl-[acyl-carrier-protein] synthase 30101
Gap junction alpha-1 protein0101
Gap junction beta-2 protein0101
Acyl-protein thioesterase 10101
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial0101
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial0202
Camphor 5-monooxygenase0001
Steroid 21-hydroxylase0101
Cholesterol side-chain cleavage enzyme, mitochondrial 0101
Cytochrome P450 2A20101
Cytochrome P450 11B1, mitochondrial 0303
Cytochrome P450 7A1 0101
Cytochrome P450 4F20303
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial0101
Cytochrome P450 7A10101
Lanosterol 14-alpha demethylase 0202
Rho-associated protein kinase 20101
Aryl hydrocarbon receptor0011
D(2) dopamine receptor isoform long1001
Sodium channel protein type 10 subunit alpha0101
Chain A, Lectin0011
Chain A, Lectin0011
Chain A, Lectin0011
Chain A, Lectin0011
Chain A, ERYTHRINA CRISTA-GALLI LECTIN0011
Chain A, ERYTHRINA CRISTA-GALLI LECTIN0011
Chain A, cellulase0011
Chain A, cellulase0011
Chain A, Galectin-30011
Chain A, Anti-tumor lectin0101
Galectin-30101
Galectin-90011
Galectin-80011
Beta-galactoside-binding lectin0101
Galectin-10113
Galectin-30112
Galectin-30113
Galectin-70011
Alpha 1,4 galactosyltransferase0001
Alpha-crystallin B chain0011
Actin0101
Neuronal acetylcholine receptor subunit beta-40303
Neuronal acetylcholine receptor subunit beta-20314
Chain A, AMINOPEPTIDASE0202
Chain A, AMINOPEPTIDASE0202
Chain A, Leucine Aminopeptidase0101
Synaptic vesicle glycoprotein 2A0303
SLC16A10 protein0004
Monocarboxylate transporter 100004
CAAX prenyl protease 2 isoform 20001
DNA primase0202
Sigma non-opioid intracellular receptor 10101
Dipeptidyl peptidase 90101
Dipeptidyl peptidase IV0101
Prolyl endopeptidase FAP0101
Prolyl endopeptidase FAP0101
Dipeptidyl peptidase 80101
Dipeptidyl peptidase 90101
Dipeptidyl peptidase 20101
Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial0101
Dual specificity tyrosine-phosphorylation-regulated kinase 1A0101
Renin0202
N-formyl peptide receptor 20123
inositol monophosphatase 12002
Chain A, protease0101
Chain B, protease0101
Chain A, protease0011
Chain B, protease0011
Chain A, protease0011
Chain B, protease0011
Chain A, protease0011
Chain B, protease0011
Chain A, protease0011
Chain B, protease0011
Chain A, protease0011
Chain B, protease0011
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, PROTEASE RETROPEPSIN0101
Chain B, PROTEASE RETROPEPSIN0101
Chain A, Protease Retropepsin0101
Chain B, Protease Retropepsin0101
Chain A, Protease Retropepsin0101
Chain B, Protease Retropepsin0101
Gag-Pol polyprotein0202
Gag-Pol polyprotein0202
Gag-Pol polyprotein0202
Gag-Pol polyprotein0505
Gag-Pol polyprotein0202
CAAX prenyl protease 1 homolog0101
Plasmepsin V 0202
Protease 09312
Potassium channel subfamily K member 90101
Type-1 angiotensin II receptor0213
Chain A, Antigen Cd11a (p180)0101
Integrin beta-20101
Intercellular adhesion molecule 10101
Integrin alpha-L0112
DNA-(apurinic or apyrimidinic site) endonuclease0213
Queuine tRNA-ribosyltransferase0101
retinoic acid receptor alpha isoform 10101
retinoic acid receptor RXR-alpha isoform a0101
histidine kinase 0101
Chemotaxis protein CheA0101
Protein polybromo-10011
DNA topoisomerase 10101
Melatonin receptor type 1C0112
5-hydroxytryptamine receptor 1E0304
Sodium-dependent dopamine transporter0101
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast0101
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast0101
Chain A, Retinoic acid receptor RXR-alpha0011
Chain A, Peroxisome proliferator-activated receptor gamma0011
Chain A, Phosphoenolpyruvate carboxykinase0101
D-aspartate oxidase 0101
D-aspartate oxidase0101
Serine racemase0303
Alpha-mannosidase 2C10112
histone-lysine N-methyltransferase NSD2 isoform 10002
C-C chemokine receptor type 50101
C-C chemokine receptor type 50101
Calmodulin-domain protein kinase 10101
Neuronal acetylcholine receptor subunit alpha-20202
Myc proto-oncogene protein0203
Nociceptin receptor0112
Melatonin receptor type 1A0224
Melatonin receptor type 1C0224
Melatonin receptor type 1B0224
Large neutral amino acids transporter small subunit 1 0202
Mucosa-associated lymphoid tissue lymphoma translocation protein 10202
UDP-glucose 6-dehydrogenase0101
UDP-glucose 6-dehydrogenase0101
UDP-glucuronosyltransferase 1A1 0101
Hydroxyacid oxidase 10101
Aldehyde oxidase 1 0303
corticotropin-releasing hormone receptor 20112
corticotropin releasing factor-binding protein0112
Dopamine beta-hydroxylase 0203
Chain A, Methionyl-tRNA synthetase0011
Chain A, Methionyl-tRNA synthetase0011
Chain A, Aminopeptidase0101
Chain A, Methionine aminopeptidase0101
S-ribosylhomocysteine lyase0101
Adenylate cyclase type 50102
Chain B, DIHYDROFOLATE REDUCTASE0011
Chain B, DIHYDROFOLATE REDUCTASE0011
Chain B, DIHYDROFOLATE REDUCTASE0011
Thymidylate synthase 0101
Thymidylate synthase 0101
ATP-binding cassette sub-family C member 30103
Dihydrofolate reductase0101
Thymidylate synthase0303
Bifunctional dihydrofolate reductase-thymidylate synthase0303
Dihydrofolate reductase0303
Thymidylate synthase0303
Bifunctional dihydrofolate reductase-thymidylate synthase0505
Folate receptor beta0101
Folate receptor alpha0101
Histidine decarboxylase0134
Trifunctional purine biosynthetic protein adenosine-30101
Bifunctional purine biosynthesis protein ATIC0404
Reduced folate transporter0202
Bifunctional dihydrofolate reductase-thymidylate synthase0304
Bifunctional dihydrofolate reductase-thymidylate synthase0101
Trifunctional purine biosynthetic protein adenosine-30101
Dihydrofolate reductase 0303
Dihydrofolate reductase0405
Proton-coupled folate transporter0101
T cell receptor, partial1001
luteinizing hormone receptor1001
Dihydrolipoyl dehydrogenase, mitochondrial0103
Dihydrolipoyl dehydrogenase 0102
5-hydroxytryptamine receptor 3B0505
Chain A, androgen receptor0011
Chain A, androgen receptor0011
Thioredoxin reductase 0101
Flavodoxin0002
G-protein coupled receptor 0101
Sodium channel protein type 4 subunit alpha0101
Voltage-dependent L-type calcium channel subunit beta-30101
Cytochrome P450 1A20101
methionyl-tRNA synthetase, putative0101
Chain A, PROGESTERONE RECEPTOR0101
Glucocorticoid receptor 0101
Tegument protein VP160011
Glucocorticoid receptor0112
Progesterone receptor0011
Glucocorticoid receptor0101
Sucrase-isomaltase 0101
Ceramide glucosyltransferase0101
Beta-galactosidase0101
Lysosomal alpha-glucosidase0101
Non-lysosomal glucosylceramidase0101
Multidrug transporter MdfA0202
Serine/threonine-protein kinase Chk20123
S-adenosylmethionine decarboxylase proenzyme0102
S-adenosylmethionine decarboxylase proenzyme0203
Chain A, Probable serine/threonine-protein kinase pknB0101
phospholipase A2, group III0101
rac GTPase-activating protein 1 isoform a0202
NEDD8-activating enzyme E1 regulatory subunit0011
NEDD8-activating enzyme E1 catalytic subunit0011
Leucine-rich repeat serine/threonine-protein kinase 20011
Mitogen-activated protein kinase kinase kinase 140101
Nuclear receptor corepressor 10303
Nuclear receptor corepressor 20404
Kinesin-like protein KIF110101
Kinesin-like protein KIFC10101
Leukotriene C4 synthase0101
Cysteinyl leukotriene receptor 10101
Cysteinyl leukotriene receptor 20101
Protein E60303
Islet amyloid polypeptide0101
Low molecular weight phosphotyrosine protein phosphatase0101
DNA-3-methyladenine glycosylase0101
Solute carrier family 22 member 120101
Solute carrier family 22 member 120404
Class A sortase SrtA 0101
Acyl-CoA desaturase 10202
Mu-type opioid receptor0101
DNA gyrase subunit B0101
Melanocortin receptor 30011
Melanocortin receptor 30123
Melanocortin receptor 50112
Melanocortin receptor 40123
Melanocyte-stimulating hormone receptor0213
Melanocyte-stimulating hormone receptor0112
5-hydroxytryptamine receptor 1B0202
Chain A, Inosine-5'-Monophosphate Dehydrogenase 20101
Inosine-5'-monophosphate dehydrogenase0102
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-10101
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-10101
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-10101
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-10101
Chain A, Pancreatic alpha-amylase0101
Chain A, Pancreatic alpha-amylase0101
DNA dC->dU-editing enzyme APOBEC-3A isoform a0101
Tyrosine-protein kinase transforming protein Fps0101
Solute carrier family 2, facilitated glucose transporter member 20202
Solute carrier family 2, facilitated glucose transporter member 4 0202
DNA primase TraC0101
2-5A-dependent ribonuclease0203
ELAV-like protein 30202
Aldo-keto reductase family 1 member C210303
Toll-like receptor 20202
Dynamin-10101
Calcium/calmodulin-dependent protein kinase II inhibitor 20101
cAMP-dependent protein kinase type I-alpha regulatory subunit [Cleaved into: cAMP-dependent protein kinase type I-alpha regulatory subunit, N-terminally processed]0101
Carboxypeptidase B20202
Prostaglandin E synthase0101
potassium voltage-gated channel subfamily KQT member 1 isoform 10011
potassium voltage-gated channel subfamily E member 10011
potassium voltage-gated channel subfamily KQT member 4 isoform a0011
potassium voltage-gated channel subfamily KQT member 30011
electroneutral potassium-chloride cotransporter KCC20112
solute carrier family 12 member 2 isoform 10101
Solute carrier family 12 member 50101
Sialidase-40101
Sialidase-10101
Sialidase-30101
Formyl peptide receptor-related sequence 10011
fMet-Leu-Phe receptor0325
FML2_HUMAN 0011
Chain A, Venom Allergen 20011
Muscarinic acetylcholine receptor 0011
Muscarinic acetylcholine receptor 0101
FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE)0001
Acid ceramidase0202
Glucose-dependent insulinotropic receptor0011
Glucose-dependent insulinotropic receptor0011
Chain A, PROTEIN (5-AMINOLAEVULINIC ACID DEHYDRATASE)0101
N(G),N(G)-dimethylarginine dimethylaminohydrolase 10002
N(G),N(G)-dimethylarginine dimethylaminohydrolase 10001
Adenosine receptor A10112
Chain B, Exotoxin A0011
Chain B, Exotoxin A0011
Chain B, Exotoxin A0011
Chain A, Hth-type Transcriptional Regulator Ttgr0011
Chain A, Hth-type Transcriptional Regulator Ttgr0011
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Neuromedin-K receptor0145
Substance-K receptor0246
Neuromedin-K receptor08412
Substance-K receptor0303
Substance-K receptor0303
Neuromedin-K receptor0213
Neurotensin receptor type 10011
Neurotensin receptor type 20113
Myelin basic protein0011
Neurotensin receptor type 10112
Neurotensin receptor type 10225
Neurotensin receptor type 20213
Sortilin0101
Chain B, Hiv-1 Reverse Transcriptase0101
Chain A, Hiv-1 Reverse Transcriptase0101
Chain A, Hiv-1 Reverse Transcriptase0101
Chain A, Hiv-1 Reverse Transcriptase0101
Chain B, Hiv-1 Reverse Transcriptase0101
Chain A, Reverse transcriptase/ribonuclease H0101
Gag-Pol polyprotein0101
Gag-Pol polyprotein0202
Gag-Pol polyprotein0303
Imidazoleglycerol-phosphate dehydratase0101
Ryanodine receptor 10101
Microsomal triglyceride transfer protein large subunit0101
Exoribonuclease H 0101
Cardiac ryanodine receptor 2 0101
Fructose-1,6-bisphosphatase 1 0001
Reverse transcriptase 0112
Cholesteryl ester transfer protein0314
Hydroxycarboxylic acid receptor 30011
Nicotinamidase0101
Hydroxycarboxylic acid receptor 20011
Hydroxycarboxylic acid receptor 20213
Hydroxycarboxylic acid receptor 20112
Chain A, NAD-dependent deacetylase0101
NAD-dependent protein deacetylase HST20202
NAD(+) hydrolase SARM10101
NAD-dependent protein deacetylase sirtuin-20213
NAD-dependent protein deacetylase sirtuin-60101
NAD-dependent protein deacetylase sirtuin-10215
NAD-dependent protein deacetylase 0101
Equilibrative nucleoside transporter 10101
Neuronal acetylcholine receptor subunit alpha-40213
Neuronal acetylcholine receptor subunit alpha-40101
Acetylcholine receptor subunit beta-like 20202
Neuronal acetylcholine receptor subunit alpha-50022
Neuronal acetylcholine receptor subunit alpha-70303
Acetylcholine-binding protein0112
Neuronal acetylcholine receptor subunit beta-30112
Neuronal acetylcholine receptor subunit alpha-60112
Neuronal acetylcholine receptor subunit alpha-50202
Liver carboxylesterase B-10101
Neuronal acetylcholine receptor subunit beta-30202
Neuronal acetylcholine receptor subunit alpha-30202
Soluble acetylcholine receptor0101
Neuronal acetylcholine receptor subunit alpha-20202
Neuronal acetylcholine receptor subunit alpha-60202
Integrin beta0011
Glycoprotein IIb0011
Phospholipase A2, membrane associated0102
Voltage-dependent L-type calcium channel subunit alpha-1C0101
Voltage-dependent L-type calcium channel subunit alpha-1S0101
Voltage-dependent L-type calcium channel subunit alpha-1D0101
Voltage-dependent L-type calcium channel subunit alpha-1F0101
Chain A, Phospholipase A2 isoform 30011
Dihydroorotate dehydrogenase (quinone), mitochondrial0303
Voltage-dependent L-type calcium channel subunit beta-40202
Voltage-dependent P/Q-type calcium channel subunit alpha-1A0202
Voltage-dependent calcium channel gamma-3 subunit0202
Voltage-dependent L-type calcium channel subunit beta-30202
Voltage-dependent calcium channel subunit alpha-2/delta-10405
Voltage-dependent calcium channel gamma-7 subunit0202
Voltage-dependent L-type calcium channel subunit beta-10202
Voltage-dependent calcium channel gamma-1 subunit0202
Voltage-dependent L-type calcium channel subunit beta-20202
Voltage-dependent R-type calcium channel subunit alpha-1E0202
Voltage-dependent calcium channel subunit alpha-2/delta-40202
Voltage-dependent calcium channel subunit alpha-2/delta-30202
Voltage-dependent calcium channel gamma-8 subunit0202
Voltage-dependent calcium channel gamma-6 subunit0202
Voltage-dependent calcium channel subunit alpha-2/delta-20404
Voltage-dependent calcium channel gamma-4 subunit0202
Voltage-dependent calcium channel gamma-5 subunit0202
Voltage-dependent calcium channel gamma-2 subunit0202
Pyruvate-flavodoxin oxidoreductase0101
Anoctamin-10101
Sodium/iodide cotransporter0101
Lysine-specific demethylase 4C0404
G-protein coupled receptor 550202
Nitric oxide synthase, inducible0101
Nitric oxide synthase, brain0202
Nociceptin receptor0134
Corticotropin-releasing factor receptor 10001
Tubulin beta 8B0011
Ras-related C3 botulinum toxin substrate 10112
Ras-related C3 botulinum toxin substrate 10101
Methylated-DNA--protein-cysteine methyltransferase0102
Phosphotyrosine protein phosphatase 0101
Hemagglutinin [Cleaved into: Hemagglutinin HA1 chain; Hemagglutinin HA2 chain]0011
DNA polymerase beta0404
DNA polymerase beta0202
Receptor-type tyrosine-protein phosphatase F0202
Receptor-type tyrosine-protein phosphatase epsilon0202
Tyrosine-protein phosphatase non-receptor type 60303
M-phase inducer phosphatase 20202
Env polyprotein 0022
Transmembrane prolyl 4-hydroxylase0022
Chain A, Adipocyte Lipid-binding Protein0011
Chain A, MUSCLE FATTY ACID BINDING PROTEIN0022
Chain A, MUSCLE FATTY ACID BINDING PROTEIN0022
Chain A, MUSCLE FATTY ACID BINDING PROTEIN0022
putative potassium channel subunit0011
Sterol O-acyltransferase 10303
Glutathione hydrolase 1 proenzyme 0011
Bifunctional cytochrome P450/NADPH--P450 reductase0011
Bombesin receptor subtype-30011
WD repeat-containing protein 50202
Histone-lysine N-methyltransferase 2A0202
Cytosolic endo-beta-N-acetylglucosaminidase0101
Interleukin-6 receptor subunit alpha0101
Thyrotropin-releasing hormone receptor0101
Glycine receptor subunit alpha-40101
Leukotriene B4 receptor 10101
Phosphatidylserine lipase ABHD16A0101
Lipoprotein lipase0101
Hepatic triacylglycerol lipase0101
Pancreatic triacylglycerol lipase0101
Platelet-activating factor acetylhydrolase0304
Neutral cholesterol ester hydrolase 10101
Diacylglycerol lipase-alpha0101
Diacylglycerol lipase-beta0101
Acyl-protein thioesterase 20101
Endothelial lipase0101
Chain A, ARGINASE 10101
Chain A, Arginase 10101
Chain A, ARGINASE 10101
Chain A, L-ARGININE\\:GLYCINE AMIDINOTRANSFERASE0101
Solute carrier family 2, facilitated glucose transporter member 90224
Chain H, Igg2b-kappa 40-50 Fab (heavy Chain)0101
Chain L, Igg2b-kappa 40-50 Fab (light Chain)0101
Chain A, Na, K-ATPase alpha subunit0011
Kruppel-like factor 50101
Sodium/potassium-transporting ATPase subunit alpha-1 0101
Sodium/potassium-transporting ATPase subunit beta-30101
MecA 0101
Lysine-specific demethylase 6B0202
Kynurenine 3-monooxygenase0101
Lysine-specific demethylase 5C0101
Prolyl 4-hydroxylase subunit alpha-10202
Peptidyl-prolyl cis-trans isomerase A 0101
Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial0101
Lysine-specific demethylase 5D0101
Lysine-specific demethylase 5B0101
Lysine-specific demethylase 2A0101
Lysine-specific demethylase 3A0101
polyadenylate-binding protein 10202
MCOLN3 protein0011
transient receptor potential cation channel, subfamily N, member 10011
Alpha-1B adrenergic receptor0505
Alpha-2A adrenergic receptor0303
Microphthalmia-associated transcription factor0001
Oxytocin receptor0011
Phenylethanolamine N-methyltransferase0214
Chain A, Fatty acid-binding protein, adipocyte0101
Type II pantothenate kinase0001
Type III pantothenate kinase0001
Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A0101
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A 0202
Xaa-Pro dipeptidase0001
Photosystem I iron-sulfur center 0001
Beta-adrenergic receptor kinase 10101
Rhodopsin kinase GRK10101
G protein-coupled receptor kinase 50101
G protein-coupled receptor kinase 50101
Rhodopsin kinase GRK10123
Beta-adrenergic receptor kinase 10001
Dual specificity mitogen-activated protein kinase kinase 2 0101
Dual specificity mitogen-activated protein kinase kinase 1 0101
Beta-lactamase 10001
Beta-lactamase 0002
Chain A, CATHEPSIN D0101
Chain B, CATHEPSIN D0101
Chain A, PLASMEPSIN II0101
Chain E, ENDOTHIAPEPSIN0101
Chain E, RHIZOPUSPEPSIN0101
Chain E, ENDOTHIAPEPSIN0101
Chain E, ENDOTHIAPEPSIN0101
Chain E, RHIZOPUSPEPSIN0101
Chain E, RHIZOPUSPEPSIN0101
Pepsin A0202
Candidapepsin-20101
Pepsin A-50101
Gag-Pro polyprotein0101
Cathepsin E0101
Plasmepsin-10101
Plasmepsin-20101
Cathepsin D 0303
Disintegrin and metalloproteinase domain-containing protein 90101
Plasmepsin 4 0101
Cysteine protease0101
Aldehyde oxidase 10202
Aldehyde oxidase 10202
Chain A, Immunoglobulin0011
Chain B, Immunoglobulin0011
Muscarinic acetylcholine receptor M50113
Thymidylate synthase0101
Alkaline phosphatase, tissue-nonspecific isozyme 0101
Intestinal-type alkaline phosphatase0101
E3 ubiquitin-protein ligase XIAP0101
Chain A, PROTEIN (CATECHOL OXIDASE)0101
Protein kinase C alpha type0101
Proto-oncogene vav0011
Protein kinase C delta type0112
Chain A, Alkaline Phosphatase0101
Chain A, ALKALINE PHOSPHATASE0101
Fe(3+)-Zn(2+) purple acid phosphatase0101
Chain E, THERMOLYSIN0101
Chain E, Thermolysin0101
Thermolysin0202
Neprilysin0202
Growth factor receptor-bound protein 20001
Acetylcholinesterase0101
XBP10202
DNA damage-inducible transcript 3 protein0202
CDGSH iron-sulfur domain-containing protein 10202
Peroxisome proliferator-activated receptor gamma0101
Carnitine O-palmitoyltransferase 2, mitochondrial0202
CDGSH iron-sulfur domain-containing protein 20202
Peroxisomal sarcosine oxidase0001
Cytochrome P450 4B10202
Cytochrome P450 2A70202
Cytochrome P450 2F10202
Transcriptional enhancer factor TEF-10112
Cytochrome P450 2C180303
Cytochrome P450 4F80202
Cytochrome P450 4A110202
Cytochrome P450 4F30202
Transcriptional enhancer factor TEF-40101
Cytochrome P450 4A220202
Vitamin D 25-hydroxylase0202
Cytochrome P450 2U10202
Cytochrome P450 2W10202
Cytochrome P450 2S10202
Transcriptional enhancer factor TEF-50101
Cytochrome P450 3A43 0202
C-X-C chemokine receptor type 40101
Atypical chemokine receptor 30011
C-X-C chemokine receptor type 40204
Sodium/potassium/calcium exchanger 40112
Sodium/potassium/calcium exchanger 20112
karyopherin alpha 2 (RAG cohort 1, importin alpha 1), isoform CRA_b0011
Beta-casein0202
luciferase0001
Glutamine synthetase0011
Cholesterol 24-hydroxylase0202
Pannexin-10101
Pannexin-10101
Glutamate 5-kinase0001
Nuclear receptor subfamily 2 group E member 10033
Free fatty acid receptor 20011
Chain A, Ferritin light chain0011
Chain A, Ferritin light chain0011
Chain A, Ferritin light chain0011
Chain A, Ferritin light chain0011
Chain A, Ferritin light chain0011
Chain A, Ferritin light chain0011
Chain A, Ferritin light chain0011
Cholecystokinin receptor type A0336
Chain A, Protocatechuate 3,4-dioxygenase alpha chain0011
Chain B, Protocatechuate 3,4-dioxygenase beta chain0011
cathepsin L10202
3-dehydroquinate synthase0101
Puromycin-sensitive aminopeptidase0101
Chain A, PUTRESCINE-BINDING PROTEIN0011
Chain A, S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN0101
Chain B, S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN0101
Chain A, S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN0101
Chain B, S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN0101
Trans-sialidase0101
Trans-sialidase0101
P2X purinoceptor 30101
P2X purinoceptor 10101
P2Y purinoceptor 40044
P2X purinoceptor 70112
P2X purinoceptor 50101
P2X purinoceptor 40101
Chain A, 2,2-dialkylglycine decarboxylase0011
dual specificity protein phosphatase 30101
tyrosine-protein phosphatase non-receptor type 22 isoform 10101
Bifunctional dihydrofolate reductase-thymidylate synthase0101
Beta-hexosaminidase subunit alpha0102
Beta-hexosaminidase subunit beta0101
Dihydrofolate reductase0202
Bifunctional dihydrofolate reductase-thymidylate synthase0202
Bifunctional dihydrofolate reductase-thymidylate synthase0202
Multidrug and toxin extrusion protein 10101
Chain A, dATP pyrophosphohydrolase0101
Chain A, Adenylate cyclase type 50101
Chain B, Adenylate cyclase type 20101
Monocarboxylate transporter 20001
Monocarboxylate transporter 10102
C-terminal-binding protein 20101
Chain A, APH(2')-Id0101
glucose-6-phosphate dehydrogenase0101
Chymotrypsin-like elastase family member 10101
Epoxide hydrolase 1 0101
Aldo-keto reductase family 1 member A10202
Aldo-keto reductase family 1 member A10202
Aldo-keto reductase family 1 member B10101
Heat shock factor protein 10101
ELAV-like protein 10101
N0101
DNA-directed RNA polymerase subunit alpha0101
DNA-directed RNA polymerase subunit omega0101
DNA-directed RNA polymerase subunit beta'0101
DNA-directed RNA polymerase subunit beta0101
Phospholipase A2, membrane associated0101
Acidic phospholipase A2 20101
Multidrug resistance protein 1a0001
Advanced glycosylation end product-specific receptor0011
Advanced glycosylation end product-specific receptor0011
Dipeptidyl peptidase 40011
Chain A, Glutamate Receptor 20101
Chain A, Glutamate Receptor 20101
Prolyl 4-hydroxylase, beta polypeptide0001
Gastric inhibitory polypeptide receptor0101
Voltage-gated sodium channel Nav1.5 cardiac isoform 0101
Chromaffin granule amine transporter0101
Synaptic vesicular amine transporter0101
Chain A, Troponin C, slow skeletal and cardiac muscles0011
Aryl hydrocarbon receptor0101
DNA polymerase alpha catalytic subunit0101
N1L 0101
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR0011
Retinol-binding protein 40011
Beta-lactoglobulin0011
DNA (cytosine-5)-methyltransferase 3B0202
MSRA protein0101
plectin 10101
Thioredoxin reductase 1, cytoplasmic0101
Type 1 InsP3 receptor isoform S2 1001
Thioredoxin reductase 2, mitochondrial0101
Ribonuclease HI0101
Chain A, 6,7-Dimethyl-8-ribityllumazine Synthase0011
Chain B, 6,7-Dimethyl-8-ribityllumazine Synthase0011
Chain H, Immunoglobulin Igg1 Heavy chain0011
Chain L, Immunoglobulin Igg1 Lambda Light Chain0011
Chain A, DODECIN0011
Chain A, DODECIN0011
Chain C, DODECIN0011
Chain E, DODECIN0011
DNA-directed RNA polymerase subunit beta0101
NH(3)-dependent NAD(+) synthetase0202
Arylacetamide deacetylase0102
DNA-directed RNA polymerase subunit beta0101
Diacylglycerol kinase alpha0101
Chain A, HIV-1 PROTEASE0101
Chain B, HIV-1 PROTEASE0101
Chain A, POL polyprotein0101
Chain B, POL polyprotein0101
Chain A, POL polyprotein0101
Chain B, POL polyprotein0101
Chain A, Endothiapepsin0101
Chain A, Endothiapepsin0101
Thromboxane-A synthase0001
Chain A, Activated Factor Xa Heavy Chain0101
Prolyl endopeptidase0101
Prostaglandin G/H synthase 20101
Cytochrome c oxidase subunit 10101
Transporter0101
Sodium-dependent serotonin transporter0101
Retina-specific copper amine oxidase0101
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B0101
Phosphodiesterase 0101
Thrombin 0011
Transcription factor AP-10101
UDP-galactopyranose mutase0022
UDP-galactopyranose mutase0022
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial0101
Dihydroorotate dehydrogenase (fumarate)0101
Acyl carrier protein, mitochondrial0101
Dihydroorotate dehydrogenase 0101
Eukaryotic elongation factor 2 kinase0101
M-phase inducer phosphatase 10303
Receptor-type tyrosine-protein phosphatase eta0202
Receptor protein-tyrosine kinase 0202
RuvB-like 10101
Small conductance calcium-activated potassium channel protein 20202
Small conductance calcium-activated potassium channel protein 10202
Neuromedin-U receptor 20011
Leukotriene C4 synthase0022
Dual specificity mitogen-activated protein kinase kinase 70022
Inhibitor of nuclear factor kappa-B kinase subunit beta0023
Peripheral plasma membrane protein CASK0022
Inhibitor of nuclear factor kappa-B kinase subunit alpha0022
Mitogen-activated protein kinase kinase kinase 130022
Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma0022
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma0022
Cyclin-dependent kinase-like 50033
Serine/threonine-protein kinase OSR10022
Low-density lipoprotein receptor0101
Fibronectin0101
Macrophage colony-stimulating factor 1 receptor0101
Wee1-like protein kinase 20022
Uncharacterized serine/threonine-protein kinase SBK30022
Serine/threonine-protein kinase MAK0022
Receptor tyrosine-protein kinase erbB-30022
G protein-coupled receptor kinase 40022
Megakaryocyte-associated tyrosine-protein kinase0022
Serine/threonine-protein kinase Nek40022
Hormonally up-regulated neu tumor-associated kinase0022
Receptor-interacting serine/threonine-protein kinase 40022
Cell division control protein 2 homolog0022
Serine/threonine-protein kinase PknB0022
Cyclin-dependent kinase-like 10022
Mitogen-activated protein kinase kinase kinase 120022
Serine/threonine-protein kinase PRP4 homolog0022
Serine/threonine-protein kinase 380022
Receptor tyrosine-protein kinase erbB-40022
Serine/threonine-protein kinase SBK10022
Mitogen-activated protein kinase kinase kinase 190022
Dual serine/threonine and tyrosine protein kinase0022
Mitogen-activated protein kinase kinase kinase 150022
Serine/threonine-protein kinase VRK20022
Homeodomain-interacting protein kinase 10022
Cyclin-dependent kinase-like 30022
Serine/threonine-protein kinase NIM10022
Serine/threonine-protein kinase ULK20022
Proprotein convertase subtilisin/kexin type 90101
Homeodomain-interacting protein kinase 40022
Serine/threonine-protein kinase Nek110022
Serine/threonine-protein kinase 350022
Rhodopsin kinase GRK70022
Serine/threonine-protein kinase 32A0022
Cyclin-dependent kinase-like 20022
Serine/threonine-protein kinase Sgk30022
Serine/threonine-protein kinase RIO20022
Transient receptor potential cation channel subfamily M member 60022
Homeodomain-interacting protein kinase 20022
Homeodomain-interacting protein kinase 30022
SNF-related serine/threonine-protein kinase0022
STE20/SPS1-related proline-alanine-rich protein kinase0022
SRSF protein kinase 30022
Microtubule-associated serine/threonine-protein kinase 10022
NS5 0123
Chain A, ADENINE-N6-DNA-METHYLTRANSFERASE TAQI0011
Chain A, Adenine-n6-dna-methyltransferase Taqi0011
Chain A, Histamine N-Methyltransferase0101
Chain A, Histamine N-Methyltransferase0101
Chain A, Modification Methylase Rsri0011
Chain A, Modification Methylase Rsri0011
Chain A, Ermc' Methyltransferase0101
Chain A, Ermc' Rrna Methyltransferase0101
Chain A, Uroporphyrin-III C-methyltransferase0101
Chain B, ADENINE-N6-DNA-METHYLTRANSFERASE TAQI0011
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase0011
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase0011
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase0011
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase0011
tRNA (cytosine(38)-C(5))-methyltransferase0112
Histone-lysine N-methyltransferase SUV39H10202
Adenosylhomocysteinase0001
Protein arginine N-methyltransferase 30101
Indolethylamine N-methyltransferase0101
Histone-lysine N-methyltransferase NSD20101
Adenosylhomocysteinase0001
rRNA adenine N-6-methyltransferase0101
tRNA (guanine-N(1)-)-methyltransferase0011
Histone-lysine N-methyltransferase SETDB10101
Retinoblastoma-binding protein 50101
Histone-lysine N-methyltransferase EZH20202
tRNA (guanine-N(1)-)-methyltransferase0011
N6-adenosine-methyltransferase catalytic subunit0101
Histone-arginine methyltransferase CARM10101
Histone-lysine N-methyltransferase KMT5C0101
Histone-lysine N-methyltransferase EZH10101
Methylosome protein 500112
Protein dpy-30 homolog0101
Histamine N-methyltransferase0001
Histone-lysine N-methyltransferase SUV39H20101
tRNA (guanine-N(1)-)-methyltransferase0011
N-lysine methyltransferase SMYD20101
Protein arginine N-methyltransferase 70101
Set1/Ash2 histone methyltransferase complex subunit ASH20101
Non-structural protein 1 0101
Met repressor 0022
Histone H3K27 methylase0001
Protein-L-isoaspartate(D-aspartate) O-methyltransferase0101
Catechol O-methyltransferase0001
Aspartate-semialdehyde dehydrogenase0101
RmtA0202
Chain A, Lysr-type Regulatory Protein0011
Chain A, Lysr-type Regulatory Protein0011
Chain A, Lysr-type Regulatory Protein0011
Chain A, 146aa long hypothetical transcriptional regulator0011
Chain A, Anthranilate phosphoribosyltransferase0101
Chain A, Anthranilate phosphoribosyltransferase0101
Chain A, Anthranilate phosphoribosyltransferase0101
Chain B, Anthranilate phosphoribosyltransferase0101
Chain C, Anthranilate phosphoribosyltransferase0101
Chain A, Anthranilate phosphoribosyltransferase0101
Anthranilate phosphoribosyltransferase0101
Tyrosine-protein phosphatase YopH0101
Ubiquitin-like domain-containing CTD phosphatase 10101
Bromodomain testis-specific protein0101
Tau-tubulin kinase 10101
Tau-tubulin kinase 20101
Chain A, Erk20101
Mitogen-activated protein kinase 20101
Mitogen-activated protein kinase 14 0112
Transient receptor potential cation channel subfamily M member 10101
Adenylate cyclase type 60101
Adenylate cyclase type 3 0101
Adenylate cyclase type 90101
D(1) dopamine receptor0101
Adenylate cyclase type 70101
Adenylate cyclase type 20101
Adenylate cyclase type 40101
Type-1 angiotensin II receptor0101
Transcriptional activator protein LuxR0303
Chain A, Shikimate kinase0011
Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase0101
Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase0101
Cholecystokinin receptor type A0101
Eukaryotic translation initiation factor 4E0011
Peptidyl-prolyl cis-trans isomerase FKBP1A0101
Peptidyl-prolyl cis-trans isomerase FKBP1B0022
Uncharacterized aarF domain-containing protein kinase 50011
Programmed cell death protein 40112
Serine/threonine-protein kinase mTOR 0101
D(3) dopamine receptor isoform e2002
Somatostatin receptor type 50101
Somatostatin receptor type 10101
Somatostatin receptor type 20101
Somatostatin receptor type 30101
Somatostatin receptor type 50101
Somatostatin receptor type 4 0101
Sulfate anion transporter 10001
C-X-C chemokine receptor type 5 isoform 10101
C-C chemokine receptor type 60101
Endoglycoceramidase II 0001
cAMP-dependent protein kinase catalytic subunit alpha 0101
Sphingosine 1-phosphate receptor 20112
Sphingosine 1-phosphate receptor 40112
Sphingosine 1-phosphate receptor 30112
Sphingosine 1-phosphate receptor 50112
alternatively spliced Trp40011
5-hydroxytryptamine receptor 1E0101
sphingosine 1-phosphate receptor 30101
D(3) dopamine receptor0101
5-hydroxytryptamine receptor 7 0101
D(4) dopamine receptor0101
D(1B) dopamine receptor0101
Chain A, Mineralocorticoid receptor0101
Chain A, Mineralocorticoid receptor0101
Orexin receptor type 10001
Cathepsin B0101
Chain A, Ribosomal protein S6 kinase alpha-10101
Chain X, Tyrosine-protein kinase Lyn0101
Chain A, Dual specificity protein kinase TTK0011
Chain A, Dual specificity protein kinase TTK0011
G1/S-specific cyclin-E20101
Zinc finger protein GLI10101
Zinc finger protein GLI20101
Glycine receptor subunit beta0101
Growth hormone secretagogue receptor type 10011
NADP-dependent malic enzyme, mitochondrial0001
Solute carrier family 13 member 30101
[tau protein] kinase 0101
Chain A, MALTOPORIN0011
Chain B, MALTOPORIN0011
ATP-dependent 6-phosphofructokinase0202
Dihydropteroate synthase0202
Protein argonaute-20011
Chain A, Glutathione S-transferase0101
Fibroblast growth factor 10011
Transcriptional activator protein LasR0101
Protein arginine N-methyltransferase 60101
Transcription regulator protein BACH10101
Transcription factor MafK 0101
D(2) dopamine receptor0101
Chain A, Carbonic anhydrase 20101
Carboxypeptidase M0101
5-hydroxytryptamine receptor 1B0101
Ectonucleoside triphosphate diphosphohydrolase 20101
Ectonucleoside triphosphate diphosphohydrolase 10101
Dual specificity protein phosphatase 50101
Ectonucleoside triphosphate diphosphohydrolase 80101
Ectonucleoside triphosphate diphosphohydrolase 3 0101
Chain A, ACETYLCHOLINESTERASE0101
Chain A, liver Carboxylesterase I0101
Gastrotropin0011
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform0202
Splicing factor 3B subunit 30101
Chain A, CES1 protein0101
Phospholipase D1 0101
Phospholipase D10101
Emopamil-binding protein-like0202
7-dehydrocholesterol reductase0112
Corticotropin releasing hormone receptor 20101
Lysine-specific demethylase 4B0101
ATP-dependent molecular chaperone HSC820101
Heat-shock protein0101
Putative heat shock protein HSP 90-alpha A40101
RAD510101
Polycomb protein SUZ120101
Disks large homolog 40101
Sodium/bile acid cotransporter0001
Ileal sodium/bile acid cotransporter0001
Ileal sodium/bile acid cotransporter0001
Solute carrier organic anion transporter family member 4A10002
Bile salt export pump0001
Cytochrome P450 14alpha-demethylase0011
NS3 protease 0203
Cathepsin L20101
Cathepsin S0102
Cathepsin K0202
NS3 protease 0101
Cathepsin F0101
Chymotrypsin-like elastase family member 10101
Peroxisome proliferator-activated receptor delta0011
Tetracycline resistance protein, class B0001
Neutrophil collagenase0101
Ras guanyl-releasing protein 30011
Solute carrier family 22 member 30001
Solute carrier family 22 member 40001
DNA-binding protein Ikaros0001
DNA damage-binding protein 10112
Chain A, ykoF0011
Chain B, ykoF0011
Chain A, ThiT0011
Thiamine transporter ThiT0011
Transketolase0011
Thiamine-binding periplasmic protein0011
1-deoxy-D-xylulose-5-phosphate synthase0011
1-deoxy-D-xylulose-5-phosphate synthase0011
Ubiquitin-like modifier activating enzyme 20101
SUMO1 activating enzyme subunit 10101
SUMO-conjugating enzyme UBC90101
Urease subunit alpha0101
Urease subunit beta 0101
Thymidine phosphorylase0001
Thymidine kinase, cytosolic 0003
Thymidine kinase 0204
Thymidine kinase0103
5'-3' exonuclease PLD30001
5'-3' exonuclease PLD40001
Chain A, Thymidylate Synthase0011
Thymidine phosphorylase0101
Chain A, ODORANT-BINDING PROTEIN0101
Chain A, ODORANT-BINDING PROTEIN0101
Chain B, Odorant-binding Protein0101
Chain A, ODORANT-BINDING PROTEIN0101
Chain A, ODORANT-BINDING PROTEIN0101
Chain A, ODORANT-BINDING PROTEIN0101
Chain X, Thyroid hormone receptor beta-10022
Chain X, Thyroid hormone receptor beta-10022
Proliferating cell nuclear antigen0202
Malate dehydrogenase, mitochondrial0101
Monocarboxylate transporter 80001
Solute carrier organic anion transporter family member 1C10001
P2Y purinoceptor 130101
Chain B, Protein farnesyltransferase beta subunit0101
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha0101
Protein farnesyltransferase subunit beta0101
Geranylgeranyl transferase type-1 subunit beta0101
Geranylgeranyl transferase type-1 subunit beta0101
Protein farnesyltransferase alpha subunit0101
CAAX farnesyltransferase subunit beta 0101
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha0011
Protein farnesyltransferase subunit beta0011
Chain A, Carbonic anhydrase 10101
Carbonic anhydrase 20101
Chain A, PLASMINOGEN0011
Chain A, PLASMINOGEN0011
REST corepressor 30202
Chain A, Nuclear Receptor ROR-beta0101
Nuclear receptor ROR-alpha0101
Nuclear receptor ROR-beta0101
Chain A, PAPAIN1001
Janus kinase 2 (a protein tyrosine kinase)0101
Cathepsin G0101
Chain A, enoyl-acyl carrier reductase0101
Chain C, enoyl-acyl carrier reductase0101
Chain A, enoyl-acyl carrier reductase0101
Chain C, enoyl-acyl carrier reductase0101
Chain A, enoyl-acyl carrier reductase0101
Chain C, enoyl-acyl carrier reductase0101
Chain A, Repressor0011
twin arginine protein translocation system - TatA protein0002
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI0101
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI0101
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI0202
Enoyl-acyl carrier reductase0101
Enoyl-ACP reductase II 0101
Chain A, Dihydrofolate Reductase0011
Chain A, Dihydrofolate reductase0101
Chain A, dihydrofolate reductase (DHFR)0101
Chain A, Dihydrofolate reductase0101
Chain A, Dihydrofolate reductase0101
Dihydrofolate reductase 0102
Dihydrofolate reductase type 10102
Dihydrofolate reductase0101
Dihydrofolate reductase0101
Dihydrofolate reductase type 1 from Tn40030101
Bifunctional dihydrofolate reductase-thymidylate synthase0101
Dihydrofolate reductase0101
Dihydrofolate reductase0101
Dihydrofolate reductase 0101
Dihydrofolate reductase 0101
Proteinase-activated receptor 20101
Chain A, CARBONIC ANHYDRASE II0101
Strictosidine synthase0001
Chain A, Trp Rna-binding Attenuation Protein0011
Chain K, Trp Rna-binding Attenuation Protein0011
Chain B, tryptophanyl-tRNA synthetase0011
Chain C, Tryptophanyl-tRNA synthetase II0011
Tryprostatin B synthase0001
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase0011
Trp operon repressor0011
Aspartyl/asparaginyl beta-hydroxylase0101
HD2 type histone deacetylase HDA106 0404
Chain A, Purine nucleoside phosphorylase0101
Chain A, Purine nucleoside phosphorylase DeoD-type0101
MSH0001
guanine nucleotide-binding protein subunit alpha-150112
trace amine-associated receptor 10112
Chain A, CHORISMATE MUTASE0101
Chain A, TYROSYL-tRNA SYNTHETASE0011
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Uracil-DNA Glycosylase0101
Coagulation factor XIII A chain0101
Fatty-acid amide hydrolase 20101
CAD protein0001
Chain A, Cytidine Deaminase0101
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit0101
Seminal ribonuclease0101
Ribonucleoside-diphosphate reductase subunit M20001
P2Y purinoceptor 140011
P2Y purinoceptor 60011
Ribonucleoside-diphosphate reductase subunit M2 B0001
P2Y purinoceptor 40011
N-acetyllactosaminide alpha-1,3-galactosyltransferase0101
P2Y purinoceptor 2 0112
P2Y purinoceptor 20011
Basic phospholipase A2 10101
Hemagglutinin0011
Basic phospholipase A2 PLA-A0101
Acidic phospholipase A2 EC-I0101
Ubiquitin carboxyl-terminal hydrolase 70101
Ubiquitin carboxyl-terminal hydrolase 470101
Sentrin-specific protease 10101
Valacyclovir hydrolase0001
Chain A, Arginase 10101
Aldo-keto reductase family 1 member A10101
Aldo-keto reductase family 1 member B70101
D-alanyl-D-alanine dipeptidase0101
Transcription intermediary factor 1-alpha0101
E3 ubiquitin-protein ligase TRIM330101
Glycoprotein0101
Aldehyde oxidase 10101
Ubiquitin carboxyl-terminal hydrolase isozyme L10101
Ubiquitin carboxyl-terminal hydrolase isozyme L30101
Dual specificity protein phosphatase 10101
M-phase inducer phosphatase 30101
Dual specificity protein phosphatase 60101
Chain A, Histone deacetylase-like amidohydrolase0101
Chain A, Histone deacetylase-like amidohydrolase0101
Histone deacetylase 80101
Histone deacetylase 0101
Gli10101
protein Wnt-3a precursor0101
Histone deacetylase 10202
Protein Tat0011
Leukotriene A-4 hydrolase0101
Apoptosis regulator BAX 0011
Histone deacetylase 10101
Histone deacetylase 0101
Renin0101
Histone deacetylase 30101
Histone deacetylase-like amidohydrolase0213
Histone deacetylase 0101
Histone deacetylase 70101
Histone deacetylase 6 0101
Histone deacetylase 40101
Histone deacetylase 0101
Histone deacetylase 60101
Histone deacetylase 0101
metabotropic glutamate receptor 5 precursor0101
Vitamin K epoxide reductase complex subunit 1-like protein 10101
Vitamin K epoxide reductase complex subunit 10101
Vitamin K epoxide reductase complex subunit 1-like protein 10101
Vitamin K epoxide reductase complex subunit 1 0202
Ectonucleoside triphosphate diphosphohydrolase 10001
Amine oxidase [flavin-containing]0101
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]